1	Journal	NNP	O	Journal	_	0	SENT_1	[p1l41t81r128b109],
2	of	IN	O	of	_	0	SENT_1	[p1l138t81r164b103],
3	the	DT	O	the	det	5	SENT_1	[p1l171t81r207b103],
4	American	NNP	ORGANIZATION	American	nn	5	SENT_1	[p1l217t81r333b103],
5	College	NNP	ORGANIZATION	College	prep_of	1	SENT_1	[p1l344t81r432b111],
6	of	IN	ORGANIZATION	of	_	0	SENT_1	[p1l443t81r470b103],
7	Cardiology	NNP	ORGANIZATION	Cardiology	nn	8	SENT_1	[p1l477t81r607b111],
8	Vol	NNP	ORGANIZATION	Vol	prep_of	1	SENT_1	[p1l1854t81r1902b103],
9	.	.	O	.	_	0	SENT_1	[p1l1854t81r1902b103],

1	55	CD	NUMBER	55	_	0	SENT_2	[p1l1914t81r1948b108],
2	,	,	O	,	_	0	SENT_2	[p1l1914t81r1948b108],
3	No.	NN	O	no.	appos	1	SENT_2	[p1l1960t81r2003b103],
4	22	CD	NUMBER	22	num	3	SENT_2	[p1l2014t82r2049b108],
5	,	,	O	,	_	0	SENT_2	[p1l2014t82r2049b108],
6	2010	CD	DATE	2010	num	7	SENT_2	[p1l2061t82r2118b104],
7	©	CD	DATE	©	appos	1	SENT_2	[p1l44t114r66b137],
8	2010	CD	DATE	2010	dep	29	SENT_2	[p1l77t116r135b137],
9	by	IN	O	by	_	0	SENT_2	[p1l145t115r173b144],
10	the	DT	O	the	det	12	SENT_2	[p1l183t115r219b137],
11	American	NNP	ORGANIZATION	American	nn	12	SENT_2	[p1l229t114r344b137],
12	College	NNP	ORGANIZATION	College	prep_by	8	SENT_2	[p1l356t114r444b144],
13	of	IN	ORGANIZATION	of	_	0	SENT_2	[p1l455t114r482b137],
14	Cardiology	NNP	ORGANIZATION	Cardiology	nn	16	SENT_2	[p1l489t114r619b144],
15	Foundation	NNP	ORGANIZATION	Foundation	nn	16	SENT_2	[p1l628t114r765b137],
16	ISSN	NNP	ORGANIZATION	ISSN	prep_of	12	SENT_2	[p1l1824t114r1889b137],
17	0735-1097	CD	DURATION	0735-1097	num	16	SENT_2	[p1l1901t114r2118b138],
18	/	:	O	/	punct	19	SENT_2	[p1l1901t114r2118b138],
19	$	$	MONEY	$	dep	12	SENT_2	[p1l1901t114r2118b138],
20	36.00	CD	MONEY	36.00	num	19	SENT_2	[p1l1901t114r2118b138],
21	Published	VBN	O	publish	partmod	19	SENT_2	[p1l44t148r159b170],
22	by	IN	O	by	_	0	SENT_2	[p1l169t148r197b177],
23	Elsevier	NNP	ORGANIZATION	Elsevier	nn	24	SENT_2	[p1l207t148r300b170],
24	Inc.	NNP	ORGANIZATION	Inc.	agent	21	SENT_2	[p1l310t148r353b170],
25	doi	FW	O	doi	dep	24	SENT_2	[p1l1758t148r2117b177],
26	:10.1016	CD	NUMBER	:10.1016	dep	25	SENT_2	[p1l1758t148r2117b177],
27	/	:	O	/	punct	19	SENT_2	[p1l1758t148r2117b177],
28	j.	NN	O	j.	nn	29	SENT_2	[p1l1758t148r2117b177],
29	jacc	NN	O	jacc	rcmod	7	SENT_2	[p1l1758t148r2117b177],
30	.2010.02.031	CD	NUMBER	.2010.02.031	dep	29	SENT_2	[p1l1758t148r2117b177],

1	CLINICAL	JJ	O	clinical	amod	4	SENT_3	[p1l73t236r256b266],
2	RESEARCH	NNP	O	RESEARCH	nn	4	SENT_3	[p1l272t236r485b266],
3	Interventional	NNP	O	Interventional	nn	4	SENT_3	[p1l1583t236r1860b266],
4	Cardiology	NNP	O	Cardiology	_	0	SENT_3	[p1l1878t236r2089b273],

1	Impact	NN	O	impact	_	0	SENT_4	[p1l122t358r338b427],
2	of	IN	O	of	_	0	SENT_4	[p1l366t357r427b416],
3	Cytochrome	NN	O	cytochrome	nn	5	SENT_4	[p1l453t357r828b427],
4	P450	NN	O	p450	nn	5	SENT_4	[p1l859t357r1026b416],
5	2C19	NN	O	2c19	prep_of	1	SENT_4	[p1l1055t357r1224b416],
6	Loss-of-Function	NNP	O	Loss-of-Function	nn	7	SENT_4	[p1l1255t357r1776b416],
7	Polymorphism	NN	O	polymorphism	dep	1	SENT_4	[p1l122t458r564b527],
8	and	CC	O	and	_	0	SENT_4	[p1l594t458r707b516],
9	of	IN	O	of	_	0	SENT_4	[p1l738t457r799b516],
10	Major	JJ	MISC	major	amod	12	SENT_4	[p1l828t458r1009b527],
11	Demographic	JJ	MISC	demographic	amod	12	SENT_4	[p1l1038t458r1451b527],
12	Characteristics	NNS	MISC	characteristic	prep_of	13	SENT_4	[p1l119t557r599b616],
13	on	IN	O	on	dep	1	SENT_4	[p1l627t574r700b616],
14	Residual	JJ	O	residual	amod	16	SENT_4	[p1l733t558r996b616],
15	Platelet	NN	O	platelet	nn	16	SENT_4	[p1l1029t558r1269b616],
16	Function	NN	O	function	pobj	13	SENT_4	[p1l1299t558r1568b616],

1	After	IN	O	after	_	0	SENT_5	[p1l117t657r274b716],
2	Loading	VBG	O	load	pobj	1	SENT_5	[p1l304t658r552b727],
3	and	CC	O	and	_	0	SENT_5	[p1l578t658r690b716],
4	Maintenance	NNP	O	Maintenance	nn	5	SENT_5	[p1l724t658r1129b716],
5	Treatment	NNP	O	Treatment	conj_and	2	SENT_5	[p1l1155t658r1481b716],
6	With	IN	O	with	_	0	SENT_5	[p1l1508t658r1651b716],
7	Clopidogrel	NNP	O	Clopidogrel	prep_with	5	SENT_5	[p1l119t757r474b827],
8	in	IN	O	in	_	0	SENT_5	[p1l507t758r559b815],
9	Patients	NNPS	O	Patients	prep_in	7	SENT_5	[p1l592t758r849b816],
10	Undergoing	VBG	O	undergo	partmod	5	SENT_5	[p1l880t758r1239b827],
11	Elective	JJ	O	elective	amod	14	SENT_5	[p1l1268t758r1508b816],
12	Coronary	JJ	O	coronary	amod	14	SENT_5	[p1l119t857r405b927],
13	Stent	NN	O	stent	nn	14	SENT_5	[p1l430t857r597b916],
14	Placement	NNP	O	Placement	dobj	10	SENT_5	[p1l628t858r958b916],

1	Willibald	NNP	PERSON	Willibald	nn	4	SENT_6	[p1l117t1003r292b1038],
2	Hochholzer	NNP	PERSON	Hochholzer	nn	4	SENT_6	[p1l309t1003r537b1045],
3	,	,	O	,	_	0	SENT_6	[p1l309t1003r537b1045],
4	MD	NNP	O	MD	_	0	SENT_6	[p1l554t1003r685b1045],
5	,	,	O	,	_	0	SENT_6	[p1l554t1003r685b1045],
6	*	CD	NUMBER	*	num	7	SENT_6	[p1l554t1003r685b1045],
7	IlI	NN	O	ili	dep	25	SENT_6	[p1l554t1003r685b1045],
8	Dietmar	NNP	PERSON	Dietmar	nn	9	SENT_6	[p1l703t1003r858b1037],
9	Trenk	NNP	PERSON	Trenk	dep	7	SENT_6	[p1l872t1002r996b1045],
10	,	,	O	,	_	0	SENT_6	[p1l872t1002r996b1045],
11	PHD	NNP	O	PHD	appos	9	SENT_6	[p1l1015t1003r1134b1045],
12	,	,	O	,	_	0	SENT_6	[p1l1015t1003r1134b1045],
13	*	CD	NUMBER	*	num	16	SENT_6	[p1l1015t1003r1134b1045],
14	Martin	NNP	PERSON	Martin	nn	16	SENT_6	[p1l1150t1003r1280b1037],
15	F.	NNP	PERSON	F.	nn	16	SENT_6	[p1l1297t1003r1332b1037],
16	Fromm	NNP	PERSON	Fromm	appos	9	SENT_6	[p1l1352t1003r1500b1045],
17	,	,	O	,	_	0	SENT_6	[p1l1352t1003r1500b1045],
18	MD	NNP	O	MD	appos	9	SENT_6	[p1l1517t1003r1633b1045],
19	,	,	O	,	_	0	SENT_6	[p1l1517t1003r1633b1045],
20	'	''	O	'	_	0	SENT_6	[p1l1517t1003r1633b1045],
21	l	NN	O	l	tmod	9	SENT_6	[p1l1517t1003r1633b1045],
22	‘	CD	NUMBER	‘	dep	25	SENT_6	[p1l1517t1003r1633b1045],
23	Christian	NNP	PERSON	Christian	nn	25	SENT_6	[p1l120t1059r291b1093],
24	M.	NNP	PERSON	M.	nn	25	SENT_6	[p1l307t1059r361b1093],
25	Valina	NNP	PERSON	Valina	dep	31	SENT_6	[p1l380t1059r509b1101],
26	,	,	O	,	_	0	SENT_6	[p1l380t1059r509b1101],
27	MD	NNP	O	MD	appos	25	SENT_6	[p1l526t1059r634b1101],
28	,	,	O	,	_	0	SENT_6	[p1l526t1059r634b1101],
29	*	CD	NUMBER	*	appos	25	SENT_6	[p1l526t1059r634b1101],
30	Christian	JJ	PERSON	christian	amod	31	SENT_6	[p1l652t1059r823b1093],
31	Stratz	NNP	PERSON	Stratz	dep	4	SENT_6	[p1l842t1059r958b1101],
32	,	,	O	,	_	0	SENT_6	[p1l842t1059r958b1101],
33	MD	NNP	O	MD	appos	31	SENT_6	[p1l976t1059r1084b1101],
34	,	,	O	,	_	0	SENT_6	[p1l976t1059r1084b1101],
35	*	CD	NUMBER	*	num	37	SENT_6	[p1l976t1059r1084b1101],
36	Hans-Peter	NNP	PERSON	Hans-Peter	nn	37	SENT_6	[p1l1101t1059r1315b1093],
37	Bestehorn	NNP	PERSON	Bestehorn	appos	31	SENT_6	[p1l1332t1059r1528b1101],
38	,	,	O	,	_	0	SENT_6	[p1l1332t1059r1528b1101],
39	MD	NNP	O	MD	appos	31	SENT_6	[p1l1545t1059r1653b1101],
40	,	,	O	,	_	0	SENT_6	[p1l1545t1059r1653b1101],
41	*	CD	NUMBER	*	num	44	SENT_6	[p1l1545t1059r1653b1101],
42	Heinz	NNP	PERSON	Heinz	nn	44	SENT_6	[p1l120t1115r234b1149],
43	Joachim	NNP	PERSON	Joachim	nn	44	SENT_6	[p1l245t1115r398b1159],
44	Bﬁttner	NNP	PERSON	Bﬁttner	appos	31	SENT_6	[p1l415t1115r566b1157],
45	,	,	O	,	_	0	SENT_6	[p1l415t1115r566b1157],
46	MD	NNP	O	MD	appos	31	SENT_6	[p1l584t1115r692b1157],
47	,	,	O	,	_	0	SENT_6	[p1l584t1115r692b1157],
48	*	CD	NUMBER	*	num	49	SENT_6	[p1l584t1115r692b1157],
49	Franz	NNP	O	Franz	appos	31	SENT_6	[p1l709t1115r927b1159],
50	—	CD	NUMBER	—	num	49	SENT_6	[p1l709t1115r927b1159],
51	]	CD	NUMBER	]	num	53	SENT_6	[p1l709t1115r927b1159],
52	osef	NN	O	osef	nn	53	SENT_6	[p1l709t1115r927b1159],
53	Neumann	NNP	PERSON	Neumann	dep	49	SENT_6	[p1l937t1115r1130b1157],
54	,	,	O	,	_	0	SENT_6	[p1l937t1115r1130b1157],
55	MD	NNP	O	MD	nn	59	SENT_6	[p1l1148t1115r1245b1149],
56	*	NNP	O	*	nn	59	SENT_6	[p1l1148t1115r1245b1149],
57	Baa	NNP	O	Baa	nn	59	SENT_6	[p1l119t1173r193b1205],
58	’	NNP	O	’	nn	59	SENT_6	[p1l119t1173r193b1205],
59	Krozingen	NNP	O	Krozingen	appos	31	SENT_6	[p1l205t1172r387b1218],
60	and	CC	O	and	_	0	SENT_6	[p1l405t1173r474b1205],
61	Erlangen	NNP	LOCATION	Erlangen	nn	63	SENT_6	[p1l485t1173r655b1218],
62	,	,	O	,	_	0	SENT_6	[p1l485t1173r655b1218],
63	Germany	NNP	LOCATION	Germany	appos	31	SENT_6	[p1l679t1172r847b1218],
64	;	:	O	;	_	0	SENT_6	[p1l679t1172r847b1218],
65	anal	JJ	O	anal	amod	66	SENT_6	[p1l865t1173r934b1205],
66	Boston	NNP	LOCATION	Boston	dep	4	SENT_6	[p1l945t1173r1069b1210],
67	,	,	O	,	_	0	SENT_6	[p1l945t1173r1069b1210],
68	Massachusetts	NNP	LOCATION	Massachusetts	appos	66	SENT_6	[p1l1088t1173r1330b1206],

1	Objectives	NNS	O	objective	nsubj	7	SENT_7	[p1l194t1303r368b1336],
2	The	DT	O	the	det	3	SENT_7	[p1l493t1307r544b1330],
3	aim	NN	O	aim	dep	1	SENT_7	[p1l556t1307r608b1330],
4	of	IN	O	of	_	0	SENT_7	[p1l620t1306r647b1330],
5	this	DT	O	this	det	6	SENT_7	[p1l658t1307r709b1330],
6	study	NN	O	study	prep_of	1	SENT_7	[p1l719t1307r795b1335],
7	was	VBD	O	be	_	0	SENT_7	[p1l806t1312r861b1330],
8	to	TO	O	to	aux	9	SENT_7	[p1l872t1308r899b1330],
9	evaluate	VB	O	evaluate	xcomp	7	SENT_7	[p1l910t1307r1031b1330],
10	the	DT	O	the	det	12	SENT_7	[p1l1042t1307r1087b1330],
11	relative	JJ	O	relative	amod	12	SENT_7	[p1l1100t1307r1202b1330],
12	impact	NN	O	impact	dobj	9	SENT_7	[p1l1215t1307r1312b1335],
13	of	IN	O	of	_	0	SENT_7	[p1l1323t1306r1350b1330],
14	demographic	JJ	O	demographic	amod	17	SENT_7	[p1l1361t1307r1548b1335],
15	and	CC	O	and	_	0	SENT_7	[p1l1559t1307r1610b1330],
16	clinical	JJ	O	clinical	conj_and	14	SENT_7	[p1l1622t1307r1719b1330],
17	variables	NNS	O	variable	prep_of	12	SENT_7	[p1l1731t1307r1859b1330],
18	versus	CC	O	versus	prep	12	SENT_7	[p1l1870t1312r1960b1330],
19	the	DT	O	the	det	20	SENT_7	[p1l1971t1307r2016b1330],
20	cytochrome	NN	O	cytochrome	dep	18	SENT_7	[p1l2027t1308r2093b1335, p1l494t1351r601b1373],

1	P450	NN	O	p450	nn	2	SENT_8	[p1l614t1350r689b1373],
2	2C19	NN	O	2c19	_	0	SENT_8	[p1l701t1350r777b1373],
3	(	CD	NUMBER	(	num	4	SENT_8	[p1l789t1350r942b1379],
4	CYP2C19	NN	O	cyp2c19	dep	2	SENT_8	[p1l789t1350r942b1379],
5	)	CD	NUMBER	)	num	6	SENT_8	[p1l789t1350r942b1379],
6	polymorphism	NN	O	polymorphism	dep	4	SENT_8	[p1l955t1351r1156b1379],
7	on	IN	O	on	_	0	SENT_8	[p1l1168t1356r1201b1373],
8	antiplatelet	JJ	O	antiplatelet	amod	9	SENT_8	[p1l1214t1351r1376b1379],
9	effects	NNS	O	effect	prep_on	2	SENT_8	[p1l1387t1350r1483b1373],
10	of	IN	O	of	_	0	SENT_8	[p1l1494t1350r1521b1373],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_8	[p1l1532t1351r1694b1379],
12	.	.	O	.	_	0	SENT_8	[p1l1532t1351r1694b1379],

1	Background	NN	O	background	nn	3	SENT_9	[p1l196t1390r393b1423],
2	Platelet	NN	O	platelet	nn	3	SENT_9	[p1l495t1393r603b1417],
3	responses	NNS	O	response	nsubj	6	SENT_9	[p1l616t1399r758b1422],
4	to	TO	O	to	_	0	SENT_9	[p1l769t1395r796b1417],
5	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_9	[p1l807t1393r961b1422],
6	show	VBP	O	show	_	0	SENT_9	[p1l973t1394r1047b1417],
7	a	DT	O	a	det	10	SENT_9	[p1l1058t1399r1073b1417],
8	marked	JJ	O	marked	amod	10	SENT_9	[p1l1086t1393r1194b1417],
9	interindividual	JJ	O	interindividual	amod	10	SENT_9	[p1l1207t1393r1406b1417],
10	variability	NN	O	variability	dobj	6	SENT_9	[p1l1418t1393r1555b1422],
11	with	IN	O	with	_	0	SENT_9	[p1l1566t1393r1624b1417],
12	substantial	JJ	O	substantial	amod	13	SENT_9	[p1l1635t1393r1791b1417],
13	impact	NN	O	impact	prep_with	6	SENT_9	[p1l1805t1393r1902b1422],
14	on	IN	O	on	_	0	SENT_9	[p1l1913t1399r1946b1417],
15	clinical	JJ	O	clinical	amod	16	SENT_9	[p1l1958t1393r2055b1417],
16	outcome	NN	O	outcome	prep_on	13	SENT_9	[p1l494t1438r626b1460],
17	.	.	O	.	_	0	SENT_9	[p1l494t1438r626b1460],

1	Several	JJ	O	several	amod	2	SENT_10	[p1l637t1436r741b1460],
2	demographic	JJ	O	demographic	nsubjpass	15	SENT_10	[p1l754t1437r940b1465],
3	and	CC	O	and	_	0	SENT_10	[p1l952t1437r1003b1460],
4	clinical	JJ	O	clinical	amod	5	SENT_10	[p1l1015t1437r1112b1460],
5	characteristics	NNS	O	characteristic	conj_and	2	SENT_10	[p1l1125t1437r1331b1460],
6	as	RB	O	as	_	0	SENT_10	[p1l1343t1442r1374b1460],
7	well	RB	O	well	_	0	SENT_10	[p1l1385t1437r1440b1460],
8	as	IN	O	as	_	0	SENT_10	[p1l1452t1442r1484b1460],
9	a	DT	O	a	det	10	SENT_10	[p1l1495t1442r1510b1460],
10	polymorphism	NN	O	polymorphism	conj_and	2	SENT_10	[p1l1524t1437r1724b1465],
11	of	IN	O	of	_	0	SENT_10	[p1l1737t1436r1764b1460],
12	CYP2C19	NN	O	cyp2c19	prep_of	10	SENT_10	[p1l1775t1436r1908b1460],
13	have	VBP	O	have	aux	15	SENT_10	[p1l1921t1437r1986b1460],
14	been	VBN	O	be	auxpass	15	SENT_10	[p1l1999t1437r2066b1460],
15	described	VBN	O	describe	_	0	SENT_10	[p1l494t1481r630b1504],
16	as	IN	O	as	_	0	SENT_10	[p1l643t1487r674b1504],
17	predictors	NNS	O	predictor	prep_as	15	SENT_10	[p1l686t1481r826b1510],
18	for	IN	O	for	_	0	SENT_10	[p1l837t1481r876b1504],
19	a	DT	O	a	det	21	SENT_10	[p1l887t1487r902b1504],
20	low	JJ	O	low	amod	21	SENT_10	[p1l915t1481r962b1504],
21	response	NN	O	response	prep_for	17	SENT_10	[p1l974t1487r1101b1510],
22	to	TO	O	to	_	0	SENT_10	[p1l1112t1482r1139b1504],
23	clopidogrel	NN	O	clopidogrel	prep_to	15	SENT_10	[p1l1151t1481r1313b1510],
24	.	.	O	.	_	0	SENT_10	[p1l1151t1481r1313b1510],

1	Methods	NNS	O	method	nsubj	4	SENT_11	[p1l195t1521r339b1547],
2	This	DT	O	this	det	3	SENT_11	[p1l493t1524r550b1547],
3	analysis	NN	O	analysis	dep	1	SENT_11	[p1l561t1524r675b1553],
4	enrolled	VBD	O	enrol	_	0	SENT_11	[p1l687t1524r799b1547],
5	760	CD	NUMBER	760	num	6	SENT_11	[p1l813t1524r869b1547],
6	patients	NNS	O	patient	dobj	4	SENT_11	[p1l882t1524r995b1553],
7	undergoing	VBG	O	undergo	partmod	6	SENT_11	[p1l1007t1524r1166b1553],
8	elective	JJ	O	elective	amod	11	SENT_11	[p1l1177t1524r1285b1547],
9	coronary	JJ	O	coronary	amod	11	SENT_11	[p1l1296t1530r1419b1553],
10	stent	NN	O	stent	nn	11	SENT_11	[p1l1429t1526r1500b1547],
11	implantation	NN	O	implantation	dobj	7	SENT_11	[p1l1512t1524r1691b1553],
12	after	IN	O	after	_	0	SENT_11	[p1l1704t1524r1770b1547],
13	loading	VBG	O	load	prepc_after	7	SENT_11	[p1l1782t1524r1886b1553],
14	with	IN	O	with	_	0	SENT_11	[p1l1896t1524r1953b1547],
15	600	CD	NUMBER	600	num	16	SENT_11	[p1l1966t1524r2023b1547],
16	mg	NN	O	mg	prep_with	13	SENT_11	[p1l2035t1527r2080b1553],
17	of	IN	O	of	_	0	SENT_11	[p1l2090t1524r2117b1547],
18	clopidogrel	NN	O	clopidogrel	prep_of	16	SENT_11	[p1l494t1568r657b1596],
19	.	.	O	.	_	0	SENT_11	[p1l494t1568r657b1596],

1	Residual	JJ	O	residual	amod	3	SENT_12	[p1l670t1568r790b1591],
2	platelet	NN	O	platelet	nn	3	SENT_12	[p1l804t1568r910b1596],
3	aggregation	NN	O	aggregation	nsubjpass	5	SENT_12	[p1l922t1568r1089b1596],
4	was	VBD	O	be	auxpass	5	SENT_12	[p1l1101t1573r1157b1591],
5	determined	VBN	O	determine	_	0	SENT_12	[p1l1168t1568r1330b1591],
6	by	IN	O	by	_	0	SENT_12	[p1l1344t1568r1375b1596],
7	optical	JJ	O	optical	amod	15	SENT_12	[p1l1385t1568r1479b1596],
8	aggregometry	NN	O	aggregometry	nn	15	SENT_12	[p1l1491t1569r1689b1596],
9	(	NN	O	(	nn	15	SENT_12	[p1l1700t1568r1856b1596],
10	adenosine	NN	LOCATION	adenosine	nn	15	SENT_12	[p1l1700t1568r1856b1596],
11	diphosphate	NN	O	diphosphate	nn	15	SENT_12	[p1l1868t1568r2043b1596],
12	5	CD	NUMBER	5	num	15	SENT_12	[p1l2054t1568r2072b1591],
13	p.	NN	O	p.	nn	15	SENT_12	[p1l495t1612r604b1641],
14	mol/l	NN	O	mol/l	nn	15	SENT_12	[p1l495t1612r604b1641],
15	)	NN	O	)	agent	5	SENT_12	[p1l495t1612r604b1641],
16	before	IN	O	before	_	0	SENT_12	[p1l616t1611r705b1634],
17	discharge	NN	O	discharge	prep_before	15	SENT_12	[p1l717t1612r861b1640],
18	.	.	O	.	_	0	SENT_12	[p1l717t1612r861b1640],

1	We	PRP	O	we	nsubj	31	SENT_13	[p1l873t1612r919b1634],
2	analyzed	VBD	O	analyze	_	0	SENT_13	[p1l930t1612r1054b1640],
3	the	DT	O	the	det	5	SENT_13	[p1l1066t1612r1111b1634],
4	predictive	JJ	O	predictive	amod	5	SENT_13	[p1l1123t1612r1259b1640],
5	value	NN	O	value	dobj	2	SENT_13	[p1l1270t1612r1346b1635],
6	of	IN	O	of	_	0	SENT_13	[p1l1357t1611r1384b1634],
7	the	DT	O	the	det	11	SENT_13	[p1l1394t1612r1439b1635],
8	CYP2C19	NN	O	cyp2c19	nn	11	SENT_13	[p1l1451t1611r1622b1635],
9	*	NN	O	*	nn	11	SENT_13	[p1l1451t1611r1622b1635],
10	2	CD	NUMBER	2	num	11	SENT_13	[p1l1451t1611r1622b1635],
11	polymorphism	NN	O	polymorphism	prep_of	5	SENT_13	[p1l1635t1612r1835b1640],
12	and	CC	O	and	_	0	SENT_13	[p1l1848t1612r1899b1635],
13	baseline	NN	O	baseline	nn	14	SENT_13	[p1l1912t1612r2030b1635],
14	variables	NNS	O	variable	conj_and	5	SENT_13	[p1l2041t1612r2101b1634, p1l494t1654r569b1677],
15	for	IN	O	for	_	0	SENT_13	[p1l580t1654r619b1677],
16	an	DT	O	a	det	19	SENT_13	[p1l630t1660r663b1677],
17	insufficient	JJ	O	insufficient	amod	19	SENT_13	[p1l676t1654r831b1677],
18	antiplatelet	JJ	O	antiplatelet	amod	19	SENT_13	[p1l843t1654r1005b1683],
19	response	NN	O	response	prep_for	14	SENT_13	[p1l1017t1660r1144b1683],
20	by	IN	O	by	_	0	SENT_13	[p1l1157t1654r1187b1683],
21	multivariable	JJ	O	multivariable	amod	23	SENT_13	[p1l1199t1654r1384b1677],
22	regression	NN	O	regression	nn	23	SENT_13	[p1l1396t1654r1541b1683],
23	analysis	NN	O	analysis	prep_by	2	SENT_13	[p1l1553t1654r1667b1683],
24	and	CC	O	and	_	0	SENT_13	[p1l1678t1654r1729b1677],
25	classification	NN	O	classification	nn	29	SENT_13	[p1l1742t1654r1925b1677],
26	and	CC	O	and	_	0	SENT_13	[p1l1938t1654r1989b1677],
27	regression	NN	O	regression	conj_and	25	SENT_13	[p1l2003t1657r2098b1683, p1l494t1698r550b1722],
28	trees	NNS	O	tree	nn	29	SENT_13	[p1l562t1700r633b1722],
29	analysis	NN	O	analysis	conj_and	23	SENT_13	[p1l644t1698r758b1727],
30	and	CC	O	and	_	0	SENT_13	[p1l770t1698r820b1722],
31	determined	VBD	O	determine	conj_and	2	SENT_13	[p1l833t1698r995b1722],
32	the	DT	O	the	det	33	SENT_13	[p1l1008t1698r1052b1722],
33	proportion	NN	O	proportion	dobj	31	SENT_13	[p1l1065t1698r1209b1727],
34	responsible	JJ	O	responsible	amod	33	SENT_13	[p1l1223t1698r1384b1727],
35	for	IN	O	for	_	0	SENT_13	[p1l1394t1698r1433b1722],
36	the	DT	O	the	det	38	SENT_13	[p1l1444t1698r1489b1722],
37	antiplatelet	JJ	O	antiplatelet	amod	38	SENT_13	[p1l1500t1698r1662b1727],
38	response	NN	O	response	prep_for	34	SENT_13	[p1l1675t1704r1801b1727],
39	of	IN	O	of	_	0	SENT_13	[p1l1813t1698r1840b1722],
40	these	DT	O	these	det	41	SENT_13	[p1l1850t1698r1928b1722],
41	predictors	NNS	O	predictor	prep_of	38	SENT_13	[p1l1940t1698r2080b1727],
42	by	IN	O	by	_	0	SENT_13	[p1l495t1743r526b1772],
43	multivariable	JJ	O	multivariable	amod	46	SENT_13	[p1l538t1743r722b1766],
44	linear	JJ	O	linear	amod	46	SENT_13	[p1l735t1743r814b1766],
45	regression	NN	O	regression	nn	46	SENT_13	[p1l826t1743r970b1772],
46	analysis	NN	O	analysis	prep_by	31	SENT_13	[p1l983t1743r1103b1772],
47	.	.	O	.	_	0	SENT_13	[p1l983t1743r1103b1772],

1	Results	NNS	O	result	nn	4	SENT_14	[p1l195t1783r319b1810],
2	Major	JJ	O	major	amod	4	SENT_14	[p1l495t1786r575b1816],
3	independent	JJ	O	independent	amod	4	SENT_14	[p1l587t1786r763b1815],
4	predictors	NNS	O	predictor	nsubj	14	SENT_14	[p1l775t1787r915b1815],
5	for	IN	O	for	_	0	SENT_14	[p1l926t1786r965b1810],
6	an	DT	O	a	det	9	SENT_14	[p1l976t1792r1009b1810],
7	insufficient	JJ	O	insufficient	amod	9	SENT_14	[p1l1022t1786r1177b1810],
8	antiplatelet	JJ	O	antiplatelet	amod	9	SENT_14	[p1l1189t1786r1351b1815],
9	response	NN	O	response	prep_for	4	SENT_14	[p1l1363t1792r1490b1815],
10	to	TO	O	to	_	0	SENT_14	[p1l1501t1788r1528b1810],
11	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_14	[p1l1540t1786r1694b1815],
12	were	VBD	O	be	cop	14	SENT_14	[p1l1706t1792r1774b1810],
13	CYP2C19	NN	O	cyp2c19	nn	14	SENT_14	[p1l1786t1786r1956b1810],
14	*	NN	O	*	_	0	SENT_14	[p1l1786t1786r1956b1810],
15	2	CD	NUMBER	2	num	19	SENT_14	[p1l1786t1786r1956b1810],
16	carrier	NN	O	carrier	nn	19	SENT_14	[p1l1968t1786r2059b1810],
17	status	NN	O	status	nn	19	SENT_14	[p1l494t1832r580b1854],
18	(	CD	NUMBER	(	num	19	SENT_14	[p1l592t1830r669b1859],
19	odds	NNS	O	odds	dep	14	SENT_14	[p1l592t1830r669b1859],
20	ratio	NN	O	ratio	nn	23	SENT_14	[p1l681t1830r744b1854],
21	[	CD	NUMBER	[	num	23	SENT_14	[p1l757t1830r824b1859],
22	OR	NN	O	or	nn	23	SENT_14	[p1l757t1830r824b1859],
23	]	NN	O	]	dep	19	SENT_14	[p1l757t1830r824b1859],
24	:	:	O	:	_	0	SENT_14	[p1l757t1830r824b1859],
25	2.74	CD	NUMBER	2.74	dep	19	SENT_14	[p1l837t1830r909b1858],
26	;	:	O	;	_	0	SENT_14	[p1l837t1830r909b1858],
27	95	CD	PERCENT	95	number	28	SENT_14	[p1l922t1830r984b1854],
28	%	NN	PERCENT	%	amod	29	SENT_14	[p1l922t1830r984b1854],
29	confidence	NN	O	confidence	dep	25	SENT_14	[p1l996t1830r1150b1854],
30	interval	NN	O	interval	nn	33	SENT_14	[p1l1162t1830r1265b1854],
31	[	CD	NUMBER	[	num	33	SENT_14	[p1l1279t1830r1331b1859],
32	CI	NN	O	ci	nn	33	SENT_14	[p1l1279t1830r1331b1859],
33	]	NN	O	]	dep	29	SENT_14	[p1l1279t1830r1331b1859],
34	:	:	O	:	_	0	SENT_14	[p1l1279t1830r1331b1859],
35	1.93	CD	NUMBER	1.93	number	38	SENT_14	[p1l1345t1830r1408b1854],
36	to	TO	O	to	dep	38	SENT_14	[p1l1420t1832r1447b1854],
37	3.90	CD	NUMBER	3.90	number	38	SENT_14	[p1l1458t1830r1534b1859],
38	)	CD	NUMBER	)	dep	19	SENT_14	[p1l1458t1830r1534b1859],
39	together	RB	O	together	_	0	SENT_14	[p1l1545t1830r1665b1859],
40	with	IN	O	with	_	0	SENT_14	[p1l1675t1830r1733b1854],
41	age	NN	O	age	nn	43	SENT_14	[p1l1745t1833r1796b1859],
42	(	CD	NUMBER	(	num	43	SENT_14	[p1l1808t1830r1866b1859],
43	OR	NN	O	or	prep_together_with	38	SENT_14	[p1l1808t1830r1866b1859],
44	:	:	O	:	_	0	SENT_14	[p1l1808t1830r1866b1859],
45	1.03	CD	NUMBER	1.03	dep	19	SENT_14	[p1l1880t1830r1951b1858],
46	;	:	O	;	_	0	SENT_14	[p1l1880t1830r1951b1858],
47	95	CD	PERCENT	95	number	48	SENT_14	[p1l1964t1830r2027b1854],
48	%	NN	PERCENT	%	amod	49	SENT_14	[p1l1964t1830r2027b1854],
49	Cl	NN	O	cl	dep	45	SENT_14	[p1l2038t1830r2072b1854],
50	:	:	O	:	_	0	SENT_14	[p1l2038t1830r2072b1854],
51	1.01	CD	NUMBER	1.01	number	53	SENT_14	[p1l495t1875r560b1899],
52	to	TO	O	to	dep	53	SENT_14	[p1l570t1876r597b1899],
53	1.05	CD	NUMBER	1.05	dep	19	SENT_14	[p1l610t1875r692b1904],
54	)	CD	NUMBER	)	dep	53	SENT_14	[p1l610t1875r692b1904],
55	,	,	O	,	_	0	SENT_14	[p1l610t1875r692b1904],
56	diabetes	NN	O	diabetes	nn	57	SENT_14	[p1l704t1875r825b1899],
57	mellitus	NN	O	mellitus	appos	53	SENT_14	[p1l838t1875r950b1899],
58	(	CD	NUMBER	(	num	59	SENT_14	[p1l961t1875r1019b1904],
59	OR	NN	O	or	dep	57	SENT_14	[p1l961t1875r1019b1904],
60	:	:	O	:	_	0	SENT_14	[p1l961t1875r1019b1904],
61	1.75	CD	NUMBER	1.75	dep	19	SENT_14	[p1l1033t1875r1104b1903],
62	;	:	O	;	_	0	SENT_14	[p1l1033t1875r1104b1903],
63	95	CD	PERCENT	95	number	64	SENT_14	[p1l1117t1875r1180b1899],
64	%	NN	PERCENT	%	amod	65	SENT_14	[p1l1117t1875r1180b1899],
65	Cl	NN	O	cl	dep	61	SENT_14	[p1l1191t1875r1225b1899],
66	:	:	O	:	_	0	SENT_14	[p1l1191t1875r1225b1899],
67	1.19	CD	NUMBER	1.19	number	70	SENT_14	[p1l1238t1875r1302b1899],
68	to	TO	O	to	dep	70	SENT_14	[p1l1313t1877r1341b1898],
69	2.56	CD	NUMBER	2.56	number	70	SENT_14	[p1l1352t1875r1435b1904],
70	)	CD	NUMBER	)	dep	19	SENT_14	[p1l1352t1875r1435b1904],
71	,	,	O	,	_	0	SENT_14	[p1l1352t1875r1435b1904],
72	and	CC	O	and	_	0	SENT_14	[p1l1447t1875r1498b1899],
73	body	NN	O	body	nn	75	SENT_14	[p1l1512t1875r1578b1904],
74	mass	NN	O	mass	nn	75	SENT_14	[p1l1590t1881r1665b1899],
75	index	NN	O	index	conj_and	70	SENT_14	[p1l1677t1875r1751b1899],
76	(	CD	NUMBER	(	num	77	SENT_14	[p1l1762t1875r1820b1904],
77	OR	NN	O	or	dep	75	SENT_14	[p1l1762t1875r1820b1904],
78	:	:	O	:	_	0	SENT_14	[p1l1762t1875r1820b1904],
79	1.06	CD	NUMBER	1.06	dep	19	SENT_14	[p1l1833t1875r1905b1903],
80	;	:	O	;	_	0	SENT_14	[p1l1833t1875r1905b1903],
81	95	CD	PERCENT	95	number	82	SENT_14	[p1l1918t1875r1981b1899],
82	%	NN	PERCENT	%	amod	83	SENT_14	[p1l1918t1875r1981b1899],
83	Cl	NN	O	cl	dep	79	SENT_14	[p1l1992t1875r2026b1899],
84	:	:	O	:	_	0	SENT_14	[p1l1992t1875r2026b1899],
85	1.02	CD	NUMBER	1.02	number	87	SENT_14	[p1l2039t1875r2102b1899],
86	to	TO	O	to	dep	87	SENT_14	[p1l494t1920r521b1941],
87	1.11	CD	NUMBER	1.11	dep	19	SENT_14	[p1l533t1918r615b1947],
88	)	CD	NUMBER	)	dep	87	SENT_14	[p1l533t1918r615b1947],
89	.	.	O	.	_	0	SENT_14	[p1l533t1918r615b1947],

1	The	DT	O	the	det	2	SENT_15	[p1l626t1918r677b1941],
2	classification	NN	O	classification	nsubj	7	SENT_15	[p1l689t1918r872b1941],
3	and	CC	O	and	_	0	SENT_15	[p1l885t1918r936b1941],
4	regression	NN	O	regression	nn	6	SENT_15	[p1l949t1918r1094b1947],
5	trees	NNS	O	tree	nn	6	SENT_15	[p1l1106t1920r1177b1941],
6	analysis	NN	O	analysis	conj_and	2	SENT_15	[p1l1188t1918r1302b1947],
7	demonstrated	VBD	O	demonstrate	_	0	SENT_15	[p1l1313t1918r1511b1941],
8	that	IN	O	that	complm	21	SENT_15	[p1l1523t1918r1580b1941],
9	CYP2C19	NN	O	cyp2c19	nn	10	SENT_15	[p1l1591t1918r1762b1942],
10	*	NN	O	*	nsubj	21	SENT_15	[p1l1591t1918r1762b1942],
11	2	CD	NUMBER	2	num	13	SENT_15	[p1l1591t1918r1762b1942],
12	carrier	NN	O	carrier	nn	13	SENT_15	[p1l1774t1918r1865b1941],
13	status	NN	O	status	dep	10	SENT_15	[p1l1875t1920r1962b1941],
14	followed	VBN	O	follow	partmod	10	SENT_15	[p1l1972t1918r2091b1941],
15	by	IN	O	by	_	0	SENT_15	[p1l495t1962r526b1991],
16	diabetes	NN	O	diabetes	nn	17	SENT_15	[p1l537t1962r658b1986],
17	mellitus	NN	O	mellitus	agent	14	SENT_15	[p1l670t1962r782b1986],
18	was	VBD	O	be	cop	21	SENT_15	[p1l793t1968r848b1986],
19	the	DT	O	the	det	21	SENT_15	[p1l859t1962r904b1986],
20	best	JJS	O	best	amod	21	SENT_15	[p1l917t1962r975b1986],
21	discriminator	NN	O	discriminator	ccomp	7	SENT_15	[p1l987t1962r1174b1986],
22	between	IN	O	between	_	0	SENT_15	[p1l1186t1962r1304b1986],
23	a	DT	O	a	det	24	SENT_15	[p1l1317t1968r1332b1986],
24	sufficient	JJ	O	sufficient	prep_between	21	SENT_15	[p1l1344t1962r1475b1986],
25	and	CC	O	and	_	0	SENT_15	[p1l1486t1962r1537b1986],
26	an	DT	O	a	det	29	SENT_15	[p1l1549t1968r1582b1986],
27	insufficient	JJ	O	insufficient	amod	29	SENT_15	[p1l1596t1962r1751b1986],
28	antiplatelet	JJ	O	antiplatelet	amod	29	SENT_15	[p1l1763t1962r1925b1991],
29	response	NN	O	response	ccomp	7	SENT_15	[p1l1937t1968r2064b1991],
30	to	TO	O	to	_	0	SENT_15	[p1l2075t1964r2102b1986],
31	clopidogrel	NN	O	clopidogrel	prep_to	29	SENT_15	[p1l494t2007r657b2036],
32	.	.	O	.	_	0	SENT_15	[p1l494t2007r657b2036],

1	The	DT	O	the	det	5	SENT_16	[p1l668t2007r719b2031],
2	full	JJ	O	full	amod	5	SENT_16	[p1l730t2007r772b2030],
3	linear	JJ	O	linear	amod	5	SENT_16	[p1l786t2007r865b2031],
4	regression	NN	O	regression	nn	5	SENT_16	[p1l877t2007r1021b2036],
5	model	NN	O	model	nsubj	12	SENT_16	[p1l1035t2007r1121b2031],
6	including	VBG	O	include	_	0	SENT_16	[p1l1134t2007r1262b2036],
7	all	PDT	O	all	predet	9	SENT_16	[p1l1273t2007r1304b2030],
8	these	DT	O	these	det	9	SENT_16	[p1l1316t2007r1393b2031],
9	parameters	NNS	O	parameter	prep_including	5	SENT_16	[p1l1406t2009r1569b2036],
10	could	MD	O	could	aux	12	SENT_16	[p1l1581t2007r1655b2031],
11	only	RB	O	only	advmod	12	SENT_16	[p1l1667t2007r1725b2036],
12	explain	VB	O	explain	_	0	SENT_16	[p1l1736t2007r1835b2036],
13	11.5	CD	PERCENT	11.5	num	14	SENT_16	[p1l1849t2007r1939b2031],
14	%	NN	PERCENT	%	dobj	12	SENT_16	[p1l1849t2007r1939b2031],
15	of	IN	O	of	_	0	SENT_16	[p1l1950t2007r1977b2030],
16	the	DT	O	the	det	19	SENT_16	[p1l1987t2007r2032b2031],
17	antiplatelet	JJ	O	antiplatelet	amod	19	SENT_16	[p1l2044t2007r2106b2031, p1l495t2050r601b2079],
18	response	NN	O	response	nn	19	SENT_16	[p1l614t2056r741b2079],
19	(	NN	O	(	prep_of	14	SENT_16	[p1l752t2050r834b2079],
20	5.2	CD	PERCENT	5.2	num	21	SENT_16	[p1l752t2050r834b2079],
21	%	NN	PERCENT	%	dep	12	SENT_16	[p1l752t2050r834b2079],
22	by	IN	O	by	_	0	SENT_16	[p1l846t2050r876b2079],
23	CYP2C19	NN	O	cyp2c19	nn	24	SENT_16	[p1l888t2050r1059b2074],
24	*	NN	O	*	prep_by	12	SENT_16	[p1l888t2050r1059b2074],
25	2	CD	NUMBER	2	num	27	SENT_16	[p1l888t2050r1059b2074],
26	carrier	NN	O	carrier	nn	27	SENT_16	[p1l1070t2050r1161b2073],
27	status	NN	O	status	npadvmod	28	SENT_16	[p1l1171t2052r1258b2073],
28	alone	RB	O	alone	dep	12	SENT_16	[p1l1270t2050r1364b2079],
29	)	RB	O	)	dep	28	SENT_16	[p1l1270t2050r1364b2079],
30	.	.	O	.	_	0	SENT_16	[p1l1270t2050r1364b2079],

1	Conclusions	NNS	O	conclusion	ccomp	8	SENT_17	[p1l194t2090r395b2117],
2	Thus	RB	O	thus	advmod	1	SENT_17	[p1l493t2094r567b2121],
3	,	,	O	,	_	0	SENT_17	[p1l493t2094r567b2121],
4	our	PRP$	O	we	poss	5	SENT_17	[p1l580t2099r625b2117],
5	study	NN	O	study	nsubj	8	SENT_17	[p1l635t2094r711b2122],
6	does	VBZ	O	do	aux	8	SENT_17	[p1l722t2094r788b2117],
7	not	RB	O	not	neg	8	SENT_17	[p1l801t2095r845b2117],
8	suggest	VB	O	suggest	_	0	SENT_17	[p1l855t2095r965b2122],
9	that	IN	O	that	complm	29	SENT_17	[p1l976t2094r1040b2121],
10	,	,	O	,	_	0	SENT_17	[p1l976t2094r1040b2121],
11	in	IN	O	in	dep	29	SENT_17	[p1l1053t2094r1075b2116],
12	patients	NNS	O	patient	pobj	11	SENT_17	[p1l1089t2094r1202b2122],
13	critically	RB	O	critically	advmod	14	SENT_17	[p1l1214t2094r1331b2122],
14	dependent	JJ	O	dependent	amod	12	SENT_17	[p1l1342t2094r1493b2122],
15	on	IN	O	on	_	0	SENT_17	[p1l1504t2099r1537b2117],
16	adequate	JJ	O	adequate	amod	18	SENT_17	[p1l1550t2094r1683b2122],
17	platelet	NN	O	platelet	nn	18	SENT_17	[p1l1696t2094r1802b2122],
18	inhibition	NN	O	inhibition	prep_on	12	SENT_17	[p1l1814t2094r1952b2121],
19	,	,	O	,	_	0	SENT_17	[p1l1814t2094r1952b2121],
20	genotyping	NN	O	genotyping	nsubj	29	SENT_17	[p1l1964t2095r2086b2122, p1l495t2138r537b2167],
21	alone	RB	O	alone	dep	20	SENT_17	[p1l547t2138r625b2161],
22	or	CC	O	or	_	0	SENT_17	[p1l636t2144r664b2161],
23	in	IN	O	in	conj_or	21	SENT_17	[p1l676t2138r698b2161],
24	combination	NN	O	combination	pobj	23	SENT_17	[p1l711t2138r886b2162],
25	with	IN	O	with	_	0	SENT_17	[p1l899t2138r956b2161],
26	clinical	JJ	O	clinical	amod	27	SENT_17	[p1l969t2138r1066b2162],
27	factors	NNS	O	factor	prep_with	24	SENT_17	[p1l1078t2138r1176b2162],
28	can	MD	O	can	aux	29	SENT_17	[p1l1187t2144r1235b2161],
29	replace	VB	O	replace	ccomp	8	SENT_17	[p1l1249t2138r1352b2167],
30	phenotyping	NN	O	phenotyping	dobj	29	SENT_17	[p1l1364t2138r1539b2167],
31	of	IN	O	of	_	0	SENT_17	[p1l1549t2138r1576b2161],
32	platelet	NN	O	platelet	nn	33	SENT_17	[p1l1588t2138r1694b2167],
33	function	NN	O	function	prep_of	30	SENT_17	[p1l1704t2138r1827b2162],
34	.	.	O	.	_	0	SENT_17	[p1l1704t2138r1827b2162],

1	(	NN	O	(	nn	2	SENT_18	[p1l1840t2138r1931b2167],
2	Effect	NN	O	effect	dep	7	SENT_18	[p1l1840t2138r1931b2167],
3	of	IN	O	of	_	0	SENT_18	[p1l1942t2138r1969b2162],
4	C	NN	O	c	prep_of	2	SENT_18	[p1l1980t2138r2059b2167, p1l494t2181r581b2210],
5	|	JJ	O	|	amod	6	SENT_18	[p1l1980t2138r2059b2167, p1l494t2181r581b2210],
6	opidogrel	NN	O	opidogrel	dep	7	SENT_18	[p1l1980t2138r2059b2167, p1l494t2181r581b2210],
7	Loading	NN	O	loading	dep	17	SENT_18	[p1l595t2181r706b2210],
8	and	CC	O	and	_	0	SENT_18	[p1l717t2181r768b2204],
9	Risk	NN	O	risk	dep	17	SENT_18	[p1l782t2181r842b2204],
10	of	IN	O	of	_	0	SENT_18	[p1l853t2181r880b2204],
11	PCI	NN	O	pcus	nn	14	SENT_18	[p1l892t2181r935b2204],
12	[	CD	NUMBER	[	num	14	SENT_18	[p1l950t2181r1136b2210],
13	EXCELSIOR	NN	O	excelsior	nn	14	SENT_18	[p1l950t2181r1136b2210],
14	]	NN	O	]	prep_of	7	SENT_18	[p1l950t2181r1136b2210],
15	;	:	O	;	_	0	SENT_18	[p1l950t2181r1136b2210],
16	NcT0O457236	NN	O	nct0o457236	nn	17	SENT_18	[p1l1149t2181r1377b2210],
17	)	NN	O	)	_	0	SENT_18	[p1l1149t2181r1377b2210],
18	.	.	O	.	_	0	SENT_18	[p1l1149t2181r1377b2210],

1	(	NN	O	(	nn	2	SENT_19	[p1l1420t2181r1439b2210],
2	J	NN	O	j	_	0	SENT_19	[p1l1420t2181r1439b2210],
3	Am	VBP	O	be	cop	5	SENT_19	[p1l1451t2181r1498b2204],
4	coll	NN	O	coll	nn	5	SENT_19	[p1l1511t2181r1561b2204],
5	cardiol	NN	O	cardiol	dep	2	SENT_19	[p1l1574t2181r1671b2204],
6	2010	CD	DATE	2010	num	5	SENT_19	[p1l1684t2181r1960b2210],
7	;	:	O	;	_	0	SENT_19	[p1l1684t2181r1960b2210],
8	55:2427	CD	NUMBER	55:2427	number	9	SENT_19	[p1l1684t2181r1960b2210],
9	—	CD	NUMBER	—	dep	2	SENT_19	[p1l1684t2181r1960b2210],
10	34	CD	NUMBER	34	num	11	SENT_19	[p1l1684t2181r1960b2210],
11	)	NN	O	)	dep	9	SENT_19	[p1l1684t2181r1960b2210],
12	©	CD	NUMBER	©	num	13	SENT_19	[p1l1971t2181r1994b2205],
13	2010	CD	DATE	2010	dep	9	SENT_19	[p1l2006t2181r2082b2204],
14	by	IN	O	by	_	0	SENT_19	[p1l495t2225r526b2254],
15	the	DT	O	the	det	17	SENT_19	[p1l536t2225r581b2249],
16	American	NNP	ORGANIZATION	American	nn	17	SENT_19	[p1l592t2225r727b2249],
17	College	NNP	ORGANIZATION	College	prep_by	13	SENT_19	[p1l740t2225r843b2254],
18	of	IN	ORGANIZATION	of	_	0	SENT_19	[p1l855t2225r882b2249],
19	Cardiology	NNP	ORGANIZATION	Cardiology	nn	20	SENT_19	[p1l893t2225r1041b2254],
20	Foundation	NNP	ORGANIZATION	Foundation	prep_of	17	SENT_19	[p1l1053t2225r1210b2249],

1	Dual	JJ	O	dual	amod	3	SENT_20	[p1l10t2525r177b2588],
2	antiplatelet	JJ	O	antiplatelet	amod	3	SENT_20	[p1l204t2525r582b2610],
3	therapy	NN	O	therapy	nsubj	11	SENT_20	[p1l606t2525r862b2610],
4	with	IN	O	with	_	0	SENT_20	[p1l881t2525r1035b2588],
5	aspirin	NN	O	aspirin	prep_with	3	SENT_20	[p1l1062t2528r1287b2610],
6	and	CC	O	and	_	0	SENT_20	[p1l1315t2525r1436b2588],
7	clopidogrel	NN	O	clopidogrel	conj_and	5	SENT_20	[p1l1463t2525r1840b2610],
8	is	VBZ	O	be	cop	11	SENT_20	[p1l1865t2528r1913b2588],
9	the	DT	O	the	det	11	SENT_20	[p1l1940t2525r2046b2588],
10	established	JJ	O	established	amod	11	SENT_20	[p1l10t2626r380b2689],
11	treatment	NN	O	treatment	_	0	SENT_20	[p1l426t2642r757b2689],
12	for	IN	O	for	_	0	SENT_20	[p1l801t2626r897b2689],
13	prevention	NN	O	prevention	prep_for	11	SENT_20	[p1l940t2629r1303b2711],
14	of	IN	O	of	_	0	SENT_20	[p1l1349t2626r1426b2689],
15	stent	JJ	O	stent	amod	16	SENT_20	[p1l1461t2642r1624b2689],
16	thrombosis	NN	O	thrombosis	prep_of	13	SENT_20	[p1l1668t2626r2045b2689],
17	after	IN	O	after	mark	21	SENT_20	[p1l11t2727r165b2790],
18	percutaneous	JJ	O	percutaneous	amod	20	SENT_20	[p1l222t2743r672b2812],
19	coronary	JJ	O	coronary	amod	20	SENT_20	[p1l735t2751r1034b2812],
20	interventions	NNS	O	intervention	nsubj	21	SENT_20	[p1l1090t2730r1538b2790],
21	(	VBP	O	(	advcl	11	SENT_20	[p1l1603t2725r1798b2804],
22	PCI	NN	O	pcus	dobj	21	SENT_20	[p1l1603t2725r1798b2804],
23	)	CD	NUMBER	)	number	24	SENT_20	[p1l1603t2725r1798b2804],
24	(	CD	NUMBER	(	dep	22	SENT_20	[p1l1865t2725r2042b2804],
25	1,2	CD	NUMBER	1,2	num	26	SENT_20	[p1l1865t2725r2042b2804],
26	)	NN	O	)	dep	24	SENT_20	[p1l1865t2725r2042b2804],
27	.	.	O	.	_	0	SENT_20	[p1l1865t2725r2042b2804],

1	The	DT	O	the	det	2	SENT_21	[p1l7t2826r147b2891],
2	eﬂicacy	NN	O	eﬂicacy	nsubjpass	7	SENT_21	[p1l191t2828r435b2913],
3	of	IN	O	of	_	0	SENT_21	[p1l475t2828r551b2891],
4	such	JJ	O	such	amod	5	SENT_21	[p1l583t2828r732b2891],
5	treatment	NN	O	treatment	prep_of	2	SENT_21	[p1l775t2844r1106b2891],
6	is	VBZ	O	be	auxpass	7	SENT_21	[p1l1146t2831r1194b2891],
7	hampered	VBN	O	hamper	_	0	SENT_21	[p1l1239t2828r1576b2913],
8	by	IN	O	by	_	0	SENT_21	[p1l1615t2828r1698b2913],
9	the	DT	O	the	det	10	SENT_21	[p1l1737t2828r1842b2891],
10	large	JJ	O	large	agent	7	SENT_21	[p1l1884t2828r2045b2913],

1	From	IN	O	from	_	0	SENT_22	[p1l9t3105r140b3149],
2	the	DT	O	the	det	3	SENT_22	[p1l169t3105r243b3149],
3	*	CD	NUMBER	*	pobj	1	SENT_22	[p1l272t3105r652b3149],
4	Herz	NNP	PERSON	Herz	dep	3	SENT_22	[p1l272t3105r652b3149],
5	.	.	O	.	_	0	SENT_22	[p1l272t3105r652b3149],

1	—	NN	O	—	_	0	SENT_23	[p1l272t3105r652b3149],
2	.	.	O	.	_	0	SENT_23	[p1l272t3105r652b3149],

1	Zentrum	NNP	MISC	Zentrum	nn	3	SENT_24	[p1l272t3105r652b3149],
2	Bad	NNP	MISC	Bad	nn	3	SENT_24	[p1l681t3105r772b3149],
3	Krozingen	NNP	MISC	Krozingen	_	0	SENT_24	[p1l802t3106r1052b3164],
4	,	,	O	,	_	0	SENT_24	[p1l802t3106r1052b3164],
5	Bad	NNP	LOCATION	Bad	nn	6	SENT_24	[p1l1082t3105r1174b3149],
6	Krozingen	NNP	LOCATION	Krozingen	appos	3	SENT_24	[p1l1203t3105r1453b3164],
7	,	,	O	,	_	0	SENT_24	[p1l1203t3105r1453b3164],
8	Germany	NNP	LOCATION	Germany	appos	3	SENT_24	[p1l1485t3105r1711b3164],
9	,	,	O	,	_	0	SENT_24	[p1l1485t3105r1711b3164],
10	Tlnstitute	NNP	O	Tlnstitute	appos	3	SENT_24	[p1l1741t3105r1972b3156],
11	of	IN	O	of	_	0	SENT_24	[p1l2002t3105r2055b3149],
12	Experimental	JJ	O	experimental	amod	15	SENT_24	[p1l10t3178r318b3237],
13	and	CC	O	and	_	0	SENT_24	[p1l354t3178r437b3222],
14	Clinical	JJ	O	clinical	amod	15	SENT_24	[p1l472t3178r650b3222],
15	Pharmacology	NN	O	pharmacology	prep_of	10	SENT_24	[p1l684t3178r1013b3237],
16	and	CC	O	and	_	0	SENT_24	[p1l1046t3178r1129b3222],
17	Toxicology	NN	O	toxicology	prep_of	10	SENT_24	[p1l1162t3177r1430b3237],
18	,	,	O	,	_	0	SENT_24	[p1l1162t3177r1430b3237],
19	University	NNP	ORGANIZATION	University	appos	3	SENT_24	[p1l1466t3179r1702b3237],
20	of	IN	ORGANIZATION	of	_	0	SENT_24	[p1l1736t3178r1788b3222],
21	Erlangen	NNP	ORGANIZATION	Erlangen	prep_of	19	SENT_24	[p1l1816t3178r2045b3237],
22	—	CD	NUMBER	—	num	21	SENT_24	[p1l1816t3178r2045b3237],
23	Nuremberg	NNP	LOCATION	Nuremberg	nn	27	SENT_24	[p1l8t3251r285b3310],
24	,	,	O	,	_	0	SENT_24	[p1l8t3251r285b3310],
25	Erlangen	NNP	LOCATION	Erlangen	appos	27	SENT_24	[p1l302t3251r521b3310],
26	,	,	O	,	_	0	SENT_24	[p1l302t3251r521b3310],
27	Germany	NNP	LOCATION	Germany	dep	3	SENT_24	[p1l538t3251r765b3310],
28	,	,	O	,	_	0	SENT_24	[p1l538t3251r765b3310],
29	and	CC	O	and	_	0	SENT_24	[p1l782t3251r865b3295],
30	the	DT	O	the	dep	3	SENT_24	[p1l878t3251r949b3295],
31	:	:	O	:	_	0	SENT_24	[p1l964t3250r1134b3302],
32	l2TIMI	NN	O	l2timus	nn	34	SENT_24	[p1l964t3250r1134b3302],
33	Study	NNP	O	Study	nn	34	SENT_24	[p1l1152t3251r1289b3310],
34	Group	NNP	O	Group	dep	27	SENT_24	[p1l1302t3251r1472b3311],
35	,	,	O	,	_	0	SENT_24	[p1l1302t3251r1472b3311],
36	Cardiovascular	NNP	MISC	Cardiovascular	nn	37	SENT_24	[p1l1489t3251r1826b3295],
37	Division	NNP	MISC	Division	appos	34	SENT_24	[p1l1839t3252r2045b3305],
38	,	,	O	,	_	0	SENT_24	[p1l1839t3252r2045b3305],
39	Brigham	NNP	ORGANIZATION	Brigham	appos	34	SENT_24	[p1l9t3324r209b3383],
40	and	CC	O	and	_	0	SENT_24	[p1l235t3324r317b3368],
41	Women	NNP	O	Women	poss	43	SENT_24	[p1l339t3324r561b3369],
42	’s	POS	O	’s	_	0	SENT_24	[p1l339t3324r561b3369],
43	Hospital	NNP	O	Hospital	appos	34	SENT_24	[p1l587t3324r796b3384],
44	,	,	O	,	_	0	SENT_24	[p1l587t3324r796b3384],
45	Department	NNP	ORGANIZATION	Department	appos	34	SENT_24	[p1l822t3325r1104b3384],
46	of	IN	ORGANIZATION	of	_	0	SENT_24	[p1l1127t3324r1180b3368],
47	Medicine	NNP	ORGANIZATION	Medicine	prep_of	45	SENT_24	[p1l1195t3324r1426b3378],
48	,	,	O	,	_	0	SENT_24	[p1l1195t3324r1426b3378],
49	Harvard	NNP	ORGANIZATION	Harvard	nn	51	SENT_24	[p1l1453t3324r1642b3368],
50	Medical	NNP	ORGANIZATION	Medical	nn	51	SENT_24	[p1l1665t3324r1854b3368],
51	School	NNP	ORGANIZATION	School	appos	47	SENT_24	[p1l1880t3324r2045b3378],
52	,	,	O	,	_	0	SENT_24	[p1l1880t3324r2045b3378],

1	variability	NN	O	variability	nsubj	14	SENT_25	[p2l54t87r403b174],
2	of	IN	O	of	_	0	SENT_25	[p2l449t87r527b151],
3	platelet	NN	O	platelet	nn	4	SENT_25	[p2l564t87r820b174],
4	inhibition	NN	O	inhibition	prep_of	1	SENT_25	[p2l868t87r1213b151],
5	by	IN	O	by	_	0	SENT_25	[p2l1261t87r1345b174],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_25	[p2l1392t87r1779b174],
7	o	NN	O	o	prep_by	4	SENT_25	[p2l1830t85r1943b166],
8	+	CC	O	+	_	0	SENT_25	[p2l1830t85r1943b166],
9	Several	JJ	O	several	amod	12	SENT_25	[p2l2000t87r2149b152, p2l58t191r182b255],
10	independent	JJ	O	independent	amod	12	SENT_25	[p2l228t191r665b278],
11	clinical	JJ	O	clinical	amod	12	SENT_25	[p2l712t191r956b255],
12	studies	NNS	O	study	conj_+	7	SENT_25	[p2l1004t191r1237b255],
13	have	VBP	O	have	aux	14	SENT_25	[p2l1287t191r1442b255],
14	demonstrated	VBN	O	demonstrate	_	0	SENT_25	[p2l1491t191r1968b255],
15	that	IN	O	that	complm	24	SENT_25	[p2l2014t191r2153b255],
16	patients	NNS	O	patient	nsubj	24	SENT_25	[p2l56t298r329b382],
17	with	IN	O	with	_	0	SENT_25	[p2l355t295r514b360],
18	high	JJ	O	high	amod	21	SENT_25	[p2l542t295r699b382],
19	residual	JJ	O	residual	amod	21	SENT_25	[p2l727t295r996b359],
20	platelet	NN	O	platelet	nn	21	SENT_25	[p2l1022t295r1278b382],
21	reactivity	NN	O	reactivity	prep_with	16	SENT_25	[p2l1305t298r1624b382],
22	on	IN	O	on	_	0	SENT_25	[p2l1650t320r1735b359],
23	clopidogrel	NN	O	clopidogrel	prep_on	21	SENT_25	[p2l1765t295r2152b382],
24	were	VBD	O	be	ccomp	14	SENT_25	[p2l54t424r218b464],
25	at	IN	O	at	_	0	SENT_25	[p2l257t416r319b463],
26	increased	VBN	O	increase	amod	27	SENT_25	[p2l354t399r675b463],
27	risk	NN	O	risk	prep_at	24	SENT_25	[p2l711t399r839b463],
28	for	IN	O	for	_	0	SENT_25	[p2l872t399r971b463],
29	stent	JJ	O	stent	amod	30	SENT_25	[p2l1007t416r1175b463],
30	thrombosis	NN	O	thrombosis	prep_for	27	SENT_25	[p2l1209t399r1596b463],
31	and	CC	O	and	_	0	SENT_25	[p2l1636t399r1761b463],
32	other	JJ	O	other	amod	33	SENT_25	[p2l1798t399r1981b463],
33	carBoston	NN	O	carboston	conj_and	30	SENT_25	[p2l2017t424r2148b463, p2l57t684r236b739],
34	,	,	O	,	_	0	SENT_25	[p2l2017t424r2148b463, p2l57t684r236b739],

1	Massachusetts	NNP	LOCATION	Massachusetts	_	0	SENT_26	[p2l260t683r610b728],
2	.	.	O	.	_	0	SENT_26	[p2l260t683r610b728],

1	This	DT	O	this	det	2	SENT_27	[p2l634t682r743b728],
2	study	NN	O	study	nsubjpass	4	SENT_27	[p2l768t683r893b744],
3	was	VBD	O	be	auxpass	4	SENT_27	[p2l911t701r998b728],
4	supported	VBN	O	support	_	0	SENT_27	[p2l1023t683r1255b744],
5	by	IN	O	by	_	0	SENT_27	[p2l1276t683r1334b744],
6	a	DT	O	a	det	7	SENT_27	[p2l1356t701r1380b728],
7	grant	NN	O	grant	agent	4	SENT_27	[p2l1401t695r1525b744],
8	from	IN	O	from	_	0	SENT_27	[p2l1547t683r1660b728],
9	the	DT	O	the	det	10	SENT_27	[p2l1683t683r1757b728],
10	Herz-Zentrum	NNP	O	Herz-Zentrum	prep_from	4	SENT_27	[p2l1781t683r2150b739],
11	,	,	O	,	_	0	SENT_27	[p2l1781t683r2150b739],
12	Bad	NNP	LOCATION	Bad	nn	13	SENT_27	[p2l57t759r151b804],
13	Krozingen	NNP	LOCATION	Krozingen	appos	10	SENT_27	[p2l173t760r429b820],
14	.	.	O	.	_	0	SENT_27	[p2l173t760r429b820],

1	Dr.	NNP	O	Dr.	nn	2	SENT_28	[p2l452t760r531b804],
2	Hochholzer	NNP	PERSON	Hochholzer	nsubjpass	4	SENT_28	[p2l554t759r835b804],
3	was	VBD	O	be	auxpass	4	SENT_28	[p2l852t777r938b804],
4	supported	VBN	O	support	_	0	SENT_28	[p2l961t759r1193b820],
5	by	IN	O	by	_	0	SENT_28	[p2l1211t759r1269b820],
6	the	DT	O	the	det	9	SENT_28	[p2l1286t759r1360b804],
7	German	JJ	O	german	amod	9	SENT_28	[p2l1382t759r1578b804],
8	Heart	NNP	O	Heart	nn	9	SENT_28	[p2l1598t759r1737b804],
9	Foundation	NNP	O	Foundation	agent	4	SENT_28	[p2l1755t759r2041b804],
10	.	.	O	.	_	0	SENT_28	[p2l1755t759r2041b804],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_29	[p2l117t836r402b897],
2	received	VBD	O	receive	_	0	SENT_29	[p2l421t835r618b881],
3	October	NNP	DATE	October	tmod	2	SENT_29	[p2l639t835r840b881],
4	12	CD	DATE	12	num	3	SENT_29	[p2l862t837r931b891],
5	,	,	DATE	,	_	0	SENT_29	[p2l862t837r931b891],
6	2009	CD	DATE	2009	num	3	SENT_29	[p2l952t837r1087b891],
7	;	:	O	;	_	0	SENT_29	[p2l952t837r1087b891],
8	revised	VBN	O	revise	amod	9	SENT_29	[p2l1109t835r1277b880],
9	manuscript	NN	O	manuscript	dobj	2	SENT_29	[p2l1297t837r1570b897],
10	received	VBD	O	receive	rcmod	9	SENT_29	[p2l1589t835r1786b880],
11	December	NNP	DATE	December	tmod	10	SENT_29	[p2l1806t835r2059b880],
12	23	CD	DATE	23	num	11	SENT_29	[p2l2076t837r2150b891],
13	,	,	O	,	_	0	SENT_29	[p2l2076t837r2150b891],

1	2009	CD	DATE	2009	_	0	SENT_30	[p2l56t913r191b967],
2	,	,	O	,	_	0	SENT_30	[p2l56t913r191b967],
3	accepted	VBN	O	accept	partmod	1	SENT_30	[p2l216t911r425b973],
4	February	NNP	DATE	February	tmod	3	SENT_30	[p2l447t911r666b972],
5	16	CD	DATE	16	num	4	SENT_30	[p2l689t913r759b967],
6	,	,	DATE	,	_	0	SENT_30	[p2l689t913r759b967],
7	2010	CD	DATE	2010	num	4	SENT_30	[p2l782t913r916b957],
8	.	.	O	.	_	0	SENT_30	[p2l782t913r916b957],

1	2428	CD	DATE	2428	num	2	SENT_31	[p2l10t993r161b1045],
2	Hochholzer	NNP	O	Hochholzer	_	0	SENT_31	[p2l331t993r647b1045],
3	et	FW	O	et	nn	4	SENT_31	[p2l667t995r724b1045],
4	al.	FW	O	al.	dep	2	SENT_31	[p2l739t993r806b1045],
5	.	.	O	.	_	0	SENT_31	[p2l739t993r806b1045],

1	P450	NN	O	p450	nn	3	SENT_32	[p2l331t1081r482b1134],
2	2019	CD	DATE	2019	num	3	SENT_32	[p2l501t1081r653b1134],
3	Polymorphisms	NNP	MISC	Polymorphisms	nsubj	17	SENT_32	[p2l675t1082r1105b1144],
4	and	CC	O	and	_	0	SENT_32	[p2l1124t1082r1225b1134],
5	Residual	NNP	O	Residual	nn	7	SENT_32	[p2l1249t1082r1486b1134],
6	Platelet	NN	O	platelet	nn	7	SENT_32	[p2l1509t1082r1724b1134],
7	Activity	NN	O	activity	nsubj	17	SENT_32	[p2l1741t1082r1951b1144],
8	and	CC	O	and	_	0	SENT_32	[p2l82t1425r191b1474],
9	Acronyms	NNS	O	acronym	nn	10	SENT_32	[p2l219t1425r529b1486],
10	EXCELSIOR	NN	O	excelsior	nsubj	17	SENT_32	[p2l963t1409r1487b1476],
11	(	CD	NUMBER	(	num	12	SENT_32	[p2l1511t1407r1788b1498],
12	Impact	NN	O	impact	dep	10	SENT_32	[p2l1511t1407r1788b1498],
13	of	IN	O	of	_	0	SENT_32	[p2l1811t1409r1891b1475],
14	Extent	NNP	O	Extent	nn	16	SENT_32	[p2l1903t1410r2142b1475],
15	diac	NN	O	diac	nn	16	SENT_32	[p2l963t1303r1103b1368],
16	complications	NNS	O	complication	prep_of	12	SENT_32	[p2l1138t1303r1626b1392],
17	(	VBP	O	(	_	0	SENT_32	[p2l1665t1301r1880b1383],
18	4-7	CD	NUMBER	4-7	num	19	SENT_32	[p2l1665t1301r1880b1383],
19	)	CD	NUMBER	)	dobj	17	SENT_32	[p2l1665t1301r1880b1383],
20	.	.	O	.	_	0	SENT_32	[p2l1665t1301r1880b1383],

1	In	IN	O	in	_	0	SENT_33	[p2l1918t1304r1995b1368],
2	the	DT	O	the	pobj	1	SENT_33	[p2l2029t1303r2139b1368],
3	of	IN	O	of	_	0	SENT_33	[p2l962t1516r1042b1582],
4	Clopidogre1	NN	O	clopidogre1	prep_of	2	SENT_33	[p2l1078t1516r1829b1605],
5	.	.	O	.	_	0	SENT_33	[p2l1078t1516r1829b1605],

1	—	NN	O	—	_	0	SENT_34	[p2l1078t1516r1829b1605],
2	.	.	O	.	_	0	SENT_34	[p2l1078t1516r1829b1605],

1	Induced	VBN	O	induce	_	0	SENT_35	[p2l1078t1516r1829b1605],
2	Platelet	NN	O	platelet	nn	3	SENT_35	[p2l1874t1516r2142b1582],
3	Inhibition	NN	O	inhibition	dep	1	SENT_35	[p2l961t1623r1322b1688],
4	During	IN	O	during	dep	3	SENT_35	[p2l1352t1624r1612b1711],
5	Elective	NNP	O	Elective	nn	7	SENT_35	[p2l1642t1623r1923b1689],
6	Stent	NNP	O	Stent	nn	7	SENT_35	[p2l1957t1623r2142b1689],
7	Implantation	NN	O	implantation	pobj	4	SENT_35	[p2l961t1729r1427b1818],
8	on	IN	O	on	_	0	SENT_35	[p2l1473t1755r1561b1794],
9	Clinical	JJ	O	clinical	amod	11	SENT_35	[p2l1609t1729r1886b1795],
10	Event	NNP	O	Event	nn	11	SENT_35	[p2l1932t1730r2142b1795],
11	Rate	NNP	O	Rate	prep_on	1	SENT_35	[p2l964t1833r1150b1916],
12	)	CD	NUMBER	)	num	13	SENT_35	[p2l964t1833r1150b1916],
13	trial	NN	O	trial	nsubj	76	SENT_35	[p2l1193t1836r1352b1916],
14	,	,	O	,	_	0	SENT_35	[p2l1193t1836r1352b1916],
15	patients	NNS	O	patient	appos	13	SENT_35	[p2l1393t1839r1670b1925],
16	with	IN	O	with	_	0	SENT_35	[p2l1707t1836r1868b1902],
17	a	DT	O	a	det	25	SENT_35	[p2l1909t1861r1943b1901],
18	high	JJ	O	high	amod	25	SENT_35	[p2l1981t1835r2140b1924],
19	on-clopidogrel	JJ	O	on-clopidogrel	amod	25	SENT_35	[p2l962t1942r1486b2031],
20	residual	JJ	O	residual	amod	25	SENT_35	[p2l1546t1942r1820b2008],
21	platelet	NN	O	platelet	nn	25	SENT_35	[p2l1880t1942r2141b2031],
22	aggregation	NN	O	aggregation	nn	25	SENT_35	[p2l963t2052r1375b2138],
23	(	CD	NUMBER	(	num	25	SENT_35	[p2l1407t2047r1638b2129],
24	RPA	NN	ORGANIZATION	rpa	nn	25	SENT_35	[p2l1407t2047r1638b2129],
25	)	NN	O	)	prep_with	15	SENT_35	[p2l1407t2047r1638b2129],
26	at	IN	O	at	_	0	SENT_35	[p2l1672t2066r1735b2115],
27	day	NN	DURATION	day	prep_at	25	SENT_35	[p2l1764t2049r1886b2138],
28	1	CD	NUMBER	1	num	27	SENT_35	[p2l1916t2053r1947b2114],
29	after	IN	O	after	mark	31	SENT_35	[p2l1983t2049r2142b2115],
30	PCI	NNP	O	PCI	nsubj	31	SENT_35	[p2l962t2156r1110b2222],
31	had	VBD	O	have	dep	15	SENT_35	[p2l1143t2156r1272b2221],
32	a	DT	O	a	det	34	SENT_35	[p2l1305t2182r1339b2221],
33	3-fold	JJ	O	3-fold	amod	34	SENT_35	[p2l1371t2156r1588b2222],
34	increase	NN	O	increase	dobj	31	SENT_35	[p2l1619t2159r1898b2221],
35	in	IN	O	in	_	0	SENT_35	[p2l1931t2159r1998b2221],
36	the	DT	O	the	det	38	SENT_35	[p2l2030t2156r2140b2221],
37	1-year	JJ	DURATION	1-year	amod	38	SENT_35	[p2l966t2266r1185b2351],
38	incidence	NN	O	incidence	prep_in	34	SENT_35	[p2l1241t2262r1574b2328],
39	of	IN	O	of	_	0	SENT_35	[p2l1634t2262r1714b2328],
40	death	NN	O	death	prep_of	38	SENT_35	[p2l1760t2262r1955b2328],
41	and	CC	O	and	_	0	SENT_35	[p2l2014t2262r2141b2328],
42	myocardial	JJ	O	myocardial	amod	43	SENT_35	[p2l962t2369r1350b2458],
43	infarction	NN	O	infarction	conj_and	38	SENT_35	[p2l1386t2369r1730b2435],
44	(	CD	NUMBER	(	num	45	SENT_35	[p2l1771t2367r1940b2449],
45	MI	NNP	O	MI	dep	43	SENT_35	[p2l1771t2367r1940b2449],
46	)	CD	NUMBER	)	num	45	SENT_35	[p2l1771t2367r1940b2449],
47	after	IN	O	after	_	0	SENT_35	[p2l1983t2369r2142b2435],
48	elective	JJ	O	elective	amod	50	SENT_35	[p2l962t2476r1221b2541],
49	stent	NN	O	stent	nn	50	SENT_35	[p2l1257t2493r1427b2541],
50	placement	NN	O	placement	prep_after	31	SENT_35	[p2l1458t2476r1824b2565],
51	as	IN	O	as	_	0	SENT_35	[p2l1857t2501r1920b2541],
52	compared	VBN	O	compare	prepc_as	31	SENT_35	[p2l1957t2501r2138b2541, p2l960t2582r1157b2671],
53	with	IN	O	with	pcomp	52	SENT_35	[p2l1194t2582r1355b2648],
54	patients	NNS	O	patient	pobj	53	SENT_35	[p2l1395t2585r1672b2671],
55	with	IN	O	with	_	0	SENT_35	[p2l1711t2582r1873b2648],
56	an	DT	O	a	det	62	SENT_35	[p2l1915t2608r1996b2648],
57	intermediate	JJ	O	intermediate	amod	62	SENT_35	[p2l2037t2585r2138b2647, p2l961t2689r1337b2754],
58	or	CC	O	or	_	0	SENT_35	[p2l1371t2714r1444b2754],
59	low	JJ	O	low	conj_or	57	SENT_35	[p2l1472t2689r1602b2755],
60	RPA	NN	O	rpa	nn	62	SENT_35	[p2l1633t2687r1811b2754],
61	oA	NN	O	oa	nn	62	SENT_35	[p2l1845t2687r1959b2769],
62	o	NN	O	o	prep_with	54	SENT_35	[p2l1845t2687r1959b2769],
63	+	CC	O	+	_	0	SENT_35	[p2l1845t2687r1959b2769],
64	The	DT	O	the	det	65	SENT_35	[p2l1993t2687r2140b2754],
65	threshold	NN	O	threshold	conj_+	15	SENT_35	[p2l961t2795r1282b2861],
66	for	IN	O	for	_	0	SENT_35	[p2l1318t2795r1415b2861],
67	high	JJ	O	high	amod	69	SENT_35	[p2l1451t2795r1605b2884],
68	on-clopidogrel	JJ	O	on-clopidogrel	amod	69	SENT_35	[p2l1642t2795r2142b2884],
69	RPA	NN	ORGANIZATION	rpa	prep_for	65	SENT_35	[p2l964t2900r1143b2967],
70	identiﬁed	VBN	O	identiﬁed	partmod	69	SENT_35	[p2l1205t2902r1549b2968],
71	by	IN	O	by	_	0	SENT_35	[p2l1610t2902r1697b2991],
72	this	DT	O	this	det	73	SENT_35	[p2l1756t2902r1885b2968],
73	study	NN	O	study	agent	70	SENT_35	[p2l1952t2902r2144b2991],
74	was	VBD	O	be	cop	76	SENT_35	[p2l958t3034r1087b3075],
75	14	CD	PERCENT	14	num	76	SENT_35	[p2l1139t3012r1286b3074],
76	%	NN	PERCENT	%	rcmod	11	SENT_35	[p2l1139t3012r1286b3074],
77	after	IN	O	after	_	0	SENT_35	[p2l1333t3009r1492b3074],
78	stimulation	NN	O	stimulation	prep_after	76	SENT_35	[p2l1538t3009r1938b3074],
79	with	IN	O	with	prep	76	SENT_35	[p2l1979t3009r2140b3075],

1	ADP	NN	O	adp	_	0	SENT_36	[p2l80t1589r189b1629],
2	=	JJ	O	=	amod	4	SENT_36	[p2l216t1602r251b1621],
3	adenosine	NN	O	adenosine	nn	4	SENT_36	[p2l279t1589r538b1630],
4	diphosphate	NN	O	diphosphate	dep	1	SENT_36	[p2l81t1673r393b1724],

1	BMI	NN	O	bmus	_	0	SENT_37	[p2l83t1793r182b1834],
2	=	JJ	O	=	amod	3	SENT_37	[p2l211t1807r247b1825],
3	body	NN	O	body	dep	1	SENT_37	[p2l276t1793r393b1844],
4	mass	NN	O	mass	nn	5	SENT_37	[p2l416t1803r548b1834],
5	index	NN	O	index	dep	1	SENT_37	[p2l571t1793r707b1834],

1	CART	NN	O	cart	_	0	SENT_38	[p2l81t1913r223b1954],
2	=	JJ	O	=	amod	3	SENT_38	[p2l249t1926r285b1945],
3	classification	NN	O	classification	dep	1	SENT_38	[p2l312t1913r652b1954],
4	and	CC	O	and	_	0	SENT_38	[p2l676t1913r765b1954],
5	regression	NN	O	regression	nn	6	SENT_38	[p2l83t1997r346b2048],
6	trees	NNS	O	tree	dep	1	SENT_38	[p2l368t1999r500b2039],

1	CYP	NN	O	cyp	_	0	SENT_39	[p2l81t2117r187b2159],
2	=	JJ	O	=	amod	4	SENT_39	[p2l214t2131r249b2149],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_39	[p2l276t2118r577b2168],
4	P450	NN	O	p450	dep	1	SENT_39	[p2l601t2117r736b2159],

1	DNA	NN	O	dna	_	0	SENT_40	[p2l83t2238r192b2278],
2	=	JJ	O	=	amod	4	SENT_40	[p2l218t2251r254b2269],
3	deoxyribonucleic	JJ	O	deoxyribonucleic	amod	4	SENT_40	[p2l281t2237r713b2288],
4	acid	NN	O	acid	dep	1	SENT_40	[p2l81t2322r186b2363],

1	Ml	NN	O	ml	_	0	SENT_41	[p2l83t2442r144b2482],
2	=	JJ	O	=	amod	4	SENT_41	[p2l173t2455r209b2474],
3	myocardial	JJ	O	myocardial	amod	4	SENT_41	[p2l237t2442r513b2493],
4	infarction	NN	O	infarction	dep	1	SENT_41	[p2l538t2442r777b2483],

1	PCI	NN	O	pcus	_	0	SENT_42	[p2l83t2562r167b2603],
2	=	JJ	O	=	amod	5	SENT_42	[p2l197t2575r232b2594],
3	percutaneous	JJ	O	percutaneous	amod	5	SENT_42	[p2l261t2563r608b2612],
4	coronary	JJ	O	coronary	amod	5	SENT_42	[p2l81t2656r303b2697],
5	intervention	NN	O	intervention	dep	1	SENT_42	[p2l325t2646r628b2687],

1	RPA	NN	O	rpa	_	0	SENT_43	[p2l84t2767r190b2807],
2	=	JJ	O	=	amod	5	SENT_43	[p2l216t2780r252b2798],
3	residual	JJ	O	residual	amod	5	SENT_43	[p2l281t2766r478b2807],
4	platelet	NN	O	platelet	nn	5	SENT_43	[p2l503t2767r697b2817],
5	aggregation	NN	O	aggregation	dep	1	SENT_43	[p2l81t2850r387b2901],

1	5-umol/l	JJ	O	5-umol/l	amod	3	SENT_44	[p3l11t28r340b112],
2	adenosine	NN	O	adenosine	nn	3	SENT_44	[p3l374t28r722b94],
3	diphosphate	NN	O	diphosphate	_	0	SENT_44	[p3l757t28r1189b117],
4	(	CD	NUMBER	(	num	6	SENT_44	[p3l1226t26r1489b108],
5	ADP	NN	O	adp	nn	6	SENT_44	[p3l1226t26r1489b108],
6	)	NN	O	)	dep	3	SENT_44	[p3l1226t26r1489b108],
7	.	.	O	.	_	0	SENT_44	[p3l1226t26r1489b108],

1	The	DT	O	the	det	2	SENT_45	[p3l96t133r240b201],
2	variability	NN	O	variability	nsubj	8	SENT_45	[p3l266t135r602b224],
3	of	IN	O	of	_	0	SENT_45	[p3l628t135r706b201],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_45	[p3l724t135r1100b224],
5	responses	NNS	O	response	prep_of	2	SENT_45	[p3l1128t161r1447b224],
6	is	VBZ	O	be	cop	8	SENT_45	[p3l1477t138r1526b201],
7	a	DT	O	a	det	8	SENT_45	[p3l1558t161r1592b201],
8	consequence	NN	O	consequence	_	0	SENT_45	[p3l1620t161r2045b224],
9	of	IN	O	of	_	0	SENT_45	[p3l2075t135r2153b201],
10	variable	JJ	O	variable	amod	11	SENT_45	[p3l7t241r268b307],
11	formation	NN	O	formation	prep_of	8	SENT_45	[p3l298t241r636b307],
12	of	IN	O	of	_	0	SENT_45	[p3l666t241r744b307],
13	the	DT	O	the	det	15	SENT_45	[p3l761t241r868b307],
14	active	JJ	O	active	amod	15	SENT_45	[p3l899t244r1088b307],
15	metabolite	NN	O	metabolite	prep_of	11	SENT_45	[p3l1118t241r1476b307],
16	(	CD	NUMBER	(	number	17	SENT_45	[p3l1508t239r1724b322],
17	9,10	CD	NUMBER	9,10	num	18	SENT_45	[p3l1508t239r1724b322],
18	)	NN	O	)	dep	15	SENT_45	[p3l1508t239r1724b322],
19	.	.	O	.	_	0	SENT_45	[p3l1508t239r1724b322],

1	The	DT	O	the	det	8	SENT_46	[p3l1755t239r1898b307],
2	highly	RB	O	highly	advmod	3	SENT_46	[p3l1929t241r2145b330],
3	polymorphic	JJ	O	polymorphic	amod	8	SENT_46	[p3l9t347r442b436],
4	cytochrome	NN	O	cytochrome	nn	8	SENT_46	[p3l465t347r861b436],
5	P450	NN	O	p450	nn	8	SENT_46	[p3l885t347r1062b413],
6	(	CD	NUMBER	(	num	8	SENT_46	[p3l1089t345r1310b427],
7	CYP	NN	O	cyp	nn	8	SENT_46	[p3l1089t345r1310b427],
8	)	NN	O	)	nn	9	SENT_46	[p3l1089t345r1310b427],
9	system	NN	O	system	nsubj	13	SENT_46	[p3l1339t364r1564b436],
10	of	IN	O	of	_	0	SENT_46	[p3l1589t347r1667b413],
11	the	DT	O	the	det	12	SENT_46	[p3l1678t347r1784b413],
12	liver	NN	O	liver	prep_of	9	SENT_46	[p3l1807t347r1953b413],
13	plays	VBZ	O	play	_	0	SENT_46	[p3l1973t347r2138b436],
14	a	DT	O	a	det	16	SENT_46	[p3l12t479r47b519],
15	key	JJ	O	key	amod	16	SENT_46	[p3l71t453r188b542],
16	role	NN	O	role	dobj	13	SENT_46	[p3l210t453r336b519],
17	in	IN	O	in	_	0	SENT_46	[p3l363t456r428b518],
18	this	DT	O	this	det	19	SENT_46	[p3l454t453r576b519],
19	respect	NN	O	respect	prep_in	13	SENT_46	[p3l603t470r839b542],
20	(	CD	NUMBER	(	number	21	SENT_46	[p3l866t451r1125b534],
21	11,12	CD	NUMBER	11,12	num	22	SENT_46	[p3l866t451r1125b534],
22	)	NN	O	)	dep	13	SENT_46	[p3l866t451r1125b534],
23	.	.	O	.	_	0	SENT_46	[p3l866t451r1125b534],

1	Speciﬁcally	RB	O	speciﬁcally	advmod	16	SENT_47	[p3l1159t453r1552b542],
2	,	,	O	,	_	0	SENT_47	[p3l1159t453r1552b542],
3	carriers	NNS	O	carrier	nsubj	16	SENT_47	[p3l1581t456r1822b519],
4	of	IN	O	of	_	0	SENT_47	[p3l1850t453r1928b519],
5	the	DT	O	the	det	9	SENT_47	[p3l1942t453r2049b519],
6	*	NN	O	*	nn	9	SENT_47	[p3l2080t456r2141b520],
7	2	CD	NUMBER	2	num	9	SENT_47	[p3l2080t456r2141b520],
8	loss	NN	O	loss	nn	9	SENT_47	[p3l9t559r555b625],
9	—	NN	O	—	prep_of	3	SENT_47	[p3l9t559r555b625],
10	of	IN	O	of	_	0	SENT_47	[p3l9t559r555b625],
11	—	CD	NUMBER	—	num	13	SENT_47	[p3l9t559r555b625],
12	function	NN	O	function	nn	13	SENT_47	[p3l9t559r555b625],
13	allele	NN	O	allele	prep_of	9	SENT_47	[p3l592t559r760b625],
14	of	IN	O	of	_	0	SENT_47	[p3l797t559r875b625],
15	CYP2C19	NN	O	cyp2c19	prep_of	13	SENT_47	[p3l906t562r1239b626],
16	generate	VBP	O	generate	_	0	SENT_47	[p3l1273t576r1558b648],
17	less	JJR	O	less	amod	18	SENT_47	[p3l1593t559r1708b625],
18	amounts	NNS	O	amount	dobj	16	SENT_47	[p3l1747t576r2036b625],
19	of	IN	O	of	_	0	SENT_47	[p3l2075t559r2153b625],
20	the	DT	O	the	det	22	SENT_47	[p3l10t665r117b731],
21	active	JJ	O	active	amod	22	SENT_47	[p3l156t668r344b731],
22	metabolite	NN	O	metabolite	prep_of	18	SENT_47	[p3l382t665r739b731],
23	of	IN	O	of	_	0	SENT_47	[p3l777t665r855b731],
24	clopidogrel	NN	O	clopidogrel	prep_of	22	SENT_47	[p3l880t665r1274b754],
25	,	,	O	,	_	0	SENT_47	[p3l880t665r1274b754],
26	resulting	VBG	O	result	partmod	18	SENT_47	[p3l1313t665r1608b754],
27	in	IN	O	in	_	0	SENT_47	[p3l1642t668r1708b730],
28	a	DT	O	a	det	31	SENT_47	[p3l1746t691r1781b731],
29	decreased	VBN	O	decrease	amod	31	SENT_47	[p3l1817t665r2142b731],
30	antiplatelet	JJ	O	antiplatelet	amod	31	SENT_47	[p3l12t771r389b860],
31	effect	NN	O	effect	prep_in	26	SENT_47	[p3l409t771r601b852],
32	,	,	O	,	_	0	SENT_47	[p3l409t771r601b852],
33	and	CC	O	and	_	0	SENT_47	[p3l627t771r751b837],
34	therefore	RB	O	therefore	advmod	16	SENT_47	[p3l771t771r1075b837],
35	carry	VBP	O	carry	conj_and	16	SENT_47	[p3l1098t796r1264b860],
36	an	DT	O	a	det	38	SENT_47	[p3l1283t797r1361b837],
37	increased	VBN	O	increase	amod	38	SENT_47	[p3l1382t771r1695b837],
38	risk	NN	O	risk	dobj	35	SENT_47	[p3l1715t771r1841b837],
39	of	IN	O	of	_	0	SENT_47	[p3l1858t771r1936b837],
40	major	JJ	O	major	amod	43	SENT_47	[p3l1946t772r2142b860],
41	adverse	JJ	O	adverse	amod	43	SENT_47	[p3l12t877r256b943],
42	cardiac	JJ	O	cardiac	amod	43	SENT_47	[p3l299t877r534b943],
43	events	NNS	O	event	prep_of	38	SENT_47	[p3l576t894r783b943],
44	after	IN	O	after	_	0	SENT_47	[p3l827t877r979b943],
45	stent	JJ	O	stent	amod	46	SENT_47	[p3l1020t894r1184b943],
46	placement	NN	O	placement	prep_after	35	SENT_47	[p3l1222t877r1573b966],
47	compared	VBN	O	compare	_	0	SENT_47	[p3l1613t877r1948b966],
48	with	IN	O	with	prepc_compared_with	35	SENT_47	[p3l1985t877r2141b943],
49	wild-type	JJ	O	wild-type	amod	50	SENT_47	[p3l7t983r333b1072],
50	homozygotes	NNS	O	homozygote	pobj	35	SENT_47	[p3l363t983r811b1072],
51	of	IN	O	of	_	0	SENT_47	[p3l843t983r921b1049],
52	this	DT	O	this	det	54	SENT_47	[p3l938t983r1060b1049],
53	gene	NN	O	gene	nn	54	SENT_47	[p3l1090t1009r1248b1072],
54	(	NN	O	(	prep_of	50	SENT_47	[p3l1281t981r1625b1064],
55	8,13	CD	NUMBER	8,13	number	56	SENT_47	[p3l1281t981r1625b1064],
56	—	CD	NUMBER	—	dep	54	SENT_47	[p3l1281t981r1625b1064],
57	17	CD	NUMBER	17	num	58	SENT_47	[p3l1281t981r1625b1064],
58	)	NN	O	)	dep	56	SENT_47	[p3l1281t981r1625b1064],
59	.	.	O	.	_	0	SENT_47	[p3l1281t981r1625b1064],

1	After	IN	O	after	_	0	SENT_48	[p3l97t1087r288b1155],
2	documentation	NN	O	documentation	prep_after	20	SENT_48	[p3l325t1089r859b1155],
3	of	IN	O	of	_	0	SENT_48	[p3l899t1089r978b1155],
4	the	DT	O	the	det	5	SENT_48	[p3l1004t1089r1114b1155],
5	impact	NN	O	impact	prep_of	2	SENT_48	[p3l1153t1092r1395b1178],
6	of	IN	O	of	_	0	SENT_48	[p3l1432t1089r1512b1155],
7	the	DT	O	the	det	8	SENT_48	[p3l1538t1089r1648b1155],
8	variability	NN	O	variability	prep_of	5	SENT_48	[p3l1683t1089r2038b1178],
9	of	IN	O	of	_	0	SENT_48	[p3l2073t1089r2152b1155],
10	the	DT	O	the	det	12	SENT_48	[p3l10t1195r120b1261],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_48	[p3l162t1195r557b1284],
12	effect	NN	O	effect	prep_of	8	SENT_48	[p3l597t1195r781b1261],
13	on	IN	O	on	_	0	SENT_48	[p3l821t1221r908b1261],
14	clinical	JJ	O	clinical	amod	15	SENT_48	[p3l949t1195r1197b1261],
15	outcome	NN	O	outcome	prep_on	12	SENT_48	[p3l1237t1212r1560b1276],
16	,	,	O	,	_	0	SENT_48	[p3l1237t1212r1560b1276],
17	there	EX	O	there	expl	20	SENT_48	[p3l1603t1195r1781b1261],
18	has	VBZ	O	have	aux	20	SENT_48	[p3l1822t1195r1934b1261],
19	been	VBN	O	be	aux	20	SENT_48	[p3l1974t1195r2140b1261],
20	growing	VBG	O	grow	_	0	SENT_48	[p3l9t1305r302b1391],
21	interest	NN	O	interest	dobj	20	SENT_48	[p3l336t1305r599b1368],
22	in	IN	O	in	_	0	SENT_48	[p3l634t1305r701b1367],
23	platelet	NN	O	platelet	nn	25	SENT_48	[p3l736t1302r997b1391],
24	function	NN	O	function	nn	25	SENT_48	[p3l1031t1302r1328b1368],
25	testing	NN	O	testing	prep_in	20	SENT_48	[p3l1364t1305r1603b1391],
26	to	TO	O	to	aux	27	SENT_48	[p3l1637t1319r1705b1368],
27	guide	VB	O	guide	xcomp	20	SENT_48	[p3l1741t1302r1934b1391],
28	antiplatelet	JJ	O	antiplatelet	amod	29	SENT_48	[p3l1972t1305r2137b1368, p3l9t1408r271b1497],
29	therapy	NN	O	therapy	dobj	27	SENT_48	[p3l323t1408r591b1497],
30	(	CD	NUMBER	(	num	32	SENT_48	[p3l645t1406r804b1488],
31	18	CD	NUMBER	18	num	32	SENT_48	[p3l645t1406r804b1488],
32	)	NN	O	)	dep	29	SENT_48	[p3l645t1406r804b1488],
33	.	.	O	.	_	0	SENT_48	[p3l645t1406r804b1488],

1	Alternatively	RB	O	alternatively	advmod	19	SENT_49	[p3l860t1406r1339b1497],
2	,	,	O	,	_	0	SENT_49	[p3l860t1406r1339b1497],
3	the	DT	O	the	det	4	SENT_49	[p3l1397t1408r1507b1474],
4	development	NN	O	development	nsubj	19	SENT_49	[p3l1564t1408r2020b1497],
5	of	IN	O	of	_	0	SENT_49	[p3l2073t1408r2153b1474],
6	means	NNS	O	means	prep_of	4	SENT_49	[p3l11t1541r232b1581],
7	to	TO	O	to	aux	8	SENT_49	[p3l262t1532r330b1581],
8	predict	VB	O	predict	infmod	6	SENT_49	[p3l359t1515r607b1604],
9	responses	NNS	O	response	dobj	8	SENT_49	[p3l633t1541r966b1604],
10	to	TO	O	to	_	0	SENT_49	[p3l997t1532r1064b1581],
11	clopidogrel	NN	O	clopidogrel	prep_to	8	SENT_49	[p3l1095t1515r1490b1604],
12	without	IN	O	without	_	0	SENT_49	[p3l1513t1515r1794b1581],
13	performing	VBG	O	perform	prepc_without	8	SENT_49	[p3l1820t1515r2138b1604, p3l10t1624r123b1710],
14	platelet	NN	O	platelet	nn	16	SENT_49	[p3l149t1621r409b1710],
15	function	NN	O	function	nn	16	SENT_49	[p3l436t1621r733b1687],
16	assays	NNS	O	assay	dobj	13	SENT_49	[p3l763t1647r966b1710],
17	is	VBZ	O	be	cop	19	SENT_49	[p3l996t1624r1046b1687],
18	highly	RB	O	highly	advmod	19	SENT_49	[p3l1077t1621r1301b1710],
19	attractive	JJ	O	attractive	_	0	SENT_49	[p3l1327t1624r1668b1687],
20	.	.	O	.	_	0	SENT_49	[p3l1327t1624r1668b1687],

1	To	TO	O	to	_	0	SENT_50	[p3l1698t1619r1803b1687],
2	this	DT	O	this	det	3	SENT_50	[p3l1833t1621r1959b1687],
3	end	NN	O	end	prep_to	17	SENT_50	[p3l1991t1621r2137b1702],
4	,	,	O	,	_	0	SENT_50	[p3l1991t1621r2137b1702],
5	testing	NN	O	testing	nsubjpass	17	SENT_50	[p3l10t1730r249b1816],
6	for	IN	O	for	_	0	SENT_50	[p3l293t1727r393b1793],
7	CYP	NN	O	cyp	nn	8	SENT_50	[p3l439t1727r613b1793],
8	polymorphisms	NNS	O	polymorphism	prep_for	5	SENT_50	[p3l658t1727r1225b1816],
9	,	,	O	,	_	0	SENT_50	[p3l658t1727r1225b1816],
10	speciﬁcally	RB	O	speciﬁcally	advmod	5	SENT_50	[p3l1275t1727r1657b1816],
11	CYP2C19	NN	O	cyp2c19	nn	12	SENT_50	[p3l1705t1730r2138b1808],
12	*	NN	O	*	dep	5	SENT_50	[p3l1705t1730r2138b1808],
13	2	CD	NUMBER	2	dep	12	SENT_50	[p3l1705t1730r2138b1808],
14	,	,	O	,	_	0	SENT_50	[p3l1705t1730r2138b1808],
15	has	VBZ	O	have	aux	17	SENT_50	[p3l10t1833r123b1899],
16	been	VBN	O	be	auxpass	17	SENT_50	[p3l151t1833r317b1899],
17	suggested	VBN	O	suggest	_	0	SENT_50	[p3l347t1833r688b1922],
18	(	CD	NUMBER	(	number	19	SENT_50	[p3l718t1831r1100b1914],
19	17,19,20	CD	NUMBER	17,19,20	num	20	SENT_50	[p3l718t1831r1100b1914],
20	)	NN	O	)	dobj	17	SENT_50	[p3l718t1831r1100b1914],
21	.	.	O	.	_	0	SENT_50	[p3l718t1831r1100b1914],

1	Irrespective	RB	O	irrespective	_	0	SENT_51	[p3l1132t1834r1540b1922],
2	of	IN	O	of	_	0	SENT_51	[p3l1569t1833r1650b1899],
3	genetic	JJ	O	genetic	amod	4	SENT_51	[p3l1664t1836r1918b1922],
4	background	NN	O	background	prep_irrespective_of	9	SENT_51	[p3l1943t1833r2138b1899, p3l9t1940r283b2029],
5	,	,	O	,	_	0	SENT_51	[p3l1943t1833r2138b1899, p3l9t1940r283b2029],
6	however	RB	O	however	advmod	9	SENT_51	[p3l322t1940r636b2021],
7	,	,	O	,	_	0	SENT_51	[p3l322t1940r636b2021],
8	there	EX	O	there	expl	9	SENT_51	[p3l675t1940r853b2006],
9	are	VBP	O	be	_	0	SENT_51	[p3l892t1966r992b2006],
10	a	DT	O	a	det	11	SENT_51	[p3l1031t1966r1065b2006],
11	number	NN	O	number	nsubj	9	SENT_51	[p3l1101t1940r1375b2006],
12	of	IN	O	of	_	0	SENT_51	[p3l1410t1940r1490b2006],
13	demographic	JJ	O	demographic	amod	16	SENT_51	[p3l1515t1940r1977b2029],
14	and	CC	O	and	_	0	SENT_51	[p3l2014t1940r2141b2006],
15	clinical	JJ	O	clinical	amod	16	SENT_51	[p3l11t2046r260b2112],
16	variables	NNS	O	variable	prep_of	11	SENT_51	[p3l294t2046r598b2112],
17	that	WDT	O	that	nsubj	18	SENT_51	[p3l638t2046r779b2112],
18	interfere	VBP	O	interfere	rcmod	16	SENT_51	[p3l816t2046r1114b2112],
19	with	IN	O	with	_	0	SENT_51	[p3l1150t2046r1311b2112],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_51	[p3l1351t2046r1746b2135],
21	responses	NNS	O	response	prep_with	18	SENT_51	[p3l1783t2072r2138b2135],
22	,	,	O	,	_	0	SENT_51	[p3l1783t2072r2138b2135],
23	such	JJ	O	such	_	0	SENT_51	[p3l12t2152r173b2218],
24	as	IN	O	as	_	0	SENT_51	[p3l239t2178r304b2218],
25	age	NN	O	age	prep_such_as	16	SENT_51	[p3l372t2178r510b2241],
26	,	,	O	,	_	0	SENT_51	[p3l372t2178r510b2241],
27	body	NN	O	body	nn	32	SENT_51	[p3l576t2152r757b2241],
28	mass	NN	O	mass	nn	32	SENT_51	[p3l819t2178r991b2218],
29	index	NN	O	index	nn	32	SENT_51	[p3l1057t2152r1256b2218],
30	(	CD	NUMBER	(	num	32	SENT_51	[p3l1322t2150r1580b2233],
31	BMI	NN	O	bmus	nn	32	SENT_51	[p3l1322t2150r1580b2233],
32	)	NN	O	)	conj_and	25	SENT_51	[p3l1322t2150r1580b2233],
33	,	,	O	,	_	0	SENT_51	[p3l1322t2150r1580b2233],
34	and	CC	O	and	_	0	SENT_51	[p3l1650t2152r1780b2218],
35	diabetes	NN	O	diabetes	conj_and	25	SENT_51	[p3l1846t2152r2139b2218],
36	(	CD	NUMBER	(	number	37	SENT_51	[p3l13t2256r418b2339],
37	6,8,21,22	CD	NUMBER	6,8,21,22	num	38	SENT_51	[p3l13t2256r418b2339],
38	)	NN	O	)	dep	35	SENT_51	[p3l13t2256r418b2339],
39	.	.	O	.	_	0	SENT_51	[p3l13t2256r418b2339],

1	The	DT	O	the	det	3	SENT_52	[p3l470t2256r616b2324],
2	relative	JJ	O	relative	amod	3	SENT_52	[p3l667t2258r920b2324],
3	role	NN	O	role	nsubj	17	SENT_52	[p3l971t2258r1102b2324],
4	of	IN	O	of	_	0	SENT_52	[p3l1153t2258r1233b2324],
5	these	DT	O	these	det	9	SENT_52	[p3l1271t2258r1450b2324],
6	demographic	JJ	O	demographic	amod	9	SENT_52	[p3l1501t2258r1963b2347],
7	and	CC	O	and	_	0	SENT_52	[p3l2014t2258r2141b2324],
8	clinical	JJ	O	clinical	amod	9	SENT_52	[p3l11t2364r260b2430],
9	variables	NNS	O	variable	prep_of	3	SENT_52	[p3l312t2364r616b2430],
10	versus	CC	O	versus	prep	9	SENT_52	[p3l671t2389r884b2430],
11	the	DT	O	the	det	14	SENT_52	[p3l943t2364r1053b2430],
12	CYP2CZ	NN	O	cyp2cz	nn	14	SENT_52	[p3l1118t2367r1412b2431],
13	9	CD	NUMBER	9	num	14	SENT_52	[p3l1423t2370r1462b2430],
14	polymorphism	NN	O	polymorphism	dep	10	SENT_52	[p3l1516t2364r2031b2453],
15	is	VBZ	O	be	cop	17	SENT_52	[p3l2089t2367r2139b2430],
16	currently	RB	DATE	currently	advmod	17	SENT_52	[p3l11t2470r328b2559],
17	unclear	JJ	O	unclear	_	0	SENT_52	[p3l363t2470r636b2536],
18	.	.	O	.	_	0	SENT_52	[p3l363t2470r636b2536],

1	Clarifying	VBG	O	clarify	csubj	4	SENT_53	[p3l682t2470r1040b2559],
2	this	DT	O	this	det	3	SENT_53	[p3l1077t2470r1204b2536],
3	issue	NN	O	issue	dobj	1	SENT_53	[p3l1245t2473r1411b2536],
4	is	VBZ	O	be	_	0	SENT_53	[p3l1451t2473r1501b2536],
5	of	IN	O	of	_	0	SENT_53	[p3l1544t2470r1623b2536],
6	major	JJ	O	major	amod	8	SENT_53	[p3l1652t2471r1855b2559],
7	clinical	JJ	O	clinical	amod	8	SENT_53	[p3l1894t2470r2142b2536],
8	interest	NN	O	interest	prep_of	4	SENT_53	[p3l10t2580r292b2658],
9	,	,	O	,	_	0	SENT_53	[p3l10t2580r292b2658],
10	because	IN	O	because	mark	13	SENT_53	[p3l316t2577r585b2643],
11	it	PRP	O	it	nsubj	13	SENT_53	[p3l609t2580r660b2643],
12	might	MD	O	might	aux	13	SENT_53	[p3l682t2577r895b2666],
13	help	VB	O	help	advcl	4	SENT_53	[p3l916t2577r1065b2666],
14	to	TO	O	to	aux	15	SENT_53	[p3l1089t2594r1158b2643],
15	guide	VB	O	guide	xcomp	13	SENT_53	[p3l1181t2577r1374b2666],
16	the	DT	O	the	det	18	SENT_53	[p3l1398t2577r1508b2643],
17	optimal	JJ	O	optimal	amod	18	SENT_53	[p3l1532t2577r1804b2666],
18	choice	NN	O	choice	dobj	15	SENT_53	[p3l1827t2577r2049b2643],
19	of	IN	O	of	_	0	SENT_53	[p3l2073t2577r2153b2643],
20	test	NN	O	test	prep_of	18	SENT_53	[p3l10t2735r135b2784],
21	for	IN	O	for	_	0	SENT_53	[p3l160t2718r261b2784],
22	assessing	VBG	O	assess	prepc_for	15	SENT_53	[p3l288t2721r602b2807],
23	a	DT	O	a	det	24	SENT_53	[p3l629t2744r663b2784],
24	patient	NN	O	patient	poss	26	SENT_53	[p3l688t2718r982b2807],
25	’s	POS	O	’s	_	0	SENT_53	[p3l688t2718r982b2807],
26	risk	NN	O	risk	dobj	22	SENT_53	[p3l1011t2718r1142b2784],
27	of	IN	O	of	_	0	SENT_53	[p3l1166t2718r1246b2784],
28	being	VBG	O	be	cop	31	SENT_53	[p3l1259t2718r1457b2807],
29	a	DT	O	a	det	31	SENT_53	[p3l1484t2744r1518b2784],
30	low	JJ	O	low	amod	31	SENT_53	[p3l1543t2718r1672b2784],
31	responder	NN	O	responder	prepc_of	26	SENT_53	[p3l1696t2718r2046b2807],
32	to	TO	O	to	_	0	SENT_53	[p3l2072t2735r2139b2784],
33	clopidogrel	NN	O	clopidogrel	prep_to	31	SENT_53	[p3l11t2859r406b2948],
34	and	CC	O	and	_	0	SENT_53	[p3l439t2859r566b2925],
35	for	IN	O	for	_	0	SENT_53	[p3l599t2859r699b2925],
36	tailoring	VBG	O	tailor	conj_and	22	SENT_53	[p3l730t2859r1031b2948],
37	antiplatelet	JJ	O	antiplatelet	amod	38	SENT_53	[p3l1063t2859r1459b2948],
38	therapy	NN	O	therapy	dobj	36	SENT_53	[p3l1490t2859r1772b2948],
39	.	.	O	.	_	0	SENT_53	[p3l1490t2859r1772b2948],

1	Therefore	RB	O	therefore	advmod	4	SENT_54	[p3l96t2963r472b3046],
2	,	,	O	,	_	0	SENT_54	[p3l96t2963r472b3046],
3	we	PRP	O	we	nsubj	4	SENT_54	[p3l524t2991r623b3031],
4	analyzed	VBD	O	analyze	_	0	SENT_54	[p3l678t2965r981b3054],
5	the	DT	O	the	det	7	SENT_54	[p3l1033t2965r1143b3031],
6	EXCELSIOR	NNP	O	EXCELSIOR	nn	7	SENT_54	[p3l1199t2965r1723b3031],
7	dataset	NN	O	dataset	dobj	4	SENT_54	[p3l1774t2965r2020b3031],
8	to	TO	O	to	aux	9	SENT_54	[p3l2071t2982r2139b3031],
9	estimate	VB	O	estimate	conj_and	9	SENT_54	[p3l11t3074r304b3137],
10	the	DT	O	the	det	12	SENT_54	[p3l340t3071r450b3137],
11	relative	JJ	O	relative	amod	12	SENT_54	[p3l487t3071r740b3137],
12	contribution	NN	O	contribution	dobj	9	SENT_54	[p3l778t3071r1218b3137],
13	of	IN	O	of	_	0	SENT_54	[p3l1254t3071r1334b3137],
14	clinical	JJ	O	clinical	amod	15	SENT_54	[p3l1358t3071r1607b3137],
15	variables	NNS	O	variable	prep_of	12	SENT_54	[p3l1638t3071r1942b3137],
16	generally	RB	O	generally	advmod	9	SENT_54	[p3l1978t3097r2137b3160, p3l11t3177r201b3266],
17	on	IN	O	on	_	0	SENT_54	[p3l222t3177r525b3243],
18	—	CD	NUMBER	—	num	19	SENT_54	[p3l222t3177r525b3243],
19	hand	NN	O	hand	prep_on	9	SENT_54	[p3l222t3177r525b3243],
20	and	CC	O	and	_	0	SENT_54	[p3l550t3177r677b3243],
21	of	IN	O	of	_	0	SENT_54	[p3l701t3177r780b3243],
22	carrier	NN	O	carrier	nn	23	SENT_54	[p3l793t3180r1017b3243],
23	status	NN	O	status	prep_of	9	SENT_54	[p3l1040t3194r1237b3243],
24	for	IN	O	for	_	0	SENT_54	[p3l1262t3177r1363b3243],
25	the	DT	O	the	det	27	SENT_54	[p3l1384t3177r1494b3243],
26	CYP2C19	NN	O	cyp2c19	nn	27	SENT_54	[p3l1525t3180r1939b3244],
27	*	NN	O	*	prep_for	23	SENT_54	[p3l1525t3180r1939b3244],
28	2	CD	NUMBER	2	num	29	SENT_54	[p3l1525t3180r1939b3244],
29	allele	NN	O	allele	dep	9	SENT_54	[p3l1963t3177r2140b3243],
30	for	IN	O	for	_	0	SENT_54	[p3l10t3283r111b3349],
31	prediction	NN	O	prediction	prep_for	9	SENT_54	[p3l141t3283r503b3372],
32	of	IN	O	of	_	0	SENT_54	[p3l537t3283r616b3349],
33	the	DT	O	the	det	35	SENT_54	[p3l637t3283r747b3349],
34	antiplatelet	JJ	O	antiplatelet	amod	35	SENT_54	[p3l782t3283r1178b3372],
35	effects	NNS	O	effect	prep_of	31	SENT_54	[p3l1211t3283r1424b3349],
36	of	IN	O	of	_	0	SENT_54	[p3l1459t3283r1539b3349],
37	clopidogrel	NN	O	clopidogrel	prep_of	35	SENT_54	[p3l1561t3283r1972b3372],
38	.	.	O	.	_	0	SENT_54	[p3l1561t3283r1972b3372],

1	Methods	NNS	O	method	_	0	SENT_55	[p3l13t3532r378b3594],

1	Study	NNP	O	Study	_	0	SENT_56	[p4l13t51r228b141],
2	population	NN	O	population	dep	1	SENT_56	[p4l282t51r712b141],
3	.	.	O	.	_	0	SENT_56	[p4l282t51r712b141],

1	Details	NNS	O	detail	nsubjpass	9	SENT_57	[p4l763t52r1013b118],
2	of	IN	O	of	_	0	SENT_57	[p4l1075t52r1154b118],
3	the	DT	O	the	det	6	SENT_57	[p4l1201t52r1312b118],
4	EXCELSIOR	NNP	O	EXCELSIOR	nn	6	SENT_57	[p4l1373t52r1897b118],
5	study	NN	O	study	nn	6	SENT_57	[p4l1956t52r2145b141],
6	design	NN	O	design	prep_of	1	SENT_57	[p4l11t158r237b247],
7	have	VBP	O	have	aux	9	SENT_57	[p4l283t158r441b224],
8	been	VBN	O	be	auxpass	9	SENT_57	[p4l486t158r652b224],
9	published	VBN	O	publish	_	0	SENT_57	[p4l697t158r1041b247],
10	previously	RB	DATE	previously	advmod	9	SENT_57	[p4l1085t158r1445b247],
11	(	CD	NUMBER	(	number	12	SENT_57	[p4l1490t156r1672b239],
12	6,8	CD	NUMBER	6,8	num	13	SENT_57	[p4l1490t156r1672b239],
13	)	NN	O	)	dobj	9	SENT_57	[p4l1490t156r1672b239],
14	.	.	O	.	_	0	SENT_57	[p4l1490t156r1672b239],

1	Brieﬂy	NNP	O	Brieﬂy	_	0	SENT_58	[p4l1723t158r1976b247],
2	,	,	O	,	_	0	SENT_58	[p4l1723t158r1976b247],
3	patients	NNS	O	patient	appos	1	SENT_58	[p4l2024t184r2138b247, p4l10t268r202b331],
4	undergoing	VBG	O	undergo	partmod	3	SENT_58	[p4l249t265r657b354],
5	elective	JJ	O	elective	amod	8	SENT_58	[p4l701t265r960b331],
6	coronary	JJ	O	coronary	amod	8	SENT_58	[p4l1007t291r1316b354],
7	stent	NN	O	stent	nn	8	SENT_58	[p4l1359t282r1530b331],
8	placement	NN	O	placement	dobj	4	SENT_58	[p4l1573t265r1938b354],
9	after	IN	O	after	_	0	SENT_58	[p4l1983t265r2142b331],
10	pretreatment	NN	O	pretreatment	prep_after	8	SENT_58	[p4l9t388r471b460],
11	with	IN	O	with	_	0	SENT_58	[p4l492t371r653b437],
12	600	CD	NUMBER	600	num	13	SENT_58	[p4l681t374r808b437],
13	mg	NN	O	mg	prep_with	4	SENT_58	[p4l837t397r949b460],
14	of	IN	O	of	_	0	SENT_58	[p4l975t371r1054b437],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_58	[p4l1070t371r1464b460],
16	and	CC	O	and	_	0	SENT_58	[p4l1491t371r1618b437],
17	aspirin	NN	O	aspirin	conj_and	13	SENT_58	[p4l1646t374r1881b460],
18	(	CD	NUMBER	(	num	17	SENT_58	[p4l1911t369r2140b451],
19	2100	CD	DATE	2100	num	20	SENT_58	[p4l1911t369r2140b451],
20	mg	NN	O	mg	dep	17	SENT_58	[p4l11t477r154b566],
21	/	:	O	/	punct	1	SENT_58	[p4l11t477r154b566],
22	day	NN	DURATION	day	nsubj	30	SENT_58	[p4l157t477r280b566],
23	for	IN	O	for	_	0	SENT_58	[p4l304t477r405b543],
24	at	IN	DURATION	at	quantmod	26	SENT_58	[p4l433t494r497b543],
25	least	JJS	DURATION	least	mwe	24	SENT_58	[p4l522t477r680b543],
26	5	CD	DURATION	5	num	27	SENT_58	[p4l707t477r745b543],
27	days	NNS	NUMBER	day	prep_for	22	SENT_58	[p4l778t475r953b566],
28	)	CD	NUMBER	)	dep	27	SENT_58	[p4l778t475r953b566],
29	were	VBD	O	be	cop	30	SENT_58	[p4l982t503r1148b543],
30	eligible	JJ	O	eligible	dep	1	SENT_58	[p4l1179t477r1430b566],
31	for	IN	O	for	_	0	SENT_58	[p4l1459t477r1560b543],
32	this	DT	O	this	det	35	SENT_58	[p4l1587t477r1714b543],
33	prospective	JJ	O	prospective	amod	35	SENT_58	[p4l1742t480r2140b566],
34	JACC	NN	O	jacc	nn	35	SENT_58	[p4l1481t581r1596b632],
35	Vol	NN	O	vol	prep_for	30	SENT_58	[p4l1616t582r1699b632],
36	.	.	O	.	_	0	SENT_58	[p4l1616t582r1699b632],

1	55	CD	NUMBER	55	_	0	SENT_59	[p4l1723t582r1797b641],
2	,	,	O	,	_	0	SENT_59	[p4l1723t582r1797b641],
3	No.	NN	O	no.	appos	1	SENT_59	[p4l1823t582r1894b632],
4	22	CD	NUMBER	22	num	3	SENT_59	[p4l1919t581r1992b641],
5	,	,	O	,	_	0	SENT_59	[p4l1919t581r1992b641],
6	2010	CD	DATE	2010	appos	1	SENT_59	[p4l2017t581r2140b632],
7	June	NNP	DATE	June	tmod	6	SENT_59	[p4l1589t670r1694b721],
8	1	CD	DATE	1	num	7	SENT_59	[p4l1718t670r1758b729],
9	,	,	O	,	_	0	SENT_59	[p4l1718t670r1758b729],
10	20101242	CD	NUMBER	20101242	number	11	SENT_59	[p4l1783t670r2141b721],
11	‘	CD	NUMBER	‘	appos	6	SENT_59	[p4l1783t670r2141b721],
12	/	:	O	/	punct	13	SENT_59	[p4l1783t670r2141b721],
13	-34	CD	NUMBER	-34	dep	11	SENT_59	[p4l1783t670r2141b721],

1	single	JJ	O	single	amod	4	SENT_60	[p4l12t889r469b978],
2	—	NN	O	—	nn	4	SENT_60	[p4l12t889r469b978],
3	center	NN	O	center	nn	4	SENT_60	[p4l12t889r469b978],
4	study	NN	O	study	nsubj	5	SENT_60	[p4l500t889r689b978],
5	conducted	VBN	O	conduct	_	0	SENT_60	[p4l717t889r1082b955],
6	in	IN	O	in	_	0	SENT_60	[p4l1112t892r1180b954],
7	a	DT	O	a	det	10	SENT_60	[p4l1213t915r1247b955],
8	referral	NN	O	referral	nn	10	SENT_60	[p4l1276t889r1529b955],
9	center	NN	O	center	nn	10	SENT_60	[p4l1560t906r1776b955],
10	setting	NN	O	setting	prep_in	5	SENT_60	[p4l1806t892r2044b978],
11	in	IN	O	in	_	0	SENT_60	[p4l2073t892r2141b954],
12	Bad	NNP	LOCATION	Bad	nn	13	SENT_60	[p4l11t995r151b1061],
13	Krozingen	NNP	LOCATION	Krozingen	prep_in	10	SENT_60	[p4l177t996r566b1084],
14	,	,	O	,	_	0	SENT_60	[p4l177t996r566b1084],
15	Germany	NNP	LOCATION	Germany	appos	13	SENT_60	[p4l595t995r944b1084],
16	.	.	O	.	_	0	SENT_60	[p4l595t995r944b1084],

1	We	PRP	O	we	nsubj	4	SENT_61	[p4l969t996r1099b1062],
2	did	VBD	O	do	aux	4	SENT_61	[p4l1125t995r1238b1061],
3	not	RB	O	not	neg	4	SENT_61	[p4l1262t1012r1379b1061],
4	include	VB	O	include	_	0	SENT_61	[p4l1402t995r1657b1061],
5	patients	NNS	O	patient	dobj	4	SENT_61	[p4l1680t998r1957b1084],
6	with	IN	O	with	_	0	SENT_61	[p4l1979t995r2141b1061],
7	acute	JJ	O	acute	amod	8	SENT_61	[p4l12t1118r192b1167],
8	MI	NNP	O	MI	prep_with	4	SENT_61	[p4l218t1102r334b1166],
9	according	VBG	O	accord	_	0	SENT_61	[p4l364t1101r707b1190],
10	to	TO	O	to	prepc_according_to	4	SENT_61	[p4l732t1118r800b1167],
11	the	DT	O	the	det	13	SENT_61	[p4l828t1101r938b1167],
12	European	JJ	ORGANIZATION	european	amod	13	SENT_61	[p4l967t1102r1312b1190],
13	Society	NNP	ORGANIZATION	Society	pobj	4	SENT_61	[p4l1342t1101r1597b1190],
14	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l1621t1101r1701b1167],
15	Cardiology	NNP	ORGANIZATION	Cardiology	nn	25	SENT_61	[p4l1717t1101r2142b1190],
16	/	:	ORGANIZATION	/	punct	24	SENT_61	[p4l1717t1101r2142b1190],
17	American	NNP	ORGANIZATION	American	nn	18	SENT_61	[p4l8t1205r358b1273],
18	College	NNP	ORGANIZATION	College	dep	24	SENT_61	[p4l390t1207r659b1296],
19	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l690t1207r770b1273],
20	Cardiology	NNP	ORGANIZATION	Cardiology	nn	22	SENT_61	[p4l789t1207r1186b1296],
21	consensus	NN	O	consensus	nn	22	SENT_61	[p4l1212t1233r1559b1273],
22	document	NN	O	document	prep_of	18	SENT_61	[p4l1592t1207r1946b1273],
23	(	CD	NUMBER	(	num	24	SENT_61	[p4l1977t1205r2138b1288],
24	23	CD	NUMBER	23	dep	25	SENT_61	[p4l1977t1205r2138b1288],
25	)	NN	O	)	prep_of	13	SENT_61	[p4l1977t1205r2138b1288],
26	;	:	O	;	_	0	SENT_61	[p4l1977t1205r2138b1288],
27	patients	NNS	O	patient	nsubj	28	SENT_61	[p4l9t1317r286b1403],
28	taking	VBG	O	take	parataxis	4	SENT_61	[p4l325t1314r548b1403],
29	chronic	JJ	O	chronic	amod	31	SENT_61	[p4l583t1314r846b1380],
30	oral	JJ	O	oral	amod	31	SENT_61	[p4l883t1314r1015b1380],
31	anticoagulation	NN	O	anticoagulation	dobj	28	SENT_61	[p4l1052t1314r1596b1403],
32	or	CC	O	or	_	0	SENT_61	[p4l1633t1340r1705b1380],
33	thienopyri	NN	O	thienopyrus	nn	36	SENT_61	[p4l1740t1314r2138b1403],
34	—	CD	NUMBER	—	num	36	SENT_61	[p4l1740t1314r2138b1403],
35	dine	NN	O	dine	nn	36	SENT_61	[p4l11t1420r162b1485],
36	treatment	NN	O	treatment	dobj	28	SENT_61	[p4l203t1437r550b1485],
37	within	IN	O	within	_	0	SENT_61	[p4l586t1420r818b1486],
38	the	DT	DURATION	the	det	41	SENT_61	[p4l859t1420r969b1485],
39	last	JJ	DURATION	last	amod	41	SENT_61	[p4l1010t1420r1130b1485],
40	2	CD	DURATION	2	num	41	SENT_61	[p4l1168t1423r1209b1486],
41	weeks	NNS	NUMBER	week	prep_within	28	SENT_61	[p4l1248t1420r1460b1486],
42	before	IN	O	before	_	0	SENT_61	[p4l1500t1420r1721b1485],
43	admission	NN	O	admission	prep_before	41	SENT_61	[p4l1765t1420r2137b1500],
44	;	:	O	;	_	0	SENT_61	[p4l1765t1420r2137b1500],
45	patients	NNS	O	patient	conj_and	41	SENT_61	[p4l9t1530r286b1616],
46	with	IN	O	with	_	0	SENT_61	[p4l329t1527r490b1593],
47	contraindications	NNS	O	contraindication	prep_with	45	SENT_61	[p4l535t1527r1144b1593],
48	to	TO	O	to	_	0	SENT_61	[p4l1191t1544r1258b1593],
49	aspirin	NN	O	aspirin	prep_to	47	SENT_61	[p4l1306t1530r1561b1616],
50	,	,	O	,	_	0	SENT_61	[p4l1306t1530r1561b1616],
51	clopidogrel	NN	O	clopidogrel	conj_or	49	SENT_61	[p4l1609t1527r2022b1616],
52	,	,	O	,	_	0	SENT_61	[p4l1609t1527r2022b1616],
53	or	CC	O	or	_	0	SENT_61	[p4l2070t1552r2142b1593],
54	heparin	NN	O	heparin	conj_or	49	SENT_61	[p4l10t1633r297b1722],
55	;	:	O	;	_	0	SENT_61	[p4l10t1633r297b1722],
56	and	CC	O	and	_	0	SENT_61	[p4l353t1633r481b1699],
57	patients	NNS	O	patient	conj_and	41	SENT_61	[p4l530t1636r807b1722],
58	with	IN	O	with	_	0	SENT_61	[p4l857t1633r1018b1699],
59	cancer	NN	O	cancer	prep_with	57	SENT_61	[p4l1070t1659r1294b1699],
60	or	CC	O	or	_	0	SENT_61	[p4l1345t1659r1417b1699],
61	hemodialysis	NN	O	hemodialysis	prep_with	57	SENT_61	[p4l1467t1633r1940b1722],
62	.	.	O	.	_	0	SENT_61	[p4l1467t1633r1940b1722],

1	The	DT	O	the	det	2	SENT_62	[p4l1993t1631r2140b1699],
2	study	NN	O	study	nsubjpass	4	SENT_62	[p4l12t1739r201b1828],
3	was	VBD	O	be	auxpass	4	SENT_62	[p4l223t1765r353b1805],
4	approved	VBN	O	approve	_	0	SENT_62	[p4l386t1739r708b1828],
5	by	IN	O	by	_	0	SENT_62	[p4l736t1739r822b1828],
6	the	DT	O	the	det	8	SENT_62	[p4l847t1739r958b1805],
7	ethics	NNS	O	ethic	nn	8	SENT_62	[p4l989t1739r1190b1805],
8	committee	NN	O	committee	agent	4	SENT_62	[p4l1222t1742r1597b1805],
9	of	IN	O	of	_	0	SENT_62	[p4l1629t1739r1709b1805],
10	the	DT	O	the	det	12	SENT_62	[p4l1726t1739r1837b1805],
11	medical	JJ	O	medical	amod	12	SENT_62	[p4l1868t1739r2142b1805],
12	faculty	NN	O	faculty	prep_of	8	SENT_62	[p4l10t1845r248b1934],
13	of	IN	O	of	_	0	SENT_62	[p4l272t1845r352b1911],
14	the	DT	O	the	det	15	SENT_62	[p4l366t1845r477b1911],
15	University	NNP	ORGANIZATION	University	prep_of	12	SENT_62	[p4l503t1846r871b1934],
16	of	IN	ORGANIZATION	of	_	0	SENT_62	[p4l895t1845r975b1911],
17	Freiburg	NNP	ORGANIZATION	Freiburg	nn	19	SENT_62	[p4l991t1845r1315b1934],
18	,	,	O	,	_	0	SENT_62	[p4l991t1845r1315b1934],
19	Germany	NNP	LOCATION	Germany	prep_of	15	SENT_62	[p4l1347t1845r1696b1934],
20	.	.	O	.	_	0	SENT_62	[p4l1347t1845r1696b1934],

1	All	DT	O	all	det	2	SENT_63	[p4l1725t1843r1837b1910],
2	patients	NNS	O	patient	nsubj	3	SENT_63	[p4l1862t1848r2138b1934],
3	gave	VBD	O	give	_	0	SENT_63	[p4l9t1978r164b2041],
4	Written	VBN	O	write	dep	3	SENT_63	[p4l194t1955r451b2018],
5	informed	VBN	O	inform	amod	6	SENT_63	[p4l484t1952r810b2018],
6	consent	NN	O	consent	dobj	4	SENT_63	[p4l843t1969r1130b2018],
7	.	.	O	.	_	0	SENT_63	[p4l843t1969r1130b2018],

1	Study	NNP	O	Study	_	0	SENT_64	[p4l13t2057r228b2147],
2	protocol	NN	O	protocol	dep	1	SENT_64	[p4l272t2057r607b2147],
3	.	.	O	.	_	0	SENT_64	[p4l272t2057r607b2147],

1	Before	IN	O	before	_	0	SENT_65	[p4l659t2058r891b2124],
2	the	DT	O	the	det	3	SENT_65	[p4l941t2058r1051b2124],
3	intervention	NN	O	intervention	prep_before	6	SENT_65	[p4l1101t2061r1533b2124],
4	all	DT	O	all	det	5	SENT_65	[p4l1584t2058r1664b2124],
5	patients	NNS	O	patient	nsubj	6	SENT_65	[p4l1711t2061r1988b2147],
6	received	VBD	O	receive	_	0	SENT_65	[p4l2040t2084r2137b2124, p4l11t2164r229b2230],
7	a	DT	O	a	det	9	SENT_65	[p4l265t2190r299b2230],
8	loading	VBG	O	load	amod	9	SENT_65	[p4l331t2164r597b2253],
9	dose	NN	O	dose	dobj	6	SENT_65	[p4l631t2164r786b2230],
10	of	IN	O	of	_	0	SENT_65	[p4l823t2164r903b2230],
11	600	CD	NUMBER	600	num	12	SENT_65	[p4l927t2167r1055b2230],
12	mg	NN	O	mg	prep_of	9	SENT_65	[p4l1092t2190r1204b2253],
13	of	IN	O	of	_	0	SENT_65	[p4l1238t2164r1318b2230],
14	clopidogrel	NN	O	clopidogrel	prep_of	12	SENT_65	[p4l1342t2164r1753b2253],
15	.	.	O	.	_	0	SENT_65	[p4l1342t2164r1753b2253],

1	Catheterization	NN	O	catheterization	nsubjpass	3	SENT_66	[p4l1795t2164r2137b2230, p4l10t2273r251b2336],
2	was	VBD	O	be	auxpass	3	SENT_66	[p4l281t2296r410b2336],
3	timed	VBN	O	time	_	0	SENT_66	[p4l445t2270r650b2336],
4	according	VBG	O	accord	_	0	SENT_66	[p4l684t2270r1027b2359],
5	to	TO	O	to	prepc_according_to	3	SENT_66	[p4l1059t2287r1127b2336],
6	the	DT	O	the	det	8	SENT_66	[p4l1161t2270r1271b2336],
7	routine	JJ	O	routine	amod	8	SENT_66	[p4l1305t2273r1558b2336],
8	schedule	NN	O	schedule	pobj	3	SENT_66	[p4l1594t2270r1894b2336],
9	of	IN	O	of	_	0	SENT_66	[p4l1929t2270r2008b2336],
10	the	DT	O	the	det	12	SENT_66	[p4l2029t2270r2140b2336],
11	catheterization	NN	O	catheterization	nn	12	SENT_66	[p4l11t2376r536b2442],
12	laboratory	NN	O	laboratory	prep_of	8	SENT_66	[p4l575t2376r951b2465],
13	.	.	O	.	_	0	SENT_66	[p4l575t2376r951b2465],

1	The	DT	O	the	det	2	SENT_67	[p4l992t2374r1139b2442],
2	PCI	NN	O	pcus	nsubjpass	7	SENT_67	[p4l1180t2376r1328b2442],
3	with	IN	O	with	_	0	SENT_67	[p4l1367t2376r1528b2442],
4	stent	NN	O	stent	nn	5	SENT_67	[p4l1569t2393r1739b2442],
5	placement	NN	O	placement	prep_with	2	SENT_67	[p4l1777t2376r2142b2465],
6	was	VBD	O	be	auxpass	7	SENT_67	[p4l7t2508r136b2548],
7	performed	VBN	O	perform	_	0	SENT_67	[p4l169t2482r539b2571],
8	as	IN	O	as	mark	9	SENT_67	[p4l571t2508r634b2548],
9	described	VBN	O	describe	advcl	7	SENT_67	[p4l669t2482r1000b2548],
10	previously	RB	DATE	previously	advmod	9	SENT_67	[p4l1031t2482r1391b2571],
11	(	CD	NUMBER	(	num	13	SENT_67	[p4l1422t2480r1604b2563],
12	3,6	CD	NUMBER	3,6	num	13	SENT_67	[p4l1422t2480r1604b2563],
13	)	NN	O	)	dobj	9	SENT_67	[p4l1422t2480r1604b2563],
14	.	.	O	.	_	0	SENT_67	[p4l1422t2480r1604b2563],

1	The	DT	O	the	det	2	SENT_68	[p4l1637t2480r1784b2548],
2	choice	NN	O	choice	nsubjpass	20	SENT_68	[p4l1818t2482r2040b2548],
3	of	IN	O	of	_	0	SENT_68	[p4l2073t2482r2153b2548],
4	stent	NN	O	stent	nn	5	SENT_68	[p4l12t2606r183b2655],
5	type	NN	O	type	prep_of	2	SENT_68	[p4l244t2606r411b2678],
6	,	,	O	,	_	0	SENT_68	[p4l244t2606r411b2678],
7	bare-metal	JJ	O	bare-metal	amod	11	SENT_68	[p4l475t2589r881b2670],
8	,	,	O	,	_	0	SENT_68	[p4l475t2589r881b2670],
9	paclitaxel	NN	O	paclitaxel	dep	11	SENT_68	[p4l944t2589r1582b2678],
10	—	NN	O	—	nn	11	SENT_68	[p4l944t2589r1582b2678],
11	eluting	NN	O	eluting	appos	5	SENT_68	[p4l944t2589r1582b2678],
12	,	,	O	,	_	0	SENT_68	[p4l944t2589r1582b2678],
13	or	CC	O	or	_	0	SENT_68	[p4l1648t2615r1720b2655],
14	sirolimus	NN	O	sirolimus	nn	15	SENT_68	[p4l1783t2589r2137b2655],
15	—	NN	O	—	nsubjpass	20	SENT_68	[p4l1783t2589r2137b2655],
16	eluting	VBG	O	elute	partmod	15	SENT_68	[p4l11t2695r257b2784],
17	stent	NN	O	stent	dobj	16	SENT_68	[p4l313t2712r501b2776],
18	,	,	O	,	_	0	SENT_68	[p4l313t2712r501b2776],
19	was	VBD	O	be	auxpass	20	SENT_68	[p4l557t2721r686b2761],
20	left	VBN	O	leave	_	0	SENT_68	[p4l743t2695r859b2761],
21	to	TO	O	to	_	0	SENT_68	[p4l913t2712r982b2761],
22	the	DT	O	the	det	23	SENT_68	[p4l1039t2695r1149b2761],
23	operator	NN	O	operator	poss	25	SENT_68	[p4l1207t2695r1549b2784],
24	’s	POS	O	’s	_	0	SENT_68	[p4l1207t2695r1549b2784],
25	discretion	NN	O	discretion	prep_to	20	SENT_68	[p4l1608t2695r1972b2761],
26	.	.	O	.	_	0	SENT_68	[p4l1608t2695r1972b2761],

1	All	DT	O	all	det	2	SENT_69	[p4l2030t2693r2142b2760],
2	patients	NNS	O	patient	nsubj	3	SENT_69	[p4l9t2804r286b2890],
3	received	VBD	O	receive	_	0	SENT_69	[p4l321t2801r608b2867],
4	an	DT	O	a	det	8	SENT_69	[p4l642t2827r722b2867],
5	intra	JJ	O	intra	amod	8	SENT_69	[p4l755t2801r1206b2867],
6	—	NN	O	—	nn	8	SENT_69	[p4l755t2801r1206b2867],
7	arterial	JJ	O	arterial	amod	8	SENT_69	[p4l755t2801r1206b2867],
8	dose	NN	O	dose	dobj	3	SENT_69	[p4l1239t2801r1394b2867],
9	of	IN	O	of	_	0	SENT_69	[p4l1429t2801r1509b2867],
10	100	CD	NUMBER	100	number	12	SENT_69	[p4l1534t2804r1659b2867],
11	to	TO	O	to	dep	12	SENT_69	[p4l1693t2818r1761b2867],
12	140	CD	NUMBER	140	num	14	SENT_69	[p4l1800t2804r1925b2867],
13	U/kg	NN	O	u/kg	nn	14	SENT_69	[p4l1957t2801r2142b2890],
14	heparin	NN	O	heparin	prep_of	8	SENT_69	[p4l10t2907r297b2996],
15	;	:	O	;	_	0	SENT_69	[p4l10t2907r297b2996],
16	glycoprotein	NN	O	glycoprotein	nn	18	SENT_69	[p4l338t2907r779b2996],
17	IIb/IIIa	NN	O	iib/iiia	nn	18	SENT_69	[p4l817t2907r1094b2973],
18	inhibitors	NNS	O	inhibitor	nsubjpass	21	SENT_69	[p4l1132t2907r1473b2973],
19	were	VBD	O	be	auxpass	21	SENT_69	[p4l1510t2933r1676b2973],
20	not	RB	O	not	neg	21	SENT_69	[p4l1717t2924r1834b2973],
21	allowed	VBN	O	allow	parataxis	3	SENT_69	[p4l1872t2907r2141b2973],
22	except	IN	O	except	_	0	SENT_69	[p4l11t3030r234b3102],
23	for	IN	O	for	prepc_except_for	21	SENT_69	[p4l266t3013r366b3079],
24	bail	NN	O	bail	pobj	21	SENT_69	[p4l396t3013r695b3079],
25	—	CD	NUMBER	—	dep	26	SENT_69	[p4l396t3013r695b3079],
26	out	RP	O	out	advmod	21	SENT_69	[p4l396t3013r695b3079],
27	.	.	O	.	_	0	SENT_69	[p4l396t3013r695b3079],

1	After	IN	O	after	_	0	SENT_70	[p4l731t3011r922b3079],
2	PCI	NNP	O	PCI	prep_after	6	SENT_70	[p4l954t3013r1123b3094],
3	,	,	O	,	_	0	SENT_70	[p4l954t3013r1123b3094],
4	all	DT	O	all	det	5	SENT_70	[p4l1161t3013r1241b3079],
5	patients	NNS	O	patient	nsubj	6	SENT_70	[p4l1272t3016r1549b3102],
6	received	VBD	O	receive	_	0	SENT_70	[p4l1584t3013r1871b3079],
7	aspirin	NN	O	aspirin	dobj	6	SENT_70	[p4l1905t3016r2140b3102],
8	(	CD	NUMBER	(	num	7	SENT_70	[p4l13t3117r243b3199],
9	2100	CD	DATE	2100	num	11	SENT_70	[p4l13t3117r243b3199],
10	mg/day	JJ	O	mg/day	amod	11	SENT_70	[p4l282t3117r596b3208],
11	)	NN	O	)	dep	7	SENT_70	[p4l282t3117r596b3208],
12	,	,	O	,	_	0	SENT_70	[p4l282t3117r596b3208],
13	lifelong	JJ	O	lifelong	conj_and	7	SENT_70	[p4l634t3119r921b3208],
14	,	,	O	,	_	0	SENT_70	[p4l634t3119r921b3208],
15	and	CC	O	and	_	0	SENT_70	[p4l963t3119r1090b3185],
16	clopidogrel	NN	O	clopidogrel	conj_and	7	SENT_70	[p4l1128t3119r1522b3208],
17	(	CD	NUMBER	(	number	18	SENT_70	[p4l1561t3117r1669b3199],
18	75	CD	NUMBER	75	num	20	SENT_70	[p4l1561t3117r1669b3199],
19	mg/day	NN	O	mg/day	nn	20	SENT_70	[p4l1711t3117r2001b3208],
20	)	NN	O	)	nsubj	43	SENT_70	[p4l1711t3117r2001b3208],
21	for	IN	O	for	_	0	SENT_70	[p4l2042t3119r2142b3185],
22	30	CD	DURATION	30	num	23	SENT_70	[p4l11t3228r95b3291],
23	days	NNS	NUMBER	day	conj_or	23	SENT_70	[p4l121t3225r270b3314],
24	after	IN	O	after	_	0	SENT_70	[p4l297t3225r456b3291],
25	placement	NN	O	placement	prep_after	23	SENT_70	[p4l477t3225r842b3314],
26	of	IN	O	of	_	0	SENT_70	[p4l866t3225r945b3291],
27	bare	JJ	O	bare	amod	30	SENT_70	[p4l955t3225r1341b3291],
28	—	NN	O	—	nn	30	SENT_70	[p4l955t3225r1341b3291],
29	metal	NN	O	metal	nn	30	SENT_70	[p4l955t3225r1341b3291],
30	stents	NNS	O	stent	prep_of	25	SENT_70	[p4l1365t3242r1563b3291],
31	or	CC	O	or	_	0	SENT_70	[p4l1590t3250r1662b3291],
32	for	IN	O	for	_	0	SENT_70	[p4l1685t3225r1785b3291],
33	6	CD	DURATION	6	num	34	SENT_70	[p4l1809t3228r1846b3291],
34	months	NNS	NUMBER	month	prep_for	23	SENT_70	[p4l1873t3225r2138b3291],
35	after	IN	O	after	_	0	SENT_70	[p4l12t3331r171b3397],
36	placement	NN	O	placement	prep_after	34	SENT_70	[p4l201t3331r566b3420],
37	of	IN	O	of	_	0	SENT_70	[p4l599t3331r678b3397],
38	at	IN	O	at	quantmod	40	SENT_70	[p4l701t3348r764b3397],
39	least	JJS	O	least	mwe	38	SENT_70	[p4l794t3331r952b3397],
40	1	CD	NUMBER	1	num	42	SENT_70	[p4l987t3334r1019b3396],
41	drug	NN	O	drug	nn	42	SENT_70	[p4l1058t3331r1504b3420],
42	—	NN	O	—	prep_of	36	SENT_70	[p4l1058t3331r1504b3420],
43	eluting	VBG	O	elute	rcmod	16	SENT_70	[p4l1058t3331r1504b3420],
44	stent	NN	O	stent	dobj	43	SENT_70	[p4l1537t3348r1724b3397],
45	.	.	O	.	_	0	SENT_70	[p4l1537t3348r1724b3397],

1	Platelet	NN	O	platelet	_	0	SENT_71	[p4l11t3436r299b3503],
2	function	NN	O	function	nn	3	SENT_71	[p4l347t3436r664b3503],
3	assay	NN	O	assay	dep	1	SENT_71	[p4l715t3463r922b3526],
4	.	.	O	.	_	0	SENT_71	[p4l715t3463r922b3526],

1	As	IN	O	as	mark	2	SENT_72	[p4l971t3435r1066b3503],
2	described	VBN	O	describe	advcl	11	SENT_72	[p4l1119t3437r1451b3503],
3	previously	RB	DATE	previously	advmod	2	SENT_72	[p4l1500t3437r1860b3526],
4	(	CD	NUMBER	(	num	6	SENT_72	[p4l1911t3435r2138b3518],
5	6,24	CD	NUMBER	6,24	num	6	SENT_72	[p4l1911t3435r2138b3518],
6	)	NN	O	)	dobj	2	SENT_72	[p4l1911t3435r2138b3518],
7	,	,	O	,	_	0	SENT_72	[p4l1911t3435r2138b3518],
8	platelet	NN	O	platelet	nn	9	SENT_72	[p4l9t3544r270b3633],
9	aggregation	NN	O	aggregation	nsubjpass	11	SENT_72	[p4l316t3547r728b3633],
10	was	VBD	O	be	auxpass	11	SENT_72	[p4l770t3570r900b3610],
11	assessed	VBN	O	assess	_	0	SENT_72	[p4l949t3544r1231b3610],
12	by	IN	O	by	_	0	SENT_72	[p4l1275t3544r1361b3633],
13	turbidimetric	JJ	O	turbidimetric	amod	14	SENT_72	[p4l1402t3544r1871b3610],
14	aggregometry	NN	O	aggregometry	agent	11	SENT_72	[p4l1917t3570r2138b3633, p4l9t3667r305b3739],
15	with	IN	O	with	_	0	SENT_72	[p4l342t3650r503b3716],
16	a	DT	O	a	det	22	SENT_72	[p4l549t3676r583b3716],
17	4	CD	NUMBER	4	num	20	SENT_72	[p4l625t3650r981b3716],
18	—	NN	O	—	nn	20	SENT_72	[p4l625t3650r981b3716],
19	channel	NN	O	channel	nn	20	SENT_72	[p4l625t3650r981b3716],
20	Bio/Data	NNP	O	Bio/Data	nn	22	SENT_72	[p4l1024t3650r1356b3716],
21	PAP4	NN	O	pap4	nn	22	SENT_72	[p4l1400t3648r1614b3715],
22	aggregometer	NN	O	aggregometer	prep_with	11	SENT_72	[p4l1659t3667r2142b3739],

1	(	NN	O	(	_	0	SENT_73	[p5l13t14r293b97],
2	Molab	NNP	PERSON	Molab	nn	6	SENT_73	[p5l13t14r293b97],
3	,	,	O	,	_	0	SENT_73	[p5l13t14r293b97],
4	Langenfeld	NNP	LOCATION	Langenfeld	appos	6	SENT_73	[p5l328t16r750b105],
5	,	,	O	,	_	0	SENT_73	[p5l328t16r750b105],
6	Germany	NNP	LOCATION	Germany	dep	1	SENT_73	[p5l787t14r1165b105],
7	)	CD	NUMBER	)	num	6	SENT_73	[p5l787t14r1165b105],
8	.	.	O	.	_	0	SENT_73	[p5l787t14r1165b105],

1	Blood	NN	O	blood	nn	2	SENT_74	[p5l1202t16r1415b82],
2	samples	NNS	O	sample	nsubjpass	8	SENT_74	[p5l1447t16r1719b105],
3	for	IN	O	for	_	0	SENT_74	[p5l1753t16r1853b82],
4	platelet	NN	O	platelet	nn	6	SENT_74	[p5l1882t16r2143b105],
5	function	NN	O	function	nn	6	SENT_74	[p5l10t122r307b188],
6	testing	NN	O	testing	prep_for	2	SENT_74	[p5l338t125r577b211],
7	were	VBD	O	be	auxpass	8	SENT_74	[p5l603t148r769b188],
8	drawn	VBN	O	draw	_	0	SENT_74	[p5l802t122r1020b188],
9	before	IN	O	before	_	0	SENT_74	[p5l1049t122r1270b188],
10	discharge	NN	O	discharge	prep_before	8	SENT_74	[p5l1303t122r1633b211],
11	at	IN	O	at	_	0	SENT_74	[p5l1667t139r1730b188],
12	day	NN	DURATION	day	prep_at	10	SENT_74	[p5l1760t122r1882b211],
13	1	CD	NUMBER	1	num	12	SENT_74	[p5l1914t125r1946b187],
14	after	IN	O	after	_	0	SENT_74	[p5l1983t122r2142b188],
15	loading	VBG	O	load	prepc_after	8	SENT_74	[p5l9t228r274b317],
16	with	IN	O	with	_	0	SENT_74	[p5l306t228r467b294],
17	clopidogrel	NN	O	clopidogrel	prep_with	15	SENT_74	[p5l505t228r918b317],
18	,	,	O	,	_	0	SENT_74	[p5l505t228r918b317],
19	2	CD	NUMBER	2	number	21	SENT_74	[p5l956t231r998b295],
20	to	TO	O	to	dep	21	SENT_74	[p5l1036t245r1105b294],
21	4	CD	NUMBER	4	num	22	SENT_74	[p5l1143t231r1184b293],
22	h	NN	O	h	appos	17	SENT_74	[p5l1221t228r1266b293],
23	after	IN	O	after	_	0	SENT_74	[p5l1304t228r1463b294],
24	intake	NN	O	intake	prep_after	15	SENT_74	[p5l1499t228r1714b294],
25	of	IN	O	of	_	0	SENT_74	[p5l1753t228r1832b294],
26	the	DT	O	the	det	30	SENT_74	[p5l1857t228r1967b294],
27	ﬁrst	JJ	O	ﬁrst	amod	30	SENT_74	[p5l2005t228r2142b294],
28	maintenance	NN	O	maintenance	nn	30	SENT_74	[p5l11t338r460b401],
29	dose	NN	O	dose	nn	30	SENT_74	[p5l493t335r648b401],
30	(	NN	O	(	prep_of	24	SENT_74	[p5l683t333r777b415],
31	in	IN	O	in	_	0	SENT_74	[p5l683t333r777b415],
32	the	DT	O	the	det	34	SENT_74	[p5l809t335r919b401],
33	Vast	JJ	O	vast	amod	34	SENT_74	[p5l948t352r1085b401],
34	majority	NN	O	majority	prep_in	30	SENT_74	[p5l1116t336r1413b424],
35	of	IN	O	of	_	0	SENT_74	[p5l1441t335r1521b401],
36	patients	NNS	O	patient	prep_of	34	SENT_74	[p5l1539t338r1816b424],
37	between	IN	O	between	_	0	SENT_74	[p5l1847t335r2140b401],
38	16	CD	NUMBER	16	prep_between	36	SENT_74	[p5l15t444r94b507],
39	and	CC	NUMBER	and	_	0	SENT_74	[p5l132t441r259b507],
40	24	CD	NUMBER	24	num	41	SENT_74	[p5l291t444r378b508],
41	h	NN	O	h	prep_between	36	SENT_74	[p5l412t441r456b506],
42	after	IN	O	after	_	0	SENT_74	[p5l492t441r651b507],
43	loading	VBG	O	load	prepc_after	15	SENT_74	[p5l682t441r947b530],
44	dose	NN	O	dose	nn	45	SENT_74	[p5l980t439r1184b521],
45	)	NN	O	)	dobj	43	SENT_74	[p5l980t439r1184b521],
46	.	.	O	.	_	0	SENT_74	[p5l980t439r1184b521],

1	Samples	NNS	O	sample	nsubjpass	22	SENT_75	[p5l1225t441r1513b530],
2	were	VBD	O	be	auxpass	3	SENT_75	[p5l1545t467r1712b507],
3	drawn	VBN	O	draw	_	0	SENT_75	[p5l1747t441r1966b507],
4	into	IN	O	into	_	0	SENT_75	[p5l2000t444r2139b507],
5	tubes	NNS	O	tube	prep_into	3	SENT_75	[p5l10t547r193b613],
6	containing	VBG	O	contain	partmod	5	SENT_75	[p5l252t550r629b636],
7	3.8	CD	PERCENT	3.8	number	8	SENT_75	[p5l684t550r858b613],
8	%	NN	PERCENT	%	amod	10	SENT_75	[p5l684t550r858b613],
9	sodium	NN	O	sodium	nn	10	SENT_75	[p5l916t547r1432b613],
10	—	NN	O	—	dobj	6	SENT_75	[p5l916t547r1432b613],
11	citrate	NN	O	citrate	nn	13	SENT_75	[p5l916t547r1432b613],
12	(	CD	NUMBER	(	num	13	SENT_75	[p5l1492t545r1824b628],
13	Sarstedt	NNP	PERSON	Sarstedt	dep	6	SENT_75	[p5l1492t545r1824b628],
14	,	,	O	,	_	0	SENT_75	[p5l1492t545r1824b628],
15	Nuem	NNP	O	Nuem	nn	17	SENT_75	[p5l1883t548r2138b613],
16	—	CD	NUMBER	—	num	17	SENT_75	[p5l1883t548r2138b613],
17	brecht	NN	O	brecht	appos	13	SENT_75	[p5l9t653r252b734],
18	,	,	O	,	_	0	SENT_75	[p5l9t653r252b734],
19	Germany	NNP	LOCATION	Germany	nn	20	SENT_75	[p5l301t651r658b742],
20	)	NNP	O	)	appos	17	SENT_75	[p5l301t651r658b742],
21	and	CC	O	and	_	0	SENT_75	[p5l707t653r834b719],
22	processed	VBN	O	process	conj_and	3	SENT_75	[p5l876t653r1216b742],
23	Within	IN	O	within	dep	22	SENT_75	[p5l1256t653r1488b719],
24	1	CD	NUMBER	1	num	25	SENT_75	[p5l1535t656r1567b718],
25	h	NN	O	h	pobj	23	SENT_75	[p5l1616t653r1660b718],
26	after	IN	O	after	_	0	SENT_75	[p5l1705t653r1864b719],
27	blooddrawing	VBG	O	blooddraw	prepc_after	3	SENT_75	[p5l1904t653r2138b719, p5l11t760r315b849],
28	.	.	O	.	_	0	SENT_75	[p5l1904t653r2138b719, p5l11t760r315b849],

1	We	PRP	O	we	nsubj	2	SENT_76	[p5l355t761r486b827],
2	prepared	VBD	O	prepare	_	0	SENT_76	[p5l525t760r836b849],
3	platelet-rich	JJ	O	platelet-rich	amod	4	SENT_76	[p5l873t760r1307b849],
4	plasma	NN	O	plasma	dobj	2	SENT_76	[p5l1345t760r1592b849],
5	by	IN	O	by	_	0	SENT_76	[p5l1629t760r1715b849],
6	centrifugation	NN	O	centrifugation	prep_by	2	SENT_76	[p5l1752t760r2138b849, p5l10t869r151b932],
7	of	IN	O	of	prep	6	SENT_76	[p5l175t866r255b932],
8	citrated	VBN	O	citrate	dep	7	SENT_76	[p5l267t866r533b932],
9	Venous	JJ	MISC	venous	amod	10	SENT_76	[p5l553t892r795b932],
10	blood	NN	O	blood	dobj	8	SENT_76	[p5l819t866r1021b932],
11	at	IN	O	at	_	0	SENT_76	[p5l1045t883r1108b932],
12	750	CD	NUMBER	750	num	13	SENT_76	[p5l1132t866r1259b932],
13	g	NN	O	g	prep_at	8	SENT_76	[p5l1283t892r1325b955],
14	for	IN	O	for	_	0	SENT_76	[p5l1347t866r1447b932],
15	2	CD	DURATION	2	num	16	SENT_76	[p5l1468t869r1509b933],
16	min	NN	DURATION	min	prep_for	13	SENT_76	[p5l1535t869r1673b931],
17	and	CC	O	and	_	0	SENT_76	[p5l1699t866r1826b932],
18	adjusted	VBN	O	adjust	dep	7	SENT_76	[p5l1850t866r2141b955],
19	to	TO	O	to	_	0	SENT_76	[p5l10t988r78b1036],
20	275	CD	NUMBER	275	number	22	SENT_76	[p5l133t970r261b1037],
21	to	TO	O	to	dep	22	SENT_76	[p5l319t988r387b1036],
22	325	CD	NUMBER	325	prep_to	18	SENT_76	[p5l443t970r569b1037],
23	X	NN	O	x	nn	25	SENT_76	[p5l636t980r688b1032],
24	109	CD	NUMBER	109	num	25	SENT_76	[p5l757t958r870b1036],
25	thrombocytes/1	NN	O	thrombocytes/1	dobj	8	SENT_76	[p5l925t970r1462b1059],
26	by	IN	O	by	_	0	SENT_76	[p5l1513t971r1600b1059],
27	dilution	NN	O	dilution	prep_by	8	SENT_76	[p5l1651t971r1928b1036],
28	with	IN	O	with	_	0	SENT_76	[p5l1979t971r2140b1036],
29	platelet	NN	O	platelet	nn	32	SENT_76	[p5l9t1077r471b1166],
30	—	NN	O	—	nn	32	SENT_76	[p5l9t1077r471b1166],
31	poor	JJ	O	poor	amod	32	SENT_76	[p5l9t1077r471b1166],
32	plasma	NN	O	plasma	prep_with	27	SENT_76	[p5l496t1077r743b1166],
33	from	IN	O	from	_	0	SENT_76	[p5l770t1077r940b1143],
34	the	DT	O	the	det	36	SENT_76	[p5l969t1077r1079b1143],
35	same	JJ	O	same	amod	36	SENT_76	[p5l1110t1103r1284b1143],
36	patient	NN	O	patient	prep_from	27	SENT_76	[p5l1312t1080r1577b1166],
37	.	.	O	.	_	0	SENT_76	[p5l1312t1080r1577b1166],

1	We	PRP	O	we	nsubj	2	SENT_77	[p5l1606t1078r1736b1144],
2	used	VBD	O	use	_	0	SENT_77	[p5l1765t1077r1924b1143],
3	ADP	NN	O	adp	nsubj	5	SENT_77	[p5l1949t1075r2140b1142],
4	(	CD	NUMBER	(	num	3	SENT_77	[p5l13t1181r591b1272],
5	Sigma	NNP	O	Sigma	xcomp	2	SENT_77	[p5l13t1181r591b1272],
6	.	.	O	.	_	0	SENT_77	[p5l13t1181r591b1272],

1	—	NN	O	—	_	0	SENT_78	[p5l13t1181r591b1272],
2	.	.	O	.	_	0	SENT_78	[p5l13t1181r591b1272],

1	Aldrich	NNP	PERSON	Aldrich	nn	5	SENT_79	[p5l13t1181r591b1272],
2	,	,	O	,	_	0	SENT_79	[p5l13t1181r591b1272],
3	Munich	NNP	LOCATION	Munich	appos	5	SENT_79	[p5l620t1183r925b1264],
4	,	,	O	,	_	0	SENT_79	[p5l620t1183r925b1264],
5	Germany	NNP	LOCATION	Germany	_	0	SENT_79	[p5l958t1181r1315b1272],
6	)	CD	NUMBER	)	num	5	SENT_79	[p5l958t1181r1315b1272],
7	to	TO	O	to	aux	8	SENT_79	[p5l1346t1200r1414b1249],
8	induce	VB	O	induce	infmod	5	SENT_79	[p5l1444t1183r1676b1249],
9	aggregation	NN	O	aggregation	dobj	8	SENT_79	[p5l1706t1186r2136b1272],
10	.	.	O	.	_	0	SENT_79	[p5l1706t1186r2136b1272],

1	Light	JJ	O	light	amod	2	SENT_80	[p5l11t1289r211b1378],
2	transmission	NN	O	transmission	nsubjpass	7	SENT_80	[p5l233t1292r679b1355],
3	in	IN	O	in	_	0	SENT_80	[p5l703t1292r771b1354],
4	platelet-rich	JJ	O	platelet-rich	amod	5	SENT_80	[p5l794t1289r1228b1378],
5	plasma	NN	O	plasma	prep_in	2	SENT_80	[p5l1251t1289r1497b1378],
6	was	VBD	O	be	auxpass	7	SENT_80	[p5l1516t1315r1645b1355],
7	determined	VBN	O	determine	_	0	SENT_80	[p5l1672t1289r2076b1355],
8	5	CD	DURATION	5	num	9	SENT_80	[p5l2100t1289r2137b1355],
9	min	NN	DURATION	min	dobj	7	SENT_80	[p5l11t1397r150b1459],
10	after	IN	O	after	_	0	SENT_80	[p5l195t1394r354b1459],
11	addition	NN	O	addition	prep_after	7	SENT_80	[p5l397t1394r690b1459],
12	of	IN	O	of	_	0	SENT_80	[p5l733t1394r814b1459],
13	ADP	NN	ORGANIZATION	adp	prep_of	11	SENT_80	[p5l842t1392r1033b1459],
14	at	IN	O	at	_	0	SENT_80	[p5l1078t1411r1141b1459],
15	a	DT	O	a	det	17	SENT_80	[p5l1184t1420r1219b1459],
16	ﬁnal	JJ	O	ﬁnal	amod	17	SENT_80	[p5l1261t1394r1415b1459],
17	concentration	NN	O	concentration	prep_at	7	SENT_80	[p5l1458t1397r1944b1459],
18	of	IN	O	of	_	0	SENT_80	[p5l1988t1394r2068b1459],
19	5	CD	NUMBER	5	prep_of	17	SENT_80	[p5l2099t1394r2137b1460],

1	umol/l	NN	O	umol/l	_	0	SENT_81	[p5l13t1500r277b1584],
2	.	.	O	.	_	0	SENT_81	[p5l13t1500r277b1584],

1	Results	NNS	O	result	nsubjpass	3	SENT_82	[p5l325t1500r577b1566],
2	were	VBD	O	be	auxpass	3	SENT_82	[p5l617t1525r783b1566],
3	expressed	VBN	O	express	_	0	SENT_82	[p5l826t1500r1160b1589],
4	as	IN	O	as	_	0	SENT_82	[p5l1203t1526r1266b1566],
5	percentage	NN	O	percentage	prep_as	3	SENT_82	[p5l1308t1517r1688b1589],
6	of	IN	O	of	_	0	SENT_82	[p5l1731t1500r1811b1566],
7	maximal	JJ	O	maximal	amod	9	SENT_82	[p5l1840t1500r2142b1566],
8	light	JJ	O	light	amod	9	SENT_82	[p5l9t1607r175b1696],
9	transmission	NN	O	transmission	prep_of	5	SENT_82	[p5l202t1610r648b1673],
10	with	IN	O	with	_	0	SENT_82	[p5l674t1607r835b1673],
11	platelet	NN	O	platelet	nn	14	SENT_82	[p5l863t1607r1324b1696],
12	—	NN	O	—	nn	14	SENT_82	[p5l863t1607r1324b1696],
13	poor	JJ	O	poor	amod	14	SENT_82	[p5l863t1607r1324b1696],
14	plasma	NN	O	plasma	prep_with	3	SENT_82	[p5l1351t1607r1597b1696],
15	from	IN	O	from	_	0	SENT_82	[p5l1625t1607r1795b1673],
16	the	DT	O	the	det	18	SENT_82	[p5l1824t1607r1935b1673],
17	same	JJ	O	same	amod	18	SENT_82	[p5l1966t1633r2140b1673],
18	patient	NN	O	patient	prep_from	3	SENT_82	[p5l9t1716r258b1802],
19	as	IN	O	as	_	0	SENT_82	[p5l292t1739r355b1779],
20	reference	NN	O	reference	nn	21	SENT_82	[p5l390t1713r709b1779],
21	(	NN	O	(	nn	25	SENT_82	[p5l747t1711r969b1793],
22	100	CD	PERCENT	100	number	23	SENT_82	[p5l747t1711r969b1793],
23	%	NN	PERCENT	%	amod	25	SENT_82	[p5l747t1711r969b1793],
24	aggregation	NN	O	aggregation	nn	25	SENT_82	[p5l1005t1711r1464b1802],
25	)	NN	O	)	prep_as	18	SENT_82	[p5l1005t1711r1464b1802],
26	.	.	O	.	_	0	SENT_82	[p5l1005t1711r1464b1802],

1	The	DT	O	the	det	2	SENT_83	[p5l1499t1711r1647b1779],
2	coefficient	NN	O	coefficient	nsubj	12	SENT_83	[p5l1682t1713r2040b1779],
3	of	IN	O	of	_	0	SENT_83	[p5l2073t1713r2152b1779],
4	Variation	NN	O	variation	prep_of	2	SENT_83	[p5l7t1823r319b1886],
5	of	IN	O	of	_	0	SENT_83	[p5l353t1820r433b1886],
6	our	PRP$	O	we	poss	9	SENT_83	[p5l455t1846r571b1886],
7	optical	JJ	O	optical	amod	9	SENT_83	[p5l603t1820r840b1909],
8	aggregometry	NN	O	aggregometry	nn	9	SENT_83	[p5l873t1837r1359b1909],
9	assay	NN	O	assay	prep_of	4	SENT_83	[p5l1389t1846r1566b1909],
10	is	VBZ	O	be	cop	12	SENT_83	[p5l1595t1823r1646b1886],
11	6.1	CD	PERCENT	6.1	num	12	SENT_83	[p5l1682t1823r1855b1886],
12	%	NN	PERCENT	%	_	0	SENT_83	[p5l1682t1823r1855b1886],
13	(	CD	NUMBER	(	number	14	SENT_83	[p5l1891t1818r2073b1901],
14	3,6	CD	NUMBER	3,6	num	15	SENT_83	[p5l1891t1818r2073b1901],
15	)	NN	O	)	dep	12	SENT_83	[p5l1891t1818r2073b1901],
16	.	.	O	.	_	0	SENT_83	[p5l1891t1818r2073b1901],

1	Genotyping	NN	O	genotyping	nsubj	4	SENT_84	[p5l13t1926r460b2015],
2	by	IN	O	by	_	0	SENT_84	[p5l481t1925r571b2015],
3	TaqMan	NNP	O	TaqMan	prep_by	1	SENT_84	[p5l591t1923r923b2015],
4	polymerase	NN	O	polymerase	_	0	SENT_84	[p5l950t1925r1367b2015],
5	chain	NN	O	chain	nn	6	SENT_84	[p5l1395t1925r1597b1992],
6	reaction	NN	O	reaction	dobj	4	SENT_84	[p5l1623t1930r1946b1992],
7	.	.	O	.	_	0	SENT_84	[p5l1623t1930r1946b1992],

1	Determination	NN	O	determination	nsubjpass	5	SENT_85	[p5l1998t1927r2138b1992, p5l10t2036r428b2099],
2	of	IN	O	of	_	0	SENT_85	[p5l470t2033r550b2099],
3	genotype	NN	O	genotype	prep_of	1	SENT_85	[p5l578t2050r899b2122],
4	was	VBD	O	be	auxpass	5	SENT_85	[p5l937t2059r1066b2099],
5	performed	VBN	O	perform	dep	10	SENT_85	[p5l1109t2033r1479b2122],
6	as	IN	O	as	_	0	SENT_85	[p5l1521t2059r1584b2099],
7	previously	RB	DATE	previously	advmod	8	SENT_85	[p5l1626t2033r1987b2122],
8	described	VBN	O	describe	amod	9	SENT_85	[p5l2025t2033r2138b2099, p5l12t2139r259b2205],
9	s	NNS	O	s	prep_as	5	SENT_85	[p5l289t2137r404b2219],
10	*	VBP	O	*	_	0	SENT_85	[p5l289t2137r404b2219],
11	In	IN	O	in	_	0	SENT_85	[p5l437t2140r514b2204],
12	brief	NN	O	brief	prep_in	21	SENT_85	[p5l540t2139r723b2220],
13	,	,	O	,	_	0	SENT_85	[p5l540t2139r723b2220],
14	genomic	JJ	O	genomic	amod	19	SENT_85	[p5l753t2142r1056b2228],
15	deoxyribonucleic	JJ	O	deoxyribonucleic	amod	19	SENT_85	[p5l1084t2139r1680b2228],
16	acid	NN	O	acid	nn	19	SENT_85	[p5l1709t2139r1849b2205],
17	(	NN	O	(	nn	19	SENT_85	[p5l1880t2137r2137b2219],
18	DNA	NN	MISC	dna	nn	19	SENT_85	[p5l1880t2137r2137b2219],
19	)	NN	O	)	nsubjpass	21	SENT_85	[p5l1880t2137r2137b2219],
20	was	VBD	O	be	auxpass	21	SENT_85	[p5l7t2272r136b2312],
21	extracted	VBN	O	extract	ccomp	10	SENT_85	[p5l192t2246r511b2312],
22	from	IN	O	from	_	0	SENT_85	[p5l563t2246r733b2312],
23	peripheral	JJ	O	peripheral	amod	29	SENT_85	[p5l785t2246r1144b2335],
24	potassium	NN	O	potassium	nn	29	SENT_85	[p5l1195t2249r1553b2335],
25	ethylenediami	NN	O	ethylenediamus	nn	29	SENT_85	[p5l1607t2246r2138b2335],
26	—	NN	O	—	nn	29	SENT_85	[p5l1607t2246r2138b2335],
27	netetraacetic	JJ	O	netetraacetic	amod	29	SENT_85	[p5l12t2355r457b2418],
28	acid	NN	O	acid	nn	29	SENT_85	[p5l494t2352r1188b2441],
29	—	NN	O	—	prep_from	21	SENT_85	[p5l494t2352r1188b2441],
30	anticoagulated	JJ	O	anticoagulated	amod	31	SENT_85	[p5l494t2352r1188b2441],
31	blood	NN	O	blood	nsubj	10	SENT_85	[p5l1222t2352r1424b2418],
32	with	IN	O	with	_	0	SENT_85	[p5l1456t2352r1617b2418],
33	the	DT	O	the	det	35	SENT_85	[p5l1654t2352r1764b2418],
34	Flexigene	NNP	O	Flexigene	nn	35	SENT_85	[p5l1802t2352r2140b2441],
35	Kit	NN	O	kit	prep_with	31	SENT_85	[p5l13t2459r124b2524],
36	(	CD	NUMBER	(	num	35	SENT_85	[p5l160t2456r579b2542],
37	CLIAGEN	NNP	LOCATION	CLIAGEN	nn	41	SENT_85	[p5l160t2456r579b2542],
38	,	,	O	,	_	0	SENT_85	[p5l160t2456r579b2542],
39	Hilden	NNP	PERSON	Hilden	appos	41	SENT_85	[p5l618t2458r887b2539],
40	,	,	O	,	_	0	SENT_85	[p5l618t2458r887b2539],
41	Germany	NNP	LOCATION	Germany	dep	31	SENT_85	[p5l927t2456r1284b2547],
42	)	CD	NUMBER	)	num	41	SENT_85	[p5l927t2456r1284b2547],
43	according	VBG	O	accord	_	0	SENT_85	[p5l1325t2458r1668b2547],
44	to	TO	O	to	prepc_according_to	41	SENT_85	[p5l1701t2475r1768b2524],
45	the	DT	O	the	det	46	SENT_85	[p5l1805t2458r1915b2524],
46	manufacturer	NN	O	manufacturer	poss	48	SENT_85	[p5l1952t2484r2137b2524, p5l9t2563r373b2628],
47	’s	POS	O	’s	_	0	SENT_85	[p5l1952t2484r2137b2524, p5l9t2563r373b2628],
48	instruction	NN	O	instruction	pobj	41	SENT_85	[p5l415t2566r817b2628],
49	.	.	O	.	_	0	SENT_85	[p5l415t2566r817b2628],

1	After	IN	O	after	_	0	SENT_86	[p5l859t2561r1050b2628],
2	extraction	NN	O	extraction	prep_after	9	SENT_86	[p5l1090t2566r1459b2643],
3	,	,	O	,	_	0	SENT_86	[p5l1090t2566r1459b2643],
4	the	DT	O	the	det	5	SENT_86	[p5l1502t2563r1612b2628],
5	concentration	NN	O	concentration	nsubjpass	9	SENT_86	[p5l1655t2566r2140b2628],
6	of	IN	O	of	_	0	SENT_86	[p5l11t2669r91b2735],
7	DNA	NN	MISC	dna	prep_of	5	SENT_86	[p5l129t2667r337b2735],
8	was	VBD	O	be	auxpass	9	SENT_86	[p5l382t2695r511b2735],
9	measured	VBN	O	measure	_	0	SENT_86	[p5l564t2669r899b2735],
10	photometrically	RB	O	photometrically	advmod	9	SENT_86	[p5l947t2669r1526b2758],
11	,	,	O	,	_	0	SENT_86	[p5l947t2669r1526b2758],
12	and	CC	O	and	_	0	SENT_86	[p5l1581t2669r1708b2735],
13	DNA	NN	O	dna	nsubjpass	15	SENT_86	[p5l1758t2667r1965b2735],
14	was	VBD	O	be	auxpass	15	SENT_86	[p5l2010t2695r2139b2735],
15	diluted	VBN	O	dilute	conj_and	9	SENT_86	[p5l11t2775r258b2841],
16	to	TO	O	to	_	0	SENT_86	[p5l311t2792r379b2841],
17	a	DT	O	a	det	18	SENT_86	[p5l436t2801r470b2841],
18	concentration	NN	O	concentration	prep_to	15	SENT_86	[p5l524t2778r1010b2841],
19	of	IN	O	of	_	0	SENT_86	[p5l1064t2775r1144b2841],
20	5	CD	NUMBER	5	num	21	SENT_86	[p5l1186t2775r1223b2841],
21	mg/l	NN	O	mg/l	prep_of	18	SENT_86	[p5l1281t2775r1464b2864],
22	.	.	O	.	_	0	SENT_86	[p5l1281t2775r1464b2864],

1	The	DT	O	the	det	3	SENT_87	[p5l1519t2773r1666b2841],
2	CYP2CZ9	NN	O	cyp2cz9	nn	3	SENT_87	[p5l1727t2778r2141b2842],
3	*	NN	O	*	_	0	SENT_87	[p5l1727t2778r2141b2842],
4	2	CD	NUMBER	2	number	5	SENT_87	[p5l1727t2778r2141b2842],
5	(	CD	NUMBER	(	num	6	SENT_87	[p5l13t2879r402b2962],
6	681G	NN	O	681g	npadvmod	7	SENT_87	[p5l13t2879r402b2962],
7	>	JJR	O	>	dep	3	SENT_87	[p5l13t2879r402b2962],
8	A	DT	O	a	dep	7	SENT_87	[p5l13t2879r402b2962],
9	;	:	O	;	_	0	SENT_87	[p5l13t2879r402b2962],
10	rs4244285	NN	O	rs4244285	nn	11	SENT_87	[p5l435t2879r830b2961],
11	)	NN	O	)	dep	3	SENT_87	[p5l435t2879r830b2961],
12	was	VBD	O	be	auxpass	13	SENT_87	[p5l860t2907r990b2947],
13	genotyped	VBN	O	genotype	rcmod	11	SENT_87	[p5l1020t2881r1388b2970],
14	with	IN	O	with	_	0	SENT_87	[p5l1414t2881r1575b2947],
15	a	DT	O	a	det	17	SENT_87	[p5l1607t2907r1641b2947],
16	commercially	RB	O	commercially	advmod	17	SENT_87	[p5l1670t2881r2145b2970],
17	available	JJ	O	available	prep_with	13	SENT_87	[p5l12t2987r331b3068],
18	,	,	O	,	_	0	SENT_87	[p5l12t2987r331b3068],
19	Validated	NNP	O	Validated	nn	25	SENT_87	[p5l380t2987r700b3053],
20	Drug	NNP	O	Drug	nn	25	SENT_87	[p5l750t2988r938b3076],
21	Metabolism	NNP	O	Metabolism	nn	25	SENT_87	[p5l985t2987r1413b3053],
22	Genotyping	NNP	O	Genotyping	nn	25	SENT_87	[p5l1465t2987r1890b3076],
23	Assay	NN	O	assay	nn	25	SENT_87	[p5l1935t2985r2145b3076],
24	JACC	NN	O	jacc	nn	25	SENT_87	[p5l9t3091r123b3142],
25	Vol	NN	O	vol	appos	17	SENT_87	[p5l150t3092r232b3142],
26	.	.	O	.	_	0	SENT_87	[p5l150t3092r232b3142],

1	55	CD	NUMBER	55	_	0	SENT_88	[p5l263t3092r336b3151],
2	,	,	O	,	_	0	SENT_88	[p5l263t3092r336b3151],
3	No.	NN	O	no.	appos	1	SENT_88	[p5l368t3092r440b3142],
4	22	CD	NUMBER	22	num	3	SENT_88	[p5l471t3091r544b3151],
5	,	,	O	,	_	0	SENT_88	[p5l471t3091r544b3151],
6	2010	CD	DATE	2010	appos	1	SENT_88	[p5l574t3091r698b3142],

1	June	NNP	DATE	June	_	0	SENT_89	[p5l9t3180r114b3231],
2	1	CD	DATE	1	num	1	SENT_89	[p5l143t3180r183b3239],
3	,	,	O	,	_	0	SENT_89	[p5l143t3180r183b3239],
4	2010:242	CD	NUMBER	2010:242	dep	1	SENT_89	[p5l215t3180r573b3231],
5	-	:	O	-	_	0	SENT_89	[p5l215t3180r573b3231],
6	/	:	O	/	punct	1	SENT_89	[p5l215t3180r573b3231],
7	-34	CD	NUMBER	-34	dep	1	SENT_89	[p5l215t3180r573b3231],

1	(	NNP	O	(	nn	3	SENT_90	[p6l13t87r325b178],
2	Applied	NNP	O	Applied	nn	3	SENT_90	[p6l13t87r325b178],
3	Biosystems	NNP	O	Biosystems	_	0	SENT_90	[p6l361t90r775b178],
4	,	,	O	,	_	0	SENT_90	[p6l361t90r775b178],
5	Frankfurt	NNP	LOCATION	Frankfurt	nn	7	SENT_90	[p6l815t89r1175b170],
6	,	,	O	,	_	0	SENT_90	[p6l815t89r1175b170],
7	Germany	NNP	LOCATION	Germany	appos	3	SENT_90	[p6l1216t87r1594b178],
8	)	CD	NUMBER	)	num	7	SENT_90	[p6l1216t87r1594b178],
9	.	.	O	.	_	0	SENT_90	[p6l1216t87r1594b178],

1	After	IN	O	after	_	0	SENT_91	[p6l1633t87r1824b155],
2	ampliﬁcation	NN	O	ampliﬁcation	nn	5	SENT_91	[p6l1860t89r2138b178, p6l11t198r225b261],
3	(	CD	NUMBER	(	num	5	SENT_91	[p6l256t193r536b278],
4	CLPCR	NN	MISC	clpcr	nn	5	SENT_91	[p6l256t193r536b278],
5	Master	NN	MISC	master	prep_after	18	SENT_91	[p6l560t196r813b261],
6	Mix	NNP	MISC	Mix	nn	13	SENT_91	[p6l838t196r1005b276],
7	,	,	O	,	_	0	SENT_91	[p6l838t196r1005b276],
8	Abgene	NNP	PERSON	Abgene	appos	13	SENT_91	[p6l1034t193r1329b284],
9	,	,	O	,	_	0	SENT_91	[p6l1034t193r1329b284],
10	Hamburg	NNP	LOCATION	Hamburg	appos	13	SENT_91	[p6l1361t195r1725b284],
11	,	,	O	,	_	0	SENT_91	[p6l1361t195r1725b284],
12	Germany	NNP	LOCATION	Germany	appos	13	SENT_91	[p6l1758t193r2138b284],
13	)	NNP	O	)	dep	5	SENT_91	[p6l1758t193r2138b284],
14	,	,	O	,	_	0	SENT_91	[p6l1758t193r2138b284],
15	reaction	NN	O	reaction	nn	16	SENT_91	[p6l10t304r293b367],
16	mixtures	NNS	O	mixture	nsubjpass	18	SENT_91	[p6l332t304r633b367],
17	were	VBD	O	be	auxpass	18	SENT_91	[p6l669t327r836b367],
18	loaded	VBN	O	load	_	0	SENT_91	[p6l873t301r1108b367],
19	in	IN	O	in	_	0	SENT_91	[p6l1145t304r1212b366],
20	an	DT	O	a	det	24	SENT_91	[p6l1252t327r1332b367],
21	ABI	NNP	O	ABI	nn	24	SENT_91	[p6l1368t299r1522b366],
22	Prism	NNP	O	Prism	nn	24	SENT_91	[p6l1562t302r1769b367],
23	Sequence	NN	O	sequence	nn	24	SENT_91	[p6l1811t301r2140b390],
24	Detector	NN	O	detector	prep_in	18	SENT_91	[p6l11t408r325b473],
25	7900	CD	NUMBER	7900	num	29	SENT_91	[p6l385t408r556b473],
26	(	NNP	O	(	nn	29	SENT_91	[p6l621t405r932b496],
27	Applied	NNP	O	Applied	nn	29	SENT_91	[p6l621t405r932b496],
28	Biosystems	NNP	O	Biosystems	nn	29	SENT_91	[p6l992t405r1434b496],
29	)	NN	O	)	dep	24	SENT_91	[p6l992t405r1434b496],
30	.	.	O	.	_	0	SENT_91	[p6l992t405r1434b496],

1	After	IN	O	after	_	0	SENT_92	[p6l1496t405r1687b473],
2	polymerase	NN	O	polymerase	nn	4	SENT_92	[p6l1744t407r2140b496],
3	chain	NN	O	chain	nn	4	SENT_92	[p6l11t513r200b579],
4	reaction	NN	O	reaction	prep_after	14	SENT_92	[p6l224t516r527b594],
5	,	,	O	,	_	0	SENT_92	[p6l224t516r527b594],
6	ﬂuorescence	NN	O	ﬂuorescence	nn	7	SENT_92	[p6l553t513r983b579],
7	yield	NN	O	yield	nsubjpass	14	SENT_92	[p6l1004t513r1174b602],
8	for	IN	O	for	_	0	SENT_92	[p6l1197t513r1298b579],
9	the	DT	O	the	det	12	SENT_92	[p6l1320t513r1430b579],
10	2	CD	NUMBER	2	num	12	SENT_92	[p6l1453t516r1494b580],
11	different	JJ	O	different	amod	12	SENT_92	[p6l1520t513r1817b579],
12	dyes	NNS	O	dye	prep_for	7	SENT_92	[p6l1840t513r1988b602],
13	was	VBD	O	be	auxpass	14	SENT_92	[p6l2010t539r2139b579],
14	measured	VBN	O	measure	_	0	SENT_92	[p6l11t619r346b685],
15	and	CC	O	and	_	0	SENT_92	[p6l380t619r507b685],
16	presented	VBN	O	present	conj_and	14	SENT_92	[p6l539t619r880b708],
17	in	IN	O	in	_	0	SENT_92	[p6l913t622r980b684],
18	a	DT	O	a	det	22	SENT_92	[p6l1015t645r1049b685],
19	2	CD	NUMBER	2	num	20	SENT_92	[p6l1079t619r1593b686],
20	—	NN	O	—	npadvmod	21	SENT_92	[p6l1079t619r1593b686],
21	dimensional	JJ	O	dimensional	amod	22	SENT_92	[p6l1079t619r1593b686],
22	graph	NN	O	graph	prep_in	14	SENT_92	[p6l1624t619r1845b708],
23	.	.	O	.	_	0	SENT_92	[p6l1624t619r1845b708],

1	Statistical	JJ	O	statistical	amod	2	SENT_93	[p6l13t724r382b791],
2	methods	NNS	O	method	_	0	SENT_93	[p6l411t724r752b791],
3	.	.	O	.	_	0	SENT_93	[p6l411t724r752b791],

1	The	DT	O	the	det	4	SENT_94	[p6l801t723r948b791],
2	sample	NN	O	sample	nn	4	SENT_94	[p6l981t725r1223b814],
3	size	NN	O	size	nn	4	SENT_94	[p6l1257t728r1383b791],
4	calculation	NN	O	calculation	nsubjpass	15	SENT_94	[p6l1416t725r1795b791],
5	based	VBN	O	base	_	0	SENT_94	[p6l1824t725r2022b791],
6	on	IN	O	on	prepc_based_on	4	SENT_94	[p6l2054t751r2141b791],
7	the	DT	O	the	det	11	SENT_94	[p6l10t831r120b897],
8	30-day	JJ	DURATION	30-day	amod	11	SENT_94	[p6l159t831r407b920],
9	primary	JJ	O	primary	amod	11	SENT_94	[p6l440t834r719b920],
10	end	NN	O	end	nn	11	SENT_94	[p6l754t831r882b897],
11	point	NN	O	point	pobj	4	SENT_94	[p6l917t834r1106b920],
12	of	IN	O	of	_	0	SENT_94	[p6l1143t831r1222b897],
13	EXCELSIOR	NNP	ORGANIZATION	EXCELSIOR	prep_of	11	SENT_94	[p6l1249t831r1773b897],
14	was	VBD	O	be	auxpass	15	SENT_94	[p6l1805t857r1933b897],
15	published	VBN	O	publish	_	0	SENT_94	[p6l1972t831r2138b920, p6l9t937r218b1003],
16	previously	RB	DATE	previously	advmod	17	SENT_94	[p6l249t937r609b1026],
17	ā	JJ	O	ā	amod	18	SENT_94	[p6l641t935r756b1017],
18	*	NN	O	*	dobj	15	SENT_94	[p6l641t935r756b1017],

1	For	IN	O	for	_	0	SENT_95	[p6l100t1044r226b1109],
2	all	DT	O	all	det	4	SENT_95	[p6l281t1043r360b1109],
3	multivariable	JJ	O	multivariable	amod	4	SENT_95	[p6l415t1043r876b1109],
4	analyses	NNS	O	analysis	prep_for	7	SENT_95	[p6l934t1043r1234b1132],
5	,	,	O	,	_	0	SENT_95	[p6l934t1043r1234b1132],
6	we	PRP	O	we	nsubj	7	SENT_95	[p6l1289t1069r1387b1109],
7	chose	VBD	O	choose	_	0	SENT_95	[p6l1445t1043r1638b1109],
8	the	DT	O	the	det	9	SENT_95	[p6l1694t1043r1804b1109],
9	baseline	NN	O	baseline	nsubj	10	SENT_95	[p6l1858t1043r2140b1109],
10	demographic	JJ	O	demographic	xcomp	7	SENT_95	[p6l11t1149r473b1238],
11	and	CC	O	and	_	0	SENT_95	[p6l502t1149r629b1215],
12	clinical	JJ	O	clinical	amod	13	SENT_95	[p6l657t1149r905b1215],
13	variables	NNS	O	variable	nsubj	26	SENT_95	[p6l928t1149r1232b1215],
14	assessed	VBN	O	assess	partmod	13	SENT_95	[p6l1263t1149r1546b1215],
15	on	IN	O	on	_	0	SENT_95	[p6l1574t1175r1661b1215],
16	admission	NN	O	admission	prep_on	14	SENT_95	[p6l1690t1149r2043b1215],
17	to	TO	O	to	_	0	SENT_95	[p6l2072t1166r2139b1215],
18	hospital	NN	O	hospital	prep_to	14	SENT_95	[p6l10t1255r291b1344],
19	with	IN	O	with	_	0	SENT_95	[p6l324t1255r485b1321],
20	a	DT	O	a	det	21	SENT_95	[p6l524t1281r559b1321],
21	difference	NN	O	difference	prep_with	14	SENT_95	[p6l597t1255r936b1321],
22	between	IN	O	between	_	0	SENT_95	[p6l973t1255r1267b1321],
23	the	DT	O	the	det	25	SENT_95	[p6l1304t1255r1414b1321],
24	2	CD	NUMBER	2	num	25	SENT_95	[p6l1451t1258r1493b1322],
25	strata	NN	O	stratum	prep_between	21	SENT_95	[p6l1533t1272r1724b1321],
26	deﬁned	VBN	O	deﬁned	conj_and	7	SENT_95	[p6l1762t1255r2023b1321],
27	by	IN	O	by	_	0	SENT_95	[p6l2058t1255r2144b1344],
28	pre	JJ	O	pre	amod	31	SENT_95	[p6l9t1361r491b1450],
29	—	NN	O	—	nn	31	SENT_95	[p6l9t1361r491b1450],
30	discharge	NN	O	discharge	nn	31	SENT_95	[p6l9t1361r491b1450],
31	RPA	NN	O	rpa	prep_by	26	SENT_95	[p6l526t1359r704b1426],
32	(	CD	NUMBER	(	num	33	SENT_95	[p6l737t1359r828b1441],
33	S	NN	O	s	amod	31	SENT_95	[p6l737t1359r828b1441],
34	14	CD	PERCENT	14	num	35	SENT_95	[p6l842t1364r990b1427],
35	%	NN	PERCENT	%	dep	33	SENT_95	[p6l842t1364r990b1427],
36	and	CC	O	and	_	0	SENT_95	[p6l1023t1361r1151b1427],
37	>	JJR	O	>	conj_and	33	SENT_95	[p6l1186t1359r1433b1441],
38	14	CD	PERCENT	14	num	39	SENT_95	[p6l1186t1359r1433b1441],
39	%	NN	PERCENT	%	dep	33	SENT_95	[p6l1186t1359r1433b1441],
40	)	CD	NUMBER	)	dep	46	SENT_95	[p6l1186t1359r1433b1441],
41	at	IN	O	at	_	0	SENT_95	[p6l1470t1378r1533b1427],
42	a	DT	O	a	det	43	SENT_95	[p6l1565t1387r1599b1427],
43	p	NN	O	p	prep_at	40	SENT_95	[p6l1628t1387r1670b1450],
44	value	NN	O	value	dep	46	SENT_95	[p6l1700t1361r1881b1427],
45	£	CD	MONEY	£	num	44	SENT_95	[p6l1919t1364r2139b1428],
46	0.20	CD	MONEY	0.20	dep	56	SENT_95	[p6l1919t1364r2139b1428],
47	with	IN	O	with	_	0	SENT_95	[p6l7t1466r168b1532],
48	or	CC	O	or	_	0	SENT_95	[p6l200t1491r272b1531],
49	without	IN	O	without	_	0	SENT_95	[p6l298t1466r578b1532],
50	CYP2C	NN	O	cyp2c	prep_without	46	SENT_95	[p6l614t1469r1028b1532],
51	]	CD	NUMBER	]	number	52	SENT_95	[p6l614t1469r1028b1532],
52	9	CD	NUMBER	9	num	53	SENT_95	[p6l614t1469r1028b1532],
53	*	NN	O	*	prep_with	46	SENT_95	[p6l614t1469r1028b1532],
54	2	CD	NUMBER	2	num	56	SENT_95	[p6l614t1469r1028b1532],
55	carrier	NN	O	carrier	nn	56	SENT_95	[p6l1059t1469r1284b1531],
56	status	NN	O	status	dep	59	SENT_95	[p6l1314t1483r1511b1531],
57	@	IN	O	@	_	0	SENT_95	[p6l1547t1464r1661b1546],
58	*	NN	O	*	prep_@	56	SENT_95	[p6l1547t1464r1661b1546],
59	For	IN	O	for	dep	76	SENT_95	[p6l1697t1467r1823b1531],
60	identiﬁcation	NN	O	identiﬁcation	pobj	59	SENT_95	[p6l1852t1466r2138b1531, p6l11t1575r225b1638],
61	of	IN	O	of	_	0	SENT_95	[p6l254t1572r334b1638],
62	possible	JJ	O	possible	amod	63	SENT_95	[p6l348t1572r628b1661],
63	predictors	NNS	O	predictor	prep_of	60	SENT_95	[p6l655t1572r1006b1661],
64	for	IN	O	for	_	0	SENT_95	[p6l1036t1572r1137b1638],
65	a	DT	O	a	det	70	SENT_95	[p6l1164t1598r1199b1638],
66	high	JJ	O	high	amod	70	SENT_95	[p6l1225t1572r1384b1661],
67	on	IN	O	on	_	0	SENT_95	[p6l1413t1572r1935b1661],
68	—	CD	NUMBER	—	prep_on	66	SENT_95	[p6l1413t1572r1935b1661],
69	clopidogrel	NN	O	clopidogrel	nn	70	SENT_95	[p6l1413t1572r1935b1661],
70	RPA	NN	O	rpa	prep_for	63	SENT_95	[p6l1964t1570r2142b1637],
71	(	CD	NUMBER	(	num	72	SENT_95	[p6l13t1676r220b1758],
72	RPA	NN	O	rpa	npadvmod	73	SENT_95	[p6l13t1676r220b1758],
73	>	JJR	O	>	amod	70	SENT_95	[p6l257t1676r504b1758],
74	14	CD	PERCENT	14	num	75	SENT_95	[p6l257t1676r504b1758],
75	%	NN	PERCENT	%	dep	73	SENT_95	[p6l257t1676r504b1758],
76	)	CD	NUMBER	)	dep	78	SENT_95	[p6l257t1676r504b1758],
77	we	PRP	O	we	nsubj	78	SENT_95	[p6l538t1704r637b1744],
78	used	VBD	O	use	dep	7	SENT_95	[p6l670t1678r830b1744],
79	multivariable	JJ	O	multivariable	amod	83	SENT_95	[p6l864t1678r1324b1744],
80	binary	JJ	O	binary	amod	83	SENT_95	[p6l1357t1678r1582b1767],
81	logistic	JJ	O	logistic	amod	83	SENT_95	[p6l1611t1678r1864b1767],
82	regression	NN	O	regression	nn	83	SENT_95	[p6l1897t1704r2138b1767, p6l12t1787r154b1850],
83	models	NNS	O	model	dobj	78	SENT_95	[p6l194t1784r443b1850],
84	with	IN	O	with	_	0	SENT_95	[p6l480t1784r642b1850],
85	RPA	NN	O	rpa	prep_with	78	SENT_95	[p6l683t1782r861b1849],
86	>	JJR	O	>	amod	85	SENT_95	[p6l904t1787r1125b1850],
87	14	CD	PERCENT	14	num	88	SENT_95	[p6l904t1787r1125b1850],
88	%	NN	PERCENT	%	dep	86	SENT_95	[p6l904t1787r1125b1850],
89	as	IN	O	as	_	0	SENT_95	[p6l1166t1810r1229b1850],
90	dependent	JJ	O	dependent	amod	91	SENT_95	[p6l1271t1784r1643b1873],
91	variable	NN	O	variable	prep_as	78	SENT_95	[p6l1677t1784r1970b1850],
92	.	.	O	.	_	0	SENT_95	[p6l1677t1784r1970b1850],

1	We	PRP	O	we	nsubj	3	SENT_96	[p6l2010t1785r2140b1851],
2	also	RB	O	also	advmod	3	SENT_96	[p6l12t1889r142b1954],
3	entered	VBD	O	enter	_	0	SENT_96	[p6l187t1889r449b1954],
4	all	DT	O	all	det	6	SENT_96	[p6l492t1889r572b1954],
5	identiﬁed	JJ	O	identiﬁed	amod	6	SENT_96	[p6l613t1889r950b1954],
6	variables	NNS	O	variable	dobj	3	SENT_96	[p6l988t1889r1292b1954],
7	in	IN	O	in	_	0	SENT_96	[p6l1336t1892r1404b1954],
8	a	DT	O	a	det	9	SENT_96	[p6l1448t1915r1482b1954],
9	classiﬁcation	NN	O	classiﬁcation	prep_in	3	SENT_96	[p6l1524t1889r1971b1954],
10	and	CC	O	and	_	0	SENT_96	[p6l2014t1889r2141b1954],
11	regression	NN	O	regression	nn	12	SENT_96	[p6l10t1998r365b2084],
12	trees	NNS	O	tree	prep_in	3	SENT_96	[p6l415t2012r577b2061],
13	(	CD	NUMBER	(	num	16	SENT_96	[p6l632t1993r938b2075],
14	CART	NN	O	cart	nn	16	SENT_96	[p6l632t1993r938b2075],
15	)	NN	O	)	nn	16	SENT_96	[p6l632t1993r938b2075],
16	analysis	NN	O	analysis	dep	12	SENT_96	[p6l993t1995r1259b2084],
17	to	TO	O	to	aux	18	SENT_96	[p6l1311t2012r1379b2061],
18	determine	VB	O	determine	xcomp	3	SENT_96	[p6l1432t1995r1788b2061],
19	the	DT	O	the	det	21	SENT_96	[p6l1839t1995r1950b2061],
20	best	JJS	O	best	amod	21	SENT_96	[p6l1999t1995r2142b2061],
21	discriminators	NNS	O	discriminator	dobj	18	SENT_96	[p6l11t2101r513b2167],
22	for	IN	O	for	_	0	SENT_96	[p6l568t2101r669b2167],
23	high	JJ	O	high	amod	35	SENT_96	[p6l721t2101r881b2190],
24	on	IN	O	on	_	0	SENT_96	[p6l935t2101r1458b2190],
25	—	CD	NUMBER	—	num	27	SENT_96	[p6l935t2101r1458b2190],
26	clopidogrel	NN	O	clopidogrel	nn	27	SENT_96	[p6l935t2101r1458b2190],
27	RPA	NN	O	rpa	prep_on	23	SENT_96	[p6l1512t2099r1690b2166],
28	(	CD	NUMBER	(	num	31	SENT_96	[p6l1745t2099r2140b2190],
29	chi	NN	O	chus	nn	31	SENT_96	[p6l1745t2099r2140b2190],
30	—	NN	O	—	nn	31	SENT_96	[p6l1745t2099r2140b2190],
31	square	NN	O	square	dep	27	SENT_96	[p6l1745t2099r2140b2190],
32	automatic	JJ	O	automatic	amod	35	SENT_96	[p6l12t2211r361b2274],
33	interaction	NN	O	interaction	nn	35	SENT_96	[p6l407t2211r789b2274],
34	detector	NN	O	detector	nn	35	SENT_96	[p6l837t2208r1124b2274],
35	algorithm	NN	O	algorithm	prep_for	21	SENT_96	[p6l1170t2208r1534b2297],
36	,	,	O	,	_	0	SENT_96	[p6l1170t2208r1534b2297],
37	p	NN	O	p	nn	39	SENT_96	[p6l1582t2234r1624b2297],
38	value	NN	O	value	nn	39	SENT_96	[p6l1669t2208r1850b2274],
39	adjustment	NN	O	adjustment	appos	35	SENT_96	[p6l1899t2208r2138b2297, p6l11t2331r194b2380],
40	by	IN	O	by	_	0	SENT_96	[p6l221t2314r307b2403],
41	Bonferroni	NNP	PERSON	Bonferroni	nn	43	SENT_96	[p6l334t2314r722b2380],
42	method	NN	O	method	nn	43	SENT_96	[p6l754t2312r1073b2394],
43	)	NN	O	)	prep_by	39	SENT_96	[p6l754t2312r1073b2394],
44	.	.	O	.	_	0	SENT_96	[p6l754t2312r1073b2394],

1	The	DT	O	the	det	2	SENT_97	[p6l1105t2312r1253b2380],
2	percentage	NN	O	percentage	nsubjpass	20	SENT_97	[p6l1283t2331r1663b2403],
3	of	IN	O	of	_	0	SENT_97	[p6l1695t2314r1775b2380],
4	variability	NN	O	variability	prep_of	2	SENT_97	[p6l1790t2314r2144b2403],
5	of	IN	O	of	prep	4	SENT_97	[p6l11t2420r91b2486],
6	on	IN	O	on	pcomp	5	SENT_97	[p6l105t2420r627b2509],
7	—	NN	O	—	nn	9	SENT_97	[p6l105t2420r627b2509],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_97	[p6l105t2420r627b2509],
9	RPA	NN	O	rpa	pobj	6	SENT_97	[p6l653t2418r831b2485],
10	that	WDT	O	that	nsubj	12	SENT_97	[p6l855t2420r996b2486],
11	could	MD	O	could	aux	12	SENT_97	[p6l1020t2420r1211b2486],
12	attribute	VB	O	attribute	rcmod	9	SENT_97	[p6l1238t2420r1537b2486],
13	to	TO	O	to	_	0	SENT_97	[p6l1562t2437r1630b2486],
14	the	DT	O	the	det	15	SENT_97	[p6l1657t2420r1767b2486],
15	variability	NN	O	variability	prep_to	12	SENT_97	[p6l1790t2420r2144b2509],
16	in	IN	O	in	_	0	SENT_97	[p6l10t2530r78b2591],
17	independent	JJ	O	independent	amod	18	SENT_97	[p6l108t2527r553b2615],
18	variables	NNS	O	variable	prep_in	15	SENT_97	[p6l578t2526r882b2592],
19	was	VBD	O	be	auxpass	20	SENT_97	[p6l910t2552r1040b2592],
20	derived	VBN	O	derive	_	0	SENT_97	[p6l1073t2527r1330b2592],
21	from	IN	O	from	_	0	SENT_97	[p6l1359t2527r1529b2592],
22	partial	JJ	O	partial	amod	24	SENT_97	[p6l1560t2527r1785b2615],
23	T	NN	O	t	nn	24	SENT_97	[p6l1819t2514r1898b2610],
24	)	NN	O	)	prep_from	20	SENT_97	[p6l1819t2514r1898b2610],
25	2	CD	NUMBER	2	dobj	26	SENT_97	[p6l1819t2514r1898b2610],
26	calculated	VBN	O	calculate	partmod	24	SENT_97	[p6l1930t2527r2138b2592, p6l9t2633r181b2699],
27	by	IN	O	by	_	0	SENT_97	[p6l203t2633r289b2722],
28	multivariable	JJ	O	multivariable	amod	31	SENT_97	[p6l311t2633r771b2700],
29	linear	JJ	O	linear	amod	31	SENT_97	[p6l795t2633r995b2699],
30	regression	NN	O	regression	nn	31	SENT_97	[p6l1017t2636r1372b2722],
31	analysis	NN	O	analysis	agent	26	SENT_97	[p6l1398t2633r1663b2722],
32	with	IN	O	with	_	0	SENT_97	[p6l1686t2633r1847b2700],
33	RPA	NN	ORGANIZATION	rpa	prep_with	31	SENT_97	[p6l1873t2632r2052b2699],
34	as	IN	O	as	_	0	SENT_97	[p6l2076t2659r2139b2699],
35	dependent	JJ	O	dependent	amod	36	SENT_97	[p6l11t2739r384b2829],
36	variable	JJ	O	variable	prep_as	33	SENT_97	[p6l418t2739r692b2805],
37	and	CC	O	and	_	0	SENT_97	[p6l734t2739r861b2805],
38	entering	VBG	O	enter	prep_as	33	SENT_97	[p6l901t2742r1194b2828],
39	dichotomous	JJ	O	dichotomous	amod	40	SENT_97	[p6l1233t2739r1691b2805],
40	variables	NNS	O	variable	dobj	38	SENT_97	[p6l1729t2739r2033b2805],
41	as	IN	O	as	_	0	SENT_97	[p6l2076t2765r2139b2805],
42	ﬁxed	JJ	O	ﬁxed	amod	43	SENT_97	[p6l10t2845r180b2911],
43	factors	NNS	O	factor	prep_as	38	SENT_97	[p6l220t2845r472b2911],
44	.	.	O	.	_	0	SENT_97	[p6l220t2845r472b2911],

1	To	TO	O	to	aux	2	SENT_98	[p6l515t2843r619b2911],
2	evaluate	VB	O	evaluate	purpcl	28	SENT_98	[p6l663t2845r945b2911],
3	the	DT	O	the	det	4	SENT_98	[p6l987t2845r1097b2911],
4	improvement	NN	O	improvement	dobj	2	SENT_98	[p6l1139t2848r1615b2935],
5	in	IN	O	in	_	0	SENT_98	[p6l1654t2848r1722b2911],
6	our	PRP$	O	we	poss	8	SENT_98	[p6l1765t2871r1881b2911],
7	binary	JJ	O	binary	amod	8	SENT_98	[p6l1919t2845r2145b2934],
8	model	NN	O	model	prep_in	2	SENT_98	[p6l11t2951r231b3017],
9	by	IN	O	by	_	0	SENT_98	[p6l252t2951r338b3040],
10	adding	VBG	O	add	prepc_by	2	SENT_98	[p6l359t2951r601b3040],
11	the	DT	O	the	det	17	SENT_98	[p6l622t2951r733b3017],
12	CYPZCJ	NNP	O	CYPZCJ	nn	17	SENT_98	[p6l764t2954r1058b3018],
13	9	CD	NUMBER	9	num	17	SENT_98	[p6l1069t2954r1177b3018],
14	*	NN	O	*	nn	17	SENT_98	[p6l1069t2954r1177b3018],
15	2	CD	NUMBER	2	num	17	SENT_98	[p6l1069t2954r1177b3018],
16	carrier	NN	O	carrier	nn	17	SENT_98	[p6l1201t2954r1426b3017],
17	status	NN	O	status	dobj	10	SENT_98	[p6l1450t2968r1646b3017],
18	to	TO	O	to	_	0	SENT_98	[p6l1671t2968r1739b3017],
19	the	DT	O	the	det	20	SENT_98	[p6l1764t2951r1874b3017],
20	model	NN	O	model	prep_to	10	SENT_98	[p6l1900t2951r2138b3032],
21	,	,	O	,	_	0	SENT_98	[p6l1900t2951r2138b3032],
22	including	VBG	O	include	_	0	SENT_98	[p6l10t3057r345b3146],
23	only	JJ	O	only	amod	25	SENT_98	[p6l402t3057r555b3146],
24	clinical	JJ	O	clinical	amod	25	SENT_98	[p6l611t3057r859b3123],
25	variables	NNS	O	variable	prep_including	2	SENT_98	[p6l913t3057r1238b3138],
26	,	,	O	,	_	0	SENT_98	[p6l913t3057r1238b3138],
27	we	PRP	O	we	nsubj	28	SENT_98	[p6l1296t3083r1395b3123],
28	calculated	VBD	O	calculate	_	0	SENT_98	[p6l1455t3057r1803b3123],
29	the	DT	O	the	det	33	SENT_98	[p6l1861t3057r1971b3123],
30	net	JJ	O	net	amod	33	SENT_98	[p6l2032t3074r2143b3123],
31	reclassiﬁcation	NN	O	reclassiﬁcation	nn	33	SENT_98	[p6l10t3163r526b3229],
32	improvement	NN	O	improvement	nn	33	SENT_98	[p6l567t3166r1042b3253],
33	(	NN	O	(	dobj	28	SENT_98	[p6l1084t3161r1306b3243],
34	based	VBN	O	base	_	0	SENT_98	[p6l1084t3161r1306b3243],
35	on	IN	O	on	prepc_based_on	28	SENT_98	[p6l1346t3189r1434b3229],
36	the	DT	O	the	det	37	SENT_98	[p6l1474t3163r1584b3229],
37	methods	NNS	O	method	pobj	28	SENT_98	[p6l1626t3163r1928b3229],
38	from	IN	O	from	_	0	SENT_98	[p6l1970t3163r2140b3229],
39	Frank	NNP	PERSON	Frank	nn	40	SENT_98	[p6l11t3269r224b3335],
40	Harrell	NNP	PERSON	Harrell	prep_from	37	SENT_98	[p6l261t3269r534b3350],
41	,	,	O	,	_	0	SENT_98	[p6l261t3269r534b3350],
42	run	VBN	O	run	partmod	40	SENT_98	[p6l577t3295r696b3335],
43	in	IN	O	in	_	0	SENT_98	[p6l736t3272r804b3334],
44	R	NN	O	r	prep_in	42	SENT_98	[p6l846t3270r922b3350],
45	,	,	O	,	_	0	SENT_98	[p6l846t3270r922b3350],
46	Version	NNP	O	Version	appos	44	SENT_98	[p6l965t3270r1239b3336],
47	2.10.1	CD	NUMBER	2.10.1	num	46	SENT_98	[p6l1277t3272r1519b3350],
48	,	,	O	,	_	0	SENT_98	[p6l1277t3272r1519b3350],
49	R	NNP	ORGANIZATION	R	nn	52	SENT_98	[p6l1564t3270r1623b3334],
50	Development	NNP	ORGANIZATION	Development	nn	52	SENT_98	[p6l1660t3269r2143b3359],
51	Core	NNP	ORGANIZATION	Core	nn	52	SENT_98	[p6l12t3374r185b3440],
52	Team	NNP	ORGANIZATION	Team	appos	44	SENT_98	[p6l243t3372r472b3454],
53	,	,	O	,	_	0	SENT_98	[p6l243t3372r472b3454],
54	Vienna	NNP	LOCATION	Vienna	appos	44	SENT_98	[p6l535t3375r808b3454],
55	,	,	O	,	_	0	SENT_98	[p6l535t3375r808b3454],
56	Austria	NNP	LOCATION	Austria	appos	44	SENT_98	[p6l869t3372r1178b3454],
57	)	CD	NUMBER	)	num	56	SENT_98	[p6l869t3372r1178b3454],
58	.	.	O	.	_	0	SENT_98	[p6l869t3372r1178b3454],

1	For	IN	O	for	_	0	SENT_99	[p6l1243t3375r1369b3440],
2	all	DT	O	all	det	5	SENT_99	[p6l1429t3374r1509b3440],
3	other	JJ	O	other	amod	5	SENT_99	[p6l1568t3374r1754b3440],
4	statistical	JJ	O	statistical	amod	5	SENT_99	[p6l1815t3374r2142b3440],
5	analyses	NNS	O	analysis	prep_for	8	SENT_99	[p7l12t20r312b109],
6	,	,	O	,	_	0	SENT_99	[p7l12t20r312b109],
7	we	PRP	O	we	nsubj	8	SENT_99	[p7l353t46r452b86],
8	used	VBD	O	use	_	0	SENT_99	[p7l493t20r652b86],
9	the	DT	O	the	det	12	SENT_99	[p7l693t20r803b86],
10	SPSS	NNP	ORGANIZATION	SPSS	nn	12	SENT_99	[p7l848t20r1039b86],
11	software	NN	O	software	nn	12	SENT_99	[p7l1085t20r1378b86],
12	package	NN	O	package	dobj	8	SENT_99	[p7l1419t20r1719b109],
13	,	,	O	,	_	0	SENT_99	[p7l1419t20r1719b109],
14	Version	NNP	O	Version	appos	12	SENT_99	[p7l1760t23r2014b86],
15	18	CD	NUMBER	18	number	16	SENT_99	[p7l2060t23r2138b86],
16	(	CD	NUMBER	(	num	24	SENT_99	[p7l13t124r256b207],
17	SPSS	NNP	ORGANIZATION	SPSS	nn	24	SENT_99	[p7l13t124r256b207],
18	,	,	O	,	_	0	SENT_99	[p7l13t124r256b207],
19	Inc.	NNP	ORGANIZATION	Inc.	appos	24	SENT_99	[p7l284t127r440b207],
20	,	,	O	,	_	0	SENT_99	[p7l284t127r440b207],
21	Chicago	NNP	LOCATION	Chicago	appos	24	SENT_99	[p7l472t126r786b215],
22	,	,	O	,	_	0	SENT_99	[p7l472t126r786b215],
23	Illinois	NNP	LOCATION	Illinois	appos	24	SENT_99	[p7l814t124r1108b207],
24	)	NN	O	)	dep	14	SENT_99	[p7l814t124r1108b207],
25	.	.	O	.	_	0	SENT_99	[p7l814t124r1108b207],

1	In	IN	O	in	_	0	SENT_100	[p7l1137t127r1215b192],
2	general	JJ	O	general	prep_in	7	SENT_100	[p7l1240t126r1514b215],
3	,	,	O	,	_	0	SENT_100	[p7l1240t126r1514b215],
4	discrete	JJ	O	discrete	amod	5	SENT_100	[p7l1544t126r1812b192],
5	Variables	NNS	O	variable	nsubjpass	7	SENT_100	[p7l1835t126r2139b192],
6	are	VBP	O	be	auxpass	7	SENT_100	[p7l12t259r113b299],
7	reported	VBN	O	report	_	0	SENT_100	[p7l150t233r449b323],
8	as	IN	O	as	_	0	SENT_100	[p7l487t259r550b299],
9	counts	NNS	O	count	prep_as	7	SENT_100	[p7l590t250r817b299],
10	(	CD	NUMBER	(	num	11	SENT_100	[p7l859t231r1345b323],
11	percentages	NNS	O	percentage	dep	12	SENT_100	[p7l859t231r1345b323],
12	)	RB	O	)	amod	9	SENT_100	[p7l859t231r1345b323],
13	,	,	O	,	_	0	SENT_100	[p7l859t231r1345b323],
14	and	CC	O	and	_	0	SENT_100	[p7l1387t233r1514b299],
15	continuous	JJ	O	continuous	amod	16	SENT_100	[p7l1551t236r1939b299],
16	Variables	NNS	O	variable	nsubjpass	18	SENT_100	[p7l1975t236r2138b300, p7l12t339r180b405],
17	are	VBP	O	be	auxpass	18	SENT_100	[p7l211t365r312b405],
18	reported	VBN	O	report	conj_and	7	SENT_100	[p7l340t339r639b429],
19	as	IN	O	as	_	0	SENT_100	[p7l667t365r730b405],
20	mean	JJ	O	mean	amod	21	SENT_100	[p7l760t365r951b405],
21	i	FW	O	i	prep_as	18	SENT_100	[p7l986t348r1040b401],
22	SD	NN	O	sd	dobj	18	SENT_100	[p7l1080t339r1212b405],
23	.	.	O	.	_	0	SENT_100	[p7l1080t339r1212b405],

1	For	IN	O	for	_	0	SENT_101	[p7l1245t340r1370b405],
2	discrete	JJ	O	discrete	amod	3	SENT_101	[p7l1397t339r1665b405],
3	Variables	NNS	O	variable	prep_for	6	SENT_101	[p7l1690t339r2015b420],
4	,	,	O	,	_	0	SENT_101	[p7l1690t339r2015b420],
5	we	PRP	O	we	nsubj	6	SENT_101	[p7l2042t365r2140b405],
6	tested	VBD	O	test	_	0	SENT_101	[p7l10t445r218b511],
7	differences	NNS	O	difference	dobj	6	SENT_101	[p7l242t445r613b511],
8	between	IN	O	between	_	0	SENT_101	[p7l636t445r930b511],
9	groups	NNS	O	group	prep_between	7	SENT_101	[p7l953t471r1189b535],
10	with	IN	O	with	_	0	SENT_101	[p7l1211t445r1372b511],
11	the	DT	O	the	det	13	SENT_101	[p7l1396t445r1506b511],
12	chi-square	JJ	O	chi-square	amod	13	SENT_101	[p7l1531t445r1898b534],
13	test	NN	O	test	prep_with	6	SENT_101	[p7l1922t462r2047b511],
14	or	CC	O	or	_	0	SENT_101	[p7l2070t471r2142b511],
15	Fisher	NNP	PERSON	Fisher	nn	17	SENT_101	[p7l11t551r233b617],
16	exact	JJ	O	exact	amod	17	SENT_101	[p7l258t568r435b617],
17	test	NN	O	test	prep_with	6	SENT_101	[p7l458t568r583b617],
18	when	WRB	O	when	advmod	23	SENT_101	[p7l602t551r797b617],
19	expected	VBN	O	expect	amod	21	SENT_101	[p7l823t551r1128b641],
20	cell	NN	O	cell	nn	21	SENT_101	[p7l1154t551r1270b617],
21	sizes	NNS	O	size	nsubj	23	SENT_101	[p7l1296t554r1453b617],
22	were	VBD	O	be	cop	23	SENT_101	[p7l1476t577r1642b617],
23	<	JJR	O	<	advcl	6	SENT_101	[p7l1674t551r1801b617],
24	5	CD	NUMBER	5	tmod	23	SENT_101	[p7l1674t551r1801b617],
25	.	.	O	.	_	0	SENT_101	[p7l1674t551r1801b617],

1	We	PRP	O	we	nsubj	2	SENT_102	[p7l1827t552r1958b618],
2	used	VBD	O	use	_	0	SENT_102	[p7l1982t551r2142b617],
3	the	DT	O	the	det	5	SENT_102	[p7l10t657r120b723],
4	2	CD	NUMBER	2	num	5	SENT_102	[p7l159t657r435b724],
5	—	NN	O	—	nsubj	6	SENT_102	[p7l159t657r435b724],
6	tailed	VBD	O	tail	ccomp	2	SENT_102	[p7l159t657r435b724],
7	2	CD	NUMBER	2	number	8	SENT_102	[p7l475t673r504b723],
8	‘	CD	NUMBER	‘	num	9	SENT_102	[p7l475t673r504b723],
9	test	NN	O	test	dobj	6	SENT_102	[p7l538t674r662b723],
10	to	TO	O	to	aux	11	SENT_102	[p7l700t674r768b723],
11	compare	VB	O	compare	xcomp	6	SENT_102	[p7l810t683r1109b747],
12	continuous	JJ	O	continuous	amod	13	SENT_102	[p7l1150t660r1537b723],
13	Variables	NNS	O	variable	dobj	11	SENT_102	[p7l1575t657r1879b723],
14	or	CC	O	or	_	0	SENT_102	[p7l1920t683r1992b723],
15	the	DT	O	the	det	16	SENT_102	[p7l2030t657r2140b723],
16	Kruskal	NNP	PERSON	Kruskal	conj_or	13	SENT_102	[p7l13t762r548b828],
17	.	.	O	.	_	0	SENT_102	[p7l13t762r548b828],

1	—	NN	O	—	_	0	SENT_103	[p7l13t762r548b828],
2	.	.	O	.	_	0	SENT_103	[p7l13t762r548b828],

1	Wallis	NNP	PERSON	Wallis	nsubj	2	SENT_104	[p7l13t762r548b828],
2	test	NN	O	test	_	0	SENT_104	[p7l609t779r734b828],
3	for	IN	O	for	_	0	SENT_104	[p7l792t762r892b828],
4	non-Gaussian	JJ	MISC	non-gaussian	amod	5	SENT_104	[p7l951t762r1449b828],
5	Variables	NNS	MISC	variable	prep_for	2	SENT_104	[p7l1506t762r1830b828],
6	.	.	O	.	_	0	SENT_104	[p7l1506t762r1830b828],

1	In	IN	O	in	_	0	SENT_105	[p7l1893t763r1971b827],
2	the	DT	O	the	det	4	SENT_105	[p7l2030t762r2140b828],
3	2	CD	NUMBER	2	num	4	SENT_105	[p7l9t868r274b935],
4	—	NN	O	—	prep_in	5	SENT_105	[p7l9t868r274b935],
5	sided	VBD	O	side	_	0	SENT_105	[p7l9t868r274b935],
6	test	NN	O	test	nsubj	5	SENT_105	[p7l306t885r449b949],
7	,	,	O	,	_	0	SENT_105	[p7l306t885r449b949],
8	a	DT	O	a	det	10	SENT_105	[p7l486t894r520b934],
9	p	NN	O	p	nn	10	SENT_105	[p7l551t894r593b958],
10	Value	NN	O	value	appos	6	SENT_105	[p7l624t868r805b934],
11	<	JJR	O	<	nsubjpass	14	SENT_105	[p7l844t868r1062b934],
12	0.05	CD	NUMBER	0.05	dep	11	SENT_105	[p7l844t868r1062b934],
13	was	VBD	O	be	auxpass	14	SENT_105	[p7l1095t894r1224b934],
14	regarded	VBN	O	regard	rcmod	10	SENT_105	[p7l1259t868r1566b957],
15	as	IN	O	as	_	0	SENT_105	[p7l1600t894r1663b934],
16	signiﬁcant	NN	O	signiﬁcant	prep_as	14	SENT_105	[p7l1699t868r2081b957],
17	.	.	O	.	_	0	SENT_105	[p7l1699t868r2081b957],

1	Results	NNS	O	result	_	0	SENT_106	[p7l13t1118r333b1181],

1	The	DT	O	the	det	3	SENT_107	[p7l8t1286r154b1354],
2	entire	JJ	O	entire	amod	3	SENT_107	[p7l200t1291r400b1354],
3	cohort	NN	O	cohort	nsubj	8	SENT_107	[p7l444t1288r674b1354],
4	of	IN	O	of	_	0	SENT_107	[p7l716t1288r795b1354],
5	the	DT	O	the	det	7	SENT_107	[p7l826t1288r936b1354],
6	EXCELSIOR	NNP	O	EXCELSIOR	nn	7	SENT_107	[p7l982t1288r1506b1354],
7	study	NN	O	study	prep_of	3	SENT_107	[p7l1548t1288r1737b1377],
8	comprised	VBD	O	comprise	_	0	SENT_107	[p7l1777t1288r2141b1377],
9	802	CD	NUMBER	802	num	10	SENT_107	[p7l13t1397r139b1461],
10	patients	NNS	O	patient	dobj	8	SENT_107	[p7l199t1397r497b1483],
11	,	,	O	,	_	0	SENT_107	[p7l199t1397r497b1483],
12	of	IN	O	of	_	0	SENT_107	[p7l560t1394r640b1460],
13	which	WDT	O	which	rel	26	SENT_107	[p7l684t1394r901b1460],
14	CYPZCZ	NNP	O	CYPZCZ	nsubj	26	SENT_107	[p7l968t1397r1262b1461],
15	9	CD	NUMBER	9	num	16	SENT_107	[p7l1273t1401r1311b1460],
16	genotype	NN	O	genotype	dep	14	SENT_107	[p7l1368t1411r1688b1483],
17	as	RB	O	as	_	0	SENT_107	[p7l1750t1420r1813b1460],
18	well	RB	O	well	_	0	SENT_107	[p7l1870t1394r2016b1460],
19	as	IN	O	as	_	0	SENT_107	[p7l2076t1420r2139b1460],
20	pre	JJ	O	pre	amod	24	SENT_107	[p7l9t1500r491b1589],
21	—	NN	O	—	nn	24	SENT_107	[p7l9t1500r491b1589],
22	discharge	NN	O	discharge	nn	24	SENT_107	[p7l9t1500r491b1589],
23	RPA	NN	O	rpa	nn	24	SENT_107	[p7l521t1499r698b1565],
24	results	NNS	O	result	nsubj	26	SENT_107	[p7l723t1500r945b1566],
25	were	VBD	O	be	cop	26	SENT_107	[p7l969t1526r1135b1566],
26	available	JJ	O	available	rcmod	10	SENT_107	[p7l1164t1500r1462b1566],
27	from	IN	O	from	_	0	SENT_107	[p7l1489t1500r1658b1566],
28	760	CD	NUMBER	760	num	29	SENT_107	[p7l1687t1502r1814b1566],
29	patients	NNS	O	patient	prep_from	26	SENT_107	[p7l1840t1503r2136b1589],
30	.	.	O	.	_	0	SENT_107	[p7l1840t1503r2136b1589],

1	A	DT	O	a	det	2	SENT_108	[p7l8t1605r75b1671],
2	table	NN	O	table	nsubjpass	9	SENT_108	[p7l133t1606r301b1672],
3	of	IN	O	of	_	0	SENT_108	[p7l362t1606r442b1672],
4	baseline	NN	O	baseline	nn	5	SENT_108	[p7l488t1606r770b1672],
5	characteristics	NNS	O	characteristic	prep_of	2	SENT_108	[p7l832t1606r1325b1672],
6	has	VBZ	O	have	aux	9	SENT_108	[p7l1387t1606r1499b1672],
7	previously	RB	DATE	previously	advmod	9	SENT_108	[p7l1560t1606r1920b1695],
8	been	VBN	O	be	auxpass	9	SENT_108	[p7l1974t1606r2140b1672],
9	published	VBN	O	publish	_	0	SENT_108	[p7l9t1712r354b1801],
10	y	NN	O	y	dobj	9	SENT_108	[p7l380t1710r495b1793],
11	+	CC	O	+	_	0	SENT_108	[p7l380t1710r495b1793],
12	The	DT	O	the	det	14	SENT_108	[p7l520t1710r667b1778],
13	mean	NN	O	mean	nn	14	SENT_108	[p7l693t1738r883b1778],
14	age	NN	O	age	conj_+	10	SENT_108	[p7l909t1738r1022b1801],
15	in	IN	O	in	_	0	SENT_108	[p7l1047t1715r1114b1777],
16	our	PRP$	O	we	poss	17	SENT_108	[p7l1139t1738r1256b1778],
17	population	NN	O	population	prep_in	14	SENT_108	[p7l1277t1712r1660b1802],
18	was	VBD	O	be	cop	20	SENT_108	[p7l1680t1738r1810b1778],
19	66	CD	DURATION	66	num	20	SENT_108	[p7l1837t1715r1919b1779],
20	years	NNS	NUMBER	year	rcmod	17	SENT_108	[p7l1942t1738r2137b1801],
21	,	,	O	,	_	0	SENT_108	[p7l1942t1738r2137b1801],
22	the	DT	O	the	det	23	SENT_108	[p7l10t1819r120b1885],
23	proportion	NN	O	proportion	nsubj	28	SENT_108	[p7l158t1822r540b1909],
24	of	IN	O	of	_	0	SENT_108	[p7l579t1819r659b1885],
25	men	NNS	O	man	prep_of	23	SENT_108	[p7l685t1845r838b1885],
26	was	VBD	O	be	cop	28	SENT_108	[p7l873t1845r1001b1885],
27	72	CD	PERCENT	72	num	28	SENT_108	[p7l1043t1821r1213b1900],
28	%	NN	PERCENT	%	ccomp	9	SENT_108	[p7l1043t1821r1213b1900],
29	,	,	O	,	_	0	SENT_108	[p7l1043t1821r1213b1900],
30	drug-eluting	JJ	O	drug-eluting	amod	31	SENT_108	[p7l1255t1819r1701b1908],
31	stents	NNS	O	stent	nsubjpass	33	SENT_108	[p7l1739t1836r1938b1885],
32	were	VBD	O	be	auxpass	33	SENT_108	[p7l1974t1845r2140b1885],
33	used	VBN	O	use	ccomp	9	SENT_108	[p7l9t1925r169b1991],
34	in	IN	O	in	_	0	SENT_108	[p7l201t1928r268b1990],
35	37	CD	PERCENT	37	num	36	SENT_108	[p7l301t1927r453b1991],
36	%	NN	PERCENT	%	prep_in	33	SENT_108	[p7l301t1927r453b1991],
37	of	IN	O	of	_	0	SENT_108	[p7l487t1925r566b1991],
38	patients	NNS	O	patient	prep_of	36	SENT_108	[p7l586t1928r884b2015],
39	,	,	O	,	_	0	SENT_108	[p7l586t1928r884b2015],
40	and	CC	O	and	_	0	SENT_108	[p7l921t1925r1048b1991],
41	no	DT	O	no	det	42	SENT_108	[p7l1081t1951r1167b1991],
42	patient	NN	O	patient	nsubjpass	44	SENT_108	[p7l1200t1928r1448b2015],
43	was	VBD	O	be	auxpass	44	SENT_108	[p7l1476t1951r1605b1991],
44	treated	VBN	O	treat	conj_and	9	SENT_108	[p7l1639t1925r1883b1991],
45	with	IN	O	with	_	0	SENT_108	[p7l1912t1925r2073b1991],
46	a	DT	O	a	det	49	SENT_108	[p7l2107t1951r2142b1991],
47	glycoprotein	NN	O	glycoprotein	nn	49	SENT_108	[p7l9t2031r450b2121],
48	IIb/IIIa	NN	O	iib/iiia	nn	49	SENT_108	[p7l483t2031r760b2097],
49	inhibitor	NN	O	inhibitor	prep_with	44	SENT_108	[p7l791t2031r1120b2097],
50	.	.	O	.	_	0	SENT_108	[p7l791t2031r1120b2097],

1	Variability	NN	O	variability	nsubj	7	SENT_109	[p7l7t2136r387b2226],
2	of	IN	O	of	_	0	SENT_109	[p7l436t2136r518b2203],
3	on-clopidogrel	JJ	O	on-clopidogrel	amod	4	SENT_109	[p7l558t2136r1088b2227],
4	RPA	NN	ORGANIZATION	rpa	prep_of	1	SENT_109	[p7l1141t2136r1321b2202],
5	in	IN	O	in	_	0	SENT_109	[p7l1370t2141r1442b2202],
6	strata	NN	O	stratum	prep_in	4	SENT_109	[p7l1495t2153r1693b2203],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_109	[p7l1743t2136r2009b2203],
8	by	IN	O	by	_	0	SENT_109	[p7l2057t2136r2145b2226],
9	CYPZCI9	NN	O	cypzci9	nn	10	SENT_109	[p7l15t2246r362b2310],
10	genotype	NN	O	genotype	prep_by	7	SENT_109	[p7l392t2259r737b2332],
11	.	.	O	.	_	0	SENT_109	[p7l392t2259r737b2332],

1	In	IN	O	in	_	0	SENT_110	[p7l786t2244r862b2308],
2	the	DT	O	the	det	4	SENT_110	[p7l894t2243r1001b2309],
3	entire	JJ	O	entire	amod	4	SENT_110	[p7l1036t2246r1228b2309],
4	cohort	NN	O	cohort	prep_in	18	SENT_110	[p7l1262t2243r1499b2324],
5	,	,	O	,	_	0	SENT_110	[p7l1262t2243r1499b2324],
6	the	DT	O	the	det	7	SENT_110	[p7l1535t2243r1641b2309],
7	proportion	NN	O	proportion	nsubj	18	SENT_110	[p7l1675t2246r2041b2333],
8	of	IN	O	of	_	0	SENT_110	[p7l2075t2243r2153b2309],
9	patients	NNS	O	patient	prep_of	7	SENT_110	[p7l9t2352r274b2439],
10	with	IN	O	with	_	0	SENT_110	[p7l305t2349r462b2415],
11	high	JJ	O	high	amod	15	SENT_110	[p7l495t2349r649b2438],
12	on	IN	O	on	_	0	SENT_110	[p7l683t2349r1183b2439],
13	—	CD	NUMBER	—	num	14	SENT_110	[p7l683t2349r1183b2439],
14	clopidogrel	NN	O	clopidogrel	prep_on	11	SENT_110	[p7l683t2349r1183b2439],
15	RPA	NN	O	rpa	prep_with	9	SENT_110	[p7l1217t2348r1392b2415],
16	was	VBD	O	be	cop	18	SENT_110	[p7l1419t2375r1545b2415],
17	28.4	CD	PERCENT	28.4	num	18	SENT_110	[p7l1579t2352r1809b2416],
18	%	NN	PERCENT	%	_	0	SENT_110	[p7l1579t2352r1809b2416],
19	.	.	O	.	_	0	SENT_110	[p7l1579t2352r1809b2416],

1	Figure	NNP	O	Figure	nsubj	3	SENT_111	[p7l1848t2350r2067b2438],
2	1	CD	NUMBER	1	num	1	SENT_111	[p7l2106t2353r2137b2414],
3	shows	VBZ	O	show	_	0	SENT_111	[p7l12t2455r222b2522],
4	a	DT	O	a	det	6	SENT_111	[p7l272t2481r307b2521],
5	scatter	NN	O	scatter	nn	6	SENT_111	[p7l354t2472r582b2521],
6	plot	NN	O	plot	dobj	3	SENT_111	[p7l626t2455r767b2545],
7	of	IN	O	of	_	0	SENT_111	[p7l813t2455r892b2521],
8	RPA	NN	ORGANIZATION	rpa	prep_of	6	SENT_111	[p7l929t2453r1108b2520],
9	in	IN	O	in	_	0	SENT_111	[p7l1153t2458r1221b2520],
10	the	DT	O	the	det	12	SENT_111	[p7l1268t2455r1378b2521],
11	3	CD	NUMBER	3	num	12	SENT_111	[p7l1426t2458r1463b2522],
12	strata	NN	O	stratum	prep_in	8	SENT_111	[p7l1515t2472r1706b2521],
13	deﬁned	VBN	O	deﬁned	partmod	12	SENT_111	[p7l1753t2455r2014b2521],
14	by	IN	O	by	_	0	SENT_111	[p7l2058t2455r2144b2544],
15	Hochholzer	NNP	PERSON	Hochholzer	agent	13	SENT_111	[p7l1334t2557r1649b2609],
16	et	FW	O	et	nn	17	SENT_111	[p7l1675t2559r1732b2609],
17	al.	FW	O	al.	tmod	13	SENT_111	[p7l1753t2557r1820b2609],
18	2429	CD	DATE	2429	dep	17	SENT_111	[p7l1989t2557r2140b2609],

1	P450	NN	O	p450	nn	3	SENT_112	[p7l168t2645r317b2698],
2	2C19	NN	O	2c19	nn	3	SENT_112	[p7l343t2645r495b2698],
3	Polymorphisms	NNS	O	polymorphism	_	0	SENT_112	[p7l523t2646r952b2708],
4	and	CC	O	and	_	0	SENT_112	[p7l977t2646r1079b2698],
5	Residual	JJ	O	residual	amod	8	SENT_112	[p7l1109t2646r1345b2698],
6	Platelet	NN	O	platelet	nn	8	SENT_112	[p7l1374t2646r1590b2698],
7	Activity	NN	O	activity	nn	8	SENT_112	[p7l1613t2646r1823b2708],
8	p	NN	O	p	conj_and	3	SENT_112	[p8l1035t239r1083b308],
9	<	JJR	O	<	dep	3	SENT_112	[p8l1114t242r1161b290],
10	0.001	CD	NUMBER	0.001	dep	9	SENT_112	[p8l1193t224r1402b291],

1	I	PRP	O	I	_	0	SENT_113	[p8l714t309r1757b336],
2	7	CD	PERCENT	7	num	3	SENT_113	[p8l748t369r885b442],
3	%	NN	PERCENT	%	dep	1	SENT_113	[p8l748t369r885b442],
4	1	CD	NUMBER	1	number	5	SENT_113	[p8l1146t369r1173b440],
5	17	CD	NUMBER	17	num	3	SENT_113	[p8l1202t369r1332b473],
6	,	,	O	,	_	0	SENT_113	[p8l1202t369r1332b473],
7	10	CD	PERCENT	10	num	8	SENT_113	[p8l1594t369r1779b442],
8	%	NN	PERCENT	%	appos	3	SENT_113	[p8l1594t369r1779b442],

1	oo	NN	O	oo	_	0	SENT_114	[p8l342t323r386b389],
2	o	NN	O	o	nn	3	SENT_114	[p8l393t323r437b389],
3	O	NN	O	o	dep	1	SENT_114	[p8l342t582r387b648],
4	?	.	O	?	_	0	SENT_114	[p8l342t582r387b648],

1	O	NN	O	o	_	0	SENT_115	[p8l393t582r437b648],

1	RPA	NNP	O	RPA	nn	3	SENT_116	[p8l203t1086r276b1281],
2	ADP	NN	O	adp	nn	3	SENT_116	[p8l203t857r276b1056],
3	5uM	NN	O	5um	_	0	SENT_116	[p8l203t636r296b822],
4	(	CD	PERCENT	(	num	5	SENT_116	[p8l202t453r296b595],
5	%	NN	PERCENT	%	dep	3	SENT_116	[p8l202t453r296b595],
6	)	CD	NUMBER	)	dep	3	SENT_116	[p8l202t453r296b595],

1	|	NN	O	|	_	0	SENT_117	[p8l341t1100r386b1165],
2	\	SYM	O	\	dep	3	SENT_117	[p8l341t1100r386b1165],
3	3	LS	NUMBER	3	dep	1	SENT_117	[p8l341t1100r386b1165],
4	-	:	O	-	_	0	SENT_117	[p8l341t841r387b906],
5	P	NN	O	p	dep	1	SENT_117	[p8l341t841r387b906],
6	CD	NNP	O	CD	nn	7	SENT_117	[p8l393t1100r437b1166],
7	CD	NNP	O	CD	dep	5	SENT_117	[p8l393t841r437b907],

1	%	NN	O	%	_	0	SENT_118	[p8l675t849r931b1159],
2	,	,	O	,	_	0	SENT_118	[p8l675t849r931b1159],
3	¥	NN	O	¥	appos	1	SENT_118	[p8l675t849r931b1159],
4	,	,	O	,	_	0	SENT_118	[p8l675t849r931b1159],
5	.	.	O	.	_	0	SENT_118	[p8l675t849r931b1159],

1	§	NN	O	§	_	0	SENT_119	[p8l675t849r931b1159],
2	.	.	O	.	_	0	SENT_119	[p8l675t849r931b1159],

1	.	.	O	.	_	0	SENT_120	[p8l675t849r931b1159],

1	;	:	O	;	_	0	SENT_121	[p8l675t849r931b1159],
2	§	NN	O	§	_	0	SENT_121	[p8l675t849r931b1159],
3	.	.	O	.	_	0	SENT_121	[p8l675t849r931b1159],

1	x	NN	O	x	nsubj	2	SENT_122	[p8l675t849r931b1159],
2	,	,	O	,	_	0	SENT_122	[p8l675t849r931b1159],
3	.	.	O	.	_	0	SENT_122	[p8l675t849r931b1159],

1	,	,	O	,	_	0	SENT_123	[p8l675t849r931b1159],
2	:	:	O	:	_	0	SENT_123	[p8l675t849r931b1159],
3	,	,	O	,	_	0	SENT_123	[p8l675t849r931b1159],
4	.	.	O	.	_	0	SENT_123	[p8l675t849r931b1159],

1	,	,	O	,	_	0	SENT_124	[p8l675t849r931b1159],
2	.	.	O	.	_	0	SENT_124	[p8l675t849r931b1159],

1	.	.	O	.	_	0	SENT_125	[p8l783t719r821b822],

1	.	.	O	.	_	0	SENT_126	[p8l783t719r821b822],

1	,	,	O	,	_	0	SENT_127	[p8l783t719r821b822],
2	.	.	O	.	_	0	SENT_127	[p8l783t719r821b822],

1	.	.	O	.	_	0	SENT_128	[p8l783t719r821b822],

1	:	:	O	:	_	0	SENT_129	[p8l783t719r821b822],
2	.	.	O	.	_	0	SENT_129	[p8l783t719r821b822],

1	ldkbéwwm	NN	O	ldkbéwwm	_	0	SENT_130	[p8l1199t823r1309b1159],

1	7	CD	PERCENT	7	num	2	SENT_131	[p8l1785t1116r1912b1181],
2	%	NN	PERCENT	%	_	0	SENT_131	[p8l1785t1116r1912b1181],
3	o	NN	O	o	dep	2	SENT_131	[p8l1898t1116r1955b1183],
4	\	IN	O	\	amod	3	SENT_131	[p8l1898t1116r1955b1183],

1	O	NN	O	o	_	0	SENT_132	[p8l393t1359r438b1425],

1	B	NN	O	b	_	0	SENT_133	[p8l202t1583r272b1673],
2	so	RB	O	so	advmod	1	SENT_133	[p8l347t1616r442b1682],
3	o	NN	O	o	dep	1	SENT_133	[p8l204t1726r302b1843],
4	?	.	O	?	_	0	SENT_133	[p8l204t1726r302b1843],

1	2	CD	NUMBER	2	_	0	SENT_134	[p8l205t1917r280b1989],
2	60	CD	NUMBER	60	number	3	SENT_134	[p8l347t1879r442b1945],
3	:5	CD	NUMBER	:5	num	1	SENT_134	[p8l226t2005r302b2049],
4	.	.	O	.	_	0	SENT_134	[p8l226t2005r302b2049],

1	Lo	NNP	O	Lo	nn	2	SENT_135	[p8l208t2060r282b2110],
2	o.	NNP	O	o.	_	0	SENT_135	[p8l205t2147r280b2203],
3	40	CD	NUMBER	40	num	4	SENT_135	[p8l346t2142r442b2209],
4	o	NN	O	o	npadvmod	5	SENT_135	[p8l205t2216r280b2278],
5	<	JJR	O	<	amod	7	SENT_135	[p8l205t2287r280b2354],
6	2	CD	NUMBER	2	dep	5	SENT_135	[p8l205t2287r280b2354],
7	E	NN	O	e	dep	2	SENT_135	[p8l205t2386r280b2514],
8	20	CD	NUMBER	20	number	9	SENT_135	[p8l346t2405r442b2471],
9	U	NN	O	u	amod	7	SENT_135	[p8l205t2526r280b2589],
10	:	:	O	:	_	0	SENT_135	[p8l205t2526r280b2589],

1	wt/wt	NN	O	wt/wt	_	0	SENT_136	[p8l688t2823r893b2893],
2	wt	JJ	O	wt	amod	1	SENT_136	[p8l1149t2823r1346b2893],
3	/	:	O	/	punct	4	SENT_136	[p8l1149t2823r1346b2893],
4	*	NN	O	*	dep	1	SENT_136	[p8l1149t2823r1346b2893],
5	2	CD	NUMBER	2	num	6	SENT_136	[p8l1149t2823r1346b2893],
6	*	NN	O	*	dep	4	SENT_136	[p8l1612t2823r1802b2893],
7	2	CD	NUMBER	2	dep	6	SENT_136	[p8l1612t2823r1802b2893],
8	/	:	O	/	punct	4	SENT_136	[p8l1612t2823r1802b2893],
9	*	CD	NUMBER	*	num	10	SENT_136	[p8l1612t2823r1802b2893],
10	2	CD	NUMBER	2	dep	1	SENT_136	[p8l1612t2823r1802b2893],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_137	[p8l829t2938r1285b3017],
2	genotype	NN	O	genotype	_	0	SENT_137	[p8l1312t2945r1731b3038],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_138	[p8l438t3184r743b3235],
2	Genotype	NN	O	genotype	_	0	SENT_138	[p8l765t3184r1062b3247],
3	and	CC	O	and	_	0	SENT_138	[p8l1089t3185r1200b3235],
4	RPA	NN	O	rpa	conj_and	2	SENT_138	[p8l1230t3185r1362b3234],

1	(	NN	O	(	nn	2	SENT_139	[p8l63t3363r137b3413],
2	A	NN	O	a	nsubj	17	SENT_139	[p8l63t3363r137b3413],
3	)	CD	NUMBER	)	num	5	SENT_139	[p8l63t3363r137b3413],
4	Scatter	NNP	O	Scatter	nn	5	SENT_139	[p8l163t3362r343b3404],
5	plot	NN	O	plot	dep	2	SENT_139	[p8l366t3363r456b3412],
6	of	IN	O	of	_	0	SENT_139	[p8l477t3362r526b3403],
7	residual	JJ	O	residual	amod	12	SENT_139	[p8l547t3363r740b3404],
8	platelet	NN	O	platelet	nn	12	SENT_139	[p8l768t3363r953b3412],
9	aggregation	NN	O	aggregation	nn	12	SENT_139	[p8l975t3363r1262b3414],
10	(	CD	NUMBER	(	num	12	SENT_139	[p8l1288t3363r1418b3413],
11	RPA	NN	ORGANIZATION	rpa	nn	12	SENT_139	[p8l1288t3363r1418b3413],
12	)	NN	O	)	prep_of	2	SENT_139	[p8l1288t3363r1418b3413],
13	in	IN	O	in	_	0	SENT_139	[p8l1444t3363r1481b3403],
14	the	DT	O	the	det	16	SENT_139	[p8l1503t3363r1582b3403],
15	3	CD	NUMBER	3	num	16	SENT_139	[p8l1607t3362r1637b3404],
16	strata	NN	O	stratum	prep_in	12	SENT_139	[p8l1660t3365r1803b3404],
17	defined	VBN	O	define	_	0	SENT_139	[p8l1827t3362r2006b3404],
18	by	IN	O	by	_	0	SENT_139	[p8l2032t3363r2085b3413],
19	CYP2C19	NN	O	cyp2c19	nn	20	SENT_139	[p8l66t3442r303b3484],
20	genotype	NN	O	genotype	prep_by	17	SENT_139	[p8l321t3445r561b3494],
21	.	.	O	.	_	0	SENT_139	[p8l321t3445r561b3494],

1	Percentage	NN	O	percentage	nsubj	2	SENT_140	[p8l588t3443r864b3494],
2	indicates	VBZ	O	indicate	_	0	SENT_140	[p8l890t3443r1112b3484],
3	medians	NNS	O	median	dobj	2	SENT_140	[p8l1137t3443r1348b3484],
4	for	IN	O	for	_	0	SENT_140	[p8l1369t3442r1436b3484],
5	genotype	NN	O	genotype	prep_for	3	SENT_140	[p8l1456t3445r1681b3494],
6	and	CC	O	and	_	0	SENT_140	[p8l1705t3443r1792b3483],
7	red	JJ	O	red	conj_and	3	SENT_140	[p8l1818t3443r1894b3484],
8	dashed	VBN	O	dash	partmod	7	SENT_140	[p8l62t3523r243b3564],
9	line	NN	O	line	nn	11	SENT_140	[p8l268t3522r356b3564],
10	displays	NNS	O	display	nn	11	SENT_140	[p8l378t3523r580b3573],
11	threshold	NN	O	threshold	dobj	8	SENT_140	[p8l601t3523r835b3564],
12	for	IN	O	for	_	0	SENT_140	[p8l858t3522r925b3564],
13	high	JJ	O	high	amod	14	SENT_140	[p8l948t3523r1045b3574],
14	RPA	NN	O	rpa	prep_for	8	SENT_140	[p8l1072t3523r1169b3563],
15	(	CD	PERCENT	(	number	16	SENT_140	[p8l1191t3522r1345b3573],
16	14	CD	PERCENT	14	num	17	SENT_140	[p8l1191t3522r1345b3573],
17	%	NN	PERCENT	%	dep	14	SENT_140	[p8l1191t3522r1345b3573],
18	)	CD	NUMBER	)	dep	17	SENT_140	[p8l1191t3522r1345b3573],
19	.	.	O	.	_	0	SENT_140	[p8l1191t3522r1345b3573],

1	The	DT	O	the	det	3	SENT_141	[p8l1369t3523r1458b3564],
2	p	NN	O	p	nn	3	SENT_141	[p8l1483t3532r1509b3572],
3	value	NN	O	value	nsubj	8	SENT_141	[p8l1530t3523r1660b3564],
4	by	IN	O	by	_	0	SENT_141	[p8l1685t3523r1737b3573],
5	Kruskal	NNP	PERSON	Kruskal	nn	7	SENT_141	[p8l1761t3523r1959b3564],
6	—	NNP	O	—	nn	7	SENT_141	[p8l1761t3523r1959b3564],
7	Wallis	NNP	PERSON	Wallis	prep_by	3	SENT_141	[p8l61t3603r209b3644],
8	test	NN	O	test	_	0	SENT_141	[p8l230t3605r328b3644],
9	between	IN	O	between	_	0	SENT_141	[p8l351t3603r556b3644],
10	strata	NN	O	stratum	prep_between	8	SENT_141	[p8l582t3605r740b3644],
11	.	.	O	.	_	0	SENT_141	[p8l582t3605r740b3644],

1	(	NN	O	(	_	0	SENT_142	[p8l766t3603r841b3653],
2	B	NN	O	b	nn	4	SENT_142	[p8l766t3603r841b3653],
3	)	CD	NUMBER	)	num	4	SENT_142	[p8l766t3603r841b3653],
4	Box	NNP	O	Box	dep	1	SENT_142	[p8l870t3603r957b3644],
5	and	CC	O	and	_	0	SENT_142	[p8l980t3603r1067b3643],
6	whisker	NN	O	whisker	nn	7	SENT_142	[p8l1090t3603r1282b3644],
7	plots	NNS	O	plot	conj_and	4	SENT_142	[p8l1305t3603r1423b3652],
8	of	IN	O	of	_	0	SENT_142	[p8l1447t3602r1495b3643],
9	RPA	NN	O	rpa	prep_of	1	SENT_142	[p8l1517t3603r1613b3643],
10	by	IN	O	by	_	0	SENT_142	[p8l1636t3603r1688b3653],
11	genotype	NN	O	genotype	prep_by	9	SENT_142	[p8l1707t3605r1947b3654],
12	.	.	O	.	_	0	SENT_142	[p8l1707t3605r1947b3654],

1	The	DT	O	the	det	2	SENT_143	[p8l1972t3603r2060b3644],
2	boxes	NNS	O	box	nsubj	3	SENT_143	[p8l64t3683r213b3724],
3	show	VBP	O	show	_	0	SENT_143	[p8l236t3683r364b3724],
4	medians	NNS	O	median	dobj	3	SENT_143	[p8l387t3683r597b3724],
5	and	CC	O	and	_	0	SENT_143	[p8l622t3683r709b3724],
6	upper	JJ	O	upper	dobj	3	SENT_143	[p8l735t3692r875b3733],
7	and	CC	O	and	_	0	SENT_143	[p8l897t3683r984b3724],
8	lower	JJR	O	lower	amod	9	SENT_143	[p8l1012t3683r1140b3724],
9	quartiles	NNS	O	quartile	conj_and	4	SENT_143	[p8l1161t3683r1376b3733],
10	of	IN	O	of	_	0	SENT_143	[p8l1400t3682r1448b3724],
11	the	DT	O	the	det	12	SENT_143	[p8l1466t3683r1544b3724],
12	data	NNS	O	datum	prep_of	9	SENT_143	[p8l1568t3683r1690b3731],
13	,	,	O	,	_	0	SENT_143	[p8l1568t3683r1690b3731],
14	whereas	IN	O	whereas	mark	17	SENT_143	[p8l1715t3683r1924b3724],
15	the	DT	O	the	det	16	SENT_143	[p8l1945t3683r2024b3724],
16	whiskers	NNS	O	whisker	nsubj	17	SENT_143	[p8l61t3762r289b3804],
17	indicate	VBP	O	indicate	advcl	3	SENT_143	[p8l314t3763r506b3804],
18	the	DT	O	the	det	22	SENT_143	[p8l528t3763r607b3804],
19	minimum	NN	O	minimum	nn	22	SENT_143	[p8l632t3763r857b3804],
20	and	CC	O	and	_	0	SENT_143	[p8l883t3763r969b3804],
21	maximum	NN	O	maximum	conj_and	19	SENT_143	[p8l996t3763r1233b3804],
22	values	NNS	O	value	dobj	17	SENT_143	[p8l1256t3763r1431b3804],
23	.	.	O	.	_	0	SENT_143	[p8l1256t3763r1431b3804],

1	ADP	NN	O	adp	_	0	SENT_144	[p8l1455t3763r1556b3803],
2	=	JJ	O	=	amod	4	SENT_144	[p8l1583t3778r1618b3791],
3	adenosine	NN	O	adenosine	nn	4	SENT_144	[p8l1647t3763r1904b3804],
4	diphosphate	NN	O	diphosphate	dep	1	SENT_144	[p9l63t15r386b65],
5	;	:	O	;	_	0	SENT_144	[p9l63t15r386b65],
6	wt	JJ	O	wt	amod	9	SENT_144	[p9l409t17r466b56],
7	=	JJ	O	=	amod	9	SENT_144	[p9l492t30r527b43],
8	wi	NN	O	wus	nn	9	SENT_144	[p9l553t15r780b65],
9	|	NN	O	|	dep	1	SENT_144	[p9l553t15r780b65],
10	d	NN	O	d	nn	12	SENT_144	[p9l553t15r780b65],
11	—	CD	NUMBER	—	num	12	SENT_144	[p9l553t15r780b65],
12	type	NN	O	type	dep	9	SENT_144	[p9l553t15r780b65],
13	.	.	O	.	_	0	SENT_144	[p9l553t15r780b65],

1	CYPZCI9	NN	O	cypzci9	nn	2	SENT_145	[p9l16t304r360b368],
2	genotype	NN	O	genotype	_	0	SENT_145	[p9l410t318r749b390],
3	:	:	O	:	_	0	SENT_145	[p9l410t318r749b390],
4	*	CD	NUMBER	*	number	5	SENT_145	[p9l812t304r875b367],
5	2	CD	NUMBER	2	num	6	SENT_145	[p9l812t304r875b367],
6	homozygotes	NNS	O	homozygote	dep	2	SENT_145	[p9l927t301r1393b390],
7	(	CD	NUMBER	(	num	8	SENT_145	[p9l1451t299r1521b381],
8	n	NN	O	n	nsubj	31	SENT_145	[p9l1451t299r1521b381],
9	=	JJ	O	=	amod	8	SENT_145	[p9l1582t326r1636b347],
10	15	CD	NUMBER	15	tmod	9	SENT_145	[p9l1702t301r1803b382],
11	,	,	O	,	_	0	SENT_145	[p9l1702t301r1803b382],
12	2	CD	PERCENT	2	num	13	SENT_145	[p9l1857t299r2016b382],
13	%	NN	PERCENT	%	nsubj	31	SENT_145	[p9l1857t299r2016b382],
14	)	CD	NUMBER	)	dep	13	SENT_145	[p9l1857t299r2016b382],
15	,	,	O	,	_	0	SENT_145	[p9l1857t299r2016b382],
16	*	CD	NUMBER	*	number	17	SENT_145	[p9l2077t304r2140b367],
17	2	CD	NUMBER	2	num	18	SENT_145	[p9l2077t304r2140b367],
18	heterozygotes	NNS	O	heterozygote	nsubj	31	SENT_145	[p9l9t407r493b496],
19	(	CD	NUMBER	(	num	20	SENT_145	[p9l528t405r599b488],
20	n	NN	O	n	dep	18	SENT_145	[p9l528t405r599b488],
21	=	JJ	O	=	amod	18	SENT_145	[p9l637t433r690b453],
22	218	CD	NUMBER	218	tmod	21	SENT_145	[p9l728t411r879b488],
23	,	,	O	,	_	0	SENT_145	[p9l728t411r879b488],
24	29	CD	PERCENT	29	num	25	SENT_145	[p9l911t405r1113b488],
25	%	NN	PERCENT	%	conj_and	8	SENT_145	[p9l911t405r1113b488],
26	)	CD	NUMBER	)	dep	25	SENT_145	[p9l911t405r1113b488],
27	,	,	O	,	_	0	SENT_145	[p9l911t405r1113b488],
28	and	CC	O	and	_	0	SENT_145	[p9l1148t407r1276b473],
29	Wild-type	JJ	MISC	wild-type	amod	30	SENT_145	[p9l1302t407r1641b497],
30	homozygotes	NNS	O	homozygote	conj_and	8	SENT_145	[p9l1672t407r2138b496],
31	(	VBP	O	(	rcmod	6	SENT_145	[p9l12t512r83b594],
32	n	NN	O	n	dobj	31	SENT_145	[p9l12t512r83b594],
33	=	JJ	O	=	amod	32	SENT_145	[p9l131t540r184b560],
34	527	CD	NUMBER	527	tmod	33	SENT_145	[p9l234t514r383b595],
35	,	,	O	,	_	0	SENT_145	[p9l234t514r383b595],
36	69	CD	PERCENT	69	num	37	SENT_145	[p9l428t512r626b594],
37	%	NN	PERCENT	%	appos	32	SENT_145	[p9l428t512r626b594],
38	)	CD	NUMBER	)	dep	37	SENT_145	[p9l428t512r626b594],
39	.	.	O	.	_	0	SENT_145	[p9l428t512r626b594],

1	Although	IN	O	although	mark	3	SENT_146	[p9l668t512r1013b603],
2	there	EX	O	there	expl	3	SENT_146	[p9l1052t514r1231b580],
3	was	VBD	O	be	advcl	18	SENT_146	[p9l1268t540r1397b580],
4	a	DT	O	a	det	7	SENT_146	[p9l1441t540r1475b580],
5	highly	RB	O	highly	advmod	6	SENT_146	[p9l1514t514r1738b603],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_146	[p9l1776t514r2142b603],
7	difference	NN	O	difference	nsubj	3	SENT_146	[p9l10t621r350b688],
8	in	IN	O	in	_	0	SENT_146	[p9l388t624r455b687],
9	RPA	NNP	O	RPA	prep_in	7	SENT_146	[p9l494t620r690b702],
10	,	,	O	,	_	0	SENT_146	[p9l494t620r690b702],
11	depending	VBG	O	depend	_	0	SENT_146	[p9l731t621r1104b711],
12	on	IN	O	on	prepc_depending_on	3	SENT_146	[p9l1140t648r1227b688],
13	CYPZCJ	NNP	O	CYPZCJ	nn	15	SENT_146	[p9l1271t625r1565b689],
14	9	CD	NUMBER	9	num	15	SENT_146	[p9l1577t628r1615b688],
15	genotype	NN	O	genotype	pobj	3	SENT_146	[p9l1649t639r1989b711],
16	,	,	O	,	_	0	SENT_146	[p9l1649t639r1989b711],
17	the	DT	O	the	nsubj	18	SENT_146	[p9l2029t621r2139b688],
18	overlap	VBP	O	overlap	_	0	SENT_146	[p9l10t728r262b817],
19	was	VBD	O	be	cop	20	SENT_146	[p9l295t754r424b794],
20	considerable	JJ	O	considerable	ccomp	18	SENT_146	[p9l463t728r918b794],
21	.	.	O	.	_	0	SENT_146	[p9l463t728r918b794],

1	Accordingly	RB	O	accordingly	advmod	9	SENT_147	[p9l955t726r1410b817],
2	,	,	O	,	_	0	SENT_147	[p9l955t726r1410b817],
3	22.4	CD	PERCENT	22.4	num	4	SENT_147	[p9l1446t731r1667b795],
4	%	NN	PERCENT	%	nsubj	9	SENT_147	[p9l1446t731r1667b795],
5	of	IN	O	of	_	0	SENT_147	[p9l1704t728r1783b794],
6	the	DT	O	the	det	8	SENT_147	[p9l1807t728r1917b794],
7	wildtype	JJ	O	wildtype	amod	8	SENT_147	[p9l1950t728r2137b794, p9l9t852r161b925],
8	homozygotes	NNS	O	homozygote	prep_of	4	SENT_147	[p9l227t835r709b925],
9	had	VBD	O	have	_	0	SENT_147	[p9l776t835r909b902],
10	to	TO	O	to	aux	12	SENT_147	[p9l974t852r1043b902],
11	be	VB	O	be	auxpass	12	SENT_147	[p9l1108t836r1190b902],
12	classiﬁed	VBN	O	classiﬁed	xcomp	9	SENT_147	[p9l1257t835r1584b902],
13	as	RB	O	as	advmod	14	SENT_147	[p9l1650t862r1715b902],
14	high	JJ	O	high	amod	16	SENT_147	[p9l1782t835r1946b925],
15	onclopidogrel	NN	O	onclopidogrel	nn	16	SENT_147	[p9l2012t862r2136b902, p9l10t942r405b1031],
16	RPA	NN	ORGANIZATION	rpa	dobj	12	SENT_147	[p9l449t940r645b1023],
17	,	,	O	,	_	0	SENT_147	[p9l449t940r645b1023],
18	whereas	IN	O	whereas	mark	36	SENT_147	[p9l687t942r970b1008],
19	58.7	CD	PERCENT	58.7	num	20	SENT_147	[p9l1015t942r1234b1008],
20	%	NN	PERCENT	%	nsubj	36	SENT_147	[p9l1015t942r1234b1008],
21	of	IN	O	of	_	0	SENT_147	[p9l1278t942r1358b1008],
22	the	DT	O	the	det	23	SENT_147	[p9l1389t942r1499b1008],
23	*	NN	O	*	prep_of	20	SENT_147	[p9l1548t945r1611b1009],
24	2	CD	NUMBER	2	num	25	SENT_147	[p9l1548t945r1611b1009],
25	heterozygotes	NNS	O	heterozygote	dep	23	SENT_147	[p9l1654t942r2138b1031],
26	and	CC	O	and	_	0	SENT_147	[p9l11t1049r138b1116],
27	53.3	CD	PERCENT	53.3	num	28	SENT_147	[p9l169t1049r388b1116],
28	%	NN	PERCENT	%	conj_and	23	SENT_147	[p9l169t1049r388b1116],
29	of	IN	O	of	_	0	SENT_147	[p9l420t1049r499b1116],
30	the	DT	O	the	det	31	SENT_147	[p9l518t1050r628b1116],
31	*	NN	O	*	prep_of	28	SENT_147	[p9l665t1053r728b1116],
32	2	CD	NUMBER	2	num	33	SENT_147	[p9l665t1053r728b1116],
33	homozygotes	NNS	O	homozygote	dep	28	SENT_147	[p9l759t1049r1224b1139],
34	did	VBD	O	do	aux	36	SENT_147	[p9l1258t1049r1371b1116],
35	not	RB	O	not	neg	36	SENT_147	[p9l1402t1067r1520b1116],
36	meet	VB	O	meet	advcl	12	SENT_147	[p9l1550t1067r1723b1116],
37	the	DT	O	the	det	38	SENT_147	[p9l1752t1050r1862b1116],
38	criteria	NNS	O	criterion	dobj	36	SENT_147	[p9l1895t1052r2141b1116],
39	for	IN	O	for	_	0	SENT_147	[p9l9t1156r110b1222],
40	high	JJ	O	high	amod	44	SENT_147	[p9l167t1156r327b1245],
41	on	IN	O	on	_	0	SENT_147	[p9l386t1156r909b1245],
42	—	CD	NUMBER	—	num	43	SENT_147	[p9l386t1156r909b1245],
43	clopidogrel	NN	O	clopidogrel	prep_on	40	SENT_147	[p9l386t1156r909b1245],
44	RPA	NN	O	rpa	prep_for	36	SENT_147	[p9l969t1154r1163b1222],
45	.	.	O	.	_	0	SENT_147	[p9l969t1154r1163b1222],

1	Thus	RB	O	thus	advmod	21	SENT_148	[p9l1224t1154r1430b1237],
2	,	,	O	,	_	0	SENT_148	[p9l1224t1154r1430b1237],
3	the	DT	O	the	det	4	SENT_148	[p9l1492t1156r1602b1222],
4	sensitivity	NN	O	sensitivity	nsubj	21	SENT_148	[p9l1663t1159r2016b1245],
5	of	IN	O	of	_	0	SENT_148	[p9l2072t1156r2152b1222],
6	CYP2CJ9	NN	O	cyp2cj9	nn	7	SENT_148	[p9l16t1267r430b1330],
7	*	NN	O	*	prep_of	4	SENT_148	[p9l16t1267r430b1330],
8	2	CD	NUMBER	2	num	10	SENT_148	[p9l16t1267r430b1330],
9	carrier	NN	O	carrier	nn	10	SENT_148	[p9l460t1266r685b1330],
10	status	NN	O	status	dep	7	SENT_148	[p9l715t1280r911b1330],
11	for	IN	O	for	_	0	SENT_148	[p9l943t1263r1044b1330],
12	detecting	VBG	O	detect	prepc_for	10	SENT_148	[p9l1073t1263r1400b1353],
13	high	JJ	O	high	amod	17	SENT_148	[p9l1428t1263r1588b1353],
14	on	IN	O	on	_	0	SENT_148	[p9l1619t1263r2141b1353],
15	—	CD	NUMBER	—	prep_on	13	SENT_148	[p9l1619t1263r2141b1353],
16	clopidogrel	NN	O	clopidogrel	nn	17	SENT_148	[p9l1619t1263r2141b1353],
17	RPA	NN	O	rpa	dobj	12	SENT_148	[p9l12t1368r190b1435],
18	was	VBD	O	be	cop	21	SENT_148	[p9l217t1396r346b1436],
19	only	RB	O	only	quantmod	20	SENT_148	[p9l382t1370r535b1459],
20	45.1	CD	PERCENT	45.1	num	21	SENT_148	[p9l563t1370r803b1451],
21	%	NN	PERCENT	%	_	0	SENT_148	[p9l563t1370r803b1451],
22	,	,	O	,	_	0	SENT_148	[p9l563t1370r803b1451],
23	whereas	IN	O	whereas	mark	28	SENT_148	[p9l835t1370r1118b1436],
24	the	DT	O	the	det	25	SENT_148	[p9l1152t1370r1263b1436],
25	speciﬁcity	NN	O	speciﬁcity	nsubj	28	SENT_148	[p9l1298t1370r1648b1459],
26	was	VBD	O	be	cop	28	SENT_148	[p9l1674t1396r1803b1436],
27	75.0	CD	PERCENT	75.0	num	28	SENT_148	[p9l1839t1370r2075b1436],
28	%	NN	PERCENT	%	advcl	21	SENT_148	[p9l1839t1370r2075b1436],
29	.	.	O	.	_	0	SENT_148	[p9l1839t1370r2075b1436],

1	Contribution	NN	O	contribution	_	0	SENT_149	[p9l12t1476r543b1544],
2	of	IN	O	of	_	0	SENT_149	[p9l613t1476r699b1544],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_149	[p9l763t1481r1139b1545],
4	genotype	NN	O	genotype	prep_of	1	SENT_149	[p9l1206t1494r1566b1567],
5	and	CC	O	and	_	0	SENT_149	[p9l1637t1476r1779b1544],
6	clinical	JJ	O	clinical	amod	7	SENT_149	[p9l1849t1476r2140b1544],
7	characteristics	NNS	O	characteristic	prep_of	1	SENT_149	[p9l10t1583r563b1650],
8	to	TO	O	to	infmod	7	SENT_149	[p9l622t1600r698b1650],
9	on	IN	O	on	_	0	SENT_149	[p9l760t1583r1335b1673],
10	—	NN	O	—	nn	12	SENT_149	[p9l760t1583r1335b1673],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_149	[p9l760t1583r1335b1673],
12	RPA	NN	O	rpa	prep_on	1	SENT_149	[p9l1395t1582r1603b1650],
13	.	.	O	.	_	0	SENT_149	[p9l1395t1582r1603b1650],

1	The	DT	O	the	det	4	SENT_150	[p9l1654t1582r1800b1650],
2	baseline	NN	O	baseline	nn	4	SENT_150	[p9l1857t1584r2139b1650],
3	demographic	JJ	O	demographic	amod	4	SENT_150	[p9l10t1691r472b1781],
4	characteristics	NNS	O	characteristic	nsubjpass	11	SENT_150	[p9l508t1691r1001b1758],
5	of	IN	O	of	_	0	SENT_150	[p9l1039t1691r1119b1758],
6	our	PRP$	O	we	poss	8	SENT_150	[p9l1144t1717r1260b1758],
7	study	NN	O	study	nn	8	SENT_150	[p9l1296t1691r1485b1781],
8	cohort	NN	O	cohort	prep_of	4	SENT_150	[p9l1518t1691r1747b1758],
9	have	VBP	O	have	aux	11	SENT_150	[p9l1781t1691r1939b1758],
10	been	VBN	O	be	auxpass	11	SENT_150	[p9l1973t1691r2140b1758],
11	published	VBN	O	publish	_	0	SENT_150	[p9l8t1798r352b1887],
12	>	JJR	O	>	acomp	11	SENT_150	[p9l396t1796r512b1878],
13	7	CD	NUMBER	7	dep	12	SENT_150	[p9l396t1796r512b1878],
14	+	CC	O	+	cc	13	SENT_150	[p9l396t1796r512b1878],
15	In	IN	O	in	_	0	SENT_150	[p9l557t1799r635b1863],
16	univariable	JJ	O	univariable	amod	17	SENT_150	[p9l676t1798r1062b1864],
17	analyses	NNS	O	analysis	prep_in	35	SENT_150	[p9l1107t1798r1407b1887],
18	,	,	O	,	_	0	SENT_150	[p9l1107t1798r1407b1887],
19	the	DT	O	the	det	22	SENT_150	[p9l1451t1798r1561b1864],
20	clinical	JJ	O	clinical	amod	22	SENT_150	[p9l1605t1798r1854b1864],
21	patient	NN	O	patient	nn	22	SENT_150	[p9l1893t1801r2142b1887],
22	characteristics	NNS	O	characteristic	nsubj	35	SENT_150	[p9l10t1905r503b1972],
23	that	WDT	O	that	nsubj	24	SENT_150	[p9l532t1905r673b1972],
24	showed	VBD	O	show	rcmod	22	SENT_150	[p9l699t1905r964b1972],
25	the	DT	O	the	det	27	SENT_150	[p9l990t1905r1100b1972],
26	strongest	JJS	O	strongest	amod	27	SENT_150	[p9l1129t1922r1449b1995],
27	association	NN	O	association	dobj	24	SENT_150	[p9l1475t1908r1858b1972],
28	to	TO	O	to	_	0	SENT_150	[p9l1884t1922r1952b1972],
29	high	JJ	O	high	amod	33	SENT_150	[p9l1980t1905r2139b1995],
30	on	IN	O	on	_	0	SENT_150	[p9l10t2012r532b2101],
31	—	CD	NUMBER	—	num	32	SENT_150	[p9l10t2012r532b2101],
32	clopidogrel	NN	O	clopidogrel	prep_on	29	SENT_150	[p9l10t2012r532b2101],
33	RPA	NN	O	rpa	prep_to	24	SENT_150	[p9l564t2010r742b2077],
34	were	VBD	O	be	cop	35	SENT_150	[p9l767t2038r934b2078],
35	age	NN	O	age	rcmod	13	SENT_150	[p9l967t2038r1100b2101],
36	,	,	O	,	_	0	SENT_150	[p9l967t2038r1100b2101],
37	BMI	NN	O	bmus	rcmod	13	SENT_150	[p9l1134t2013r1329b2093],
38	,	,	O	,	_	0	SENT_150	[p9l1134t2013r1329b2093],
39	and	CC	O	and	_	0	SENT_150	[p9l1364t2012r1491b2078],
40	diabetes	NN	O	diabetes	nn	41	SENT_150	[p9l1522t2012r1804b2078],
41	mellitus	NN	O	mellitus	rcmod	13	SENT_150	[p9l1838t2012r2135b2078],
42	.	.	O	.	_	0	SENT_150	[p9l1838t2012r2135b2078],

1	In	IN	O	in	_	0	SENT_151	[p9l9t2120r86b2185],
2	addition	NN	O	addition	prep_in	5	SENT_151	[p9l134t2119r447b2200],
3	,	,	O	,	_	0	SENT_151	[p9l134t2119r447b2200],
4	we	PRP	O	we	nsubj	5	SENT_151	[p9l493t2146r591b2186],
5	found	VBD	O	find	dep	8	SENT_151	[p9l638t2119r846b2186],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_151	[p9l893t2119r1258b2209],
7	differences	NNS	O	difference	dobj	5	SENT_151	[p9l1304t2119r1674b2186],
8	(	VBP	O	(	_	0	SENT_151	[p9l1726t2117r1793b2209],
9	p	NN	O	p	dep	10	SENT_151	[p9l1726t2117r1793b2209],
10	<	JJR	O	<	dobj	8	SENT_151	[p9l1846t2130r1906b2181],
11	0.05	CD	NUMBER	0.05	nsubj	8	SENT_151	[p9l1959t2117r2136b2200],
12	)	CD	NUMBER	)	number	13	SENT_151	[p9l1959t2117r2136b2200],
13	2430	CD	DATE	2430	num	14	SENT_151	[p9l10t2222r160b2275],
14	Hochholzer	NNP	O	Hochholzer	dep	11	SENT_151	[p9l333t2222r650b2275],
15	et	FW	O	et	nn	16	SENT_151	[p9l670t2224r727b2275],
16	al.	FW	O	al.	dep	14	SENT_151	[p9l742t2222r809b2275],
17	.	.	O	.	_	0	SENT_151	[p9l742t2222r809b2275],

1	P450	NN	O	p450	_	0	SENT_152	[p9l333t2311r484b2364],
2	26	CD	NUMBER	26	num	1	SENT_152	[p9l503t2311r579b2364],
3	19	CD	NUMBER	19	num	4	SENT_152	[p9l587t2311r656b2364],
4	Polymorphisms	NNS	O	polymorphism	dep	1	SENT_152	[p9l678t2312r1110b2374],
5	and	CC	O	and	_	0	SENT_152	[p9l1129t2312r1230b2364],
6	Residual	JJ	O	residual	amod	8	SENT_152	[p9l1254t2312r1492b2364],
7	Platelet	NN	O	platelet	nn	8	SENT_152	[p9l1515t2312r1732b2364],
8	Activity	NN	O	activity	conj_and	4	SENT_152	[p9l1749t2312r1959b2373],

1	Table	NNP	O	Table	_	0	SENT_153	[p9l63t2616r233b2665],
2	1	CD	NUMBER	1	dep	1	SENT_153	[p9l262t2616r301b2665],

1	Multivariate	JJ	O	multivariate	amod	5	SENT_154	[p9l413t2575r793b2626],
2	Binary	NNP	O	Binary	nn	5	SENT_154	[p9l822t2575r1019b2638],
3	Logistic	NNP	O	Logistic	nn	5	SENT_154	[p9l1047t2575r1294b2638],
4	Regression	NN	O	regression	nn	5	SENT_154	[p9l1325t2575r1672b2638],
5	Analysis	NN	O	analysis	_	0	SENT_154	[p9l1700t2575r1963b2638],
6	for	IN	O	for	_	0	SENT_154	[p9l409t2655r493b2706],
7	Low	JJ	O	low	amod	8	SENT_154	[p9l520t2656r643b2706],
8	Response	NN	O	response	prep_for	5	SENT_154	[p9l672t2656r977b2718],
9	to	TO	O	to	_	0	SENT_154	[p9l1003t2657r1067b2706],
10	Clopidogrel	NNP	MISC	Clopidogrel	prep_to	5	SENT_154	[p9l1094t2655r1448b2718],

1	95	CD	PERCENT	95	number	2	SENT_155	[p9l1344t2825r1451b2866],
2	%	NN	PERCENT	%	amod	3	SENT_155	[p9l1344t2825r1451b2866],
3	Confidence	NN	O	confidence	_	0	SENT_155	[p9l1474t2825r1761b2866],

1	Odds	NNS	O	odds	_	0	SENT_156	[p9l920t2896r1046b2937],
2	Ratio	NNP	O	Ratio	nn	3	SENT_156	[p9l1071t2896r1204b2937],
3	Interval	NNP	O	Interval	dep	1	SENT_156	[p9l1458t2896r1647b2937],
4	p	NN	O	p	nn	5	SENT_156	[p9l1902t2906r1929b2946],
5	Value	NN	O	value	dep	1	SENT_156	[p9l1950t2896r2092b2937],

1	CYP2C19	NN	O	cyp2c19	nn	3	SENT_157	[p9l65t2993r325b3034],
2	*	CD	NUMBER	*	num	3	SENT_157	[p9l65t2993r325b3034],
3	polymorphism	NN	O	polymorphism	_	0	SENT_157	[p9l350t2994r698b3043],
4	2.738	CD	NUMBER	2.738	number	5	SENT_157	[p9l988t2994r1136b3034],
5	1.925	CD	NUMBER	1.925	num	6	SENT_157	[p9l1390t2993r1716b3034],
6	—	NN	O	—	dobj	8	SENT_157	[p9l1390t2993r1716b3034],
7	3.895	CD	NUMBER	3.895	npadvmod	8	SENT_157	[p9l1390t2993r1716b3034],
8	<	JJR	O	<	dep	3	SENT_157	[p9l1901t2993r2095b3034],
9	0.001	CD	NUMBER	0.001	num	10	SENT_157	[p9l1901t2993r2095b3034],
10	Age	NN	O	age	dep	20	SENT_157	[p9l62t3074r156b3123],
11	(	CD	NUMBER	(	num	12	SENT_157	[p9l176t3074r279b3123],
12	yrs	NNS	DURATION	yr	dep	10	SENT_157	[p9l176t3074r279b3123],
13	)	CD	NUMBER	)	number	14	SENT_157	[p9l176t3074r279b3123],
14	1.031	CD	NUMBER	1.031	num	15	SENT_157	[p9l990t3073r1136b3113],
15	1.010	CD	NUMBER	1.010	dep	12	SENT_157	[p9l1390t3073r1714b3113],
16	—	NN	O	—	dep	20	SENT_157	[p9l1390t3073r1714b3113],
17	1.052	CD	NUMBER	1.052	num	16	SENT_157	[p9l1390t3073r1714b3113],
18	0.003	CD	NUMBER	0.003	num	20	SENT_157	[p9l1947t3073r2093b3113],
19	Arterial	JJ	O	arterial	amod	20	SENT_157	[p9l62t3152r241b3192],
20	hypertension	NN	O	hypertension	dep	26	SENT_157	[p9l265t3152r579b3201],
21	1.348	CD	NUMBER	1.348	num	22	SENT_157	[p9l990t3152r1136b3192],
22	0.830-2	CD	NUMBER	0.830-2	dep	20	SENT_157	[p9l1389t3152r1716b3192],
23	.190	CD	NUMBER	.190	number	24	SENT_157	[p9l1389t3152r1716b3192],
24	0.228	CD	NUMBER	0.228	num	25	SENT_157	[p9l1947t3152r2094b3192],
25	Diabetes	NNP	O	Diabetes	dep	22	SENT_157	[p9l66t3232r282b3272],
26	mellitus	NN	O	mellitus	dep	29	SENT_157	[p9l303t3232r498b3272],
27	1.745	CD	NUMBER	1.745	num	26	SENT_157	[p9l990t3231r1135b3272],
28	1.189-2	CD	NUMBER	1.189-2	num	29	SENT_157	[p9l1390t3231r1714b3272],
29	.562	CD	NUMBER	.562	dep	35	SENT_157	[p9l1390t3231r1714b3272],
30	0.004	CD	NUMBER	0.004	num	33	SENT_157	[p9l1947t3231r2094b3272],
31	Body	NN	O	body	nn	33	SENT_157	[p9l66t3312r185b3361],
32	mass	NN	O	mass	nn	33	SENT_157	[p9l205t3321r335b3351],
33	index	NN	O	index	dep	29	SENT_157	[p9l356t3312r486b3351],
34	(	CD	NUMBER	(	num	35	SENT_157	[p9l505t3298r702b3361],
35	kg/m2	NN	O	kg/m2	dep	43	SENT_157	[p9l505t3298r702b3361],
36	)	CD	NUMBER	)	number	37	SENT_157	[p9l505t3298r702b3361],
37	1.061	CD	NUMBER	1.061	dep	35	SENT_157	[p9l990t3311r1137b3351],
38	1.016	CD	NUMBER	1.016	num	39	SENT_157	[p9l1390t3311r1715b3351],
39	—	NN	O	—	dep	37	SENT_157	[p9l1390t3311r1715b3351],
40	1.109	CD	NUMBER	1.109	number	41	SENT_157	[p9l1390t3311r1715b3351],
41	0.008	CD	NUMBER	0.008	num	42	SENT_157	[p9l1946t3311r2094b3351],
42	Platelets	NNS	O	platelet	nsubj	43	SENT_157	[p9l66t3390r280b3430],
43	(	VBP	O	(	ccomp	8	SENT_157	[p9l300t3390r357b3439],
44	>	JJR	O	>	acomp	43	SENT_157	[p9l300t3390r357b3439],
45	<	JJR	O	<	dep	44	SENT_157	[p9l300t3390r357b3439],
46	109/I	CD	NUMBER	109/i	num	47	SENT_157	[p9l384t3377r533b3439],
47	)	NN	O	)	dep	54	SENT_157	[p9l384t3377r533b3439],
48	0.997	CD	NUMBER	0.997	num	49	SENT_157	[p9l988t3390r1134b3430],
49	0.994	CD	NUMBER	0.994	dep	47	SENT_157	[p9l1389t3390r1716b3430],
50	—	NN	O	—	dep	54	SENT_157	[p9l1389t3390r1716b3430],
51	1.000	CD	NUMBER	1.000	num	50	SENT_157	[p9l1389t3390r1716b3430],
52	0.059	CD	NUMBER	0.059	num	54	SENT_157	[p9l1947t3390r2093b3430],
53	ACE	NN	O	ace	nn	54	SENT_157	[p9l62t3469r160b3509],
54	inhibitors	NNS	O	inhibitor	dep	3	SENT_157	[p9l182t3469r409b3509],
55	1.065	CD	NUMBER	1.065	num	57	SENT_157	[p9l990t3468r1135b3509],
56	0.751	CD	NUMBER	0.751	num	57	SENT_157	[p9l1389t3468r1717b3509],
57	—	NN	O	—	dep	54	SENT_157	[p9l1389t3468r1717b3509],
58	1.511	CD	NUMBER	1.511	number	59	SENT_157	[p9l1389t3468r1717b3509],
59	0.724	CD	NUMBER	0.724	dep	57	SENT_157	[p9l1946t3468r2094b3509],

1	Nitrates	NNS	O	nitrate	_	0	SENT_158	[p9l66t3550r258b3590],
2	1.095	CD	NUMBER	1.095	num	3	SENT_158	[p9l990t3549r1135b3590],
3	0.754-1	CD	NUMBER	0.754-1	dep	1	SENT_158	[p9l1389t3549r1716b3590],
4	.590	CD	NUMBER	.590	number	5	SENT_158	[p9l1389t3549r1716b3590],
5	0.632	CD	NUMBER	0.632	dep	3	SENT_158	[p9l1947t3549r2092b3590],

1	Verapamil/diltiazem	NNP	O	Verapamil/diltiazem	dep	9	SENT_159	[p9l62t3629r569b3678],
2	2.569	CD	NUMBER	2.569	num	1	SENT_159	[p9l988t3629r1135b3669],
3	1.185	CD	NUMBER	1.185	dep	1	SENT_159	[p9l1390t3629r1714b3669],
4	—	NN	O	—	dep	9	SENT_159	[p9l1390t3629r1714b3669],
5	5.572	CD	NUMBER	5.572	num	4	SENT_159	[p9l1390t3629r1714b3669],
6	0.017	CD	NUMBER	0.017	num	9	SENT_159	[p9l1946t3629r2093b3669],
7	Previous	JJ	O	previous	amod	9	SENT_159	[p9l66t3708r274b3748],
8	balloon	NN	O	balloon	nn	9	SENT_159	[p9l295t3708r472b3748],
9	angioplasty	NN	O	angioplasty	dep	14	SENT_159	[p9l494t3708r777b3757],
10	1.509	CD	NUMBER	1.509	number	11	SENT_159	[p9l990t3707r1135b3748],
11	1.058	CD	NUMBER	1.058	dep	9	SENT_159	[p9l1390t3707r1716b3748],
12	—	NN	O	—	dep	11	SENT_159	[p9l1390t3707r1716b3748],
13	2.154	CD	NUMBER	2.154	num	14	SENT_159	[p9l1390t3707r1716b3748],
14	0.023	CD	NUMBER	0.023	_	0	SENT_159	[p9l1947t3708r2093b3748],

1	Previous	JJ	O	previous	amod	2	SENT_160	[p10l66t23r274b63],
2	CABG	NN	O	cabg	dep	13	SENT_160	[p10l293t22r429b63],
3	1.282	CD	NUMBER	1.282	number	4	SENT_160	[p10l990t22r1134b63],
4	0.783-2	CD	NUMBER	0.783-2	num	6	SENT_160	[p10l1389t22r1717b63],
5	.101	CD	NUMBER	.101	number	6	SENT_160	[p10l1389t22r1717b63],
6	0.323	CD	NUMBER	0.323	npadvmod	7	SENT_160	[p10l1946t22r2093b63],
7	Impaired	JJ	O	impaired	amod	8	SENT_160	[p10l66t102r282b151],
8	LV	NN	O	lv	dep	2	SENT_160	[p10l307t102r363b141],
9	function1	NN	O	function1	dep	8	SENT_160	[p10l380t102r613b151],
10	'	''	O	'	_	0	SENT_160	[p10l380t102r613b151],
11	1.100	CD	NUMBER	1.100	dep	13	SENT_160	[p10l990t102r1135b142],
12	0.768-1	CD	NUMBER	0.768-1	num	13	SENT_160	[p10l1389t102r1716b142],
13	.575	CD	NUMBER	.575	dep	25	SENT_160	[p10l1389t102r1716b142],
14	0.602	CD	NUMBER	0.602	num	17	SENT_160	[p10l1947t102r2092b142],
15	CCS	NN	O	cc	nn	17	SENT_160	[p10l64t181r161b221],
16	angina	NN	O	angina	nn	17	SENT_160	[p10l181t182r346b231],
17	class	NN	O	class	dep	13	SENT_160	[p10l368t182r490b222],
18	III	CD	NUMBER	iii	number	22	SENT_160	[p10l512t182r550b221],
19	or	CC	O	or	_	0	SENT_160	[p10l573t191r621b222],
20	IV	CD	NUMBER	iv	conj_or	22	SENT_160	[p10l642t182r685b221],
21	0.667	CD	NUMBER	0.667	number	22	SENT_160	[p10l988t181r1134b222],
22	0.443	CD	NUMBER	0.443	num	23	SENT_160	[p10l1389t181r1715b222],
23	—	NN	O	—	dep	17	SENT_160	[p10l1389t181r1715b222],
24	1.003	CD	NUMBER	1.003	num	25	SENT_160	[p10l1389t181r1715b222],
25	0.052	CD	NUMBER	0.052	_	0	SENT_160	[p10l1946t181r2092b222],

1	Residual	JJ	O	residual	amod	3	SENT_161	[p10l12t334r197b369],
2	platelet	NN	O	platelet	nn	3	SENT_161	[p10l217t334r380b377],
3	aggregation	NN	O	aggregation	dep	4	SENT_161	[p10l396t334r654b378],
4	>	JJR	O	>	_	0	SENT_161	[p10l675t333r824b369],
5	14	CD	PERCENT	14	number	6	SENT_161	[p10l675t333r824b369],
6	%	NN	PERCENT	%	amod	4	SENT_161	[p10l675t333r824b369],
7	.	.	O	.	_	0	SENT_161	[p10l675t333r824b369],

1	*	NN	O	*	nn	4	SENT_162	[p10l844t333r1130b378],
2	Cytochrome	NN	O	cytochrome	nn	4	SENT_162	[p10l844t333r1130b378],
3	P450	NN	O	p450	nn	4	SENT_162	[p10l1149t333r1265b369],
4	2C19	NN	O	2c19	dep	10	SENT_162	[p10l1282t333r1399b369],
5	681G	NN	O	681g	dep	4	SENT_162	[p10l1416t333r1621b376],
6	>	JJR	O	>	dep	5	SENT_162	[p10l1416t333r1621b376],
7	A	DT	O	a	dep	6	SENT_162	[p10l1416t333r1621b376],
8	;	:	O	;	_	0	SENT_162	[p10l1416t333r1621b376],
9	Timpaired	NNP	O	Timpaired	nsubj	10	SENT_162	[p10l1641t334r1862b377],
10	left	VBD	O	leave	_	0	SENT_162	[p10l1881t333r1950b369],
11	ventricular	JJ	O	ventricular	amod	18	SENT_162	[p10l1965t334r2152b369, p10l12t404r65b440],
12	(	NN	O	(	nn	18	SENT_162	[p10l82t404r164b448],
13	LV	NN	O	lv	nn	18	SENT_162	[p10l82t404r164b448],
14	)	CD	NUMBER	)	num	18	SENT_162	[p10l82t404r164b448],
15	function	NN	O	function	nn	18	SENT_162	[p10l180t404r356b440],
16	(	CD	NUMBER	(	num	18	SENT_162	[p10l376t404r561b449],
17	ejection	NN	O	ejection	nn	18	SENT_162	[p10l376t404r561b449],
18	fraction	NN	O	fraction	dobj	10	SENT_162	[p10l580t404r745b440],
19	<	JJR	O	<	dep	10	SENT_162	[p10l767t404r932b448],
20	55	CD	PERCENT	55	num	21	SENT_162	[p10l767t404r932b448],
21	%	NN	PERCENT	%	dep	19	SENT_162	[p10l767t404r932b448],
22	)	CD	NUMBER	)	dep	21	SENT_162	[p10l767t404r932b448],
23	.	.	O	.	_	0	SENT_162	[p10l767t404r932b448],

1	ACE	NN	O	ace	nn	3	SENT_163	[p10l60t475r146b510],
2	=	JJ	O	=	amod	3	SENT_163	[p10l164t487r195b499],
3	angiotensin	NN	O	angiotensin	_	0	SENT_163	[p10l213t475r464b519],
4	converting	VBG	O	convert	partmod	3	SENT_163	[p10l479t475r707b519],
5	enzyme	NN	O	enzyme	dobj	4	SENT_163	[p10l718t483r897b519],
6	;	:	O	;	_	0	SENT_163	[p10l718t483r897b519],
7	CABG	NN	O	cabg	nn	12	SENT_163	[p10l911t475r1031b510],
8	=	JJ	O	=	amod	12	SENT_163	[p10l1050t487r1082b499],
9	coronary	JJ	O	coronary	amod	12	SENT_163	[p10l1099t483r1287b519],
10	artery	NN	O	artery	nn	12	SENT_163	[p10l1299t477r1425b519],
11	bypass	NN	O	bypass	nn	12	SENT_163	[p10l1439t475r1587b519],
12	grafting	NN	O	grafting	dep	5	SENT_163	[p10l1599t475r1778b519],
13	;	:	O	;	_	0	SENT_163	[p10l1599t475r1778b519],
14	CCS	NN	O	cc	dep	5	SENT_163	[p10l1793t475r1879b510],
15	=	JJ	O	=	amod	16	SENT_163	[p10l1896t487r1927b499],
16	Canadian	JJ	MISC	canadian	amod	14	SENT_163	[p10l1945t475r2149b510],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_164	[p10l10t545r333b581],
2	Society	NNP	O	Society	_	0	SENT_164	[p10l348t545r517b590],
3	.	.	O	.	_	0	SENT_164	[p10l348t545r517b590],

1	between	IN	O	between	dep	22	SENT_165	[p10l9t714r303b780],
2	patients	NNS	O	patient	pobj	1	SENT_165	[p10l335t717r613b803],
3	with	IN	O	with	_	0	SENT_165	[p10l644t714r806b780],
4	high	JJ	O	high	amod	6	SENT_165	[p10l839t714r999b803],
5	on-clopidogrel	JJ	O	on-clopidogrel	amod	6	SENT_165	[p10l1033t714r1557b803],
6	RPA	NN	ORGANIZATION	rpa	prep_with	2	SENT_165	[p10l1591t712r1770b779],
7	and	CC	O	and	_	0	SENT_165	[p10l1803t714r1930b780],
8	those	DT	O	those	conj_and	2	SENT_165	[p10l1962t714r2149b780],
9	with	IN	O	with	_	0	SENT_165	[p10l7t820r169b886],
10	a	DT	O	a	quantmod	14	SENT_165	[p10l205t846r239b886],
11	low	JJ	O	low	quantmod	14	SENT_165	[p10l270t820r994b886],
12	—	CD	NUMBER	—	number	14	SENT_165	[p10l270t820r994b886],
13	to	TO	O	to	dep	14	SENT_165	[p10l270t820r994b886],
14	—	CD	NUMBER	—	num	17	SENT_165	[p10l270t820r994b886],
15	intermediate	JJ	O	intermediate	amod	17	SENT_165	[p10l270t820r994b886],
16	on-clopidogrel	JJ	O	on-clopidogrel	amod	17	SENT_165	[p10l1030t820r1554b909],
17	RPA	NN	ORGANIZATION	rpa	prep_with	8	SENT_165	[p10l1590t818r1769b885],
18	in	IN	O	in	_	0	SENT_165	[p10l1801t823r1869b885],
19	arterial	JJ	O	arterial	amod	20	SENT_165	[p10l1905t820r2151b886],
20	hypertension	NN	O	hypertension	prep_in	8	SENT_165	[p10l11t927r490b1016],
21	,	,	O	,	_	0	SENT_165	[p10l11t927r490b1016],
22	treatment	NN	O	treatment	_	0	SENT_165	[p10l520t944r868b993],
23	with	IN	O	with	_	0	SENT_165	[p10l890t927r1052b993],
24	a	DT	O	a	det	29	SENT_165	[p10l1081t953r1115b993],
25	nondihydropyridine	JJ	O	nondihydropyridine	amod	29	SENT_165	[p10l1143t927r1850b1016],
26	calcium	NN	O	calcium	nn	29	SENT_165	[p10l1880t927r2150b993],
27	antagonist	NN	O	antagonist	nn	29	SENT_165	[p10l12t1072r380b1158],
28	(	CD	NUMBER	(	num	29	SENT_165	[p10l425t1067r797b1158],
29	verapamil	NN	O	verapamil	prep_with	22	SENT_165	[p10l425t1067r797b1158],
30	or	CC	O	or	_	0	SENT_165	[p10l840t1095r912b1135],
31	diltiazem	NN	O	diltiazem	nn	32	SENT_165	[p10l955t1067r1332b1150],
32	)	NN	O	)	prep_with	22	SENT_165	[p10l955t1067r1332b1150],
33	,	,	O	,	_	0	SENT_165	[p10l955t1067r1332b1150],
34	and	CC	O	and	_	0	SENT_165	[p10l1380t1069r1507b1135],
35	previous	JJ	O	previous	amod	37	SENT_165	[p10l1549t1072r1843b1158],
36	balloon	NN	O	balloon	nn	37	SENT_165	[p10l1886t1069r2150b1135],
37	angioplasty	NN	O	angioplasty	prep_with	22	SENT_165	[p10l12t1212r428b1301],
38	.	.	O	.	_	0	SENT_165	[p10l12t1212r428b1301],

1	Further	JJ	O	further	amod	6	SENT_166	[p10l468t1212r740b1278],
2	potentially	RB	O	potentially	advmod	3	SENT_166	[p10l771t1212r1152b1301],
3	relevant	JJ	O	relevant	amod	6	SENT_166	[p10l1182t1212r1462b1278],
4	but	CC	O	but	_	0	SENT_166	[p10l1493t1212r1612b1278],
5	nonsignificant	JJ	O	nonsignificant	amod	6	SENT_166	[p10l1646t1212r2152b1301],
6	differences	NNS	O	difference	nsubj	13	SENT_166	[p10l11t1318r383b1384],
7	between	IN	O	between	_	0	SENT_166	[p10l413t1318r708b1384],
8	the	DT	O	the	det	12	SENT_166	[p10l738t1318r848b1384],
9	2	CD	NUMBER	2	num	12	SENT_166	[p10l878t1321r919b1385],
10	strata	NN	O	stratum	nn	12	SENT_166	[p10l952t1335r1144b1384],
11	(	NN	O	(	nn	12	SENT_166	[p10l1176t1316r1243b1407],
12	p	NN	O	p	prep_between	6	SENT_166	[p10l1176t1316r1243b1407],
13	S	NN	O	s	_	0	SENT_166	[p10l1280t1330r1339b1376],
14	0.20	CD	NUMBER	0.20	num	15	SENT_166	[p10l1376t1316r1554b1398],
15	)	NN	O	)	nsubjpass	22	SENT_166	[p10l1376t1316r1554b1398],
16	deﬁned	VBN	O	deﬁned	partmod	15	SENT_166	[p10l1589t1318r1851b1384],
17	by	IN	O	by	_	0	SENT_166	[p10l1878t1318r1964b1407],
18	high	JJ	O	high	amod	20	SENT_166	[p10l1990t1318r2150b1407],
19	on-clopidogrel	JJ	O	on-clopidogrel	amod	20	SENT_166	[p10l11t1424r535b1513],
20	RPA	NN	ORGANIZATION	rpa	agent	16	SENT_166	[p10l566t1422r745b1489],
21	were	VBD	O	be	auxpass	22	SENT_166	[p10l769t1450r936b1490],
22	found	VBN	O	find	ccomp	13	SENT_166	[p10l966t1424r1174b1490],
23	in	IN	O	in	_	0	SENT_166	[p10l1203t1427r1271b1489],
24	platelet	NN	O	platelet	nn	25	SENT_166	[p10l1299t1424r1561b1513],
25	count	NN	O	count	prep_in	22	SENT_166	[p10l1590t1441r1789b1490],
26	as	RB	O	as	prep	22	SENT_166	[p10l1819t1450r1881b1490],
27	well	RB	O	well	dep	26	SENT_166	[p10l1909t1424r2055b1490],
28	as	IN	O	as	_	0	SENT_166	[p10l2085t1450r2148b1490],
29	J	NNP	O	J	prep_as	27	SENT_166	[p10l1486t1527r1601b1578],
30	/	:	O	/	punct	27	SENT_166	[p10l1486t1527r1601b1578],
31	-	:	O	-	_	0	SENT_166	[p10l1486t1527r1601b1578],
32	\	CD	NUMBER	\	num	33	SENT_166	[p10l1486t1527r1601b1578],
33	CC	NN	O	cc	dep	27	SENT_166	[p10l1486t1527r1601b1578],
34	Vol	NN	O	vol	dep	33	SENT_166	[p10l1622t1528r1705b1578],
35	.	.	O	.	_	0	SENT_166	[p10l1622t1528r1705b1578],

1	55	CD	NUMBER	55	_	0	SENT_167	[p10l1730t1528r1803b1587],
2	,	,	O	,	_	0	SENT_167	[p10l1730t1528r1803b1587],
3	No.	NN	O	no.	amod	1	SENT_167	[p10l1830t1528r1901b1578],
4	22	CD	NUMBER	22	number	3	SENT_167	[p10l1927t1527r2000b1587],
5	,	,	O	,	_	0	SENT_167	[p10l1927t1527r2000b1587],
6	2010	CD	DATE	2010	appos	1	SENT_167	[p10l2025t1527r2149b1578],
7	June	NNP	DATE	June	tmod	6	SENT_167	[p10l1595t1617r1700b1667],
8	1	CD	DATE	1	num	7	SENT_167	[p10l1724t1617r1764b1675],
9	,	,	O	,	_	0	SENT_167	[p10l1724t1617r1764b1675],
10	2010:2427	CD	NUMBER	2010:2427	num	7	SENT_167	[p10l1789t1616r2150b1667],
11	—	CD	NUMBER	—	num	12	SENT_167	[p10l1789t1616r2150b1667],
12	34	CD	NUMBER	34	dep	1	SENT_167	[p10l1789t1616r2150b1667],

1	in	IN	O	in	_	0	SENT_168	[p10l8t1839r76b1901],
2	treatment	NN	O	treatment	nsubj	6	SENT_168	[p10l109t1853r456b1902],
3	with	IN	O	with	_	0	SENT_168	[p10l483t1836r645b1902],
4	angiotensin	NN	O	angiotensin	prep_with	2	SENT_168	[p10l678t1839r1505b1925],
5	—	CD	NUMBER	—	num	4	SENT_168	[p10l678t1839r1505b1925],
6	converting	VBG	O	convert	prepc_in	19	SENT_168	[p10l678t1839r1505b1925],
7	enzyme	NN	O	enzyme	nn	8	SENT_168	[p10l1536t1862r1804b1925],
8	inhibitor	NN	O	inhibitor	nsubj	18	SENT_168	[p10l1837t1836r2151b1902],
9	and	CC	O	and	_	0	SENT_168	[p10l10t1945r138b2011],
10	nitrates	NNS	O	nitrate	nsubj	18	SENT_168	[p10l176t1948r458b2026],
11	,	,	O	,	_	0	SENT_168	[p10l176t1948r458b2026],
12	previous	JJ	O	previous	amod	14	SENT_168	[p10l498t1948r792b2034],
13	coronary	JJ	O	coronary	amod	14	SENT_168	[p10l832t1971r1143b2034],
14	artery	NN	O	artery	appos	8	SENT_168	[p10l1178t1962r1382b2034],
15	bypass	NN	O	bypass	nn	16	SENT_168	[p10l1413t1945r1642b2034],
16	grafting	NN	O	grafting	dep	14	SENT_168	[p10l1680t1945r1980b2034],
17	,	,	O	,	_	0	SENT_168	[p10l1680t1945r1980b2034],
18	impaired	JJ	O	impaired	xcomp	6	SENT_168	[p10l2021t1948r2146b2010, p10l7t2053r229b2142],
19	left	VBD	O	leave	_	0	SENT_168	[p10l273t2053r389b2119],
20	ventricular	JJ	O	ventricular	amod	24	SENT_168	[p10l429t2053r811b2119],
21	function	NN	O	function	nn	24	SENT_168	[p10l856t2053r1153b2119],
22	(	CD	NUMBER	(	num	24	SENT_168	[p10l1202t2051r1504b2142],
23	ejection	NN	O	ejection	nn	24	SENT_168	[p10l1202t2051r1504b2142],
24	fraction	NN	O	fraction	nsubj	25	SENT_168	[p10l1550t2053r1824b2119],
25	<	JJR	O	<	xcomp	19	SENT_168	[p10l1875t2051r2146b2134],
26	55	CD	PERCENT	55	num	27	SENT_168	[p10l1875t2051r2146b2134],
27	%	NN	PERCENT	%	nsubj	19	SENT_168	[p10l1875t2051r2146b2134],
28	)	CD	NUMBER	)	dep	27	SENT_168	[p10l1875t2051r2146b2134],
29	,	,	O	,	_	0	SENT_168	[p10l1875t2051r2146b2134],
30	and	CC	O	and	_	0	SENT_168	[p10l10t2161r138b2227],
31	Canadian	JJ	O	canadian	amod	35	SENT_168	[p10l165t2161r506b2227],
32	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	35	SENT_168	[p10l534t2161r1063b2227],
33	Society	NNP	ORGANIZATION	Society	nn	35	SENT_168	[p10l1091t2161r1347b2250],
34	angina	NN	O	angina	nn	35	SENT_168	[p10l1371t2164r1605b2250],
35	class	NN	O	class	nsubj	19	SENT_168	[p10l1631t2161r1786b2227],
36	III	CD	NUMBER	iii	advmod	35	SENT_168	[p10l1814t2162r1908b2226],
37	or	CC	O	or	_	0	SENT_168	[p10l1937t2187r2009b2227],
38	IV	CD	NUMBER	iv	conj_or	36	SENT_168	[p10l2033t2162r2145b2228],
39	.	.	O	.	_	0	SENT_168	[p10l2033t2162r2145b2228],

1	These	DT	O	these	det	2	SENT_169	[p10l6t2267r223b2335],
2	variables	NNS	O	variable	nsubjpass	4	SENT_169	[p10l273t2269r578b2335],
3	were	VBD	O	be	auxpass	4	SENT_169	[p10l628t2295r796b2335],
4	included	VBN	O	include	_	0	SENT_169	[p10l848t2269r1153b2335],
5	in	IN	O	in	_	0	SENT_169	[p10l1205t2272r1273b2335],
6	a	DT	O	a	det	11	SENT_169	[p10l1326t2295r1361b2335],
7	multivariable	JJ	O	multivariable	amod	11	SENT_169	[p10l1413t2269r1876b2335],
8	binary	JJ	O	binary	amod	11	SENT_169	[p10l1927t2269r2153b2358],
9	logistic	JJ	O	logistic	amod	11	SENT_169	[p10l7t2378r269b2467],
10	regression	NN	O	regression	nn	11	SENT_169	[p10l333t2381r700b2467],
11	model	NN	O	model	prep_in	4	SENT_169	[p10l766t2378r991b2444],
12	for	IN	O	for	_	0	SENT_169	[p10l1054t2378r1158b2444],
13	prediction	NN	O	prediction	prep_for	11	SENT_169	[p10l1220t2378r1594b2467],
14	of	IN	O	of	_	0	SENT_169	[p10l1659t2378r1740b2444],
15	high	JJ	O	high	amod	17	SENT_169	[p10l1793t2378r1957b2467],
16	onclopidogrel	NN	O	onclopidogrel	nn	17	SENT_169	[p10l2022t2404r2145b2444, p10l9t2486r406b2575],
17	RPA	NN	O	rpa	prep_of	13	SENT_169	[p10l448t2485r644b2552],
18	.	.	O	.	_	0	SENT_169	[p10l448t2485r644b2552],

1	As	IN	O	as	mark	2	SENT_170	[p10l687t2485r782b2552],
2	shown	VBN	O	show	advcl	9	SENT_170	[p10l827t2486r1055b2552],
3	in	IN	O	in	_	0	SENT_170	[p10l1096t2489r1164b2552],
4	Table	NNP	O	Table	prep_in	2	SENT_170	[p10l1203t2484r1408b2552],
5	1	CD	NUMBER	1	num	4	SENT_170	[p10l1455t2490r1511b2567],
6	,	,	O	,	_	0	SENT_170	[p10l1455t2490r1511b2567],
7	this	DT	O	this	det	8	SENT_170	[p10l1556t2486r1683b2552],
8	model	NN	O	model	nsubj	9	SENT_170	[p10l1727t2486r1947b2552],
9	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_170	[p10l1989t2512r2146b2552, p10l8t2594r242b2660],
10	that	IN	O	that	complm	19	SENT_170	[p10l292t2594r434b2660],
11	CYP2CZ9	NN	O	cyp2cz9	nn	12	SENT_170	[p10l491t2597r907b2661],
12	*	NN	O	*	nsubj	19	SENT_170	[p10l491t2597r907b2661],
13	2	CD	NUMBER	2	num	15	SENT_170	[p10l491t2597r907b2661],
14	carrier	NN	O	carrier	nn	15	SENT_170	[p10l959t2597r1184b2660],
15	status	NN	O	status	dep	12	SENT_170	[p10l1235t2611r1433b2660],
16	was	VBD	O	be	cop	19	SENT_170	[p10l1482t2620r1612b2661],
17	the	DT	O	the	det	19	SENT_170	[p10l1665t2594r1776b2660],
18	strongest	JJS	O	strongest	amod	19	SENT_170	[p10l1829t2611r2151b2683],
19	predictor	NN	O	predictor	ccomp	9	SENT_170	[p10l7t2702r332b2791],
20	of	IN	O	of	_	0	SENT_170	[p10l367t2702r447b2768],
21	high	JJ	O	high	amod	23	SENT_170	[p10l471t2702r631b2791],
22	on-clopidogrel	JJ	O	on-clopidogrel	amod	23	SENT_170	[p10l668t2702r1193b2791],
23	RPA	NN	O	rpa	prep_of	19	SENT_170	[p10l1230t2700r1426b2768],
24	.	.	O	.	_	0	SENT_170	[p10l1230t2700r1426b2768],

1	Also	RB	O	also	advmod	10	SENT_171	[p10l1464t2701r1648b2783],
2	,	,	O	,	_	0	SENT_171	[p10l1464t2701r1648b2783],
3	age	NN	O	age	nsubj	10	SENT_171	[p10l1689t2728r1823b2791],
4	,	,	O	,	_	0	SENT_171	[p10l1689t2728r1823b2791],
5	diabetes	NN	O	diabetes	nn	6	SENT_171	[p10l1863t2702r2148b2768],
6	mellitus	NN	O	mellitus	nsubj	10	SENT_171	[p10l9t2810r310b2891],
7	,	,	O	,	_	0	SENT_171	[p10l9t2810r310b2891],
8	and	CC	O	and	_	0	SENT_171	[p10l363t2810r491b2876],
9	BMI	NNP	O	BMI	nsubj	10	SENT_171	[p10l540t2811r714b2875],
10	prevailed	VBD	O	prevail	_	0	SENT_171	[p10l763t2810r1084b2899],
11	as	IN	O	as	_	0	SENT_171	[p10l1133t2836r1197b2876],
12	strong	JJ	O	strong	amod	13	SENT_171	[p10l1249t2827r1472b2899],
13	predictors	NNS	O	predictor	prep_as	10	SENT_171	[p10l1518t2810r1870b2899],
14	in	IN	O	in	_	0	SENT_171	[p10l1921t2813r1989b2875],
15	the	DT	O	the	det	17	SENT_171	[p10l2038t2810r2148b2876],
16	multivariable	JJ	O	multivariable	amod	17	SENT_171	[p10l9t2918r472b2984],
17	analysis	NN	O	analysis	prep_in	10	SENT_171	[p10l503t2918r790b3007],
18	.	.	O	.	_	0	SENT_171	[p10l503t2918r790b3007],

1	Other	JJ	O	other	amod	2	SENT_172	[p10l825t2918r1040b2984],
2	clinical	JJ	O	clinical	nsubj	23	SENT_172	[p10l1069t2918r1336b2999],
3	,	,	O	,	_	0	SENT_172	[p10l1069t2918r1336b2999],
4	procedural	JJ	O	procedural	conj_and	2	SENT_172	[p10l1367t2918r1764b3007],
5	,	,	O	,	_	0	SENT_172	[p10l1367t2918r1764b3007],
6	and	CC	O	and	_	0	SENT_172	[p10l1797t2918r1926b2984],
7	pharmacotherapeutic	JJ	O	pharmacotherapeutic	amod	8	SENT_172	[p10l1953t2918r2147b3007, p10l9t3027r599b3116],
8	characteristics	NNS	O	characteristic	conj_and	2	SENT_172	[p10l642t3027r1138b3093],
9	with	IN	O	with	_	0	SENT_172	[p10l1179t3027r1341b3093],
10	a	DT	O	a	det	12	SENT_172	[p10l1386t3053r1420b3093],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_172	[p10l1464t3027r1830b3116],
12	association	NN	O	association	prep_with	8	SENT_172	[p10l1873t3030r2147b3093, p10l8t3138r149b3201],
13	with	IN	O	with	_	0	SENT_172	[p10l193t3135r356b3201],
14	high	JJ	O	high	amod	18	SENT_172	[p10l403t3135r563b3224],
15	on	IN	O	on	_	0	SENT_172	[p10l612t3135r1136b3224],
16	—	CD	NUMBER	—	num	17	SENT_172	[p10l612t3135r1136b3224],
17	clopidogrel	NN	O	clopidogrel	prep_on	14	SENT_172	[p10l612t3135r1136b3224],
18	RPA	NN	O	rpa	prep_with	12	SENT_172	[p10l1185t3134r1364b3201],
19	in	IN	O	in	_	0	SENT_172	[p10l1410t3138r1478b3201],
20	the	DT	O	the	det	22	SENT_172	[p10l1526t3135r1636b3201],
21	multivariable	JJ	O	multivariable	amod	22	SENT_172	[p10l1685t3135r2148b3201],
22	model	NN	O	model	prep_in	18	SENT_172	[p10l9t3243r230b3309],
23	were	VBD	O	be	_	0	SENT_172	[p10l260t3269r447b3309],
24	:	:	O	:	_	0	SENT_172	[p10l260t3269r447b3309],
25	treatment	NN	O	treatment	dobj	23	SENT_172	[p10l486t3260r835b3309],
26	with	IN	O	with	_	0	SENT_172	[p10l864t3243r1026b3309],
27	a	DT	O	a	det	32	SENT_172	[p10l1063t3269r1097b3309],
28	nondihydropyridine	JJ	O	nondihydropyridine	amod	32	SENT_172	[p10l1132t3243r1841b3332],
29	calcium	NN	O	calcium	nn	32	SENT_172	[p10l1878t3243r2148b3309],
30	antagonist	NN	O	antagonist	nn	32	SENT_172	[p10l10t3355r378b3441],
31	(	CD	NUMBER	(	num	32	SENT_172	[p10l412t3350r784b3441],
32	verapamil	NN	O	verapamil	prep_with	25	SENT_172	[p10l412t3350r784b3441],
33	or	CC	O	or	_	0	SENT_172	[p10l816t3378r888b3418],
34	diltiazem	NN	O	diltiazem	nn	35	SENT_172	[p10l920t3350r1297b3433],
35	)	NN	O	)	prep_with	25	SENT_172	[p10l920t3350r1297b3433],
36	,	,	O	,	_	0	SENT_172	[p10l920t3350r1297b3433],
37	and	CC	O	and	_	0	SENT_172	[p10l1334t3352r1462b3418],
38	a	DT	O	a	det	41	SENT_172	[p10l1495t3378r1529b3418],
39	previous	JJ	O	previous	amod	41	SENT_172	[p10l1559t3355r1853b3441],
40	balloon	NN	O	balloon	nn	41	SENT_172	[p10l1885t3352r2149b3418],
41	angioplasty	NN	O	angioplasty	conj_and	32	SENT_172	[p10l10t3460r427b3549],
42	.	.	O	.	_	0	SENT_172	[p10l10t3460r427b3549],

1	Addition	NN	O	addition	_	0	SENT_173	[p10l467t3459r793b3526],
2	of	IN	O	of	_	0	SENT_173	[p10l832t3460r913b3526],
3	the	DT	O	the	det	5	SENT_173	[p10l938t3460r1049b3526],
4	clinical	JJ	O	clinical	amod	5	SENT_173	[p10l1088t3460r1338b3526],
5	variables	NNS	O	variable	prep_of	1	SENT_173	[p10l1371t3460r1676b3527],
6	to	TO	O	to	_	0	SENT_173	[p10l1716t3477r1784b3526],
7	a	DT	O	a	det	10	SENT_173	[p10l1826t3486r1860b3526],
8	logistic	JJ	O	logistic	amod	10	SENT_173	[p10l1896t3460r2150b3549],
9	regression	NN	O	regression	nn	10	SENT_173	[p10l8t3571r365b3657],
10	model	NN	O	model	prep_to	5	SENT_173	[p10l412t3568r633b3634],
11	that	WDT	O	that	nsubj	12	SENT_173	[p10l678t3568r820b3634],
12	contained	VBD	O	contain	rcmod	1	SENT_173	[p10l865t3568r1213b3634],
13	only	RB	O	only	advmod	18	SENT_173	[p10l1260t3568r1413b3657],
14	CYP2C19	NN	O	cyp2c19	nn	18	SENT_173	[p10l1463t3571r1879b3635],
15	*	NN	O	*	nn	18	SENT_173	[p10l1463t3571r1879b3635],
16	2	CD	NUMBER	2	num	18	SENT_173	[p10l1463t3571r1879b3635],
17	carrier	NN	O	carrier	nn	18	SENT_173	[p10l1926t3571r2151b3634],
18	status	NN	O	status	dobj	12	SENT_173	[p10l10t3693r207b3742],
19	as	IN	O	as	_	0	SENT_173	[p10l235t3702r298b3742],
20	independent	JJ	O	independent	prep_as	18	SENT_173	[p10l324t3676r770b3765],
21	variable	JJ	O	variable	amod	25	SENT_173	[p10l789t3676r1064b3742],
22	increased	VBN	O	increase	amod	25	SENT_173	[p10l1089t3676r1417b3742],
23	chi	NN	O	chus	nn	25	SENT_173	[p10l1442t3676r1810b3765],
24	—	NN	O	—	nn	25	SENT_173	[p10l1442t3676r1810b3765],
25	square	NN	O	square	dep	1	SENT_173	[p10l1442t3676r1810b3765],
26	of	IN	O	of	_	0	SENT_173	[p10l1836t3676r1916b3742],
27	model	NN	O	model	prep_of	25	SENT_173	[p10l1929t3676r2150b3742],
28	from	IN	O	from	_	0	SENT_173	[p11l8t16r179b83],
29	28.4	CD	NUMBER	28.4	number	31	SENT_173	[p11l211t19r366b84],
30	to	TO	NUMBER	to	dep	31	SENT_173	[p11l399t33r467b83],
31	82.3	CD	NUMBER	82.3	prep_from	25	SENT_173	[p11l505t19r673b83],
32	.	.	O	.	_	0	SENT_173	[p11l505t19r673b83],

1	From	IN	O	from	_	0	SENT_174	[p11l98t126r294b191],
2	CART	NN	O	cart	nn	3	SENT_174	[p11l342t123r596b192],
3	analysis	NN	O	analysis	prep_from	11	SENT_174	[p11l641t125r929b214],
4	,	,	O	,	_	0	SENT_174	[p11l641t125r929b214],
5	CYP2CZ9	NN	O	cyp2cz9	nn	6	SENT_174	[p11l985t128r1401b192],
6	*	NN	O	*	nsubj	11	SENT_174	[p11l985t128r1401b192],
7	2	CD	NUMBER	2	num	9	SENT_174	[p11l985t128r1401b192],
8	carrier	NN	O	carrier	nn	9	SENT_174	[p11l1446t128r1672b191],
9	status	NN	O	status	npadvmod	10	SENT_174	[p11l1717t142r1914b191],
10	again	RB	O	again	advmod	11	SENT_174	[p11l1963t128r2149b214],
11	emerged	VBD	O	emerge	_	0	SENT_174	[p11l9t233r312b322],
12	as	IN	O	as	_	0	SENT_174	[p11l345t259r408b299],
13	the	DT	O	the	det	15	SENT_174	[p11l442t233r552b299],
14	strongest	JJS	O	strongest	amod	15	SENT_174	[p11l587t250r908b322],
15	Variable	JJ	O	variable	prep_as	11	SENT_174	[p11l935t233r1209b299],
16	for	IN	O	for	_	0	SENT_174	[p11l1242t233r1343b299],
17	classiﬁcation	NN	O	classiﬁcation	nn	19	SENT_174	[p11l1374t233r1823b299],
18	(	CD	NUMBER	(	num	19	SENT_174	[p11l1857t231r2019b322],
19	Fig	NN	O	fig	prep_for	15	SENT_174	[p11l1857t231r2019b322],
20	.	.	O	.	_	0	SENT_174	[p11l1857t231r2019b322],

1	2	CD	NUMBER	2	num	2	SENT_175	[p11l2054t231r2145b314],
2	)	CD	NUMBER	)	_	0	SENT_175	[p11l2054t231r2145b314],
3	.	.	O	.	_	0	SENT_175	[p11l2054t231r2145b314],

1	The	DT	O	the	det	5	SENT_176	[p11l6t339r153b408],
2	second	JJ	ORDINAL	second	amod	4	SENT_176	[p11l200t341r440b408],
3	most	RBS	O	most	advmod	4	SENT_176	[p11l485t358r660b408],
4	relevant	JJ	O	relevant	amod	5	SENT_176	[p11l702t341r983b408],
5	Variable	NNP	O	Variable	nsubj	8	SENT_176	[p11l1022t341r1297b408],
6	was	VBD	O	be	cop	8	SENT_176	[p11l1338t367r1468b408],
7	diabetes	NNP	O	diabetes	nn	8	SENT_176	[p11l1515t341r1798b408],
8	mellitus	NN	O	mellitus	_	0	SENT_176	[p11l1846t341r2146b422],
9	,	,	O	,	_	0	SENT_176	[p11l1846t341r2146b422],
10	followed	VBN	O	follow	_	0	SENT_176	[p11l8t450r314b516],
11	by	IN	O	by	prepc_followed_by	8	SENT_176	[p11l356t450r442b539],
12	BMI	NN	O	bmus	pobj	8	SENT_176	[p11l484t451r678b516],
13	.	.	O	.	_	0	SENT_176	[p11l484t451r678b516],

1	The	DT	O	the	det	2	SENT_177	[p11l724t448r872b516],
2	frequency	NN	O	frequency	nsubj	17	SENT_177	[p11l917t450r1266b539],
3	of	IN	O	of	_	0	SENT_177	[p11l1307t450r1388b516],
4	high	JJ	O	high	amod	8	SENT_177	[p11l1421t450r1581b539],
5	on	IN	O	on	_	0	SENT_177	[p11l1626t450r2151b539],
6	—	CD	NUMBER	—	num	7	SENT_177	[p11l1626t450r2151b539],
7	clopidogrel	NN	O	clopidogrel	prep_on	4	SENT_177	[p11l1626t450r2151b539],
8	RPA	NN	O	rpa	prep_of	2	SENT_177	[p11l11t557r190b624],
9	in	IN	O	in	_	0	SENT_177	[p11l222t561r290b624],
10	the	DT	O	the	det	11	SENT_177	[p11l324t558r435b625],
11	classes	NNS	O	class	prep_in	8	SENT_177	[p11l471t558r696b625],
12	derived	VBN	O	derive	partmod	11	SENT_177	[p11l733t558r991b625],
13	from	IN	O	from	_	0	SENT_177	[p11l1025t558r1195b625],
14	this	DT	O	this	det	16	SENT_177	[p11l1230t558r1358b625],
15	CART	NN	O	cart	nn	16	SENT_177	[p11l1395t556r1648b625],
16	model	NN	O	model	prep_from	12	SENT_177	[p11l1683t558r1904b625],
17	Varied	VBN	O	vary	_	0	SENT_177	[p11l1933t558r2150b625],
18	from	IN	O	from	_	0	SENT_177	[p11l8t667r179b733],
19	48	CD	PERCENT	48	num	20	SENT_177	[p11l211t670r364b734],
20	%	NN	PERCENT	%	prep_from	17	SENT_177	[p11l211t670r364b734],
21	in	IN	O	in	_	0	SENT_177	[p11l396t670r464b733],
22	CYP2CZ9	NN	O	cyp2cz9	nn	23	SENT_177	[p11l502t670r918b734],
23	*	NN	O	*	prep_in	20	SENT_177	[p11l502t670r918b734],
24	2	CD	NUMBER	2	num	25	SENT_177	[p11l502t670r918b734],
25	carriers	NNS	O	carrier	nn	46	SENT_177	[p11l950t670r1204b733],
26	with	IN	O	with	_	0	SENT_177	[p11l1233t667r1395b733],
27	BMI	NN	O	bmus	nn	29	SENT_177	[p11l1427t668r1601b732],
28	Z26	NN	O	z26	nn	29	SENT_177	[p11l1640t670r1793b734],
29	kg/m2	NN	O	kg/m2	prep_with	25	SENT_177	[p11l1827t653r2047b756],
30	to	TO	O	to	_	0	SENT_177	[p11l2079t684r2148b733],
31	16	CD	PERCENT	16	num	32	SENT_177	[p11l13t778r161b841],
32	%	NN	PERCENT	%	prep_to	29	SENT_177	[p11l13t778r161b841],
33	in	IN	O	in	_	0	SENT_177	[p11l192t778r260b840],
34	nondiabetic	JJ	O	nondiabetic	amod	35	SENT_177	[p11l293t775r709b841],
35	CYPZCZ	NNP	O	CYPZCZ	prep_in	32	SENT_177	[p11l746t778r1042b842],
36	9	CD	NUMBER	9	num	40	SENT_177	[p11l1053t781r1092b841],
37	wild	JJ	O	wild	amod	40	SENT_177	[p11l1117t775r1459b864],
38	—	NN	O	—	nn	40	SENT_177	[p11l1117t775r1459b864],
39	type	NN	O	type	nn	40	SENT_177	[p11l1117t775r1459b864],
40	homozygotes	NNS	O	homozygote	npadvmod	44	SENT_177	[p11l1490t775r1958b864],
41	with	IN	O	with	_	0	SENT_177	[p11l1987t775r2149b841],
42	a	DT	O	a	det	43	SENT_177	[p11l10t909r45b949],
43	BMI	NN	O	bmus	prep_with	40	SENT_177	[p11l77t884r251b948],
44	<	JJR	O	<	amod	46	SENT_177	[p11l291t886r445b949],
45	30	CD	NUMBER	30	dep	44	SENT_177	[p11l291t886r445b949],
46	kg/m2	NN	O	kg/m2	dobj	17	SENT_177	[p11l480t869r719b972],
47	.	.	O	.	_	0	SENT_177	[p11l480t869r719b972],

1	y	NN	O	y	nn	2	SENT_178	[p11l721t1223r938b1333],
2	W	NN	O	w	_	0	SENT_178	[p11l1265t1223r1482b1333],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_179	[p11l995t1389r1217b1421],
2	*	NN	O	*	_	0	SENT_179	[p11l995t1389r1217b1421],
3	2	CD	NUMBER	2	dep	2	SENT_179	[p11l995t1389r1217b1421],

1	carrier	NN	O	carrier	_	0	SENT_180	[p11l1049t1440r1166b1472],

1	Diabetes	NNP	O	Diabetes	dep	8	SENT_181	[p11l435t1509r596b1540],
2	mellitus	NN	O	mellitus	nn	4	SENT_181	[p11l611t1509r749b1540],
3	Body	NN	O	body	nn	4	SENT_181	[p11l1412t1509r1504b1549],
4	mass	NN	O	mass	dep	1	SENT_181	[p11l1519t1517r1615b1540],
5	index	NN	O	index	nn	6	SENT_181	[p11l1630t1509r1727b1540],
6	nol	NN	O	nol	dep	8	SENT_181	[p11l536t1556r601b1616],
7	yes	RB	O	yes	advmod	8	SENT_181	[p11l752t1574r809b1603],
8	<	JJR	O	<	dep	12	SENT_181	[p11l1356t1571r1375b1589],
9	26	CD	NUMBER	26	num	10	SENT_181	[p11l1387t1566r1427b1595],
10	L	NN	O	l	dep	8	SENT_181	[p11l1564t1556r1585b1616],
11	2	CD	NUMBER	2	num	12	SENT_181	[p11l1598t1571r1618b1594],
12	26	CD	NUMBER	26	_	0	SENT_181	[p11l1629t1568r1669b1595],

1	C	NN	O	c	_	0	SENT_182	[p11l876t1674r997b1794],
2	!	.	O	!	_	0	SENT_182	[p11l876t1674r997b1794],

1	G	NN	O	g	_	0	SENT_183	[p11l1210t1687r1309b1786],
2	I	NN	O	i	dep	1	SENT_183	[p11l1507t1669r1639b1800],
3	+	CC	O	+	rcmod	2	SENT_183	[p11l1507t1669r1639b1800],

1	Body	NN	O	body	_	0	SENT_184	[p11l429t1859r521b1898],
2	mass	NN	O	mass	nn	3	SENT_184	[p11l535t1866r632b1891],
3	index	NN	O	index	dep	1	SENT_184	[p11l646t1859r744b1891],

1	<	JJR	O	<	amod	2	SENT_185	[p11l502t1928r521b1945],
2	p	NN	O	p	_	0	SENT_185	[p11l534t1912r600b1972],
3	I	NN	O	i	dep	2	SENT_185	[p11l534t1912r600b1972],
4	+	CC	O	+	rcmod	3	SENT_185	[p11l534t1912r600b1972],

1	29	CD	PERCENT	29	num	4	SENT_186	[p11l990t2000r1059b2027],
2	%	NN	PERCENT	%	nn	4	SENT_186	[p11l990t2000r1059b2027],
3	o	NN	O	o	nn	4	SENT_186	[p11l1372t2019r1397b2044],
4	RPA	NN	O	rpa	_	0	SENT_186	[p11l1417t2018r1497b2048],
5	>	JJR	O	>	dep	4	SENT_186	[p11l1508t2024r1528b2044],
6	14	CD	PERCENT	14	number	7	SENT_186	[p11l1546t2018r1623b2050],
7	%	NN	PERCENT	%	amod	8	SENT_186	[p11l1546t2018r1623b2050],
8	o	NN	O	o	dep	5	SENT_186	[p11l1371t2066r1398b2092],
9	RPAs14	CD	PERCENT	rpas14	num	10	SENT_186	[p11l1417t2064r1621b2098],
10	%	NN	PERCENT	%	dep	4	SENT_186	[p11l1417t2064r1621b2098],

1	CART	NN	O	cart	nn	2	SENT_187	[p11l242t2240r324b2264],
2	Analysis	NN	O	analysis	_	0	SENT_187	[p11l336t2240r459b2270],
3	for	IN	O	for	_	0	SENT_187	[p11l471t2240r510b2264],
4	Low	JJ	O	low	amod	5	SENT_187	[p11l523t2241r580b2264],
5	Response	NN	O	response	prep_for	2	SENT_187	[p11l593t2241r736b2270],
6	to	TO	O	to	_	0	SENT_187	[p11l748t2241r778b2264],
7	clopidogrel	NN	O	clopidogrel	prep_to	2	SENT_187	[p11l791t2240r956b2270],
8	Including	VBG	O	include	_	0	SENT_187	[p11l971t2240r1105b2270],
9	the	DT	O	the	det	11	SENT_187	[p11l1116t2241r1164b2264],
10	cYP2c19	NN	O	cyp2c19	nn	11	SENT_187	[p11l1178t2240r1322b2264],
11	681G	NN	O	681g	dep	12	SENT_187	[p11l1332t2240r1412b2264],
12	>	JJR	O	>	prep_including	2	SENT_187	[p11l1418t2241r1462b2264],
13	A	DT	O	a	det	15	SENT_187	[p11l1418t2241r1462b2264],
14	Polymorphism	NN	MISC	polymorphism	nn	15	SENT_187	[p11l1476t2240r1681b2270],
15	Correlation	NN	MISC	correlation	dep	12	SENT_187	[p11l68t2324r189b2343],
16	and	CC	O	and	_	0	SENT_187	[p11l200t2324r240b2343],
17	regression	NN	O	regression	nn	18	SENT_187	[p11l251t2324r367b2348],
18	trees	NNS	O	tree	conj_and	12	SENT_187	[p11l377t2325r434b2343],
19	(	CD	NUMBER	(	num	22	SENT_187	[p11l444t2324r518b2348],
20	CART	NN	O	cart	nn	22	SENT_187	[p11l444t2324r518b2348],
21	)	NN	O	)	nn	22	SENT_187	[p11l444t2324r518b2348],
22	analysis	NN	O	analysis	dep	18	SENT_187	[p11l528t2324r619b2348],
23	for	IN	O	for	prep	2	SENT_187	[p11l628t2324r658b2343],
24	low	JJ	O	low	amod	25	SENT_187	[p11l668t2324r704b2343],
25	response	NN	O	response	dep	35	SENT_187	[p11l714t2329r817b2348],
26	to	TO	O	to	_	0	SENT_187	[p11l826t2325r848b2343],
27	clopidogrel	NN	O	clopidogrel	nn	31	SENT_187	[p11l858t2324r978b2348],
28	(	CD	NUMBER	(	num	31	SENT_187	[p11l989t2324r1084b2348],
29	residual	JJ	O	residual	amod	31	SENT_187	[p11l989t2324r1084b2348],
30	platelet	NN	O	platelet	nn	31	SENT_187	[p11l1095t2324r1179b2348],
31	aggregation	NN	O	aggregation	prep_to	25	SENT_187	[p11l1188t2324r1317b2348],
32	[	CD	NUMBER	[	num	33	SENT_187	[p11l1328t2324r1387b2348],
33	RPA	NN	O	rpa	dep	35	SENT_187	[p11l1328t2324r1387b2348],
34	]	CD	NUMBER	]	num	35	SENT_187	[p11l1328t2324r1387b2348],
35	>	JJR	O	>	dep	38	SENT_187	[p11l1398t2324r1475b2348],
36	14	CD	PERCENT	14	num	37	SENT_187	[p11l1398t2324r1475b2348],
37	%	NN	PERCENT	%	dep	35	SENT_187	[p11l1398t2324r1475b2348],
38	)	CD	NUMBER	)	dep	23	SENT_187	[p11l1398t2324r1475b2348],
39	including	VBG	O	include	_	0	SENT_187	[p11l1486t2324r1584b2348],
40	the	DT	O	the	det	42	SENT_187	[p11l1592t2324r1628b2343],
41	CYP2C19	NN	O	cyp2c19	nn	42	SENT_187	[p11l1640t2324r1748b2343],
42	681G	NN	O	681g	prep_including	2	SENT_187	[p11l1755t2324r1856b2343],
43	>	JJR	O	>	amod	45	SENT_187	[p11l1755t2324r1856b2343],
44	A	DT	O	a	det	45	SENT_187	[p11l1755t2324r1856b2343],
45	polymorphism	NN	O	polymorphism	dep	42	SENT_187	[p11l1866t2324r2028b2348],
46	.	.	O	.	_	0	SENT_187	[p11l1866t2324r2028b2348],

1	JACC	NNP	O	JACC	nn	2	SENT_188	[p11l9t2546r124b2597],
2	Vol	NNP	O	Vol	_	0	SENT_188	[p11l151t2547r233b2597],
3	.	.	O	.	_	0	SENT_188	[p11l151t2547r233b2597],

1	55	CD	NUMBER	55	_	0	SENT_189	[p11l264t2547r338b2606],
2	,	,	O	,	_	0	SENT_189	[p11l264t2547r338b2606],
3	No.	NN	O	no.	amod	1	SENT_189	[p11l370t2547r442b2597],
4	22	CD	NUMBER	22	number	3	SENT_189	[p11l473t2546r546b2606],
5	,	,	O	,	_	0	SENT_189	[p11l473t2546r546b2606],
6	2010	CD	DATE	2010	appos	1	SENT_189	[p11l577t2547r701b2597],
7	June	NNP	DATE	June	tmod	6	SENT_189	[p11l9t2636r114b2686],
8	1	CD	DATE	1	num	7	SENT_189	[p11l144t2636r184b2694],
9	,	,	O	,	_	0	SENT_189	[p11l144t2636r184b2694],
10	2010:2427	CD	NUMBER	2010:2427	num	7	SENT_189	[p11l216t2635r575b2686],
11	—	CD	NUMBER	—	num	12	SENT_189	[p11l216t2635r575b2686],
12	34	CD	NUMBER	34	dep	1	SENT_189	[p11l216t2635r575b2686],

1	Table	NNP	O	Table	_	0	SENT_190	[p11l63t2936r233b2985],
2	2	CD	NUMBER	2	dep	1	SENT_190	[p11l262t2935r299b2985],

1	Multivariable	JJ	O	multivariable	amod	3	SENT_191	[p11l413t2895r823b2946],
2	Linear	JJ	O	linear	amod	3	SENT_191	[p11l852t2895r1042b2946],
3	Regression	NN	O	regression	_	0	SENT_191	[p11l1071t2895r1418b2958],
4	Model	NNP	O	Model	dep	3	SENT_191	[p11l1450t2896r1639b2946],
5	for	IN	O	for	_	0	SENT_191	[p11l409t2975r493b3026],
6	RPA	NNP	ORGANIZATION	RPA	prep_for	3	SENT_191	[p11l521t2976r653b3025],
7	After	IN	O	after	dep	3	SENT_191	[p11l678t2975r834b3026],
8	Stimulation	NN	O	stimulation	pobj	7	SENT_191	[p11l859t2975r1221b3026],
9	With	IN	O	with	dep	3	SENT_191	[p11l1248t2975r1393b3026],
10	5	CD	NUMBER	5	num	11	SENT_191	[p11l1424t2976r1462b3026],
11	prmol	NN	O	prmol	pobj	9	SENT_191	[p11l1491t2976r1696b3040],
12	/	:	O	/	punct	3	SENT_191	[p11l1491t2976r1696b3040],
13	I	PRP	O	I	dep	3	SENT_191	[p11l1701t2976r1712b3025],
14	ADP	NN	O	adp	dep	13	SENT_191	[p11l1739t2976r1875b3025],

1	Partial	JJ	O	partial	amod	2	SENT_192	[p11l1216t3145r1380b3186],
2	112	CD	NUMBER	112	dep	9	SENT_192	[p11l1406t3133r1466b3197],
3	p	NN	O	p	nn	5	SENT_192	[p11l1902t3155r1929b3195],
4	Value	NN	O	value	nn	5	SENT_192	[p11l1950t3145r2092b3186],
5	CYP2C19	NN	O	cyp2c19	dep	2	SENT_192	[p11l65t3241r325b3282],
6	*	CD	NUMBER	*	num	7	SENT_192	[p11l65t3241r325b3282],
7	polymorphism	NN	O	polymorphism	dep	9	SENT_192	[p11l349t3242r698b3291],
8	0.052	CD	NUMBER	0.052	num	9	SENT_192	[p11l1291t3242r1437b3282],
9	<	JJR	O	<	dep	13	SENT_192	[p11l1901t3242r2095b3282],
10	0.001	CD	NUMBER	0.001	num	11	SENT_192	[p11l1901t3242r2095b3282],
11	Age	NN	O	age	dep	9	SENT_192	[p11l62t3319r156b3368],
12	(	CD	NUMBER	(	num	13	SENT_192	[p11l176t3319r279b3368],
13	yrs	NNS	DURATION	yr	dep	15	SENT_192	[p11l176t3319r279b3368],
14	)	CD	NUMBER	)	num	15	SENT_192	[p11l176t3319r279b3368],
15	0.010	CD	NUMBER	0.010	dep	29	SENT_192	[p11l1291t3318r1438b3359],
16	0.006	CD	NUMBER	0.006	num	18	SENT_192	[p11l1947t3319r2093b3359],
17	Arterial	JJ	O	arterial	amod	18	SENT_192	[p11l62t3397r241b3436],
18	hypertension	NN	O	hypertension	dep	15	SENT_192	[p11l265t3397r579b3446],
19	0.001	CD	NUMBER	0.001	number	20	SENT_192	[p11l1291t3396r1439b3436],
20	0.386	CD	NUMBER	0.386	num	27	SENT_192	[p11l1946t3396r2094b3436],
21	Diabetes	NNP	O	Diabetes	nn	27	SENT_192	[p11l66t3473r281b3513],
22	mellitus	NN	O	mellitus	amod	27	SENT_192	[p11l303t3473r498b3513],
23	0.012	CD	NUMBER	0.012	num	22	SENT_192	[p11l1291t3473r1436b3513],
24	0.003	CD	NUMBER	0.003	num	26	SENT_192	[p11l1947t3473r2093b3513],
25	Body	NN	O	body	nn	26	SENT_192	[p11l66t3552r184b3601],
26	mass	NN	O	mass	dep	22	SENT_192	[p11l205t3561r335b3591],
27	index	NN	O	index	dep	18	SENT_192	[p11l357t3552r486b3591],
28	(	CD	NUMBER	(	num	29	SENT_192	[p11l505t3539r702b3601],
29	kg/m2	NN	O	kg/m2	dep	33	SENT_192	[p11l505t3539r702b3601],
30	)	CD	NUMBER	)	num	33	SENT_192	[p11l505t3539r702b3601],
31	0.010	CD	NUMBER	0.010	num	33	SENT_192	[p11l1291t3551r1438b3592],
32	0.008	CD	NUMBER	0.008	num	33	SENT_192	[p11l1947t3551r2094b3592],
33	Platelets	NNS	O	platelet	_	0	SENT_192	[p11l66t3629r280b3668],
34	(	VBP	O	(	rcmod	33	SENT_192	[p11l300t3629r357b3677],
35	>	JJR	O	>	npadvmod	36	SENT_192	[p11l300t3629r357b3677],
36	<	JJR	O	<	acomp	34	SENT_192	[p11l300t3629r357b3677],
37	109/I	CD	NUMBER	109/i	num	38	SENT_192	[p11l384t3615r533b3677],
38	)	NN	O	)	dep	36	SENT_192	[p11l384t3615r533b3677],
39	0.010	CD	NUMBER	0.010	number	40	SENT_192	[p11l1291t3628r1438b3668],
40	0.006	CD	NUMBER	0.006	num	42	SENT_192	[p11l1947t3628r2093b3668],
41	ACE	NN	O	ace	nn	42	SENT_192	[p11l62t3705r160b3746],
42	inhibitors	NNS	O	inhibitor	dep	38	SENT_192	[p11l182t3705r409b3746],
43	0.001	CD	NUMBER	0.001	num	44	SENT_192	[p11l1291t3705r1439b3746],
44	0.403	CD	NUMBER	0.403	dep	38	SENT_192	[p11l1947t3705r2093b3746],

1	Nitrates	NNS	O	nitrate	dep	19	SENT_193	[p12l66t26r258b66],
2	<	JJR	O	<	dep	1	SENT_193	[p12l1245t25r1439b66],
3	0.001	CD	NUMBER	0.001	number	4	SENT_193	[p12l1245t25r1439b66],
4	0.890	CD	NUMBER	0.890	num	14	SENT_193	[p12l1947t26r2094b66],
5	Verapamil/diltiazem	NNP	O	Verapamil/diltiazem	nn	14	SENT_193	[p12l62t105r569b153],
6	0.010	CD	NUMBER	0.010	number	7	SENT_193	[p12l1291t104r1438b144],
7	0.006	CD	NUMBER	0.006	num	10	SENT_193	[p12l1947t104r2094b144],
8	Previous	JJ	O	previous	amod	10	SENT_193	[p12l66t181r274b221],
9	balloon	NN	O	balloon	nn	10	SENT_193	[p12l295t181r472b221],
10	angioplasty	NN	O	angioplasty	npadvmod	13	SENT_193	[p12l494t181r777b230],
11	0.007	CD	NUMBER	0.007	number	12	SENT_193	[p12l1291t181r1437b221],
12	0.026	CD	NUMBER	0.026	num	10	SENT_193	[p12l1947t181r2093b221],
13	Previous	JJ	O	previous	amod	14	SENT_193	[p12l66t258r274b298],
14	CABG	NN	O	cabg	dep	2	SENT_193	[p12l294t258r429b298],
15	0.001	CD	NUMBER	0.001	number	16	SENT_193	[p12l1291t257r1439b298],
16	0.435	CD	NUMBER	0.435	num	14	SENT_193	[p12l1947t257r2093b298],
17	Impaired	JJ	O	impaired	amod	18	SENT_193	[p12l66t337r282b385],
18	LV	NN	O	lv	dep	19	SENT_193	[p12l307t337r363b376],
19	function1	NN	O	function1	dep	31	SENT_193	[p12l380t336r614b385],
20	'	''	O	'	_	0	SENT_193	[p12l380t336r614b385],
21	<	JJR	O	<	dep	19	SENT_193	[p12l1245t336r1439b376],
22	0.001	CD	NUMBER	0.001	number	23	SENT_193	[p12l1245t336r1439b376],
23	0.945	CD	NUMBER	0.945	dep	21	SENT_193	[p12l1947t336r2094b376],
24	CCS	NN	O	cc	nn	26	SENT_193	[p12l64t413r161b453],
25	angina	NN	O	angina	nn	26	SENT_193	[p12l181t413r346b462],
26	class	NN	O	class	dep	23	SENT_193	[p12l368t413r490b453],
27	III	CD	NUMBER	iii	advmod	23	SENT_193	[p12l512t413r550b452],
28	or	CC	O	or	_	0	SENT_193	[p12l573t422r621b453],
29	IV	CD	NUMBER	iv	advmod	23	SENT_193	[p12l642t413r685b452],
30	0.004	CD	NUMBER	0.004	num	31	SENT_193	[p12l1291t413r1438b453],
31	0.081	CD	NUMBER	0.081	_	0	SENT_193	[p12l1947t413r2094b453],

1	*	NN	O	*	nn	3	SENT_194	[p12l11t565r298b609],
2	Cytochrome	NN	O	cytochrome	nn	3	SENT_194	[p12l11t565r298b609],
3	P450	NN	O	p450	_	0	SENT_194	[p12l318t565r434b600],
4	2019	CD	DATE	2019	num	5	SENT_194	[p12l453t565r569b600],
5	681G	NN	O	681g	npadvmod	6	SENT_194	[p12l588t565r793b607],
6	>	JJR	O	>	dep	3	SENT_194	[p12l588t565r793b607],
7	A	DT	O	a	dep	6	SENT_194	[p12l588t565r793b607],
8	;	:	O	;	_	0	SENT_194	[p12l588t565r793b607],
9	1	CD	NUMBER	1	dep	6	SENT_194	[p12l813t565r1034b609],
10	'	''	O	'	_	0	SENT_194	[p12l813t565r1034b609],
11	impaired	JJ	O	impaired	amod	13	SENT_194	[p12l813t565r1034b609],
12	LV	NN	O	lv	nn	13	SENT_194	[p12l1056t565r1105b600],
13	function	NN	O	function	dep	9	SENT_194	[p12l1120t565r1297b601],
14	(	CD	NUMBER	(	num	16	SENT_194	[p12l1316t565r1502b610],
15	ejection	NN	O	ejection	nn	16	SENT_194	[p12l1316t565r1502b610],
16	fraction	NN	O	fraction	dep	3	SENT_194	[p12l1520t565r1685b601],
17	<	JJR	O	<	dep	16	SENT_194	[p12l1708t565r1872b609],
18	55	CD	PERCENT	55	num	19	SENT_194	[p12l1708t565r1872b609],
19	%	NN	PERCENT	%	dep	3	SENT_194	[p12l1708t565r1872b609],
20	)	CD	NUMBER	)	dep	19	SENT_194	[p12l1708t565r1872b609],
21	.	.	O	.	_	0	SENT_194	[p12l1708t565r1872b609],

1	ADP	NN	O	adp	_	0	SENT_195	[p12l60t636r154b671],
2	=	JJ	O	=	amod	4	SENT_195	[p12l176t648r207b660],
3	adenosine	NN	O	adenosine	nn	4	SENT_195	[p12l230t636r454b671],
4	diphosphate	NN	O	diphosphate	dep	1	SENT_195	[p12l472t636r753b679],
5	;	:	O	;	_	0	SENT_195	[p12l472t636r753b679],
6	RPA	NN	O	rpa	nn	10	SENT_195	[p12l775t636r865b671],
7	=	JJ	O	=	amod	10	SENT_195	[p12l887t648r918b660],
8	residual	JJ	O	residual	amod	10	SENT_195	[p12l942t636r1111b671],
9	platelet	NN	O	platelet	nn	10	SENT_195	[p12l1132t636r1296b679],
10	aggregation	NN	O	aggregation	dep	1	SENT_195	[p12l1313t636r1584b680],
11	;	:	O	;	_	0	SENT_195	[p12l1313t636r1584b680],
12	other	JJ	O	other	amod	13	SENT_195	[p12l1604t636r1717b671],
13	abbreviations	NNS	O	abbreviation	dep	10	SENT_195	[p12l1735t636r2029b671],
14	as	IN	O	as	prep	13	SENT_195	[p12l2047t644r2095b671],
15	in	IN	O	in	pcomp	14	SENT_195	[p12l2114t636r2149b671],

1	Table	NNP	O	Table	_	0	SENT_196	[p12l8t705r127b740],
2	1	CD	NUMBER	1	dep	1	SENT_196	[p12l146t705r183b740],
3	.	.	O	.	_	0	SENT_196	[p12l146t705r183b740],

1	We	PRP	O	we	nsubj	13	SENT_197	[p12l96t897r227b963],
2	also	RB	O	also	advmod	3	SENT_197	[p12l270t896r401b962],
3	analyzed	VBD	O	analyze	_	0	SENT_197	[p12l445t896r750b985],
4	on	IN	O	on	_	0	SENT_197	[p12l791t896r1315b985],
5	—	CD	NUMBER	—	num	7	SENT_197	[p12l791t896r1315b985],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_197	[p12l791t896r1315b985],
7	RPA	NN	O	rpa	prep_on	3	SENT_197	[p12l1357t895r1536b961],
8	as	IN	O	as	_	0	SENT_197	[p12l1577t922r1640b962],
9	a	DT	O	a	det	11	SENT_197	[p12l1685t922r1719b962],
10	continuous	JJ	O	continuous	amod	11	SENT_197	[p12l1760t899r2149b962],
11	Variable	JJ	O	variable	prep_as	3	SENT_197	[p12l7t1001r281b1067],
12	and	CC	O	and	_	0	SENT_197	[p12l328t1001r456b1067],
13	estimated	VBD	O	estimate	conj_and	3	SENT_197	[p12l501t1001r842b1067],
14	the	DT	O	the	det	16	SENT_197	[p12l885t1001r996b1067],
15	individual	JJ	O	individual	amod	16	SENT_197	[p12l1041t1001r1396b1067],
16	contribution	NN	O	contribution	dobj	13	SENT_197	[p12l1440t1001r1881b1067],
17	of	IN	O	of	_	0	SENT_197	[p12l1927t1001r2006b1066],
18	the	DT	O	the	det	20	SENT_197	[p12l2039t1001r2149b1066],
19	same	JJ	O	same	amod	20	SENT_197	[p12l12t1133r186b1173],
20	Variables	NNS	O	variable	prep_of	16	SENT_197	[p12l234t1107r539b1173],
21	as	IN	O	as	dep	13	SENT_197	[p12l592t1133r655b1173],
22	in	IN	O	in	_	0	SENT_197	[p12l707t1110r775b1172],
23	the	DT	O	the	det	25	SENT_197	[p12l825t1107r936b1173],
24	logistic	JJ	O	logistic	amod	25	SENT_197	[p12l985t1107r1239b1196],
25	model	NN	O	model	prep_in	13	SENT_197	[p12l1289t1107r1510b1173],
26	to	TO	O	to	_	0	SENT_197	[p12l1559t1124r1627b1173],
27	the	DT	O	the	det	28	SENT_197	[p12l1679t1107r1789b1173],
28	Variation	NN	O	variation	prep_to	25	SENT_197	[p12l1837t1110r2150b1173],
29	of	IN	O	of	prep	28	SENT_197	[p12l11t1213r91b1279],
30	on	IN	O	on	pcomp	29	SENT_197	[p12l103t1213r628b1302],
31	—	NN	O	—	nn	33	SENT_197	[p12l103t1213r628b1302],
32	clopidogrel	NN	O	clopidogrel	nn	33	SENT_197	[p12l103t1213r628b1302],
33	RPA	NN	ORGANIZATION	rpa	pobj	30	SENT_197	[p12l652t1212r830b1278],
34	in	IN	O	in	_	0	SENT_197	[p12l852t1216r920b1278],
35	a	DT	O	a	det	38	SENT_197	[p12l945t1239r979b1279],
36	linear	JJ	O	linear	amod	38	SENT_197	[p12l1000t1213r1200b1279],
37	regression	NN	O	regression	nn	38	SENT_197	[p12l1221t1216r1578b1302],
38	model	NN	O	model	prep_in	33	SENT_197	[p12l1602t1213r1839b1279],
39	.	.	O	.	_	0	SENT_197	[p12l1602t1213r1839b1279],

1	A	DT	O	a	det	4	SENT_198	[p12l1865t1212r1932b1278],
2	linear	JJ	O	linear	amod	4	SENT_198	[p12l1952t1213r2152b1279],
3	regression	NN	O	regression	nn	4	SENT_198	[p12l10t1322r366b1408],
4	model	NN	O	model	nsubj	15	SENT_198	[p12l413t1319r634b1385],
5	that	WDT	O	that	nsubj	7	SENT_198	[p12l679t1319r820b1385],
6	only	RB	O	only	advmod	7	SENT_198	[p12l865t1319r1019b1408],
7	comprises	VBZ	O	comprise	rcmod	4	SENT_198	[p12l1061t1322r1410b1408],
8	CYP2CZ9	CD	NUMBER	cyp2cz9	dobj	7	SENT_198	[p12l1465t1322r1881b1386],
9	"	``	O	"	punct	8	SENT_198	[p12l1465t1322r1881b1386],
10	‘	NN	O	‘	nn	13	SENT_198	[p12l1465t1322r1881b1386],
11	2	CD	NUMBER	2	num	13	SENT_198	[p12l1465t1322r1881b1386],
12	carrier	NN	O	carrier	nn	13	SENT_198	[p12l1927t1322r2152b1385],
13	status	NN	O	status	dep	8	SENT_198	[p12l12t1442r209b1491],
14	could	MD	O	could	aux	15	SENT_198	[p12l237t1425r428b1491],
15	explain	VB	O	explain	_	0	SENT_198	[p12l454t1425r705b1514],
16	4.6	CD	PERCENT	4.6	num	17	SENT_198	[p12l729t1428r905b1491],
17	%	NN	PERCENT	%	dobj	15	SENT_198	[p12l729t1428r905b1491],
18	of	IN	O	of	_	0	SENT_198	[p12l931t1425r1011b1491],
19	the	DT	O	the	det	20	SENT_198	[p12l1024t1425r1134b1491],
20	Variability	NN	O	variability	prep_of	17	SENT_198	[p12l1156t1425r1512b1514],
21	in	IN	O	in	dep	15	SENT_198	[p12l1533t1428r1601b1490],
22	on	IN	O	on	_	0	SENT_198	[p12l1627t1425r2151b1514],
23	—	NN	O	—	nn	25	SENT_198	[p12l1627t1425r2151b1514],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_198	[p12l1627t1425r2151b1514],
25	RPA	NN	ORGANIZATION	rpa	prep_on	15	SENT_198	[p12l13t1530r210b1612],
26	,	,	O	,	_	0	SENT_198	[p12l13t1530r210b1612],
27	whereas	IN	O	whereas	mark	43	SENT_198	[p12l233t1531r517b1598],
28	the	DT	O	the	det	30	SENT_198	[p12l542t1531r653b1597],
29	full	JJ	O	full	amod	30	SENT_198	[p12l677t1531r794b1597],
30	model	NN	O	model	nsubj	43	SENT_198	[p12l817t1531r1038b1597],
31	comprising	VBG	O	comprise	partmod	30	SENT_198	[p12l1061t1534r1458b1620],
32	CYPZCZ	NNP	O	CYPZCZ	dobj	31	SENT_198	[p12l1487t1534r1783b1598],
33	9	CD	NUMBER	9	num	32	SENT_198	[p12l1794t1534r1903b1598],
34	*	NN	O	*	nn	37	SENT_198	[p12l1794t1534r1903b1598],
35	2	CD	NUMBER	2	num	37	SENT_198	[p12l1794t1534r1903b1598],
36	carrier	NN	O	carrier	nn	37	SENT_198	[p12l1927t1534r2152b1597],
37	status	NN	O	status	dep	32	SENT_198	[p12l12t1654r209b1703],
38	and	CC	O	and	_	0	SENT_198	[p12l243t1637r370b1703],
39	the	DT	O	the	det	41	SENT_198	[p12l400t1637r510b1703],
40	clinical	JJ	O	clinical	amod	41	SENT_198	[p12l542t1637r791b1703],
41	Variables	NNP	O	Variables	conj_and	32	SENT_198	[p12l817t1637r1122b1703],
42	could	MD	O	could	aux	43	SENT_198	[p12l1155t1637r1347b1703],
43	explain	VB	O	explain	dep	25	SENT_198	[p12l1377t1637r1628b1726],
44	11.5	CD	PERCENT	11.5	num	45	SENT_198	[p12l1663t1637r1897b1703],
45	%	NN	PERCENT	%	dobj	43	SENT_198	[p12l1663t1637r1897b1703],
46	.	.	O	.	_	0	SENT_198	[p12l1663t1637r1897b1703],

1	In	IN	O	in	_	0	SENT_199	[p12l1931t1638r2009b1702],
2	the	DT	O	the	det	4	SENT_199	[p12l2038t1637r2149b1703],
3	full	JJ	O	full	amod	4	SENT_199	[p12l10t1743r127b1810],
4	model	NN	O	model	prep_in	11	SENT_199	[p12l163t1743r384b1810],
5	(	CD	NUMBER	(	num	6	SENT_199	[p12l423t1741r652b1824],
6	Table	NNP	O	Table	dep	4	SENT_199	[p12l423t1741r652b1824],
7	2	CD	NUMBER	2	number	8	SENT_199	[p12l688t1741r780b1824],
8	)	CD	NUMBER	)	dep	6	SENT_199	[p12l688t1741r780b1824],
9	,	,	O	,	_	0	SENT_199	[p12l688t1741r780b1824],
10	we	PRP	O	we	nsubj	11	SENT_199	[p12l817t1770r915b1810],
11	found	VBD	O	find	_	0	SENT_199	[p12l953t1743r1161b1810],
12	that	IN	O	that	complm	23	SENT_199	[p12l1198t1743r1339b1810],
13	5.2	CD	PERCENT	5.2	num	14	SENT_199	[p12l1375t1743r1550b1811],
14	%	NN	PERCENT	%	nsubjpass	23	SENT_199	[p12l1375t1743r1550b1811],
15	of	IN	O	of	_	0	SENT_199	[p12l1588t1743r1668b1810],
16	the	DT	O	the	det	18	SENT_199	[p12l1693t1743r1804b1810],
17	observed	VBN	O	observe	amod	18	SENT_199	[p12l1842t1743r2151b1810],
18	Variability	NN	O	variability	prep_of	14	SENT_199	[p12l7t1850r363b1939],
19	in	IN	O	in	_	0	SENT_199	[p12l385t1853r453b1916],
20	RPA	NNP	ORGANIZATION	RPA	prep_in	18	SENT_199	[p12l481t1849r660b1916],
21	could	MD	O	could	aux	23	SENT_199	[p12l685t1850r877b1916],
22	be	VB	O	be	auxpass	23	SENT_199	[p12l900t1850r981b1916],
23	attributed	VBN	O	attribute	ccomp	11	SENT_199	[p12l1009t1850r1357b1916],
24	to	TO	O	to	_	0	SENT_199	[p12l1383t1867r1450b1916],
25	CYP2	NN	O	cyp2	nn	26	SENT_199	[p12l1485t1853r1680b1917],
26	C	NN	O	c	prep_to	23	SENT_199	[p12l1690t1853r1780b1917],
27	]	CD	NUMBER	]	number	28	SENT_199	[p12l1690t1853r1780b1917],
28	9	CD	NUMBER	9	dep	26	SENT_199	[p12l1792t1853r1900b1917],
29	*	NN	O	*	nn	32	SENT_199	[p12l1792t1853r1900b1917],
30	2	CD	NUMBER	2	num	32	SENT_199	[p12l1792t1853r1900b1917],
31	carrier	NN	O	carrier	nn	32	SENT_199	[p12l1927t1853r2152b1916],
32	status	NN	O	status	dep	26	SENT_199	[p12l12t1973r209b2022],
33	(	CD	NUMBER	(	num	34	SENT_199	[p12l245t1954r312b2045],
34	p	NN	O	p	npadvmod	35	SENT_199	[p12l245t1954r312b2045],
35	<	JJR	O	<	amod	32	SENT_199	[p12l350t1967r410b2017],
36	0.001	CD	NUMBER	0.001	num	37	SENT_199	[p12l447t1954r693b2037],
37	)	NN	O	)	dep	32	SENT_199	[p12l447t1954r693b2037],
38	,	,	O	,	_	0	SENT_199	[p12l447t1954r693b2037],
39	1.0	CD	PERCENT	1.0	num	40	SENT_199	[p12l732t1959r903b2023],
40	%	NN	PERCENT	%	advmod	26	SENT_199	[p12l732t1959r903b2023],
41	to	TO	O	to	_	0	SENT_199	[p12l934t1973r1002b2022],
42	age	NN	O	age	nn	44	SENT_199	[p12l1036t1982r1149b2045],
43	(	NN	O	(	nn	44	SENT_199	[p12l1184t1954r1252b2045],
44	p	NN	O	p	prep_to	40	SENT_199	[p12l1184t1954r1252b2045],
45	=	JJ	O	=	amod	47	SENT_199	[p12l1293t1982r1346b2002],
46	0.006	CD	NUMBER	0.006	tmod	45	SENT_199	[p12l1387t1954r1633b2037],
47	)	NN	O	)	dep	26	SENT_199	[p12l1387t1954r1633b2037],
48	,	,	O	,	_	0	SENT_199	[p12l1387t1954r1633b2037],
49	1.0	CD	PERCENT	1.0	num	50	SENT_199	[p12l1671t1959r1843b2023],
50	%	NN	PERCENT	%	advmod	57	SENT_199	[p12l1671t1959r1843b2023],
51	to	TO	O	to	_	0	SENT_199	[p12l1873t1973r1941b2022],
52	BMI	NNP	O	BMI	nn	54	SENT_199	[p12l1974t1957r2148b2022],
53	(	CD	NUMBER	(	num	54	SENT_199	[p12l13t2060r80b2151],
54	p	NN	O	p	prep_to	50	SENT_199	[p12l13t2060r80b2151],
55	=	JJ	O	=	amod	57	SENT_199	[p12l114t2088r168b2108],
56	0.008	CD	NUMBER	0.008	num	57	SENT_199	[p12l201t2060r448b2143],
57	)	NN	O	)	dep	26	SENT_199	[p12l201t2060r448b2143],
58	,	,	O	,	_	0	SENT_199	[p12l201t2060r448b2143],
59	and	CC	O	and	_	0	SENT_199	[p12l476t2062r604b2128],
60	1.2	CD	PERCENT	1.2	num	61	SENT_199	[p12l631t2065r802b2129],
61	%	NN	PERCENT	%	advmod	73	SENT_199	[p12l631t2065r802b2129],
62	to	TO	O	to	_	0	SENT_199	[p12l826t2079r894b2128],
63	the	DT	O	the	det	64	SENT_199	[p12l919t2062r1029b2128],
64	presence	NN	O	presence	prep_to	61	SENT_199	[p12l1053t2088r1356b2151],
65	or	CC	O	or	_	0	SENT_199	[p12l1381t2088r1454b2128],
66	absence	NN	O	absence	prep_to	61	SENT_199	[p12l1477t2062r1747b2128],
67	of	IN	O	of	_	0	SENT_199	[p12l1772t2062r1852b2128],
68	diabetes	NN	O	diabetes	nn	70	SENT_199	[p12l1865t2062r2148b2128],
69	(	CD	NUMBER	(	num	70	SENT_199	[p12l13t2167r80b2258],
70	p	NN	O	p	prep_of	64	SENT_199	[p12l13t2167r80b2258],
71	=	JJ	O	=	amod	73	SENT_199	[p12l124t2195r177b2215],
72	0.003	CD	NUMBER	0.003	num	73	SENT_199	[p12l220t2167r465b2250],
73	)	NN	O	)	conj_and	47	SENT_199	[p12l220t2167r465b2250],
74	.	.	O	.	_	0	SENT_199	[p12l220t2167r465b2250],

1	Classiﬁcation	NN	O	classiﬁcation	nsubj	11	SENT_200	[p12l12t2274r521b2342],
2	of	IN	O	of	_	0	SENT_200	[p12l561t2274r645b2341],
3	the	DT	O	the	det	4	SENT_200	[p12l672t2274r790b2341],
4	probability	NN	O	probability	prep_of	1	SENT_200	[p12l829t2274r1241b2364],
5	of	IN	O	of	_	0	SENT_200	[p12l1277t2274r1361b2341],
6	high	JJ	O	high	amod	10	SENT_200	[p12l1387t2274r1557b2364],
7	on	IN	O	on	_	0	SENT_200	[p12l1597t2274r2151b2364],
8	—	CD	NUMBER	—	num	9	SENT_200	[p12l1597t2274r2151b2364],
9	clopidogrel	NN	O	clopidogrel	prep_on	6	SENT_200	[p12l1597t2274r2151b2364],
10	RPA	NN	O	rpa	prep_of	4	SENT_200	[p12l12t2380r197b2447],
11	based	VBN	O	base	_	0	SENT_200	[p12l243t2380r454b2448],
12	on	IN	O	on	_	0	SENT_200	[p12l504t2407r598b2447],
13	clinical	JJ	O	clinical	amod	14	SENT_200	[p12l650t2380r920b2448],
14	characteristics	NNS	O	characteristic	prep_on	11	SENT_200	[p12l970t2380r1501b2448],
15	alone	RB	O	alone	advmod	11	SENT_200	[p12l1554t2380r1775b2447],
16	.	.	O	.	_	0	SENT_200	[p12l1554t2380r1775b2447],

1	Figure	NNP	O	Figure	nsubj	3	SENT_201	[p12l1828t2382r2057b2470],
2	3	CD	NUMBER	3	num	1	SENT_201	[p12l2110t2384r2146b2448],
3	illustrates	VBZ	O	illustrate	_	0	SENT_201	[p12l10t2487r347b2553],
4	the	DT	O	the	det	5	SENT_201	[p12l376t2487r487b2553],
5	interaction	NN	O	interaction	dobj	3	SENT_201	[p12l516t2490r900b2553],
6	of	IN	O	of	_	0	SENT_201	[p12l928t2487r1009b2553],
7	age	NN	O	age	prep_of	5	SENT_201	[p12l1026t2513r1160b2576],
8	,	,	O	,	_	0	SENT_201	[p12l1026t2513r1160b2576],
9	BMI	NN	O	bmus	prep_of	5	SENT_201	[p12l1191t2488r1387b2568],
10	,	,	O	,	_	0	SENT_201	[p12l1191t2488r1387b2568],
11	and	CC	O	and	_	0	SENT_201	[p12l1419t2487r1547b2553],
12	diabetes	NN	O	diabetes	prep_of	5	SENT_201	[p12l1575t2487r1859b2553],
13	in	IN	O	in	_	0	SENT_201	[p12l1888t2490r1956b2553],
14	their	PRP$	O	they	poss	15	SENT_201	[p12l1984t2487r2151b2553],
15	Hochholzer	NNP	O	Hochholzer	prep_in	7	SENT_201	[p12l1341t2590r1657b2643],
16	et	FW	O	et	nn	17	SENT_201	[p12l1684t2592r1741b2643],
17	al.	FW	O	al.	dep	15	SENT_201	[p12l1762t2590r1829b2643],
18	2431	CD	DATE	2431	dep	17	SENT_201	[p12l2000t2590r2147b2643],

1	P450	NN	O	p450	nn	3	SENT_202	[p12l170t2679r320b2732],
2	2019	CD	DATE	2019	num	3	SENT_202	[p12l346t2679r499b2732],
3	Polymorphisms	NNP	O	Polymorphisms	_	0	SENT_202	[p12l526t2680r958b2742],
4	and	CC	O	and	_	0	SENT_202	[p12l983t2680r1084b2732],
5	Residual	NNP	O	Residual	conj_and	3	SENT_202	[p12l1115t2680r1352b2732],
6	Platelet	NN	O	platelet	nn	8	SENT_202	[p12l1381t2680r1598b2732],
7	Activity	NN	O	activity	nn	8	SENT_202	[p12l1621t2680r1832b2741],
8	impact	NN	O	impact	dep	3	SENT_202	[p12l10t2905r257b2991],
9	on	IN	O	on	_	0	SENT_202	[p12l319t2928r407b2968],
10	the	DT	O	the	det	11	SENT_202	[p12l471t2902r583b2968],
11	percentage	NN	O	percentage	prep_on	8	SENT_202	[p12l645t2919r1032b2991],
12	of	IN	O	of	_	0	SENT_202	[p12l1097t2902r1178b2968],
13	patients	NNS	O	patient	prep_of	11	SENT_202	[p12l1228t2905r1510b2991],
14	with	IN	O	with	_	0	SENT_202	[p12l1572t2902r1735b2968],
15	high	JJ	O	high	amod	17	SENT_202	[p12l1799t2902r1961b2991],
16	onclopidogrel	NN	O	onclopidogrel	nn	17	SENT_202	[p12l2025t2928r2147b2968, p12l11t3008r408b3097],
17	RPA	NN	O	rpa	prep_with	13	SENT_202	[p12l450t3006r645b3074],
18	.	.	O	.	_	0	SENT_202	[p12l450t3006r645b3074],

1	In	IN	O	in	_	0	SENT_203	[p12l690t3009r768b3073],
2	nondiabetic	JJ	O	nondiabetic	amod	3	SENT_203	[p12l811t3008r1227b3074],
3	subjects	NNS	O	subject	prep_in	23	SENT_203	[p12l1269t3008r1563b3097],
4	,	,	O	,	_	0	SENT_203	[p12l1269t3008r1563b3097],
5	the	DT	O	the	det	6	SENT_203	[p12l1607t3008r1717b3074],
6	increase	NN	O	increase	nsubj	23	SENT_203	[p12l1760t3011r2040b3074],
7	in	IN	O	in	_	0	SENT_203	[p12l2082t3011r2150b3073],
8	the	DT	O	the	det	9	SENT_203	[p12l10t3115r121b3181],
9	proportion	NN	O	proportion	prep_in	6	SENT_203	[p12l160t3118r544b3204],
10	of	IN	O	of	_	0	SENT_203	[p12l584t3115r664b3181],
11	patients	NNS	O	patient	prep_of	9	SENT_203	[p12l690t3118r968b3204],
12	with	IN	O	with	_	0	SENT_203	[p12l1006t3115r1168b3181],
13	high	JJ	O	high	amod	17	SENT_203	[p12l1208t3115r1368b3204],
14	on	IN	O	on	_	0	SENT_203	[p12l1408t3115r1932b3204],
15	—	CD	NUMBER	—	num	16	SENT_203	[p12l1408t3115r1932b3204],
16	clopidogrel	NN	O	clopidogrel	prep_on	13	SENT_203	[p12l1408t3115r1932b3204],
17	RPA	NN	O	rpa	prep_with	11	SENT_203	[p12l1973t3113r2152b3180],
18	with	IN	O	with	_	0	SENT_203	[p12l7t3221r169b3287],
19	age	NN	O	age	prep_with	17	SENT_203	[p12l210t3247r324b3310],
20	and	CC	O	and	_	0	SENT_203	[p12l367t3221r495b3287],
21	BMI	NN	O	bmus	conj_and	19	SENT_203	[p12l534t3222r708b3286],
22	was	VBD	O	be	cop	23	SENT_203	[p12l747t3247r876b3287],
23	conspicuous	JJ	O	conspicuous	_	0	SENT_203	[p12l919t3224r1368b3310],
24	,	,	O	,	_	0	SENT_203	[p12l919t3224r1368b3310],
25	ranging	VBG	O	range	partmod	23	SENT_203	[p12l1411t3224r1684b3310],
26	from	IN	O	from	_	0	SENT_203	[p12l1722t3221r1893b3287],
27	9	CD	PERCENT	9	num	28	SENT_203	[p12l1935t3224r2042b3287],
28	%	NN	PERCENT	%	prep_from	25	SENT_203	[p12l1935t3224r2042b3287],
29	in	IN	O	in	_	0	SENT_203	[p12l2082t3224r2150b3286],
30	lean	JJ	O	lean	amod	32	SENT_203	[p12l9t3327r153b3393],
31	(	NN	O	(	nn	32	SENT_203	[p12l188t3325r389b3407],
32	BMI	NN	O	bmus	prep_in	28	SENT_203	[p12l188t3325r389b3407],
33	<	JJR	O	<	dep	41	SENT_203	[p12l427t3327r579b3394],
34	25	CD	NUMBER	25	num	35	SENT_203	[p12l427t3327r579b3394],
35	kg/m2	NN	O	kg/m2	dep	33	SENT_203	[p12l614t3314r885b3416],
36	)	NN	O	)	nn	40	SENT_203	[p12l614t3314r885b3416],
37	,	,	O	,	_	0	SENT_203	[p12l614t3314r885b3416],
38	young	JJ	O	young	amod	40	SENT_203	[p12l916t3353r1137b3416],
39	(	JJ	O	(	amod	40	SENT_203	[p12l1169t3325r1311b3416],
40	age	NN	O	age	dep	41	SENT_203	[p12l1169t3325r1311b3416],
41	<	JJR	O	<	dep	45	SENT_203	[p12l1349t3330r1503b3393],
42	60	CD	DURATION	60	num	43	SENT_203	[p12l1349t3330r1503b3393],
43	years	NNS	NUMBER	year	dep	41	SENT_203	[p12l1533t3325r1735b3416],
44	)	CD	NUMBER	)	num	45	SENT_203	[p12l1533t3325r1735b3416],
45	patients	NNS	O	patient	dep	25	SENT_203	[p12l1769t3330r2047b3416],
46	to	TO	O	to	_	0	SENT_203	[p12l2081t3344r2149b3393],
47	50	CD	PERCENT	50	num	48	SENT_203	[p12l11t3433r163b3500],
48	%	NN	PERCENT	%	prep_to	25	SENT_203	[p12l11t3433r163b3500],
49	in	IN	O	in	_	0	SENT_203	[p12l202t3436r270b3498],
50	obese	JJ	O	obese	amod	52	SENT_203	[p12l308t3433r501b3499],
51	(	NN	O	(	nn	52	SENT_203	[p12l543t3431r743b3514],
52	BMI	NN	O	bmus	prep_in	48	SENT_203	[p12l543t3431r743b3514],
53	>	JJR	O	>	dep	61	SENT_203	[p12l788t3436r943b3500],
54	30	CD	NUMBER	30	num	55	SENT_203	[p12l788t3436r943b3500],
55	kg/m2	NN	O	kg/m2	dep	53	SENT_203	[p12l982t3420r1252b3522],
56	)	NN	O	)	nn	60	SENT_203	[p12l982t3420r1252b3522],
57	,	,	O	,	_	0	SENT_203	[p12l982t3420r1252b3522],
58	elderly	JJ	O	elderly	amod	60	SENT_203	[p12l1294t3433r1531b3522],
59	(	JJ	O	(	amod	60	SENT_203	[p12l1568t3431r1710b3522],
60	age	NN	O	age	dep	61	SENT_203	[p12l1568t3431r1710b3522],
61	>	JJR	O	>	dep	65	SENT_203	[p12l1754t3435r1908b3500],
62	70	CD	DURATION	70	num	63	SENT_203	[p12l1754t3435r1908b3500],
63	years	NNS	NUMBER	year	dep	61	SENT_203	[p12l1944t3431r2147b3522],
64	)	CD	NUMBER	)	num	65	SENT_203	[p12l1944t3431r2147b3522],
65	patients	NNS	O	patient	dep	48	SENT_203	[p12l9t3543r307b3629],
66	.	.	O	.	_	0	SENT_203	[p12l9t3543r307b3629],

1	By	IN	O	by	_	0	SENT_204	[p12l359t3541r457b3629],
2	contrast	NN	O	contrast	prep_by	10	SENT_204	[p12l502t3557r802b3621],
3	,	,	O	,	_	0	SENT_204	[p12l502t3557r802b3621],
4	diabetic	JJ	O	diabetic	amod	5	SENT_204	[p12l853t3540r1130b3606],
5	patients	NNS	O	patient	nsubj	10	SENT_204	[p12l1176t3543r1475b3629],
6	,	,	O	,	_	0	SENT_204	[p12l1176t3543r1475b3629],
7	in	IN	O	in	_	0	SENT_204	[p12l1525t3543r1593b3606],
8	general	JJ	O	general	prep_in	5	SENT_204	[p12l1639t3540r1914b3629],
9	,	,	O	,	_	0	SENT_204	[p12l1639t3540r1914b3629],
10	comprised	VBN	O	comprise	_	0	SENT_204	[p12l1965t3566r2147b3606, p12l9t3646r224b3735],
11	more	RBR	O	more	advmod	10	SENT_204	[p12l265t3672r445b3712],
12	patients	NNS	O	patient	dobj	10	SENT_204	[p12l486t3649r764b3735],
13	with	IN	O	with	_	0	SENT_204	[p12l803t3646r965b3713],
14	high	JJ	O	high	amod	18	SENT_204	[p12l1005t3646r1165b3735],
15	on	IN	O	on	_	0	SENT_204	[p12l1207t3646r1731b3735],
16	—	CD	NUMBER	—	num	17	SENT_204	[p12l1207t3646r1731b3735],
17	clopidogrel	NN	O	clopidogrel	prep_on	14	SENT_204	[p12l1207t3646r1731b3735],
18	RPA	NN	O	rpa	prep_with	10	SENT_204	[p12l1774t3645r1952b3711],
19	than	IN	O	than	_	0	SENT_204	[p12l1991t3646r2150b3712],
20	nondiabetic	JJ	O	nondiabetic	amod	21	SENT_204	[p13l12t15r428b81],
21	patients	NNS	O	patient	prep_than	18	SENT_204	[p13l453t18r753b104],
22	,	,	O	,	_	0	SENT_204	[p13l453t18r753b104],
23	but	CC	O	but	_	0	SENT_204	[p13l781t15r900b81],
24	the	DT	O	the	det	25	SENT_204	[p13l925t15r1036b81],
25	effect	NN	O	effect	nsubj	32	SENT_204	[p13l1065t15r1251b81],
26	of	IN	O	of	_	0	SENT_204	[p13l1277t15r1357b81],
27	age	NN	O	age	prep_of	25	SENT_204	[p13l1373t41r1487b104],
28	and	CC	O	and	_	0	SENT_204	[p13l1516t15r1644b81],
29	BMI	NN	O	bmus	conj_and	27	SENT_204	[p13l1672t16r1846b81],
30	was	VBD	O	be	cop	32	SENT_204	[p13l1871t41r2000b82],
31	less	RBR	O	less	advmod	32	SENT_204	[p13l2028t15r2149b81],
32	prominent	JJ	O	prominent	conj_but	10	SENT_204	[p13l9t124r404b210],
33	.	.	O	.	_	0	SENT_204	[p13l9t124r404b210],

1	With	IN	O	with	_	0	SENT_205	[p13l436t121r631b188],
2	a	DT	O	a	det	5	SENT_205	[p13l665t147r699b187],
3	chi	NN	O	chus	nn	5	SENT_205	[p13l731t121r1100b210],
4	—	NN	O	—	nn	5	SENT_205	[p13l731t121r1100b210],
5	square	NN	O	square	prep_with	20	SENT_205	[p13l731t121r1100b210],
6	of	IN	O	of	_	0	SENT_205	[p13l1134t121r1214b187],
7	50.7	CD	NUMBER	50.7	prep_of	5	SENT_205	[p13l1234t121r1407b202],
8	,	,	O	,	_	0	SENT_205	[p13l1234t121r1407b202],
9	a	DT	O	a	det	12	SENT_205	[p13l1444t147r1478b187],
10	logistic	JJ	O	logistic	amod	12	SENT_205	[p13l1508t121r1762b210],
11	regression	NN	O	regression	nn	12	SENT_205	[p13l1794t124r2150b210],
12	model	NN	O	model	nsubj	20	SENT_205	[p13l11t227r232b293],
13	that	WDT	O	that	nsubj	14	SENT_205	[p13l265t227r407b293],
14	included	VBD	O	include	rcmod	12	SENT_205	[p13l438t227r743b293],
15	only	RB	O	only	advmod	17	SENT_205	[p13l776t227r930b316],
16	clinical	JJ	O	clinical	amod	17	SENT_205	[p13l961t227r1210b293],
17	variables	NNS	O	variable	dobj	14	SENT_205	[p13l1239t227r1545b293],
18	was	VBD	O	be	cop	20	SENT_205	[p13l1576t253r1706b294],
19	less	RBR	O	less	advmod	20	SENT_205	[p13l1740t227r1861b293],
20	predictive	JJ	O	predictive	_	0	SENT_205	[p13l1895t227r2147b316, p13l10t336r136b399],
21	than	IN	O	than	_	0	SENT_205	[p13l165t333r324b399],
22	the	DT	O	the	det	24	SENT_205	[p13l353t333r464b399],
23	full	JJ	O	full	amod	24	SENT_205	[p13l493t333r610b399],
24	model	NN	O	model	prep_than	20	SENT_205	[p13l638t333r859b399],
25	comprising	VBG	O	comprise	partmod	24	SENT_205	[p13l888t336r1285b422],
26	also	RB	O	also	advmod	31	SENT_205	[p13l1314t333r1445b399],
27	CYP2CZ9	NN	O	cyp2cz9	nn	31	SENT_205	[p13l1482t336r1897b400],
28	*	NN	O	*	nn	31	SENT_205	[p13l1482t336r1897b400],
29	2	CD	NUMBER	2	num	31	SENT_205	[p13l1482t336r1897b400],
30	carrier	NN	O	carrier	nn	31	SENT_205	[p13l1927t336r2152b399],
31	status	NN	O	status	dobj	25	SENT_205	[p13l12t456r200b505],
32	(	CD	NUMBER	(	nsubj	33	SENT_205	[p13l227t437r352b520],
33	see	VBP	O	see	rcmod	31	SENT_205	[p13l227t437r352b520],
34	the	DT	O	the	det	37	SENT_205	[p13l374t439r482b505],
35	preceding	VBG	O	precede	amod	37	SENT_205	[p13l503t439r839b528],
36	text	NN	O	text	nn	37	SENT_205	[p13l859t437r1028b519],
37	)	NN	O	)	dobj	33	SENT_205	[p13l859t437r1028b519],
38	.	.	O	.	_	0	SENT_205	[p13l859t437r1028b519],

1	The	DT	O	the	det	2	SENT_206	[p13l1052t437r1196b505],
2	addition	NN	O	addition	nsubj	12	SENT_206	[p13l1220t439r1502b505],
3	of	IN	O	of	_	0	SENT_206	[p13l1525t439r1603b505],
4	the	DT	O	the	det	7	SENT_206	[p13l1613t439r1719b505],
5	CYPZCZ	NNP	O	CYPZCZ	nn	7	SENT_206	[p13l1750t442r2037b506],
6	9	CD	NUMBER	9	num	7	SENT_206	[p13l2046t442r2151b506],
7	*	NN	O	*	prep_of	2	SENT_206	[p13l2046t442r2151b506],
8	2	CD	NUMBER	2	num	10	SENT_206	[p13l2046t442r2151b506],
9	carrier	NN	O	carrier	nn	10	SENT_206	[p13l11t549r237b612],
10	status	NN	O	status	dep	7	SENT_206	[p13l291t563r488b612],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_206	[p13l545t546r976b635],
12	improved	VBD	O	improve	_	0	SENT_206	[p13l1026t546r1363b635],
13	both	CC	O	both	prep	12	SENT_206	[p13l1414t546r1579b612],
14	reclassiﬁcation	NN	O	reclassiﬁcation	nn	18	SENT_206	[p13l1632t546r2150b612],
15	(	CD	NUMBER	(	num	18	SENT_206	[p13l13t650r153b733],
16	net	JJ	O	net	amod	18	SENT_206	[p13l13t650r153b733],
17	reclassiﬁcation	NN	O	reclassiﬁcation	nn	18	SENT_206	[p13l181t652r699b718],
18	improvement	NN	O	improvement	dep	13	SENT_206	[p13l730t655r1207b741],
19	=	JJ	O	=	amod	23	SENT_206	[p13l1245t678r1298b698],
20	0.403	CD	NUMBER	0.403	tmod	19	SENT_206	[p13l1339t655r1555b733],
21	,	,	O	,	_	0	SENT_206	[p13l1339t655r1555b733],
22	p	NN	O	p	appos	20	SENT_206	[p13l1588t678r1630b741],
23	<	JJR	O	<	tmod	12	SENT_206	[p13l1667t663r1727b713],
24	0.001	CD	NUMBER	0.001	num	25	SENT_206	[p13l1764t650r1987b732],
25	)	NN	O	)	npadvmod	29	SENT_206	[p13l1764t650r1987b732],
26	and	CC	O	and	_	0	SENT_206	[p13l2023t652r2151b718],
27	the	DT	O	the	det	28	SENT_206	[p13l10t758r121b824],
28	discrimination	NN	O	discrimination	conj_and	25	SENT_206	[p13l155t758r669b824],
29	as	IN	O	as	advmod	30	SENT_206	[p13l703t784r766b824],
30	calculated	VBN	O	calculate	partmod	23	SENT_206	[p13l801t758r1150b824],
31	by	IN	O	by	_	0	SENT_206	[p13l1180t758r1266b847],
32	the	DT	O	the	det	35	SENT_206	[p13l1294t758r1405b824],
33	integrated	VBN	O	integrate	amod	35	SENT_206	[p13l1437t758r1798b847],
34	discrimination	NN	O	discrimination	nn	35	SENT_206	[p13l1830t758r2148b824, p13l12t867r237b930],
35	improvement	NN	O	improvement	agent	30	SENT_206	[p13l270t867r748b954],
36	(	CD	NUMBER	(	num	37	SENT_206	[p13l783t862r849b953],
37	p	NN	O	p	npadvmod	38	SENT_206	[p13l783t862r849b953],
38	<	JJR	O	<	amod	35	SENT_206	[p13l890t875r950b925],
39	0.001	CD	NUMBER	0.001	num	40	SENT_206	[p13l989t862r1234b945],
40	)	NN	O	)	dep	23	SENT_206	[p13l989t862r1234b945],
41	.	.	O	.	_	0	SENT_206	[p13l989t862r1234b945],

1	When	WRB	O	when	advmod	9	SENT_207	[p13l96t970r323b1037],
2	CYP2CZ9	NN	O	cyp2cz9	nn	3	SENT_207	[p13l356t973r772b1037],
3	*	NN	O	*	nsubjpass	9	SENT_207	[p13l356t973r772b1037],
4	2	CD	NUMBER	2	num	6	SENT_207	[p13l356t973r772b1037],
5	carrier	NN	O	carrier	nn	6	SENT_207	[p13l799t973r1024b1036],
6	status	NN	O	status	dep	3	SENT_207	[p13l1050t987r1247b1036],
7	was	VBD	O	be	auxpass	9	SENT_207	[p13l1271t996r1401b1036],
8	not	RB	O	not	neg	9	SENT_207	[p13l1430t987r1548b1036],
9	entered	VBN	O	enter	_	0	SENT_207	[p13l1573t970r1836b1036],
10	(	CD	NUMBER	(	num	11	SENT_207	[p13l1865t968r2027b1059],
11	Fig	NN	O	fig	dobj	9	SENT_207	[p13l1865t968r2027b1059],
12	.	.	O	.	_	0	SENT_207	[p13l1865t968r2027b1059],

1	4	CD	NUMBER	4	num	2	SENT_208	[p13l2057t968r2148b1051],
2	)	NN	O	)	nsubj	7	SENT_208	[p13l2057t968r2148b1051],
3	,	,	O	,	_	0	SENT_208	[p13l2057t968r2148b1051],
4	the	DT	O	the	det	6	SENT_208	[p13l11t1076r121b1142],
5	CART	NNP	O	CART	nn	6	SENT_208	[p13l175t1074r428b1143],
6	model	NN	O	model	appos	2	SENT_208	[p13l479t1076r700b1142],
7	identiﬁed	VBD	O	identiﬁed	_	0	SENT_208	[p13l750t1076r1089b1142],
8	diabetes	NN	O	diabetes	nn	9	SENT_208	[p13l1140t1076r1424b1142],
9	mellitus	NN	O	mellitus	dobj	7	SENT_208	[p13l1478t1076r1778b1157],
10	,	,	O	,	_	0	SENT_208	[p13l1478t1076r1778b1157],
11	age	NN	O	age	conj_and	9	SENT_208	[p13l1834t1102r1968b1165],
12	,	,	O	,	_	0	SENT_208	[p13l1834t1102r1968b1165],
13	and	CC	O	and	_	0	SENT_208	[p13l2023t1076r2151b1142],
14	hypertension	NN	O	hypertension	dobj	7	SENT_208	[p13l11t1182r470b1271],
15	as	IN	O	as	_	0	SENT_208	[p13l511t1208r574b1248],
16	variables	NNS	O	variable	prep_as	7	SENT_208	[p13l611t1182r916b1248],
17	with	IN	O	with	_	0	SENT_208	[p13l953t1182r1115b1248],
18	statistically	RB	O	statistically	advmod	19	SENT_208	[p13l1155t1182r1548b1271],
19	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_208	[p13l1585t1182r1952b1271],
20	relevance	NN	O	relevance	prep_with	16	SENT_208	[p13l1988t1182r2148b1248, p13l7t1314r216b1354],
21	to	TO	O	to	_	0	SENT_208	[p13l284t1305r354b1354],
22	classiﬁcation	NN	O	classiﬁcation	prep_to	7	SENT_208	[p13l425t1288r925b1354],
23	.	.	O	.	_	0	SENT_208	[p13l425t1288r925b1354],

1	The	DT	O	the	det	2	SENT_209	[p13l994t1286r1146b1354],
2	frequency	NN	O	frequency	nsubj	7	SENT_209	[p13l1214t1288r1583b1378],
3	of	IN	O	of	_	0	SENT_209	[p13l1647t1288r1730b1354],
4	high	JJ	O	high	amod	6	SENT_209	[p13l1785t1288r1953b1377],
5	onclopidogrel	NN	O	onclopidogrel	nn	6	SENT_209	[p13l2021t1314r2147b1354, p13l12t1394r408b1483],
6	RPA	NN	ORGANIZATION	rpa	prep_of	2	SENT_209	[p13l451t1393r630b1460],
7	varied	VBD	O	vary	_	0	SENT_209	[p13l667t1394r883b1460],
8	from	IN	O	from	_	0	SENT_209	[p13l924t1394r1095b1460],
9	38	CD	PERCENT	38	num	10	SENT_209	[p13l1138t1397r1290b1461],
10	%	NN	PERCENT	%	prep_from	7	SENT_209	[p13l1138t1397r1290b1461],
11	in	IN	O	in	_	0	SENT_209	[p13l1331t1397r1400b1459],
12	diabetic	JJ	O	diabetic	amod	13	SENT_209	[p13l1443t1394r1719b1460],
13	patients	NNS	O	patient	prep_in	10	SENT_209	[p13l1760t1397r2038b1483],
14	to	TO	O	to	_	0	SENT_209	[p13l2081t1411r2149b1460],
15	16	CD	PERCENT	16	num	16	SENT_209	[p13l15t1503r164b1566],
16	%	NN	PERCENT	%	prep_to	7	SENT_209	[p13l15t1503r164b1566],
17	in	IN	O	in	_	0	SENT_209	[p13l197t1503r264b1565],
18	nondiabetic	JJ	O	nondiabetic	amod	19	SENT_209	[p13l299t1500r715b1566],
19	patients	NNS	O	patient	prep_in	16	SENT_209	[p13l746t1503r1025b1589],
20	without	IN	O	without	_	0	SENT_209	[p13l1056t1500r1338b1566],
21	hypertension	NN	O	hypertension	prep_without	7	SENT_209	[p13l1369t1500r1847b1589],
22	.	.	O	.	_	0	SENT_209	[p13l1369t1500r1847b1589],

1	In	IN	O	in	_	0	SENT_210	[p13l100t1607r177b1672],
2	the	DT	O	the	det	6	SENT_210	[p13l211t1606r322b1672],
3	multivariable	JJ	O	multivariable	amod	6	SENT_210	[p13l358t1606r820b1672],
4	linear	JJ	O	linear	amod	6	SENT_210	[p13l854t1606r1055b1672],
5	regression	NN	O	regression	nn	6	SENT_210	[p13l1087t1609r1444b1695],
6	model	NN	O	model	prep_in	18	SENT_210	[p13l1479t1606r1718b1687],
7	,	,	O	,	_	0	SENT_210	[p13l1479t1606r1718b1687],
8	the	DT	O	the	det	16	SENT_210	[p13l1755t1606r1866b1672],
9	clinical	JJ	O	clinical	amod	10	SENT_210	[p13l1902t1606r2151b1672],
10	variables	NNS	O	variable	dep	16	SENT_210	[p13l7t1712r313b1778],
11	without	IN	O	without	_	0	SENT_210	[p13l355t1712r637b1778],
12	CYP2CZ9	NN	O	cyp2cz9	prep_without	10	SENT_210	[p13l687t1715r1103b1779],
13	*	NN	O	*	nn	16	SENT_210	[p13l687t1715r1103b1779],
14	2	CD	NUMBER	2	num	16	SENT_210	[p13l687t1715r1103b1779],
15	carrier	NN	O	carrier	nn	16	SENT_210	[p13l1148t1715r1373b1778],
16	status	NN	O	status	nsubj	18	SENT_210	[p13l1418t1729r1615b1778],
17	could	MD	O	could	aux	18	SENT_210	[p13l1662t1712r1854b1778],
18	explain	VB	O	explain	_	0	SENT_210	[p13l1900t1712r2151b1801],
19	6.7	CD	PERCENT	6.7	num	20	SENT_210	[p13l12t1820r186b1885],
20	%	NN	PERCENT	%	dobj	18	SENT_210	[p13l12t1820r186b1885],
21	of	IN	O	of	_	0	SENT_210	[p13l220t1818r300b1884],
22	the	DT	O	the	det	23	SENT_210	[p13l321t1818r432b1884],
23	variability	NN	O	variability	prep_of	20	SENT_210	[p13l462t1818r818b1907],
24	in	IN	O	in	prep	18	SENT_210	[p13l848t1821r916b1883],
25	on	IN	O	on	pcomp	24	SENT_210	[p13l950t1818r1474b1907],
26	—	NN	O	—	nn	28	SENT_210	[p13l950t1818r1474b1907],
27	clopidogrel	NN	O	clopidogrel	nn	28	SENT_210	[p13l950t1818r1474b1907],
28	RPA	NN	O	rpa	pobj	25	SENT_210	[p13l1508t1817r1703b1884],
29	.	.	O	.	_	0	SENT_210	[p13l1508t1817r1703b1884],

1	Discussion	NN	O	discussion	_	0	SENT_211	[p13l13t2028r471b2091],

1	Genetic	JJ	O	genetic	amod	2	SENT_212	[p13l13t2181r309b2248],
2	impact	NN	O	impact	_	0	SENT_212	[p13l333t2185r590b2270],
3	on	IN	O	on	_	0	SENT_212	[p13l613t2207r707b2247],
4	platelet	NN	O	platelet	nn	5	SENT_212	[p13l731t2180r1013b2270],
5	function	NN	O	function	prep_on	2	SENT_212	[p13l1035t2180r1375b2247],
6	.	.	O	.	_	0	SENT_212	[p13l1035t2180r1375b2247],

1	The	DT	O	the	det	3	SENT_213	[p13l1423t2179r1571b2247],
2	central	JJ	O	central	amod	3	SENT_213	[p13l1598t2181r1837b2247],
3	message	NN	O	message	nsubj	30	SENT_213	[p13l1862t2207r2150b2270],
4	of	IN	O	of	_	0	SENT_213	[p13l11t2287r92b2353],
5	our	PRP$	O	we	poss	6	SENT_213	[p13l122t2313r239b2353],
6	analysis	NN	O	analysis	prep_of	3	SENT_213	[p13l280t2287r547b2376],
7	of	IN	O	of	_	0	SENT_213	[p13l591t2287r670b2353],
8	the	DT	O	the	det	9	SENT_213	[p13l700t2287r810b2353],
9	interaction	NN	O	interaction	prep_of	6	SENT_213	[p13l852t2290r1236b2353],
10	of	IN	O	of	_	0	SENT_213	[p13l1279t2287r1358b2353],
11	genomic	JJ	O	genomic	amod	14	SENT_213	[p13l1387t2290r1691b2376],
12	and	CC	O	and	_	0	SENT_213	[p13l1733t2287r1861b2353],
13	clinical	JJ	O	clinical	conj_and	11	SENT_213	[p13l1903t2287r2152b2353],
14	factors	NNS	O	factor	prep_of	9	SENT_213	[p13l11t2393r243b2459],
15	with	IN	O	with	prep	6	SENT_213	[p13l298t2393r459b2459],
16	on	IN	O	on	pcomp	15	SENT_213	[p13l517t2393r1041b2482],
17	—	NN	O	—	nn	20	SENT_213	[p13l517t2393r1041b2482],
18	clopidogrel	NN	O	clopidogrel	nn	20	SENT_213	[p13l517t2393r1041b2482],
19	platelet	NN	O	platelet	nn	20	SENT_213	[p13l1095t2393r1357b2482],
20	function	NN	O	function	pobj	16	SENT_213	[p13l1412t2393r1710b2459],
21	in	IN	O	in	_	0	SENT_213	[p13l1766t2396r1834b2458],
22	a	DT	O	a	det	24	SENT_213	[p13l1892t2419r1926b2459],
23	large	JJ	O	large	amod	24	SENT_213	[p13l1980t2393r2150b2482],
24	cohort	NN	O	cohort	prep_in	20	SENT_213	[p13l12t2499r242b2565],
25	of	IN	O	of	_	0	SENT_213	[p13l296t2499r376b2565],
26	patients	NNS	O	patient	prep_of	24	SENT_213	[p13l418t2502r696b2588],
27	undergoing	VBG	O	undergo	partmod	26	SENT_213	[p13l752t2499r1161b2588],
28	elective	JJ	O	elective	amod	29	SENT_213	[p13l1216t2499r1475b2565],
29	PCI	NN	O	pcus	dobj	27	SENT_213	[p13l1532t2499r1680b2565],
30	is	VBZ	O	be	_	0	SENT_213	[p13l1737t2502r1787b2565],
31	that	IN	O	that	complm	48	SENT_213	[p13l1844t2499r1986b2565],
32	the	DT	O	the	det	39	SENT_213	[p13l2039t2499r2150b2565],
33	CYP2C	NN	O	cyp2c	nn	39	SENT_213	[p13l18t2608r436b2672],
34	]	CD	NUMBER	]	num	39	SENT_213	[p13l18t2608r436b2672],
35	9	CD	NUMBER	9	num	39	SENT_213	[p13l18t2608r436b2672],
36	*	NN	O	*	nn	39	SENT_213	[p13l18t2608r436b2672],
37	2	CD	NUMBER	2	num	39	SENT_213	[p13l18t2608r436b2672],
38	loss	NN	O	loss	nn	39	SENT_213	[p13l497t2605r1075b2671],
39	—	NN	O	—	nsubj	48	SENT_213	[p13l497t2605r1075b2671],
40	of	IN	O	of	_	0	SENT_213	[p13l497t2605r1075b2671],
41	—	CD	NUMBER	—	num	43	SENT_213	[p13l497t2605r1075b2671],
42	function	NN	O	function	nn	43	SENT_213	[p13l497t2605r1075b2671],
43	polymorphism	NN	O	polymorphism	prep_of	48	SENT_213	[p13l1137t2605r1658b2694],
44	and	CC	O	and	_	0	SENT_213	[p13l1723t2605r1852b2671],
45	several	JJ	O	several	amod	47	SENT_213	[p13l1915t2605r2151b2671],
46	clinical	JJ	O	clinical	amod	47	SENT_213	[p13l12t2711r261b2777],
47	variables	NNS	O	variable	conj_and	43	SENT_213	[p13l287t2711r592b2778],
48	show	VBP	O	show	ccomp	30	SENT_213	[p13l626t2711r810b2777],
49	a	DT	O	a	det	53	SENT_213	[p13l838t2737r873b2777],
50	statistical	JJ	O	statistical	amod	53	SENT_213	[p13l904t2711r1233b2777],
51	highly	RB	O	highly	advmod	52	SENT_213	[p13l1262t2711r1488b2800],
52	signiﬁcant	JJ	O	signiﬁcant	amod	53	SENT_213	[p13l1516t2711r1882b2800],
53	association	NN	O	association	dobj	48	SENT_213	[p13l1913t2714r2148b2777, p13l12t2820r189b2883],
54	with	IN	O	with	_	0	SENT_213	[p13l230t2817r392b2883],
55	high	JJ	O	high	amod	59	SENT_213	[p13l435t2817r595b2906],
56	on	IN	O	on	_	0	SENT_213	[p13l639t2817r1164b2906],
57	—	CD	NUMBER	—	num	58	SENT_213	[p13l639t2817r1164b2906],
58	clopidogrel	NN	O	clopidogrel	prep_on	55	SENT_213	[p13l639t2817r1164b2906],
59	RPA	NN	O	rpa	prep_with	53	SENT_213	[p13l1208t2816r1403b2883],
60	.	.	O	.	_	0	SENT_213	[p13l1208t2816r1403b2883],

1	Nevertheless	RB	O	nevertheless	_	0	SENT_214	[p13l1451t2817r1923b2898],
2	,	,	O	,	_	0	SENT_214	[p13l1451t2817r1923b2898],
3	these	DT	O	these	appos	1	SENT_214	[p13l1970t2817r2150b2883],

1	NO	NN	O	no	nn	3	SENT_215	[p14l442t91r493b121],
2	diabetes	NN	O	diabetes	nn	3	SENT_215	[p14l505t91r664b121],
3	mellitus	NN	O	mellitus	_	0	SENT_215	[p14l678t91r824b121],
4	Diabetes	NNP	O	Diabetes	dep	3	SENT_215	[p14l1208t91r1370b121],
5	mellitus	NN	O	mellitus	dep	3	SENT_215	[p14l1383t91r1529b121],

1	S	NN	O	s	_	0	SENT_216	[p14l370t244r395b263],
2	a3	NN	O	a3	nn	3	SENT_216	[p14l396t244r418b263],
3	S	NN	O	s	dep	1	SENT_216	[p14l1144t244r1170b263],
4	3	CD	NUMBER	3	dep	3	SENT_216	[p14l1171t244r1193b263],

1	‘	NN	O	‘	_	0	SENT_217	[p14l369t325r406b345],
2	=	JJ	O	=	amod	3	SENT_217	[p14l369t325r406b345],
3	3	CD	NUMBER	3	dep	1	SENT_217	[p14l369t325r406b345],
4	a	DT	O	a	det	5	SENT_217	[p14l401t325r418b345],
5	~	NN	O	~	dep	1	SENT_217	[p14l401t325r418b345],

1	‘	NN	O	‘	nsubj	2	SENT_218	[p14l1144t325r1181b344],
2	é	VBD	O	é	_	0	SENT_218	[p14l1144t325r1181b344],
3	a	DT	O	a	dobj	2	SENT_218	[p14l1176t325r1193b344],

1	8	CD	NUMBER	8	num	2	SENT_219	[p14l370t409r395b428],
2	3	CD	NUMBER	3	_	0	SENT_219	[p14l396t409r418b428],
3	!	.	O	!	_	0	SENT_219	[p14l396t409r418b428],

1	8	CD	NUMBER	8	_	0	SENT_220	[p14l1145t409r1170b428],
2	33	CD	NUMBER	33	num	3	SENT_220	[p14l1171t409r1193b428],
3	B	NN	O	b	dep	1	SENT_220	[p14l369t490r395b509],
4	33	CD	NUMBER	33	dep	1	SENT_220	[p14l396t490r418b509],

1	Patients	NNS	O	patient	_	0	SENT_221	[p14l331t523r352b632],
2	with	IN	O	with	_	0	SENT_221	[p14l331t459r352b515],
3	RPA	NN	O	rpa	dep	4	SENT_221	[p14l331t392r352b450],
4	>	JJR	O	>	prep_with	1	SENT_221	[p14l331t313r354b385],
5	14	CD	PERCENT	14	number	6	SENT_221	[p14l331t313r354b385],
6	%	NN	PERCENT	%	amod	4	SENT_221	[p14l331t313r354b385],
7	(	CD	NUMBER	(	num	8	SENT_221	[p14l331t262r358b303],
8	Va	NNP	O	Va	dep	1	SENT_221	[p14l331t262r358b303],
9	)	CD	NUMBER	)	num	8	SENT_221	[p14l331t262r358b303],
10	3	CD	NUMBER	3	number	11	SENT_221	[p14l370t571r395b591],
11	2	CD	NUMBER	2	dep	8	SENT_221	[p14l396t571r419b591],
12	?	.	O	?	_	0	SENT_221	[p14l396t571r419b591],

1	Patients	NNS	O	patient	_	0	SENT_222	[p14l1107t523r1129b632],
2	with	IN	O	with	_	0	SENT_222	[p14l1107t459r1129b515],
3	RPA	NN	O	rpa	prep_with	1	SENT_222	[p14l1107t392r1129b450],
4	>	JJR	O	>	dep	1	SENT_222	[p14l1107t313r1130b385],
5	1-4	CD	PERCENT	1-4	num	6	SENT_222	[p14l1107t313r1130b385],
6	%	NN	PERCENT	%	rcmod	4	SENT_222	[p14l1107t313r1130b385],
7	(	CD	PERCENT	(	num	8	SENT_222	[p14l1107t262r1135b303],
8	%	NN	PERCENT	%	dep	6	SENT_222	[p14l1107t262r1135b303],
9	)	CD	NUMBER	)	number	10	SENT_222	[p14l1107t262r1135b303],
10	3	CD	NUMBER	3	num	8	SENT_222	[p14l1145t571r1170b591],
11	z	SYM	O	z	dep	6	SENT_222	[p14l1171t571r1193b590],
12	!	.	O	!	_	0	SENT_222	[p14l1171t571r1193b590],

1	o	NN	O	o	nn	2	SENT_223	[p14l382t652r418b672],
2	%	NN	O	%	nsubj	6	SENT_223	[p14l382t652r418b672],
3	2530	CD	DATE	2530	advmod	6	SENT_223	[p14l902t685r962b716],
4	79	CD	NUMBER	79	num	5	SENT_223	[p14l981t671r1020b695],
5	-70	CD	NUMBER	-70	dep	3	SENT_223	[p14l481t688r523b710],
6	go	VBP	O	go	_	0	SENT_223	[p14l567t698r594b718],
7	_	NN	O	_	dep	8	SENT_223	[p14l601t712r607b717],
8	<	JJR	O	<	dobj	6	SENT_223	[p14l613t705r652b726],
9	70	CD	NUMBER	70	npadvmod	10	SENT_223	[p14l613t705r652b726],
10	<	JJR	O	<	dep	15	SENT_223	[p14l697t716r737b735],
11	60	CD	NUMBER	60	num	14	SENT_223	[p14l697t716r737b735],
12	A99	NN	O	a99	nn	14	SENT_223	[p14l528t732r580b762],
13	(	NN	O	(	nn	14	SENT_223	[p14l589t739r682b777],
14	Years	NNS	DURATION	year	nsubj	15	SENT_223	[p14l589t739r682b777],
15	)	VBP	O	)	dep	6	SENT_223	[p14l589t739r682b777],
16	god	NN	O	god	nn	17	SENT_223	[p14l820t745r890b780],
17	‘	NN	O	‘	dobj	15	SENT_223	[p14l820t745r890b780],
18	!	.	O	!	_	0	SENT_223	[p14l820t745r890b780],

1	‘“	NN	O	‘“	_	0	SENT_224	[p14l898t735r940b759],
2	a	DT	O	a	dep	1	SENT_224	[p14l898t735r940b759],

1	Proportion	NN	O	proportion	_	0	SENT_225	[p14l243t849r394b879],
2	of	IN	O	of	_	0	SENT_225	[p14l407t849r436b873],
3	Patients	NNS	O	patient	prep_of	1	SENT_225	[p14l448t849r570b873],
4	With	IN	O	with	_	0	SENT_225	[p14l582t849r650b873],
5	Low	JJ	O	low	amod	6	SENT_225	[p14l665t850r722b873],
6	Response	NN	O	response	prep_with	1	SENT_225	[p14l735t850r878b879],
7	to	TO	O	to	_	0	SENT_225	[p14l890t850r920b873],
8	clopidogrel	NN	O	clopidogrel	prep_to	1	SENT_225	[p14l932t849r1098b879],
9	According	VBG	O	accord	prep	1	SENT_225	[p14l1111t849r1261b879],
10	to	TO	O	to	pcomp	9	SENT_225	[p14l1272t850r1302b873],
11	Age	NNP	O	Age	pobj	10	SENT_225	[p14l1314t850r1379b879],
12	,	,	O	,	_	0	SENT_225	[p14l1314t850r1379b879],
13	Body	NNP	MISC	Body	nn	15	SENT_225	[p14l1395t850r1466b879],
14	Mass	NNP	MISC	Mass	nn	15	SENT_225	[p14l1480t850r1558b873],
15	Index	NNP	MISC	Index	pobj	10	SENT_225	[p14l1572t850r1660b878],
16	,	,	O	,	_	0	SENT_225	[p14l1572t850r1660b878],
17	and	CC	O	and	_	0	SENT_225	[p14l1674t850r1725b873],
18	Diabetes	NNP	O	Diabetes	nn	20	SENT_225	[p14l1740t849r1869b873],
19	Mellitus	NNP	O	Mellitus	nn	20	SENT_225	[p14l1883t849r2001b873],
20	Proportion	NNP	O	Proportion	pobj	10	SENT_225	[p14l69t933r186b957],
21	of	IN	O	of	_	0	SENT_225	[p14l198t933r221b952],
22	patients	NNS	O	patient	prep_of	1	SENT_225	[p14l231t933r324b957],
23	with	IN	O	with	prep	1	SENT_225	[p14l334t933r380b952],
24	low	JJ	O	low	amod	25	SENT_225	[p14l393t933r430b952],
25	response	NN	O	response	dep	35	SENT_225	[p14l441t938r548b957],
26	to	TO	O	to	_	0	SENT_225	[p14l558t934r580b952],
27	clopidogrel	NN	O	clopidogrel	nn	31	SENT_225	[p14l591t933r716b957],
28	(	CD	NUMBER	(	num	31	SENT_225	[p14l728t933r828b957],
29	residual	JJ	O	residual	amod	31	SENT_225	[p14l728t933r828b957],
30	platelet	NN	O	platelet	nn	31	SENT_225	[p14l840t933r927b957],
31	aggregation	NN	O	aggregation	prep_to	25	SENT_225	[p14l938t933r1072b957],
32	[	CD	NUMBER	[	num	33	SENT_225	[p14l1085t933r1145b957],
33	RPA	NN	O	rpa	dep	35	SENT_225	[p14l1085t933r1145b957],
34	]	CD	NUMBER	]	num	35	SENT_225	[p14l1085t933r1145b957],
35	>	JJR	O	>	dep	38	SENT_225	[p14l1158t933r1236b957],
36	14	CD	PERCENT	14	num	37	SENT_225	[p14l1158t933r1236b957],
37	%	NN	PERCENT	%	dep	35	SENT_225	[p14l1158t933r1236b957],
38	)	CD	NUMBER	)	dep	23	SENT_225	[p14l1158t933r1236b957],
39	according	VBG	O	accord	_	0	SENT_225	[p14l1248t933r1360b957],
40	to	TO	O	to	prepc_according_to	1	SENT_225	[p14l1369t934r1391b952],
41	age	NN	O	age	pobj	1	SENT_225	[p14l1403t936r1450b957],
42	,	,	O	,	_	0	SENT_225	[p14l1403t936r1450b957],
43	body	NN	O	body	nn	45	SENT_225	[p14l1463t933r1517b957],
44	mass	NN	O	mass	nn	45	SENT_225	[p14l1527t938r1589b952],
45	index	NN	O	index	conj_and	41	SENT_225	[p14l1601t933r1668b956],
46	,	,	O	,	_	0	SENT_225	[p14l1601t933r1668b956],
47	and	CC	O	and	_	0	SENT_225	[p14l1680t933r1721b952],
48	diabetes	NN	O	diabetes	nn	49	SENT_225	[p14l1733t933r1833b952],
49	mellitus	NN	O	mellitus	conj_and	41	SENT_225	[p14l1845t933r1943b952],
50	.	.	O	.	_	0	SENT_225	[p14l1845t933r1943b952],

1	2432	CD	DATE	2432	num	2	SENT_226	[p14l43t1069r114b1094],
2	Hochholzer	NNP	O	Hochholzer	_	0	SENT_226	[p14l194t1069r342b1094],
3	et	FW	O	et	nn	4	SENT_226	[p14l351t1070r378b1094],
4	al.	FW	O	al.	dep	2	SENT_226	[p14l385t1069r416b1094],
5	.	.	O	.	_	0	SENT_226	[p14l385t1069r416b1094],

1	JACC	NNP	O	JACC	nn	2	SENT_227	[p14l1808t1070r1862b1094],
2	Vol	NNP	O	Vol	_	0	SENT_227	[p14l1871t1070r1910b1094],
3	.	.	O	.	_	0	SENT_227	[p14l1871t1070r1910b1094],

1	55	CD	NUMBER	55	dep	9	SENT_228	[p14l1922t1070r1956b1098],
2	,	,	O	,	_	0	SENT_228	[p14l1922t1070r1956b1098],
3	No.	NN	O	no.	appos	1	SENT_228	[p14l1968t1070r2002b1094],
4	22	CD	NUMBER	22	num	3	SENT_228	[p14l2013t1070r2048b1098],
5	,	,	O	,	_	0	SENT_228	[p14l2013t1070r2048b1098],
6	2010	CD	DATE	2010	appos	1	SENT_228	[p14l2059t1070r2117b1094],
7	F450	NN	DATE	f450	dep	9	SENT_228	[p14l194t1110r264b1135],
8	2019	CD	DATE	2019	num	7	SENT_228	[p14l274t1110r345b1135],
9	Polymorphisms	NNP	O	Polymorphisms	dep	19	SENT_228	[p14l355t1110r557b1140],
10	and	CC	O	and	_	0	SENT_228	[p14l565t1110r613b1135],
11	Residual	NNP	O	Residual	dep	19	SENT_228	[p14l624t1110r735b1135],
12	Platelet	NN	O	platelet	nn	13	SENT_228	[p14l746t1110r847b1135],
13	Activity	NN	O	activity	dep	9	SENT_228	[p14l855t1110r953b1140],
14	June	NNP	DATE	June	tmod	13	SENT_228	[p14l1859t1111r1908b1135],
15	1	CD	DATE	1	num	14	SENT_228	[p14l1919t1111r1938b1139],
16	,	,	O	,	_	0	SENT_228	[p14l1919t1111r1938b1139],
17	2010:2427	CD	NUMBER	2010:2427	num	14	SENT_228	[p14l1949t1111r2117b1135],
18	—	CD	NUMBER	—	num	19	SENT_228	[p14l1949t1111r2117b1135],
19	34	CD	NUMBER	34	_	0	SENT_228	[p14l1949t1111r2117b1135],

1	ygm	NN	O	ygm	_	0	SENT_229	[p14l764t1271r1521b1567],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_230	[p14l991t1585r1152b1615],
2	mellitus	NN	O	mellitus	dep	1	SENT_230	[p14l1167t1585r1305b1615],

1	Arterial	JJ	O	arterial	_	0	SENT_231	[p14l426t1684r556b1714],
2	hypertension	NN	O	hypertension	prep	1	SENT_231	[p14l572t1684r805b1723],
3	yes	UH	O	yes	dep	2	SENT_231	[p14l536t1748r592b1777],
4	,1	CD	NUMBER	,1	dep	1	SENT_231	[p14l611t1730r634b1791],
5	,	,	O	,	_	0	SENT_231	[p14l611t1730r634b1791],
6	no	DT	O	no	det	12	SENT_231	[p14l792t1748r830b1770],
7	@	SYM	O	@	dep	9	SENT_231	[p14l510t1804r733b2027],
8	6	CD	NUMBER	6	number	9	SENT_231	[p14l926t1843r1095b1980],
9	””	CD	NUMBER	””	num	10	SENT_231	[p14l926t1843r1095b1980],
10	Body	NN	O	body	nn	12	SENT_231	[p14l461t2037r553b2076],
11	mass	NN	O	mass	nn	12	SENT_231	[p14l567t2045r663b2069],
12	index	NN	O	index	appos	4	SENT_231	[p14l678t2037r774b2069],

1	<	JJR	O	<	_	0	SENT_232	[p14l534t2100r553b2118],
2	30	CD	MONEY	30	number	3	SENT_232	[p14l566t2085r632b2144],
3	$	$	MONEY	$	amod	1	SENT_232	[p14l566t2085r632b2144],
4	-	:	MONEY	-	_	0	SENT_232	[p14l656t2083r916b2204],
5	A	NN	O	a	dep	1	SENT_232	[p14l656t2083r916b2204],

1	38	CD	PERCENT	38	num	2	SENT_233	[p14l1033t2184r1099b2213],
2	%	NN	PERCENT	%	_	0	SENT_233	[p14l1033t2184r1099b2213],
3	9	CD	NUMBER	9	num	4	SENT_233	[p14l1387t2185r1412b2210],
4	RPA	NN	ORGANIZATION	rpa	npadvmod	5	SENT_233	[p14l1432t2184r1543b2215],
5	>	JJR	O	>	amod	10	SENT_233	[p14l1432t2184r1543b2215],
6	14	CD	PERCENT	14	number	7	SENT_233	[p14l1561t2184r1637b2216],
7	%	NN	PERCENT	%	amod	10	SENT_233	[p14l1561t2184r1637b2216],
8	G	NN	O	g	nn	10	SENT_233	[p14l926t2200r1047b2322],
9	o	NN	O	o	nn	10	SENT_233	[p14l1387t2230r1413b2258],
10	RPAS	NNS	O	rpa	dep	2	SENT_233	[p14l1432t2230r1543b2262],
11	14	CD	PERCENT	14	number	12	SENT_233	[p14l1558t2230r1635b2262],
12	%	NN	PERCENT	%	amod	10	SENT_233	[p14l1558t2230r1635b2262],

1	CART	NN	O	cart	nn	2	SENT_234	[p14l242t2427r324b2451],
2	Analysis	NN	O	analysis	_	0	SENT_234	[p14l336t2427r459b2457],
3	for	IN	O	for	_	0	SENT_234	[p14l471t2427r510b2451],
4	Low	JJ	O	low	amod	5	SENT_234	[p14l523t2428r581b2451],
5	Response	NN	O	response	prep_for	2	SENT_234	[p14l594t2428r736b2457],
6	to	TO	O	to	_	0	SENT_234	[p14l748t2428r778b2451],
7	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_234	[p14l791t2427r956b2457],
8	Excluding	VBG	O	exclude	partmod	7	SENT_234	[p14l971t2427r1115b2457],
9	the	DT	O	the	det	11	SENT_234	[p14l1126t2428r1174b2451],
10	CYP2c19	NN	O	cyp2c19	nn	11	SENT_234	[p14l1188t2427r1331b2451],
11	681G	NN	O	681g	dep	12	SENT_234	[p14l1342t2427r1472b2451],
12	>	JJR	O	>	dobj	8	SENT_234	[p14l1342t2427r1472b2451],
13	A	DT	O	a	det	15	SENT_234	[p14l1342t2427r1472b2451],
14	Polymorphism	NN	MISC	polymorphism	nn	15	SENT_234	[p14l1485t2427r1690b2457],
15	Correlation	NN	MISC	correlation	dep	35	SENT_234	[p14l69t2511r190b2530],
16	and	CC	O	and	_	0	SENT_234	[p14l201t2511r240b2530],
17	regression	NN	O	regression	nn	18	SENT_234	[p14l252t2511r368b2535],
18	trees	NNS	O	tree	dep	35	SENT_234	[p14l377t2512r435b2530],
19	(	CD	NUMBER	(	num	22	SENT_234	[p14l445t2511r518b2535],
20	CART	NN	O	cart	nn	22	SENT_234	[p14l445t2511r518b2535],
21	)	NN	O	)	nn	22	SENT_234	[p14l445t2511r518b2535],
22	analysis	NN	O	analysis	dep	15	SENT_234	[p14l529t2511r619b2535],
23	for	IN	O	for	_	0	SENT_234	[p14l628t2511r659b2530],
24	low	JJ	O	low	amod	25	SENT_234	[p14l668t2511r704b2530],
25	response	NN	O	response	prep_for	22	SENT_234	[p14l714t2516r818b2535],
26	to	TO	O	to	_	0	SENT_234	[p14l826t2512r848b2530],
27	clopidogrel	NN	O	clopidogrel	nn	31	SENT_234	[p14l858t2511r978b2535],
28	(	CD	NUMBER	(	num	31	SENT_234	[p14l989t2511r1084b2535],
29	residual	JJ	O	residual	amod	31	SENT_234	[p14l989t2511r1084b2535],
30	platelet	NN	O	platelet	nn	31	SENT_234	[p14l1096t2511r1179b2535],
31	aggregation	NN	O	aggregation	prep_to	25	SENT_234	[p14l1188t2511r1317b2535],
32	[	CD	NUMBER	[	num	33	SENT_234	[p14l1329t2511r1387b2535],
33	RPA	NN	O	rpa	dep	35	SENT_234	[p14l1329t2511r1387b2535],
34	]	CD	NUMBER	]	num	35	SENT_234	[p14l1329t2511r1387b2535],
35	>	JJR	O	>	dep	38	SENT_234	[p14l1398t2511r1475b2535],
36	14	CD	PERCENT	14	num	37	SENT_234	[p14l1398t2511r1475b2535],
37	%	NN	PERCENT	%	dep	35	SENT_234	[p14l1398t2511r1475b2535],
38	)	CD	NUMBER	)	dep	12	SENT_234	[p14l1398t2511r1475b2535],
39	excluding	VBG	O	exclude	_	0	SENT_234	[p14l1485t2511r1590b2535],
40	the	DT	O	the	det	41	SENT_234	[p14l1598t2511r1634b2530],
41	CYP2C19	NN	O	cyp2c19	prep_excluding	8	SENT_234	[p14l1645t2511r1753b2530],
42	68	CD	NUMBER	68	num	41	SENT_234	[p14l1761t2511r1862b2530],
43	:	:	O	:	_	0	SENT_234	[p14l1761t2511r1862b2530],
44	LG	NNP	O	LG	dep	2	SENT_234	[p14l1761t2511r1862b2530],
45	>	JJR	O	>	amod	47	SENT_234	[p14l1761t2511r1862b2530],
46	A	DT	O	a	det	47	SENT_234	[p14l1761t2511r1862b2530],
47	polymorphism	NN	O	polymorphism	dep	44	SENT_234	[p14l1871t2511r2034b2535],
48	.	.	O	.	_	0	SENT_234	[p14l1871t2511r2034b2535],

1	Variables	NNS	O	variable	nsubj	4	SENT_235	[p14l42t2614r184b2645],
2	do	VBP	O	do	aux	4	SENT_235	[p14l199t2614r239b2645],
3	not	RB	O	not	neg	4	SENT_235	[p14l254t2622r309b2645],
4	suﬂice	VB	O	suﬂice	ccomp	15	SENT_235	[p14l323t2614r423b2645],
5	to	TO	O	to	aux	6	SENT_235	[p14l437t2622r469b2645],
6	predict	VB	O	predict	xcomp	4	SENT_235	[p14l482t2614r599b2656],
7	high	JJ	O	high	acomp	6	SENT_235	[p14l612t2614r686b2656],
8	on	IN	O	on	_	0	SENT_235	[p14l700t2613r1043b2656],
9	—	CD	NUMBER	—	num	11	SENT_235	[p14l700t2613r1043b2656],
10	clopidogre1RPA	NN	O	clopidogre1rpa	nn	11	SENT_235	[p14l700t2613r1043b2656],
11	knowledge	NN	O	knowledge	prep_on	6	SENT_235	[p14l1119t2614r1307b2656],
12	,	,	O	,	_	0	SENT_235	[p14l1119t2614r1307b2656],
13	we	PRP	O	we	nsubj	15	SENT_235	[p14l1332t2626r1378b2645],
14	were	VBD	O	be	cop	15	SENT_235	[p14l1403t2626r1481b2645],
15	able	JJ	O	able	_	0	SENT_235	[p14l1508t2614r1572b2645],
16	to	TO	O	to	aux	17	SENT_235	[p14l1598t2622r1630b2645],
17	include	VB	O	include	xcomp	15	SENT_235	[p14l1657t2614r1776b2645],
18	the	DT	O	the	det	29	SENT_235	[p14l1803t2614r1854b2645],
19	most	RBS	O	most	advmod	20	SENT_235	[p14l1881t2622r1962b2645],
20	relevant	JJ	O	relevant	amod	29	SENT_235	[p14l1987t2614r2118b2645],
21	with	IN	O	with	_	0	SENT_235	[p14l12t2672r173b2738],
22	the	DT	O	the	det	23	SENT_235	[p14l197t2672r307b2737],
23	precision	NN	O	precision	prep_with	20	SENT_235	[p14l331t2675r649b2760],
24	needed	VBN	O	need	partmod	23	SENT_235	[p14l675t2672r923b2737],
25	for	IN	O	for	_	0	SENT_235	[p14l947t2672r1047b2737],
26	clinical	JJ	O	clinical	amod	27	SENT_235	[p14l1071t2672r1318b2737],
27	decision	NN	O	decision	prep_for	24	SENT_235	[p14l1342t2672r1949b2760],
28	—	CD	NUMBER	—	num	29	SENT_235	[p14l1342t2672r1949b2760],
29	making	NN	O	making	dobj	17	SENT_235	[p14l1342t2672r1949b2760],
30	.	.	O	.	_	0	SENT_235	[p14l1342t2672r1949b2760],

1	This	DT	O	this	dep	116	SENT_236	[p14l1975t2670r2138b2737],
2	message	NN	O	message	dep	116	SENT_236	[p14l17t2803r303b2865],
3	is	VBZ	O	be	dep	116	SENT_236	[p14l335t2780r385b2842],
4	based	VBN	O	base	dep	116	SENT_236	[p14l417t2777r614b2842],
5	on	IN	O	on	dep	116	SENT_236	[p14l646t2803r733b2842],
6	4	CD	NUMBER	4	dep	116	SENT_236	[p14l764t2781r806b2841],
7	key	JJ	O	key	dep	116	SENT_236	[p14l838t2777r958b2865],
8	observations	NNS	O	observation	dep	116	SENT_236	[p14l987t2777r1441b2843],
9	:	:	O	:	_	0	SENT_236	[p14l987t2777r1441b2843],
10	1	CD	NUMBER	1	dep	116	SENT_236	[p14l1481t2775r1543b2857],
11	)	CD	NUMBER	)	dep	116	SENT_236	[p14l1481t2775r1543b2857],
12	the	DT	O	the	dep	116	SENT_236	[p14l1579t2777r1688b2842],
13	C'YP	NN	O	c'yp	dep	116	SENT_236	[p14l1728t2780r2140b2843],
14	2C19	NN	O	2c19	dep	116	SENT_236	[p14l1728t2780r2140b2843],
15	*	NN	O	*	dep	116	SENT_236	[p14l1728t2780r2140b2843],
16	2	CD	NUMBER	2	dep	116	SENT_236	[p14l1728t2780r2140b2843],
17	loss	NN	O	loss	dep	116	SENT_236	[p14l14t2883r585b2948],
18	—	CD	NUMBER	—	dep	116	SENT_236	[p14l14t2883r585b2948],
19	of-function	NN	O	of-function	dep	116	SENT_236	[p14l14t2883r585b2948],
20	polymorphism	NN	O	polymorphism	dep	116	SENT_236	[p14l617t2883r1131b2971],
21	Was	VBD	O	be	dep	116	SENT_236	[p14l1161t2909r1290b2949],
22	the	DT	O	the	dep	116	SENT_236	[p14l1325t2883r1435b2948],
23	strongest	JJS	O	strongest	dep	116	SENT_236	[p14l1470t2900r1789b2971],
24	predictor	NN	O	predictor	dep	116	SENT_236	[p14l1820t2883r2141b2971],
25	of	IN	O	of	dep	116	SENT_236	[p14l17t2988r96b3053],
26	high	JJ	O	high	dep	116	SENT_236	[p14l116t2988r275b3076],
27	on	IN	O	on	dep	116	SENT_236	[p14l307t2988r827b3076],
28	—	CD	NUMBER	—	dep	116	SENT_236	[p14l307t2988r827b3076],
29	clopidogrel	NN	O	clopidogrel	dep	116	SENT_236	[p14l307t2988r827b3076],
30	RPA	NN	O	rpa	dep	116	SENT_236	[p14l861t2987r1056b3068],
31	;	:	O	;	_	0	SENT_236	[p14l861t2987r1056b3068],
32	2	CD	NUMBER	2	dep	116	SENT_236	[p14l1089t2986r1157b3068],
33	)	CD	NUMBER	)	dep	116	SENT_236	[p14l1089t2986r1157b3068],
34	diabetes	NN	O	diabetes	dep	116	SENT_236	[p14l1193t2988r1475b3053],
35	mellitus	NN	O	mellitus	dep	116	SENT_236	[p14l1509t2988r1807b3068],
36	,	,	O	,	_	0	SENT_236	[p14l1509t2988r1807b3068],
37	age	NN	O	age	dep	116	SENT_236	[p14l1844t3014r1977b3076],
38	,	,	O	,	_	0	SENT_236	[p14l1844t3014r1977b3076],
39	and	CC	O	and	dep	116	SENT_236	[p14l2013t2988r2140b3053],
40	BMI	NNP	O	BMI	dep	116	SENT_236	[p14l16t3094r189b3158],
41	were	VBD	O	be	dep	116	SENT_236	[p14l221t3118r387b3159],
42	the	DT	O	the	dep	116	SENT_236	[p14l421t3093r530b3158],
43	clinical	JJ	O	clinical	dep	116	SENT_236	[p14l566t3093r813b3158],
44	patient	NN	O	patient	dep	116	SENT_236	[p14l845t3096r1092b3181],
45	characteristics	NNS	O	characteristic	dep	116	SENT_236	[p14l1125t3093r1617b3158],
46	most	RBS	O	most	dep	116	SENT_236	[p14l1653t3110r1826b3158],
47	strongly	RB	O	strongly	dep	116	SENT_236	[p14l1859t3093r2144b3181],
48	associated	VBN	O	associate	dep	116	SENT_236	[p14l17t3198r368b3263],
49	with	IN	O	with	dep	116	SENT_236	[p14l394t3198r555b3264],
50	high	JJ	O	high	dep	116	SENT_236	[p14l585t3198r744b3286],
51	on	IN	O	on	dep	116	SENT_236	[p14l775t3198r1296b3286],
52	—	CD	NUMBER	—	dep	116	SENT_236	[p14l775t3198r1296b3286],
53	clopidogrel	NN	O	clopidogrel	dep	116	SENT_236	[p14l775t3198r1296b3286],
54	RPA	NN	O	rpa	dep	116	SENT_236	[p14l1327t3197r1523b3278],
55	;	:	O	;	_	0	SENT_236	[p14l1327t3197r1523b3278],
56	3	CD	NUMBER	3	dep	116	SENT_236	[p14l1556t3196r1622b3278],
57	)	NN	O	)	dep	116	SENT_236	[p14l1556t3196r1622b3278],
58	a	DT	O	a	dep	116	SENT_236	[p14l1658t3224r1692b3263],
59	CYP2C19	NN	O	cyp2c19	dep	116	SENT_236	[p14l1728t3201r2140b3264],
60	*	NN	O	*	dep	116	SENT_236	[p14l1728t3201r2140b3264],
61	2	CD	NUMBER	2	dep	116	SENT_236	[p14l1728t3201r2140b3264],
62	carrier	NN	O	carrier	dep	116	SENT_236	[p14l17t3307r240b3369],
63	status	NN	O	status	dep	116	SENT_236	[p14l288t3321r484b3369],
64	together	RB	O	together	dep	116	SENT_236	[p14l533t3304r829b3392],
65	with	IN	O	with	dep	116	SENT_236	[p14l872t3304r1032b3370],
66	all	DT	O	all	dep	116	SENT_236	[p14l1082t3304r1161b3369],
67	demographic	JJ	O	demographic	dep	116	SENT_236	[p14l1209t3304r1669b3392],
68	and	CC	O	and	dep	116	SENT_236	[p14l1718t3304r1845b3369],
69	clinical	JJ	O	clinical	dep	116	SENT_236	[p14l1893t3304r2141b3369],
70	predictors	NNS	O	predictor	dep	116	SENT_236	[p14l15t3409r365b3497],
71	for	IN	O	for	dep	116	SENT_236	[p14l393t3409r493b3474],
72	high	JJ	O	high	dep	116	SENT_236	[p14l518t3409r677b3497],
73	on	IN	O	on	dep	116	SENT_236	[p14l705t3409r1225b3497],
74	—	CD	NUMBER	—	dep	116	SENT_236	[p14l705t3409r1225b3497],
75	clopidogrel	NN	O	clopidogrel	dep	116	SENT_236	[p14l705t3409r1225b3497],
76	could	MD	O	could	dep	116	SENT_236	[p14l1252t3409r1443b3474],
77	only	RB	O	only	dep	116	SENT_236	[p14l1469t3409r1621b3497],
78	explain	VB	O	explain	dep	116	SENT_236	[p14l1646t3409r1895b3497],
79	11.5	CD	PERCENT	11.5	dep	116	SENT_236	[p14l1925t3409r2140b3475],
80	%	NN	PERCENT	%	dep	116	SENT_236	[p14l1925t3409r2140b3475],
81	of	IN	O	of	dep	116	SENT_236	[p14l17t3514r96b3579],
82	residual	JJ	O	residual	dep	116	SENT_236	[p14l130t3514r403b3579],
83	platelet	NN	O	platelet	dep	116	SENT_236	[p14l446t3514r706b3602],
84	reactivity	NN	O	reactivity	dep	116	SENT_236	[p14l750t3517r1090b3602],
85	;	:	O	;	_	0	SENT_236	[p14l750t3517r1090b3602],
86	and	CC	O	and	dep	116	SENT_236	[p14l1140t3514r1267b3579],
87	4	CD	NUMBER	4	dep	116	SENT_236	[p14l1312t3512r1379b3594],
88	)	CD	NUMBER	)	dep	116	SENT_236	[p14l1312t3512r1379b3594],
89	the	DT	O	the	dep	116	SENT_236	[p14l1429t3514r1538b3579],
90	CART	NN	O	cart	dep	116	SENT_236	[p14l1587t3512r1838b3580],
91	derived	VBN	O	derive	dep	116	SENT_236	[p14l1884t3514r2141b3580],
92	from	IN	O	from	dep	116	SENT_236	[p14l16t3619r185b3684],
93	these	DT	O	these	dep	116	SENT_236	[p14l213t3619r392b3684],
94	Variables	NNS	O	variable	dep	116	SENT_236	[p14l417t3619r720b3685],
95	did	VBD	O	do	dep	116	SENT_236	[p14l750t3619r863b3684],
96	not	RB	O	not	dep	116	SENT_236	[p14l891t3636r1008b3684],
97	identify	VB	O	identify	dep	116	SENT_236	[p14l1034t3619r1307b3707],
98	any	DT	O	any	dep	116	SENT_236	[p14l1332t3645r1455b3707],
99	subgroup	NN	O	subgroup	dep	116	SENT_236	[p14l1480t3619r1802b3707],
100	in	IN	O	in	dep	116	SENT_236	[p14l1832t3622r1899b3684],
101	which	WDT	O	which	dep	116	SENT_236	[p14l1923t3619r2140b3685],
102	more	JJR	O	more	dep	116	SENT_236	[p14l17t3749r195b3789],
103	than	IN	O	than	dep	116	SENT_236	[p14l247t3724r405b3789],
104	48	CD	PERCENT	48	dep	116	SENT_236	[p14l455t3727r607b3790],
105	%	NN	PERCENT	%	dep	116	SENT_236	[p14l455t3727r607b3790],
106	or	CC	O	or	dep	116	SENT_236	[p14l659t3749r731b3789],
107	<	JJR	PERCENT	<	dep	116	SENT_236	[p14l785t3727r1006b3790],
108	16	CD	PERCENT	16	dep	116	SENT_236	[p14l785t3727r1006b3790],
109	%	NN	PERCENT	%	dep	116	SENT_236	[p14l785t3727r1006b3790],
110	of	IN	O	of	dep	116	SENT_236	[p14l1058t3724r1137b3789],
111	the	DT	O	the	dep	116	SENT_236	[p14l1176t3724r1286b3789],
112	patients	NNS	O	patient	dep	116	SENT_236	[p14l1336t3727r1612b3812],
113	showed	VBD	O	show	dep	116	SENT_236	[p14l1667t3724r1930b3790],
114	high	JJ	O	high	dep	116	SENT_236	[p14l1981t3724r2139b3812],
115	on-clopidogrel	JJ	O	on-clopidogrel	dep	116	SENT_236	[p15l17t16r537b104],
116	RPA	NN	O	rpa	_	0	SENT_236	[p15l571t15r765b81],
117	.	.	O	.	_	0	SENT_236	[p15l571t15r765b81],

1	Despite	IN	O	despite	_	0	SENT_237	[p15l105t122r377b209],
2	a	DT	O	a	det	5	SENT_237	[p15l421t147r455b186],
3	statistically	RB	O	statistically	advmod	4	SENT_237	[p15l497t121r887b209],
4	robust	JJ	O	robust	amod	5	SENT_237	[p15l925t121r1147b186],
5	association	NN	O	association	prep_despite	24	SENT_237	[p15l1188t124r1569b186],
6	of	IN	O	of	_	0	SENT_237	[p15l1612t121r1692b186],
7	CYP2C	NN	O	cyp2c	prep_of	5	SENT_237	[p15l1728t124r2140b187],
8	]	CD	NUMBER	]	number	9	SENT_237	[p15l1728t124r2140b187],
9	9	CD	NUMBER	9	dep	7	SENT_237	[p15l1728t124r2140b187],
10	*	NN	O	*	nn	13	SENT_237	[p15l1728t124r2140b187],
11	2	CD	NUMBER	2	num	13	SENT_237	[p15l1728t124r2140b187],
12	carrier	NN	O	carrier	nn	13	SENT_237	[p15l17t229r240b291],
13	status	NN	O	status	dep	9	SENT_237	[p15l281t243r477b291],
14	with	IN	O	with	_	0	SENT_237	[p15l516t226r677b292],
15	high	JJ	O	high	amod	17	SENT_237	[p15l718t226r877b314],
16	on-clopidogrel	JJ	O	on-clopidogrel	amod	17	SENT_237	[p15l919t226r1440b314],
17	RPA	NN	ORGANIZATION	rpa	prep_with	5	SENT_237	[p15l1482t225r1677b306],
18	,	,	O	,	_	0	SENT_237	[p15l1482t225r1677b306],
19	CYP2C19	NN	O	cyp2c19	nn	20	SENT_237	[p15l1728t229r2140b292],
20	*	NN	O	*	nsubj	24	SENT_237	[p15l1728t229r2140b292],
21	2	CD	NUMBER	2	num	23	SENT_237	[p15l1728t229r2140b292],
22	carrier	NN	O	carrier	nn	23	SENT_237	[p15l17t334r240b396],
23	status	NN	O	status	dep	20	SENT_237	[p15l277t348r473b396],
24	accounted	VBD	O	account	_	0	SENT_237	[p15l513t331r868b396],
25	for	IN	O	for	_	0	SENT_237	[p15l904t331r1004b396],
26	only	RB	O	only	quantmod	27	SENT_237	[p15l1040t331r1192b419],
27	4.6	CD	PERCENT	4.6	num	28	SENT_237	[p15l1225t334r1399b397],
28	%	NN	PERCENT	%	prep_for	24	SENT_237	[p15l1225t334r1399b397],
29	of	IN	O	of	_	0	SENT_237	[p15l1437t331r1517b396],
30	the	DT	O	the	det	31	SENT_237	[p15l1542t331r1651b396],
31	variability	NN	O	variability	prep_of	28	SENT_237	[p15l1686t331r2039b419],
32	in	IN	O	in	_	0	SENT_237	[p15l2072t334r2139b396],
33	on-clopidogrel	JJ	O	on-clopidogrel	amod	34	SENT_237	[p15l17t436r537b524],
34	RPA	NN	ORGANIZATION	rpa	prep_in	24	SENT_237	[p15l563t434r757b501],
35	.	.	O	.	_	0	SENT_237	[p15l563t434r757b501],

1	A	DT	O	a	det	3	SENT_238	[p15l785t435r851b501],
2	possible	JJ	O	possible	amod	3	SENT_238	[p15l874t436r1152b524],
3	explanation	NN	O	explanation	nsubj	8	SENT_238	[p15l1179t436r1585b524],
4	for	IN	O	for	_	0	SENT_238	[p15l1611t436r1711b501],
5	this	DT	O	this	det	6	SENT_238	[p15l1735t436r1861b501],
6	ﬁnding	NN	O	ﬁnding	prep_for	3	SENT_238	[p15l1888t436r2142b524],
7	might	MD	O	might	aux	8	SENT_238	[p15l17t542r228b630],
8	be	VB	O	be	_	0	SENT_238	[p15l252t542r333b607],
9	that	IN	O	that	complm	14	SENT_238	[p15l361t542r502b607],
10	other	JJ	O	other	amod	12	SENT_238	[p15l528t542r714b607],
11	genomic	JJ	O	genomic	amod	12	SENT_238	[p15l739t545r1041b630],
12	conditions	NNS	O	condition	nsubj	14	SENT_238	[p15l1069t542r1435b607],
13	could	MD	O	could	aux	14	SENT_238	[p15l1466t542r1656b607],
14	play	VB	O	play	ccomp	8	SENT_238	[p15l1682t542r1829b630],
15	a	DT	O	a	det	16	SENT_238	[p15l1854t568r1888b607],
16	role	NN	O	role	dobj	14	SENT_238	[p15l1915t542r2046b607],
17	as	RB	O	as	advmod	18	SENT_238	[p15l2075t568r2138b607],
18	well	RB	O	well	advmod	14	SENT_238	[p15l12t647r174b713],
19	.	.	O	.	_	0	SENT_238	[p15l12t647r174b713],

1	However	RB	O	however	advmod	14	SENT_239	[p15l236t648r576b727],
2	,	,	O	,	_	0	SENT_239	[p15l236t648r576b727],
3	other	JJ	O	other	amod	5	SENT_239	[p15l637t647r823b712],
4	CYP	NN	O	cyp	nn	5	SENT_239	[p15l880t647r1053b713],
5	polymorphisms	NNS	O	polymorphism	nsubj	14	SENT_239	[p15l1109t647r1653b735],
6	that	WDT	O	that	dobj	12	SENT_239	[p15l1711t647r1852b712],
7	several	JJ	O	several	amod	8	SENT_239	[p15l1908t647r2141b713],
8	groups	NNS	O	group	nsubj	12	SENT_239	[p15l15t778r250b841],
9	including	VBG	O	include	_	0	SENT_239	[p15l305t753r638b841],
10	ourselves	PRP	O	ourselves	prep_including	8	SENT_239	[p15l690t753r1003b819],
11	previously	RB	DATE	previously	advmod	12	SENT_239	[p15l1057t753r1415b841],
12	investigated	VBD	O	investigate	rcmod	5	SENT_239	[p15l1465t753r1885b841],
13	either	CC	O	either	advmod	12	SENT_239	[p15l1939t753r2141b818],
14	had	VBD	O	have	_	0	SENT_239	[p15l16t858r145b923],
15	little	JJ	O	little	amod	16	SENT_239	[p15l190t858r351b923],
16	impact	NN	O	impact	dobj	14	SENT_239	[p15l398t861r640b947],
17	on	IN	O	on	_	0	SENT_239	[p15l686t884r773b923],
18	platelet	NN	O	platelet	nn	19	SENT_239	[p15l819t858r1079b946],
19	function	NN	O	function	prep_on	16	SENT_239	[p15l1125t858r1421b923],
20	during	IN	O	during	_	0	SENT_239	[p15l1469t858r1701b946],
21	clopidogrel	NN	O	clopidogrel	nn	22	SENT_239	[p15l1748t858r2141b946],
22	treatment	NN	O	treatment	prep_during	14	SENT_239	[p15l16t981r361b1029],
23	or	CC	O	or	_	0	SENT_239	[p15l387t989r458b1029],
24	were	VBD	O	be	cop	26	SENT_239	[p15l479t989r645b1030],
25	too	RB	O	too	advmod	26	SENT_239	[p15l672t981r784b1029],
26	rare	JJ	O	rare	conj_or	14	SENT_239	[p15l812t989r944b1029],
27	to	TO	O	to	aux	28	SENT_239	[p15l971t981r1039b1029],
28	play	VB	O	play	xcomp	26	SENT_239	[p15l1065t964r1211b1052],
29	a	DT	O	a	det	30	SENT_239	[p15l1235t990r1269b1029],
30	role	NN	O	role	dobj	28	SENT_239	[p15l1295t964r1426b1029],
31	in	IN	O	in	_	0	SENT_239	[p15l1452t967r1520b1029],
32	the	DT	O	the	det	35	SENT_239	[p15l1546t964r1656b1029],
33	given	VBN	O	give	amod	35	SENT_239	[p15l1682t967r1869b1052],
34	sample	NN	O	sample	nn	35	SENT_239	[p15l1897t964r2138b1052],
35	size	NN	O	size	prep_in	30	SENT_239	[p15l17t1072r143b1135],
36	(	CD	NUMBER	(	number	37	SENT_239	[p15l174t1067r666b1149],
37	14,15,25,26	CD	NUMBER	14,15,25,26	num	38	SENT_239	[p15l174t1067r666b1149],
38	)	NN	O	)	dobj	14	SENT_239	[p15l174t1067r666b1149],
39	.	.	O	.	_	0	SENT_239	[p15l174t1067r666b1149],

1	Likewise	RB	O	likewise	advmod	8	SENT_240	[p15l699t1069r1032b1149],
2	,	,	O	,	_	0	SENT_240	[p15l699t1069r1032b1149],
3	we	PRP	O	we	nsubj	8	SENT_240	[p15l1059t1095r1157b1135],
4	and	CC	O	and	_	0	SENT_240	[p15l1186t1069r1313b1135],
5	others	NNS	O	other	nsubj	8	SENT_240	[p15l1341t1069r1554b1135],
6	did	VBD	O	do	aux	8	SENT_240	[p15l1585t1069r1697b1135],
7	not	RB	O	not	neg	8	SENT_240	[p15l1724t1086r1842b1135],
8	detect	VB	O	detect	_	0	SENT_240	[p15l1868t1069r2080b1135],
9	a	DT	O	a	det	11	SENT_240	[p15l2107t1095r2141b1135],
10	relevant	JJ	O	relevant	amod	11	SENT_240	[p15l15t1176r294b1242],
11	contribution	NN	O	contribution	dobj	8	SENT_240	[p15l342t1176r780b1241],
12	of	IN	O	of	_	0	SENT_240	[p15l830t1176r910b1241],
13	known	JJ	O	known	amod	14	SENT_240	[p15l947t1176r1186b1242],
14	polymorphisms	NNS	O	polymorphism	prep_of	11	SENT_240	[p15l1234t1176r1778b1265],
15	of	IN	O	of	_	0	SENT_240	[p15l1830t1176r1909b1241],
16	genes	NNS	O	gene	prep_of	14	SENT_240	[p15l1945t1202r2138b1264],
17	encoding	VBG	O	encode	xcomp	8	SENT_240	[p15l17t1316r340b1404],
18	for	IN	O	for	_	0	SENT_240	[p15l366t1316r467b1381],
19	transporter	NN	O	transporter	nn	20	SENT_240	[p15l494t1333r884b1404],
20	proteins	NNS	O	protein	prep_for	17	SENT_240	[p15l910t1319r1194b1405],
21	high	JJ	O	high	amod	23	SENT_240	[p15l1225t1316r1384b1404],
22	on-clopidogrel	JJ	O	on-clopidogrel	amod	23	SENT_240	[p15l1414t1316r1934b1405],
23	RPA	NN	O	rpa	dobj	17	SENT_240	[p15l1964t1315r2142b1381],
24	(	CD	NUMBER	(	num	26	SENT_240	[p15l19t1419r324b1501],
25	26-28	CD	NUMBER	26-28	num	26	SENT_240	[p15l19t1419r324b1501],
26	)	NN	O	)	dep	23	SENT_240	[p15l19t1419r324b1501],
27	,	,	O	,	_	0	SENT_240	[p15l19t1419r324b1501],
28	although	IN	O	although	mark	31	SENT_240	[p15l391t1421r704b1509],
29	1	CD	NUMBER	1	num	30	SENT_240	[p15l770t1425r802b1486],
30	study	NN	O	study	nsubj	31	SENT_240	[p15l871t1421r1060b1509],
31	reported	VBD	O	report	dep	23	SENT_240	[p15l1118t1421r1418b1509],
32	an	DT	O	a	det	33	SENT_240	[p15l1481t1447r1561b1486],
33	association	NN	O	association	dobj	31	SENT_240	[p15l1625t1424r2009b1486],
34	of	IN	O	of	_	0	SENT_240	[p15l2072t1421r2151b1486],
35	ﬂBCB1	NN	O	ﬂbcb1	nn	36	SENT_240	[p15l7t1529r277b1592],
36	polymorphism	NN	O	polymorphism	prep_of	33	SENT_240	[p15l328t1526r842b1615],
37	with	IN	O	with	_	0	SENT_240	[p15l888t1526r1049b1592],
38	clinical	JJ	O	clinical	amod	39	SENT_240	[p15l1099t1526r1346b1591],
39	outcome	NN	O	outcome	prep_with	31	SENT_240	[p15l1395t1543r1697b1591],
40	in	IN	O	in	_	0	SENT_240	[p15l1747t1529r1814b1591],
41	patients	NNS	O	patient	prep_in	39	SENT_240	[p15l1862t1529r2138b1615],
42	taking	VBG	O	take	partmod	41	SENT_240	[p15l16t1631r238b1719],
43	clopidogrel	NN	O	clopidogrel	dobj	42	SENT_240	[p15l290t1631r683b1720],
44	(	CD	NUMBER	(	num	43	SENT_240	[p15l737t1629r896b1711],
45	29	CD	NUMBER	29	num	46	SENT_240	[p15l737t1629r896b1711],
46	)	NN	O	)	dep	43	SENT_240	[p15l737t1629r896b1711],
47	.	.	O	.	_	0	SENT_240	[p15l737t1629r896b1711],

1	Thus	RB	O	thus	_	0	SENT_241	[p15l949t1629r1155b1711],
2	,	,	O	,	_	0	SENT_241	[p15l949t1629r1155b1711],
3	according	VBG	O	accord	_	0	SENT_241	[p15l1212t1631r1554b1719],
4	to	TO	O	to	prepc_according_to	1	SENT_241	[p15l1604t1648r1672b1696],
5	the	DT	O	the	det	8	SENT_241	[p15l1725t1631r1835b1696],
6	current	JJ	DATE	current	amod	8	SENT_241	[p15l1889t1648r2141b1696],
7	genetic	JJ	O	genetic	amod	8	SENT_241	[p15l9t1774r262b1860],
8	polymorphism	NN	O	polymorphism	pobj	1	SENT_241	[p15l316t1771r850b1861],
9	.	.	O	.	_	0	SENT_241	[p15l316t1771r850b1861],

1	Apart	RB	O	apart	advmod	2	SENT_242	[p15l907t1770r1116b1860],
2	from	IN	O	from	_	0	SENT_242	[p15l1170t1771r1340b1837],
3	genetic	JJ	O	genetic	amod	4	SENT_242	[p15l1394t1774r1648b1860],
4	background	NN	O	background	pobj	2	SENT_242	[p15l1700t1771r2138b1860],
5	,	,	O	,	_	0	SENT_242	[p15l1700t1771r2138b1860],

1	clinical	JJ	O	clinical	amod	2	SENT_243	[p15l11t1911r260b1977],
2	conditions	NNS	O	condition	nsubj	8	SENT_243	[p15l310t1911r677b1977],
3	and	CC	O	and	_	0	SENT_243	[p15l732t1911r859b1977],
4	concomitant	JJ	O	concomitant	amod	6	SENT_243	[p15l910t1914r1353b1977],
5	drug	NN	O	drug	nn	6	SENT_243	[p15l1404t1911r1566b2000],
6	therapy	NN	O	therapy	conj_and	2	SENT_243	[p15l1615t1911r1882b2001],
7	might	MD	O	might	aux	8	SENT_243	[p15l1930t1911r2142b2000],
8	interfere	VB	O	interfere	_	0	SENT_243	[p15l10t2017r308b2083],
9	with	IN	O	with	_	0	SENT_243	[p15l335t2017r497b2083],
10	on-clopidogrel	JJ	O	on-clopidogrel	amod	11	SENT_243	[p15l528t2017r1050b2107],
11	RPA	NN	O	rpa	prep_with	8	SENT_243	[p15l1082t2016r1277b2083],
12	.	.	O	.	_	0	SENT_243	[p15l1082t2016r1277b2083],

1	We	PRP	O	we	nsubj	2	SENT_244	[p15l1308t2018r1439b2084],
2	found	VBD	O	find	_	0	SENT_244	[p15l1470t2017r1678b2083],
3	that	IN	O	that	complm	17	SENT_244	[p15l1708t2017r1849b2083],
4	consideration	NN	O	consideration	nsubj	17	SENT_244	[p15l1879t2017r2137b2083, p15l11t2126r258b2189],
5	of	IN	O	of	_	0	SENT_244	[p15l321t2123r401b2189],
6	the	DT	O	the	det	8	SENT_244	[p15l451t2123r561b2189],
7	clinical	JJ	O	clinical	amod	8	SENT_244	[p15l625t2123r874b2189],
8	conditions	NNS	O	condition	prep_of	4	SENT_244	[p15l936t2123r1305b2189],
9	in	IN	O	in	_	0	SENT_244	[p15l1369t2126r1437b2189],
10	conjunction	NN	O	conjunction	prep_in	8	SENT_244	[p15l1500t2125r1920b2212],
11	with	IN	O	with	_	0	SENT_244	[p15l1978t2123r2140b2189],
12	CYP2CZ9	NN	O	cyp2cz9	nn	13	SENT_244	[p15l17t2232r431b2296],
13	”‘	NN	O	”‘	prep_with	10	SENT_244	[p15l17t2232r431b2296],
14	2	CD	NUMBER	2	num	16	SENT_244	[p15l17t2232r431b2296],
15	carrier	NN	O	carrier	nn	16	SENT_244	[p15l468t2232r692b2295],
16	status	NN	O	status	dep	13	SENT_244	[p15l728t2246r924b2295],
17	improved	VBD	O	improve	ccomp	2	SENT_244	[p15l962t2229r1298b2318],
18	the	DT	O	the	det	19	SENT_244	[p15l1333t2229r1443b2295],
19	prediction	NN	O	prediction	dobj	17	SENT_244	[p15l1479t2229r1841b2319],
20	of	IN	O	of	_	0	SENT_244	[p15l1878t2229r1958b2295],
21	high	JJ	O	high	amod	23	SENT_244	[p15l1981t2229r2141b2318],
22	on-clopidogrel	JJ	O	on-clopidogrel	amod	23	SENT_244	[p15l11t2335r533b2424],
23	RPA	NN	ORGANIZATION	rpa	prep_of	19	SENT_244	[p15l577t2334r773b2416],
24	,	,	O	,	_	0	SENT_244	[p15l577t2334r773b2416],
25	and	CC	O	and	_	0	SENT_244	[p15l820t2335r948b2401],
26	11.5	CD	PERCENT	11.5	num	27	SENT_244	[p15l994t2335r1209b2401],
27	%	NN	PERCENT	%	nsubjpass	36	SENT_244	[p15l994t2335r1209b2401],
28	of	IN	O	of	_	0	SENT_244	[p15l1253t2335r1332b2401],
29	the	DT	O	the	det	30	SENT_244	[p15l1363t2335r1473b2401],
30	variability	NN	O	variability	prep_of	27	SENT_244	[p15l1513t2335r1867b2424],
31	in	IN	O	in	_	0	SENT_244	[p15l1906t2338r1974b2400],
32	onclopidogrel	JJ	O	onclopidogrel	amod	33	SENT_244	[p15l2017t2361r2138b2401, p15l11t2441r406b2530],
33	RPA	NN	ORGANIZATION	rpa	prep_in	30	SENT_244	[p15l447t2440r625b2506],
34	could	MD	O	could	aux	36	SENT_244	[p15l665t2441r856b2507],
35	be	VB	O	be	auxpass	36	SENT_244	[p15l893t2441r974b2507],
36	explained	VBN	O	explain	conj_and	2	SENT_244	[p15l1016t2441r1351b2531],
37	by	IN	O	by	_	0	SENT_244	[p15l1388t2441r1474b2530],
38	a	DT	O	a	det	39	SENT_244	[p15l1512t2467r1547b2507],
39	combination	NN	O	combination	agent	36	SENT_244	[p15l1587t2441r2032b2507],
40	of	IN	O	of	_	0	SENT_244	[p15l2073t2441r2153b2507],
41	clinical	JJ	O	clinical	amod	42	SENT_244	[p15l11t2546r260b2612],
42	variables	NNS	O	variable	prep_of	39	SENT_244	[p15l287t2546r591b2612],
43	and	CC	O	and	_	0	SENT_244	[p15l627t2546r754b2612],
44	CYP2CZ9	NN	O	cyp2cz9	nn	45	SENT_244	[p15l793t2549r1207b2612],
45	*	NN	O	*	conj_and	39	SENT_244	[p15l793t2549r1207b2612],
46	2	CD	NUMBER	2	num	48	SENT_244	[p15l793t2549r1207b2612],
47	carrier	NN	O	carrier	nn	48	SENT_244	[p15l1239t2549r1464b2612],
48	status	NN	O	status	dep	45	SENT_244	[p15l1496t2563r1712b2612],
49	.	.	O	.	_	0	SENT_244	[p15l1496t2563r1712b2612],

1	The	DT	O	the	_	0	SENT_245	[p15l1746t2544r1893b2612],
2	strongest	JJS	O	strongest	dep	1	SENT_245	[p15l1928t2563r2138b2612, p15l9t2669r150b2741],

1	clinical	JJ	O	clinical	amod	3	SENT_246	[p15l207t2652r455b2718],
2	patient	NN	O	patient	nn	3	SENT_246	[p15l510t2655r759b2742],
3	characteristics	NNS	O	characteristic	nsubj	11	SENT_246	[p15l816t2652r1309b2718],
4	to	TO	O	to	aux	5	SENT_246	[p15l1369t2669r1437b2718],
5	predict	VB	O	predict	infmod	3	SENT_246	[p15l1495t2652r1744b2742],
6	high	JJ	O	high	amod	8	SENT_246	[p15l1800t2652r1959b2741],
7	onclopidogrel	NN	O	onclopidogrel	nn	8	SENT_246	[p15l2017t2678r2138b2718, p15l11t2758r406b2848],
8	RPA	NN	ORGANIZATION	rpa	dobj	5	SENT_246	[p15l456t2757r633b2823],
9	were	VBD	O	be	cop	11	SENT_246	[p15l677t2784r843b2824],
10	diabetes	NNS	O	diabetes	nn	11	SENT_246	[p15l894t2758r1176b2824],
11	mellitus	NN	O	mellitus	_	0	SENT_246	[p15l1228t2758r1527b2839],
12	,	,	O	,	_	0	SENT_246	[p15l1228t2758r1527b2839],
13	age	NN	O	age	conj_and	11	SENT_246	[p15l1580t2784r1714b2847],
14	,	,	O	,	_	0	SENT_246	[p15l1580t2784r1714b2847],
15	and	CC	O	and	_	0	SENT_246	[p15l1767t2758r1895b2824],
16	BMI	NNP	O	BMI	conj_and	11	SENT_246	[p15l1943t2759r2136b2824],
17	.	.	O	.	_	0	SENT_246	[p15l1943t2759r2136b2824],

1	Considered	VBN	O	consider	partmod	9	SENT_247	[p15l12t2864r420b2931],
2	together	RB	O	together	advmod	1	SENT_247	[p15l445t2864r759b2953],
3	,	,	O	,	_	0	SENT_247	[p15l445t2864r759b2953],
4	these	DT	O	these	det	6	SENT_247	[p15l788t2864r968b2930],
5	clinical	JJ	O	clinical	amod	6	SENT_247	[p15l996t2864r1243b2930],
6	factors	NNS	O	factor	nsubj	9	SENT_247	[p15l1268t2864r1500b2930],
7	are	VBP	O	be	cop	9	SENT_247	[p15l1529t2890r1630b2930],
8	more	RBR	O	more	advmod	9	SENT_247	[p15l1657t2890r1836b2930],
9	relevant	JJ	O	relevant	_	0	SENT_247	[p15l1863t2864r2143b2931],
10	for	IN	O	for	_	0	SENT_247	[p15l10t2970r111b3036],
11	prediction	NN	O	prediction	prep_for	9	SENT_247	[p15l132t2970r494b3060],
12	of	IN	O	of	_	0	SENT_247	[p15l518t2970r598b3036],
13	high	JJ	O	high	amod	15	SENT_247	[p15l609t2970r768b3059],
14	on-clopidogrel	JJ	O	on-clopidogrel	amod	15	SENT_247	[p15l793t2970r1315b3059],
15	RPA	NN	ORGANIZATION	rpa	prep_of	11	SENT_247	[p15l1339t2969r1517b3035],
16	than	IN	O	than	_	0	SENT_247	[p15l1539t2970r1697b3036],
17	CYPZCZ	NNP	O	CYPZCZ	nn	19	SENT_247	[p15l1727t2973r2022b3037],
18	9	CD	NUMBER	9	num	19	SENT_247	[p15l2033t2973r2141b3037],
19	*	NN	O	*	prep_than	15	SENT_247	[p15l2033t2973r2141b3037],
20	2	CD	NUMBER	2	num	22	SENT_247	[p15l2033t2973r2141b3037],
21	carrier	NN	O	carrier	nn	22	SENT_247	[p15l11t3079r236b3142],
22	status	NN	O	status	npadvmod	23	SENT_247	[p15l287t3093r484b3142],
23	alone	RB	O	alone	advmod	11	SENT_247	[p15l539t3076r743b3156],
24	,	,	O	,	_	0	SENT_247	[p15l539t3076r743b3156],
25	and	CC	O	and	_	0	SENT_247	[p15l800t3076r927b3142],
26	addition	NN	O	addition	conj_and	11	SENT_247	[p15l980t3076r1273b3142],
27	of	IN	O	of	_	0	SENT_247	[p15l1325t3076r1405b3142],
28	CYP2C	NN	O	cyp2c	prep_of	26	SENT_247	[p15l1452t3079r1866b3142],
29	]	CD	NUMBER	]	number	30	SENT_247	[p15l1452t3079r1866b3142],
30	9	CD	NUMBER	9	num	28	SENT_247	[p15l1452t3079r1866b3142],
31	*	NN	O	*	nn	34	SENT_247	[p15l1452t3079r1866b3142],
32	2	CD	NUMBER	2	num	34	SENT_247	[p15l1452t3079r1866b3142],
33	carrier	NN	O	carrier	nn	34	SENT_247	[p15l1918t3079r2142b3142],
34	status	NN	O	status	nsubj	40	SENT_247	[p15l12t3199r208b3248],
35	to	TO	O	to	_	0	SENT_247	[p15l257t3199r325b3248],
36	these	DT	O	these	det	37	SENT_247	[p15l374t3182r553b3248],
37	factors	NNS	O	factor	prep_to	34	SENT_247	[p15l602t3182r833b3248],
38	could	MD	O	could	aux	40	SENT_247	[p15l883t3182r1075b3248],
39	not	RB	O	not	neg	40	SENT_247	[p15l1122t3199r1240b3248],
40	improve	VB	O	improve	rcmod	26	SENT_247	[p15l1285t3185r1573b3272],
41	the	DT	O	the	det	42	SENT_247	[p15l1622t3182r1731b3248],
42	prediction	NN	O	prediction	dobj	40	SENT_247	[p15l1778t3182r2140b3272],
43	substantially	RB	O	substantially	advmod	40	SENT_247	[p15l12t3288r466b3377],
44	.	.	O	.	_	0	SENT_247	[p15l12t3288r466b3377],

1	Impact	NN	O	impact	_	0	SENT_248	[p15l11t3395r277b3484],
2	of	IN	O	of	_	0	SENT_248	[p15l334t3393r418b3460],
3	medication	NN	O	medication	nn	6	SENT_248	[p15l465t3393r882b3460],
4	and	CC	O	and	_	0	SENT_248	[p15l942t3393r1078b3460],
5	patient	NN	O	patient	nn	6	SENT_248	[p15l1135t3398r1400b3483],
6	characteristics	NNS	O	characteristic	prep_of	1	SENT_248	[p15l1458t3393r1986b3460],
7	on	IN	O	on	_	0	SENT_248	[p15l2047t3420r2141b3460],
8	platelet	NN	O	platelet	nn	9	SENT_248	[p15l9t3499r290b3589],
9	function	NN	O	function	prep_on	1	SENT_248	[p15l324t3499r662b3566],
10	.	.	O	.	_	0	SENT_248	[p15l324t3499r662b3566],

1	Our	PRP$	O	we	poss	2	SENT_249	[p15l715t3500r860b3567],
2	ﬁndings	NNS	O	ﬁndings	nsubj	12	SENT_249	[p15l895t3500r1178b3589],
3	on	IN	O	on	_	0	SENT_249	[p15l1217t3526r1304b3566],
4	diabetes	NN	O	diabetes	nn	5	SENT_249	[p15l1342t3500r1624b3566],
5	mellitus	NN	O	mellitus	prep_on	2	SENT_249	[p15l1664t3500r1963b3581],
6	,	,	O	,	_	0	SENT_249	[p15l1664t3500r1963b3581],
7	age	NN	O	age	conj_and	5	SENT_249	[p15l2004t3526r2138b3589],
8	,	,	O	,	_	0	SENT_249	[p15l2004t3526r2138b3589],
9	and	CC	O	and	_	0	SENT_249	[p15l12t3605r139b3671],
10	BMI	NNP	O	BMI	conj_and	5	SENT_249	[p15l162t3606r335b3670],
11	are	VBP	O	be	cop	12	SENT_249	[p15l361t3630r462b3671],
12	consistent	JJ	O	consistent	_	0	SENT_249	[p15l487t3608r841b3671],
13	with	IN	O	with	_	0	SENT_249	[p15l859t3605r1020b3671],
14	some	DT	O	some	prep_with	12	SENT_249	[p15l1045t3631r1224b3671],
15	but	CC	O	but	_	0	SENT_249	[p15l1246t3605r1365b3671],
16	not	RB	O	not	_	0	SENT_249	[p15l1387t3622r1504b3671],
17	all	DT	O	all	det	19	SENT_249	[p15l1527t3605r1607b3671],
18	clinical	JJ	O	clinical	amod	19	SENT_249	[p15l1629t3605r1878b3671],
19	studies	NNS	O	study	prep_with	12	SENT_249	[p15l1901t3605r2139b3671],
20	that	WDT	O	that	nsubj	21	SENT_249	[p16l10t27r151b93],
21	investigated	VBD	O	investigate	rcmod	19	SENT_249	[p16l195t27r617b116],
22	factors	NNS	O	factor	nsubj	23	SENT_249	[p16l661t27r893b93],
23	affecting	VBG	O	affect	dep	21	SENT_249	[p16l941t27r1240b116],
24	response	NN	O	response	dobj	23	SENT_249	[p16l1283t53r1586b117],
25	to	TO	O	to	_	0	SENT_249	[p16l1632t44r1700b93],
26	clopidogrel	NN	O	clopidogrel	prep_to	23	SENT_249	[p16l1748t27r2142b117],
27	Without	IN	O	without	_	0	SENT_249	[p16l7t133r287b200],
28	assessment	NN	O	assessment	prep_without	23	SENT_249	[p16l326t150r710b199],
29	of	IN	O	of	_	0	SENT_249	[p16l749t133r828b199],
30	the	DT	O	the	det	32	SENT_249	[p16l856t133r965b199],
31	genetic	JJ	O	genetic	amod	32	SENT_249	[p16l1004t136r1257b222],
32	background	NN	O	background	prep_of	28	SENT_249	[p16l1294t133r1713b222],
33	(	CD	NUMBER	(	number	34	SENT_249	[p16l1754t131r2136b214],
34	21,30,31	CD	NUMBER	21,30,31	num	35	SENT_249	[p16l1754t131r2136b214],
35	)	NN	O	)	dep	32	SENT_249	[p16l1754t131r2136b214],
36	.	.	O	.	_	0	SENT_249	[p16l1754t131r2136b214],

1	Diabetes	NNP	O	Diabetes	nsubjpass	5	SENT_250	[p16l10t238r320b304],
2	has	VBZ	O	have	aux	5	SENT_250	[p16l345t238r457b304],
3	also	RB	O	also	advmod	5	SENT_250	[p16l485t238r615b304],
4	been	VBN	O	be	auxpass	5	SENT_250	[p16l638t238r804b304],
5	associated	VBN	O	associate	_	0	SENT_250	[p16l830t238r1182b304],
6	in	IN	O	in	_	0	SENT_250	[p16l1205t241r1272b303],
7	2	CD	NUMBER	2	num	9	SENT_250	[p16l1294t241r1336b305],
8	other	JJ	O	other	amod	9	SENT_250	[p16l1362t238r1548b304],
9	studies	NNS	O	study	prep_in	5	SENT_250	[p16l1571t238r1809b304],
10	with	IN	O	with	_	0	SENT_250	[p16l1831t238r1992b304],
11	low	JJ	O	low	amod	12	SENT_250	[p16l2015t238r2144b304],
12	response	NN	O	response	prep_with	9	SENT_250	[p16l10t370r313b433],
13	to	TO	O	to	_	0	SENT_250	[p16l346t361r414b410],
14	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_250	[p16l449t344r844b434],
15	in	IN	O	in	_	0	SENT_250	[p16l875t347r943b409],
16	patients	NNS	O	patient	prep_in	14	SENT_250	[p16l975t347r1252b434],
17	after	IN	O	after	_	0	SENT_250	[p16l1288t344r1446b410],
18	coronary	JJ	O	coronary	amod	19	SENT_250	[p16l1479t370r1787b433],
19	intervention	NN	O	intervention	prep_after	5	SENT_250	[p16l1817t347r2137b410, p16l10t453r151b516],
20	(	CD	NUMBER	(	number	21	SENT_250	[p16l191t448r462b531],
21	21,30	CD	NUMBER	21,30	num	22	SENT_250	[p16l191t448r462b531],
22	)	NN	O	)	dep	5	SENT_250	[p16l191t448r462b531],
23	.	.	O	.	_	0	SENT_250	[p16l191t448r462b531],

1	The	DT	O	the	det	2	SENT_251	[p16l502t448r648b516],
2	impact	NN	O	impact	nsubj	12	SENT_251	[p16l687t453r930b539],
3	of	IN	O	of	_	0	SENT_251	[p16l966t450r1046b516],
4	age	NN	O	age	prep_of	2	SENT_251	[p16l1073t476r1187b539],
5	on	IN	O	on	_	0	SENT_251	[p16l1226t476r1314b516],
6	the	DT	O	the	det	7	SENT_251	[p16l1351t450r1461b516],
7	response	NN	O	response	prep_on	4	SENT_251	[p16l1500t476r1802b540],
8	to	TO	O	to	_	0	SENT_251	[p16l1841t467r1909b516],
9	many	JJ	O	many	amod	10	SENT_251	[p16l1949t476r2144b539],
10	drugs	NNS	O	drug	prep_to	7	SENT_251	[p16l11t556r201b645],
11	is	VBZ	O	be	cop	12	SENT_251	[p16l260t559r310b622],
12	well-known	JJ	O	well-known	_	0	SENT_251	[p16l364t556r789b622],
13	(	CD	NUMBER	(	number	14	SENT_251	[p16l848t554r1008b637],
14	32	CD	NUMBER	32	num	15	SENT_251	[p16l848t554r1008b637],
15	)	NN	O	)	dep	12	SENT_251	[p16l848t554r1008b637],
16	.	.	O	.	_	0	SENT_251	[p16l848t554r1008b637],

1	Surprisingly	RB	O	surprisingly	advmod	5	SENT_252	[p16l1072t556r1515b646],
2	,	,	O	,	_	0	SENT_252	[p16l1072t556r1515b646],
3	little	JJ	O	little	nsubjpass	5	SENT_252	[p16l1574t556r1734b622],
4	is	VBZ	O	be	auxpass	5	SENT_252	[p16l1791t559r1842b622],
5	known	VBN	O	know	_	0	SENT_252	[p16l1900t556r2140b623],
6	regarding	VBG	O	regard	_	0	SENT_252	[p16l10t663r349b752],
7	the	DT	O	the	det	8	SENT_252	[p16l381t663r491b729],
8	interaction	NN	O	interaction	prep_regarding	5	SENT_252	[p16l526t666r908b729],
9	of	IN	O	of	_	0	SENT_252	[p16l943t663r1023b729],
10	age	NN	O	age	prep_of	8	SENT_252	[p16l1047t689r1160b752],
11	with	IN	O	with	_	0	SENT_252	[p16l1191t663r1352b729],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_252	[p16l1387t663r1782b753],
13	response	NN	O	response	prep_with	10	SENT_252	[p16l1815t689r2136b753],
14	.	.	O	.	_	0	SENT_252	[p16l1815t689r2136b753],

1	Only	RB	O	only	advmod	3	SENT_253	[p16l12t769r193b858],
2	1	CD	NUMBER	1	num	3	SENT_253	[p16l217t773r248b834],
3	trial	NN	O	trial	nsubj	5	SENT_253	[p16l277t769r418b835],
4	has	VBZ	O	have	aux	5	SENT_253	[p16l441t769r553b835],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_253	[p16l579t769r916b835],
6	an	DT	O	a	det	7	SENT_253	[p16l940t795r1021b835],
7	age	NN	O	age	dobj	5	SENT_253	[p16l1046t795r1159b858],
8	above	IN	O	above	_	0	SENT_253	[p16l1185t769r1383b835],
9	65	CD	DURATION	65	num	10	SENT_253	[p16l1409t769r1490b835],
10	years	NNS	NUMBER	year	prep_above	7	SENT_253	[p16l1514t795r1688b858],
11	as	IN	O	as	_	0	SENT_253	[p16l1715t795r1778b835],
12	a	DT	O	a	det	17	SENT_253	[p16l1805t795r1840b835],
13	possible	JJ	O	possible	amod	17	SENT_253	[p16l1861t769r2140b859],
14	but	CC	O	but	_	0	SENT_253	[p16l8t875r127b941],
15	not	RB	O	not	_	0	SENT_253	[p16l152t892r269b941],
16	strong	JJ	O	strong	conj_negcc	13	SENT_253	[p16l295t892r517b964],
17	predictor	NN	O	predictor	prep_as	5	SENT_253	[p16l540t875r863b964],
18	for	IN	O	for	_	0	SENT_253	[p16l887t875r988b941],
19	a	DT	O	a	det	22	SENT_253	[p16l1014t901r1048b941],
20	low	JJ	O	low	amod	21	SENT_253	[p16l1071t875r1201b941],
21	antiplatelet	JJ	O	antiplatelet	amod	22	SENT_253	[p16l1225t875r1621b965],
22	response	NN	O	response	prep_for	17	SENT_253	[p16l1645t901r1947b965],
23	(	CD	NUMBER	(	number	24	SENT_253	[p16l1977t873r2136b955],
24	21	CD	NUMBER	21	num	25	SENT_253	[p16l1977t873r2136b955],
25	)	NN	O	)	dep	22	SENT_253	[p16l1977t873r2136b955],
26	.	.	O	.	_	0	SENT_253	[p16l1977t873r2136b955],

1	JACC	NNP	O	JACC	nn	2	SENT_254	[p16l9t979r123b1030],
2	Vol	NNP	O	Vol	_	0	SENT_254	[p16l150t980r232b1030],
3	.	.	O	.	_	0	SENT_254	[p16l150t980r232b1030],

1	55	CD	NUMBER	55	_	0	SENT_255	[p16l263t980r336b1039],
2	,	,	O	,	_	0	SENT_255	[p16l263t980r336b1039],
3	No.	NN	O	no.	appos	1	SENT_255	[p16l368t980r440b1030],
4	22	CD	NUMBER	22	num	3	SENT_255	[p16l471t979r544b1039],
5	,	,	O	,	_	0	SENT_255	[p16l471t979r544b1039],
6	2010	CD	DATE	2010	num	7	SENT_255	[p16l574t979r698b1030],
7	June	NNP	DATE	June	appos	3	SENT_255	[p16l9t1068r114b1119],
8	1	CD	DATE	1	num	7	SENT_255	[p16l143t1068r183b1127],
9	,	,	O	,	_	0	SENT_255	[p16l143t1068r183b1127],
10	2010:242	CD	NUMBER	2010:242	appos	7	SENT_255	[p16l215t1068r573b1119],
11	-	:	O	-	_	0	SENT_255	[p16l215t1068r573b1119],
12	/	:	O	/	punct	13	SENT_255	[p16l215t1068r573b1119],
13	-34	CD	NUMBER	-34	dep	3	SENT_255	[p16l215t1068r573b1119],

1	Data	NNS	O	datum	nsubj	9	SENT_256	[p16l11t1288r185b1353],
2	regarding	VBG	O	regard	_	0	SENT_256	[p16l209t1287r548b1376],
3	BMI	NNP	O	BMI	prep_regarding	1	SENT_256	[p16l572t1288r767b1368],
4	,	,	O	,	_	0	SENT_256	[p16l572t1288r767b1368],
5	so	RB	O	so	advmod	6	SENT_256	[p16l797t1313r867b1353],
6	far	RB	O	far	advmod	9	SENT_256	[p16l894t1287r1006b1368],
7	,	,	O	,	_	0	SENT_256	[p16l894t1287r1006b1368],
8	were	VBD	O	be	cop	9	SENT_256	[p16l1031t1313r1197b1353],
9	inconsistent	JJ	O	inconsistent	_	0	SENT_256	[p16l1224t1290r1668b1368],
10	,	,	O	,	_	0	SENT_256	[p16l1224t1290r1668b1368],
11	because	IN	O	because	mark	16	SENT_256	[p16l1695t1287r1964b1353],
12	only	RB	O	only	advmod	14	SENT_256	[p16l1992t1287r2145b1376],
13	1	CD	NUMBER	1	num	14	SENT_256	[p16l15t1396r46b1458],
14	analysis	NN	O	analysis	nsubj	16	SENT_256	[p16l86t1393r351b1482],
15	could	MD	O	could	aux	16	SENT_256	[p16l386t1393r577b1459],
16	detect	VB	O	detect	advcl	9	SENT_256	[p16l610t1393r822b1459],
17	an	DT	O	a	det	18	SENT_256	[p16l855t1419r935b1459],
18	impact	NN	O	impact	dobj	16	SENT_256	[p16l967t1396r1209b1482],
19	of	IN	O	of	_	0	SENT_256	[p16l1241t1393r1321b1459],
20	the	DT	O	the	det	21	SENT_256	[p16l1341t1393r1451b1459],
21	BMI	NN	O	bmus	prep_of	18	SENT_256	[p16l1485t1394r1658b1458],
22	on	IN	O	on	_	0	SENT_256	[p16l1693t1419r1780b1459],
23	the	DT	O	the	det	24	SENT_256	[p16l1813t1393r1923b1459],
24	effect	NN	O	effect	prep_on	16	SENT_256	[p16l1957t1393r2142b1459],
25	of	IN	O	of	_	0	SENT_256	[p16l11t1499r91b1565],
26	clopidogrel	NN	O	clopidogrel	prep_of	24	SENT_256	[p16l115t1499r509b1588],
27	(	CD	NUMBER	(	num	26	SENT_256	[p16l546t1497r705b1579],
28	31	CD	NUMBER	31	num	29	SENT_256	[p16l546t1497r705b1579],
29	)	NN	O	)	dep	26	SENT_256	[p16l546t1497r705b1579],
30	.	.	O	.	_	0	SENT_256	[p16l546t1497r705b1579],

1	Another	DT	O	another	det	3	SENT_257	[p16l742t1497r1044b1565],
2	multivariable	JJ	O	multivariable	amod	3	SENT_257	[p16l1078t1499r1538b1565],
3	analysis	NN	O	analysis	nsubj	4	SENT_257	[p16l1575t1499r1841b1588],
4	did	VBD	O	do	_	0	SENT_257	[p16l1878t1499r1990b1565],
5	not	RB	O	not	neg	7	SENT_257	[p16l2026t1516r2143b1565],
6	conﬁrm	JJ	O	conﬁrm	amod	7	SENT_257	[p16l11t1605r285b1671],
7	BMI	NN	O	bmus	dobj	4	SENT_257	[p16l327t1606r500b1670],
8	as	IN	O	as	_	0	SENT_257	[p16l545t1631r608b1671],
9	predictive	JJ	O	predictive	prep_as	4	SENT_257	[p16l650t1605r996b1694],
10	for	IN	O	for	_	0	SENT_257	[p16l1037t1605r1138b1671],
11	an	DT	O	a	det	13	SENT_257	[p16l1178t1631r1259b1671],
12	insuﬂicient	JJ	O	insuﬂicient	amod	13	SENT_257	[p16l1300t1605r1688b1671],
13	response	NN	O	response	prep_for	9	SENT_257	[p16l1727t1631r2030b1694],
14	to	TO	O	to	_	0	SENT_257	[p16l2071t1622r2139b1671],
15	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_257	[p16l11t1711r406b1800],
16	(	CD	NUMBER	(	num	15	SENT_257	[p16l441t1709r600b1791],
17	21	CD	NUMBER	21	num	18	SENT_257	[p16l441t1709r600b1791],
18	)	NN	O	)	dep	15	SENT_257	[p16l441t1709r600b1791],
19	.	.	O	.	_	0	SENT_257	[p16l441t1709r600b1791],

1	There	EX	O	there	expl	2	SENT_258	[p16l96t1815r311b1883],
2	are	VBP	O	be	_	0	SENT_258	[p16l354t1843r454b1883],
3	2	CD	NUMBER	2	num	5	SENT_258	[p16l492t1820r534b1884],
4	previous	JJ	O	previous	amod	5	SENT_258	[p16l574t1820r867b1906],
5	studies	NNS	O	study	nsubj	2	SENT_258	[p16l910t1817r1147b1883],
6	that	WDT	O	that	nsubj	7	SENT_258	[p16l1189t1817r1330b1883],
7	investigated	VBD	O	investigate	rcmod	5	SENT_258	[p16l1368t1817r1790b1906],
8	the	DT	O	the	det	9	SENT_258	[p16l1829t1817r1939b1883],
9	relevance	NN	O	relevance	nsubj	18	SENT_258	[p16l1979t1817r2138b1883, p16l7t1950r204b1990],
10	of	IN	O	of	_	0	SENT_258	[p16l259t1924r339b1990],
11	genetic	JJ	O	genetic	amod	14	SENT_258	[p16l378t1927r632b2013],
12	and	CC	O	and	_	0	SENT_258	[p16l685t1924r813b1990],
13	nongenetic	JJ	O	nongenetic	conj_and	11	SENT_258	[p16l866t1927r1256b2013],
14	factors	NNS	O	factor	prep_of	9	SENT_258	[p16l1308t1924r1540b1990],
15	for	IN	O	for	_	0	SENT_258	[p16l1594t1924r1695b1990],
16	clopidogrel	NN	O	clopidogrel	nn	17	SENT_258	[p16l1747t1924r2142b2013],
17	responses	NNS	O	response	prep_for	14	SENT_258	[p16l10t2056r343b2119],
18	(	VBP	O	(	ccomp	7	SENT_258	[p16l388t2028r659b2111],
19	33,34	CD	NUMBER	33,34	number	20	SENT_258	[p16l388t2028r659b2111],
20	)	CD	NUMBER	)	dobj	18	SENT_258	[p16l388t2028r659b2111],
21	.	.	O	.	_	0	SENT_258	[p16l388t2028r659b2111],

1	Aleil	NNP	O	Aleil	nsubj	4	SENT_259	[p16l700t2028r873b2096],
2	et	FW	O	et	nn	4	SENT_259	[p16l912t2047r976b2096],
3	al.	FW	O	al.	nn	4	SENT_259	[p16l1015t2030r1089b2096],
4	(	FW	O	(	_	0	SENT_259	[p16l1135t2028r1273b2110],
5	33	CD	NUMBER	33	number	6	SENT_259	[p16l1135t2028r1273b2110],
6	)	CD	NUMBER	)	num	9	SENT_259	[p16l1135t2028r1273b2110],
7	identiﬁed	JJ	O	identiﬁed	amod	9	SENT_259	[p16l1316t2030r1653b2096],
8	body	NN	O	body	nn	9	SENT_259	[p16l1690t2030r1866b2119],
9	weight	NN	O	weight	dobj	4	SENT_259	[p16l1898t2030r2142b2119],
10	and	CC	O	and	_	0	SENT_259	[p16l12t2135r139b2200],
11	CYP2CJ9	NN	O	cyp2cj9	nn	12	SENT_259	[p16l183t2138r596b2201],
12	*	NN	O	*	conj_and	9	SENT_259	[p16l183t2138r596b2201],
13	2	CD	NUMBER	2	num	15	SENT_259	[p16l183t2138r596b2201],
14	carrier	NN	O	carrier	nn	15	SENT_259	[p16l634t2138r858b2200],
15	status	NN	O	status	dep	12	SENT_259	[p16l894t2152r1091b2200],
16	but	CC	O	but	_	0	SENT_259	[p16l1128t2135r1246b2200],
17	not	RB	O	not	_	0	SENT_259	[p16l1282t2152r1399b2200],
18	diabetes	NN	O	diabetes	nn	19	SENT_259	[p16l1436t2135r1718b2200],
19	mellitus	NN	O	mellitus	conj_negcc	9	SENT_259	[p16l1758t2135r2036b2200],
20	as	IN	O	as	_	0	SENT_259	[p16l2076t2161r2139b2200],
21	independent	JJ	O	independent	amod	22	SENT_259	[p16l10t2241r455b2330],
22	predictors	NNS	O	predictor	prep_as	19	SENT_259	[p16l475t2241r826b2330],
23	for	IN	O	for	_	0	SENT_259	[p16l850t2241r951b2307],
24	a	DT	O	a	det	26	SENT_259	[p16l974t2267r1008b2307],
25	low	JJ	O	low	amod	26	SENT_259	[p16l1028t2241r1158b2307],
26	response	NN	O	response	prep_for	4	SENT_259	[p16l1177t2267r1480b2330],
27	to	TO	O	to	_	0	SENT_259	[p16l1503t2258r1571b2307],
28	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_259	[p16l1596t2241r1991b2330],
29	and	CC	O	and	_	0	SENT_259	[p16l2014t2241r2141b2307],
30	showed	VBD	O	show	conj_and	4	SENT_259	[p16l12t2346r277b2412],
31	that	IN	O	that	complm	38	SENT_259	[p16l305t2346r446b2411],
32	an	DT	O	a	det	33	SENT_259	[p16l475t2372r555b2411],
33	increase	NN	O	increase	nsubj	38	SENT_259	[p16l584t2349r864b2411],
34	in	IN	O	in	_	0	SENT_259	[p16l893t2349r961b2411],
35	maintenance	NN	O	maintenance	nn	36	SENT_259	[p16l991t2349r1440b2411],
36	dose	NN	O	dose	prep_in	33	SENT_259	[p16l1470t2346r1625b2411],
37	can	MD	O	can	aux	38	SENT_259	[p16l1656t2372r1774b2411],
38	overcome	VB	O	overcome	ccomp	30	SENT_259	[p16l1803t2371r2140b2412],
39	this	DT	O	this	det	40	SENT_259	[p16l10t2452r137b2518],
40	effect	NN	O	effect	dobj	38	SENT_259	[p16l171t2452r373b2518],
41	.	.	O	.	_	0	SENT_259	[p16l171t2452r373b2518],

1	In	IN	O	in	_	0	SENT_260	[p16l409t2453r486b2517],
2	the	DT	O	the	det	3	SENT_260	[p16l518t2452r628b2518],
3	analysis	NN	O	analysis	prep_in	15	SENT_260	[p16l662t2452r927b2541],
4	of	IN	O	of	_	0	SENT_260	[p16l961t2452r1041b2518],
5	Geisler	NNP	PERSON	Geisler	prep_of	3	SENT_260	[p16l1063t2452r1316b2518],
6	et	FW	O	et	nsubj	15	SENT_260	[p16l1347t2469r1410b2518],
7	al.	FW	O	al.	nn	8	SENT_260	[p16l1442t2452r1516b2518],
8	(	FW	O	(	dep	6	SENT_260	[p16l1555t2450r1716b2533],
9	34	CD	NUMBER	34	num	10	SENT_260	[p16l1555t2450r1716b2533],
10	)	NN	O	)	dep	6	SENT_260	[p16l1555t2450r1716b2533],
11	,	,	O	,	_	0	SENT_260	[p16l1555t2450r1716b2533],
12	nongenetic	JJ	O	nongenetic	amod	13	SENT_260	[p16l1752t2455r2141b2541],
13	factors	NNS	O	factor	appos	10	SENT_260	[p16l10t2558r242b2624],
14	were	VBD	O	be	cop	15	SENT_260	[p16l270t2584r437b2624],
15	less-relevant	JJ	O	less-relevant	_	0	SENT_260	[p16l467t2558r907b2624],
16	compared	VBN	O	compare	_	0	SENT_260	[p16l937t2558r1284b2647],
17	with	IN	O	with	prepc_compared_with	15	SENT_260	[p16l1310t2558r1471b2624],
18	our	PRP$	O	we	poss	20	SENT_260	[p16l1502t2584r1620b2624],
19	current	JJ	DATE	current	amod	20	SENT_260	[p16l1649t2575r1902b2624],
20	study	NN	O	study	pobj	15	SENT_260	[p16l1933t2558r2137b2647],
21	,	,	O	,	_	0	SENT_260	[p16l1933t2558r2137b2647],
22	but	CC	O	but	_	0	SENT_260	[p16l8t2664r127b2730],
23	age	NN	O	age	nn	26	SENT_260	[p16l157t2690r271b2753],
24	and	CC	O	and	_	0	SENT_260	[p16l304t2664r431b2730],
25	diabetes	NN	O	diabetes	nn	26	SENT_260	[p16l462t2664r744b2730],
26	mellitus	NN	O	mellitus	nsubjpass	29	SENT_260	[p16l778t2664r1056b2730],
27	were	VBD	O	be	auxpass	29	SENT_260	[p16l1084t2689r1251b2730],
28	also	RB	O	also	advmod	29	SENT_260	[p16l1284t2664r1414b2730],
29	identiﬁed	VBN	O	identiﬁed	conj_but	15	SENT_260	[p16l1447t2664r1784b2730],
30	as	IN	O	as	_	0	SENT_260	[p16l1816t2690r1878b2730],
31	significant	JJ	O	significant	amod	32	SENT_260	[p16l1913t2664r2138b2753, p16l10t2773r183b2836],
32	predictors	NNS	O	predictor	prep_as	29	SENT_260	[p16l220t2770r571b2859],
33	of	IN	O	of	_	0	SENT_260	[p16l613t2770r693b2836],
34	clopidogrel	NN	O	clopidogrel	nn	35	SENT_260	[p16l722t2770r1116b2859],
35	response	NN	O	response	prep_of	32	SENT_260	[p16l1155t2796r1477b2859],
36	.	.	O	.	_	0	SENT_260	[p16l1155t2796r1477b2859],

1	We	PRP	O	we	nsubj	2	SENT_261	[p16l1517t2771r1648b2837],
2	attribute	VBP	O	attribute	dep	13	SENT_261	[p16l1690t2770r1989b2836],
3	the	DT	O	the	det	4	SENT_261	[p16l2029t2770r2140b2836],
4	discrepancies	NNS	O	discrepancy	dobj	2	SENT_261	[p16l11t2876r472b2965],
5	with	IN	O	with	_	0	SENT_261	[p16l494t2876r656b2942],
6	our	PRP$	O	we	poss	7	SENT_261	[p16l680t2902r797b2942],
7	results	NNS	O	result	prep_with	4	SENT_261	[p16l819t2876r1042b2942],
8	to	TO	O	to	_	0	SENT_261	[p16l1067t2893r1135b2942],
9	substantially	RB	O	substantially	advmod	10	SENT_261	[p16l1162t2876r1602b2965],
10	smaller	JJR	O	smaller	amod	12	SENT_261	[p16l1623t2876r1875b2942],
11	sample	NN	O	sample	nn	12	SENT_261	[p16l1898t2876r2140b2965],
12	sizes	NNS	O	size	prep_to	2	SENT_261	[p16l12t2985r169b3048],
13	(	VBP	O	(	_	0	SENT_261	[p16l201t2980r272b3062],
14	n	NN	O	n	dep	15	SENT_261	[p16l201t2980r272b3062],
15	=	JJ	O	=	dep	13	SENT_261	[p16l308t3008r361b3028],
16	153	CD	NUMBER	153	tmod	15	SENT_261	[p16l403t2982r524b3048],
17	and	CC	O	and	_	0	SENT_261	[p16l558t2982r685b3048],
18	n	NN	O	n	dep	19	SENT_261	[p16l713t3008r756b3047],
19	=	JJ	O	=	dep	13	SENT_261	[p16l793t3008r846b3028],
20	237	CD	NUMBER	237	nsubj	13	SENT_261	[p16l881t2983r1032b3063],
21	,	,	O	,	_	0	SENT_261	[p16l881t2983r1032b3063],
22	respectively	RB	O	respectively	advmod	23	SENT_261	[p16l1063t2980r1495b3071],
23	)	CD	NUMBER	)	appos	20	SENT_261	[p16l1063t2980r1495b3071],
24	and	CC	O	and	_	0	SENT_261	[p16l1528t2982r1656b3048],
25	the	DT	O	the	det	26	SENT_261	[p16l1683t2982r1793b3048],
26	inclusion	NN	O	inclusion	appos	20	SENT_261	[p16l1821t2982r2140b3048],
27	of	IN	O	of	_	0	SENT_261	[p16l11t3088r91b3154],
28	both	CC	O	both	preconj	29	SENT_261	[p16l110t3088r274b3154],
29	stable	JJ	O	stable	amod	32	SENT_261	[p16l308t3088r506b3154],
30	and	CC	O	and	_	0	SENT_261	[p16l541t3088r668b3154],
31	unstable	JJ	O	unstable	conj_and	29	SENT_261	[p16l700t3088r992b3154],
32	patients	NNS	O	patient	prep_of	23	SENT_261	[p16l1025t3091r1302b3177],
33	in	IN	O	in	_	0	SENT_261	[p16l1337t3091r1404b3153],
34	the	DT	O	the	det	36	SENT_261	[p16l1437t3088r1547b3154],
35	second	JJ	ORDINAL	second	amod	36	SENT_261	[p16l1582t3088r1822b3154],
36	study	NN	O	study	prep_in	32	SENT_261	[p16l1856t3088r2059b3177],
37	.	.	O	.	_	0	SENT_261	[p16l1856t3088r2059b3177],

1	We	PRP	O	we	nsubj	2	SENT_262	[p16l95t3195r226b3261],
2	identiﬁed	VBD	O	identiﬁed	ccomp	22	SENT_262	[p16l267t3194r624b3275],
3	,	,	O	,	_	0	SENT_262	[p16l267t3194r624b3275],
4	apart	RB	O	apart	_	0	SENT_262	[p16l669t3211r846b3283],
5	from	IN	O	from	_	0	SENT_262	[p16l885t3194r1055b3260],
6	the	DT	O	the	det	8	SENT_262	[p16l1096t3194r1206b3260],
7	patient	NN	O	patient	nn	8	SENT_262	[p16l1247t3197r1495b3283],
8	characteristics	NNS	O	characteristic	prep_apart_from	10	SENT_262	[p16l1535t3194r2029b3260],
9	to	TO	O	to	aux	10	SENT_262	[p16l2071t3211r2139b3260],
10	predict	VB	O	predict	xcomp	2	SENT_262	[p16l9t3300r258b3389],
11	high	JJ	O	high	amod	13	SENT_262	[p16l293t3300r453b3389],
12	on-clopidogrel	JJ	O	on-clopidogrel	amod	13	SENT_262	[p16l490t3300r1013b3389],
13	RPA	NN	ORGANIZATION	rpa	dobj	10	SENT_262	[p16l1051t3298r1247b3381],
14	,	,	O	,	_	0	SENT_262	[p16l1051t3298r1247b3381],
15	interaction	NN	O	interaction	nsubj	22	SENT_262	[p16l1287t3303r1670b3366],
16	of	IN	O	of	_	0	SENT_262	[p16l1708t3300r1787b3366],
17	nondihy	JJ	O	nondihy	amod	21	SENT_262	[p16l1814t3300r2138b3389],
18	—	NN	O	—	nn	21	SENT_262	[p16l1814t3300r2138b3389],
19	dropyridine	NN	O	dropyridine	nn	21	SENT_262	[p16l11t3407r421b3496],
20	calcium	NN	O	calcium	nn	21	SENT_262	[p16l461t3407r730b3473],
21	antagonists	NNS	O	antagonist	prep_of	15	SENT_262	[p16l771t3410r1166b3496],
22	(	VBP	O	(	_	0	SENT_262	[p16l1209t3405r1580b3496],
23	verapamil	NN	O	verapamil	nn	26	SENT_262	[p16l1209t3405r1580b3496],
24	and	CC	O	and	_	0	SENT_262	[p16l1619t3407r1746b3473],
25	diltiazem	NN	O	diltiazem	nn	26	SENT_262	[p16l1785t3405r2137b3487],
26	)	NN	O	)	dobj	22	SENT_262	[p16l1785t3405r2137b3487],
27	with	IN	O	with	_	0	SENT_262	[p16l7t3513r168b3579],
28	the	DT	O	the	det	29	SENT_262	[p16l200t3513r310b3579],
29	effect	NN	O	effect	prep_with	26	SENT_262	[p16l344t3513r529b3579],
30	of	IN	O	of	_	0	SENT_262	[p16l560t3513r640b3579],
31	clopidogrel	NN	O	clopidogrel	prep_of	29	SENT_262	[p16l661t3513r1320b3602],
32	—	CD	NUMBER	—	num	31	SENT_262	[p16l661t3513r1320b3602],
33	most	RBS	O	most	advmod	34	SENT_262	[p16l661t3513r1320b3602],
34	likely	JJ	O	likely	dep	22	SENT_262	[p16l1349t3513r1541b3602],
35	due	JJ	O	due	_	0	SENT_262	[p16l1570t3513r1694b3579],
36	to	TO	O	to	_	0	SENT_262	[p16l1727t3530r1795b3579],
37	common	JJ	O	common	amod	38	SENT_262	[p16l1829t3539r2140b3579],
38	metabolism	NN	O	metabolism	prep_due_to	34	SENT_262	[p16l11t3619r421b3685],
39	via	IN	O	via	_	0	SENT_262	[p16l479t3622r581b3685],
40	hepatic	JJ	O	hepatic	amod	41	SENT_262	[p16l641t3619r897b3708],
41	cytochromes	NNS	O	cytochrome	prep_via	38	SENT_262	[p16l958t3619r1420b3708],
42	.	.	O	.	_	0	SENT_262	[p16l958t3619r1420b3708],

1	Our	PRP$	O	we	poss	2	SENT_263	[p16l1487t3619r1632b3685],
2	ﬁndings	NNS	O	ﬁndings	nsubj	13	SENT_263	[p16l1692t3619r1975b3708],
3	are	VBP	O	be	cop	13	SENT_263	[p16l2040t3645r2140b3685],
4	partially	RB	O	partially	advmod	13	SENT_263	[p16l9t3725r299b3814],
5	in	IN	O	in	_	0	SENT_263	[p16l343t3728r410b3790],
6	line	NN	O	line	prep_in	4	SENT_263	[p16l457t3725r585b3791],
7	with	IN	O	with	_	0	SENT_263	[p16l630t3725r791b3791],
8	a	DT	O	a	det	10	SENT_263	[p16l840t3751r874b3791],
9	recent	JJ	O	recent	amod	10	SENT_263	[p16l921t3742r1137b3791],
10	study	NN	O	study	prep_with	6	SENT_263	[p16l1184t3725r1373b3814],
11	(	CD	NUMBER	(	number	12	SENT_263	[p16l1420t3723r1579b3805],
12	35	CD	NUMBER	35	num	13	SENT_263	[p16l1420t3723r1579b3805],
13	)	NN	O	)	_	0	SENT_263	[p16l1420t3723r1579b3805],
14	.	.	O	.	_	0	SENT_263	[p16l1420t3723r1579b3805],

1	In	IN	O	in	_	0	SENT_264	[p16l1631t3726r1708b3790],
2	this	DT	O	this	det	3	SENT_264	[p16l1755t3725r1882b3791],
3	study	NN	O	study	pobj	1	SENT_264	[p16l1933t3725r2137b3814],
4	,	,	O	,	_	0	SENT_264	[p16l1933t3725r2137b3814],

1	however	RB	O	however	advmod	7	SENT_265	[p17l10t15r324b96],
2	,	,	O	,	_	0	SENT_265	[p17l10t15r324b96],
3	nearly	RB	O	nearly	quantmod	4	SENT_265	[p17l361t15r576b104],
4	all	DT	O	all	num	5	SENT_265	[p17l606t15r686b81],
5	patients	NNS	O	patient	nsubjpass	7	SENT_265	[p17l717t18r994b104],
6	were	VBD	O	be	auxpass	7	SENT_265	[p17l1024t41r1191b81],
7	treated	VBN	O	treat	_	0	SENT_265	[p17l1225t15r1469b81],
8	with	IN	O	with	_	0	SENT_265	[p17l1498t15r1659b81],
9	dihydropyri	NN	O	dihydropyrus	prep_with	7	SENT_265	[p17l1693t15r2138b104],
10	—	CD	NUMBER	—	nsubj	11	SENT_265	[p17l1693t15r2138b104],
11	dine	VBP	O	dine	parataxis	7	SENT_265	[p17l11t121r161b186],
12	calcium	NN	O	calcium	nn	15	SENT_265	[p17l198t121r783b186],
13	—	NN	O	—	nn	15	SENT_265	[p17l198t121r783b186],
14	channel	NN	O	channel	nn	15	SENT_265	[p17l198t121r783b186],
15	blockers	NNS	O	blocker	dobj	11	SENT_265	[p17l814t121r1125b201],
16	,	,	O	,	_	0	SENT_265	[p17l814t121r1125b201],
17	Whereas	IN	O	whereas	mark	26	SENT_265	[p17l1159t121r1442b187],
18	in	IN	O	in	_	0	SENT_265	[p17l1479t124r1546b186],
19	our	PRP$	O	we	poss	20	SENT_265	[p17l1582t146r1699b186],
20	dataset	NN	O	dataset	prep_in	26	SENT_265	[p17l1734t121r1979b186],
21	this	DT	O	this	det	22	SENT_265	[p17l2012t121r2139b186],
22	type	NN	O	type	nsubj	26	SENT_265	[p17l10t245r157b317],
23	of	IN	O	of	_	0	SENT_265	[p17l211t228r291b294],
24	calcium	NN	O	calcium	nn	25	SENT_265	[p17l333t228r602b294],
25	antagonist	NN	O	antagonist	prep_of	22	SENT_265	[p17l657t231r1024b317],
26	had	VBD	O	have	dep	7	SENT_265	[p17l1075t228r1204b294],
27	no	DT	O	no	det	29	SENT_265	[p17l1257t254r1343b294],
28	signiﬁcant	JJ	O	signiﬁcant	amod	29	SENT_265	[p17l1399t228r1764b317],
29	effect	NN	O	effect	dobj	26	SENT_265	[p17l1816t228r2001b294],
30	on	IN	O	on	_	0	SENT_265	[p17l2053t254r2140b294],
31	clopidogrel	NN	O	clopidogrel	nn	32	SENT_265	[p17l11t371r406b460],
32	response	NN	O	response	prep_on	29	SENT_265	[p17l447t397r768b460],
33	.	.	O	.	_	0	SENT_265	[p17l447t397r768b460],

1	Because	IN	O	because	mark	8	SENT_266	[p17l815t372r1096b437],
2	only	RB	O	only	advmod	4	SENT_266	[p17l1140t371r1293b460],
3	a	DT	O	a	det	4	SENT_266	[p17l1333t397r1367b437],
4	minority	NN	O	minority	nsubj	8	SENT_266	[p17l1409t374r1717b460],
5	of	IN	O	of	_	0	SENT_266	[p17l1756t371r1836b437],
6	our	PRP$	O	we	poss	7	SENT_266	[p17l1867t397r1984b437],
7	patients	NNS	O	patient	prep_of	4	SENT_266	[p17l2024t397r2138b460, p17l10t480r202b543],
8	(	VBP	O	(	advcl	32	SENT_266	[p17l239t475r466b557],
9	4.1	CD	PERCENT	4.1	number	10	SENT_266	[p17l239t475r466b557],
10	%	NN	PERCENT	%	amod	11	SENT_266	[p17l239t475r466b557],
11	)	CD	NUMBER	)	nsubj	12	SENT_266	[p17l239t475r466b557],
12	received	VBD	O	receive	ccomp	8	SENT_266	[p17l501t477r787b543],
13	nondihydropyridine	JJ	O	nondihydropyridine	amod	17	SENT_266	[p17l819t477r1524b566],
14	calcium	NN	O	calcium	nn	17	SENT_266	[p17l1558t477r2142b543],
15	—	NN	O	—	nn	17	SENT_266	[p17l1558t477r2142b543],
16	channel	NN	O	channel	nn	17	SENT_266	[p17l1558t477r2142b543],
17	blockers	NNS	O	blocker	dobj	12	SENT_266	[p17l8t583r319b663],
18	,	,	O	,	_	0	SENT_266	[p17l8t583r319b663],
19	the	DT	O	the	det	20	SENT_266	[p17l376t583r486b648],
20	relevance	NN	O	relevance	nsubjpass	32	SENT_266	[p17l540t583r863b649],
21	of	IN	O	of	_	0	SENT_266	[p17l919t583r999b648],
22	this	DT	O	this	det	23	SENT_266	[p17l1040t583r1167b648],
23	treatment	NN	O	treatment	prep_of	20	SENT_266	[p17l1223t600r1569b648],
24	to	TO	O	to	_	0	SENT_266	[p17l1622t600r1689b648],
25	the	DT	O	the	det	30	SENT_266	[p17l1745t583r1855b648],
26	overall	JJ	O	overall	amod	30	SENT_266	[p17l1911t583r2142b649],
27	on	IN	O	on	_	0	SENT_266	[p17l11t689r533b778],
28	—	CD	NUMBER	—	prep_on	26	SENT_266	[p17l11t689r533b778],
29	clopidogrel	NN	O	clopidogrel	nn	30	SENT_266	[p17l11t689r533b778],
30	RPA	NN	O	rpa	prep_to	23	SENT_266	[p17l583t687r761b754],
31	was	VBD	O	be	auxpass	32	SENT_266	[p17l805t715r934b755],
32	limited	VBN	O	limit	_	0	SENT_266	[p17l983t689r1254b755],
33	.	.	O	.	_	0	SENT_266	[p17l983t689r1254b755],

1	Nevertheless	RB	O	nevertheless	advmod	5	SENT_267	[p17l1306t689r1777b770],
2	,	,	O	,	_	0	SENT_267	[p17l1306t689r1777b770],
3	our	PRP$	O	we	poss	4	SENT_267	[p17l1829t715r1946b755],
4	data	NNS	O	datum	nsubj	5	SENT_267	[p17l1994t689r2142b755],
5	suggest	VBP	O	suggest	_	0	SENT_267	[p17l12t813r280b885],
6	avoiding	VBG	O	avoid	xcomp	5	SENT_267	[p17l346t796r661b885],
7	nondihydropyridine	JJ	O	nondihydropyridine	amod	11	SENT_267	[p17l726t796r1463b885],
8	calcium	NN	O	calcium	nn	11	SENT_267	[p17l1530t796r2141b862],
9	—	NN	O	—	nn	11	SENT_267	[p17l1530t796r2141b862],
10	channel	NN	O	channel	nn	11	SENT_267	[p17l1530t796r2141b862],
11	blockers	NNS	O	blocker	dobj	6	SENT_267	[p17l8t934r297b1000],
12	in	IN	O	in	_	0	SENT_267	[p17l332t937r400b999],
13	patients	NNS	O	patient	prep_in	11	SENT_267	[p17l432t937r709b1023],
14	needing	VBG	O	need	partmod	13	SENT_267	[p17l744t934r1025b1023],
15	treatment	NN	O	treatment	dobj	14	SENT_267	[p17l1056t951r1402b1000],
16	with	IN	O	with	_	0	SENT_267	[p17l1431t934r1592b1000],
17	clopidogrel	NN	O	clopidogrel	prep_with	14	SENT_267	[p17l1626t934r2037b1023],
18	.	.	O	.	_	0	SENT_267	[p17l1626t934r2037b1023],

1	Study	NNP	O	Study	_	0	SENT_268	[p17l13t1039r228b1129],
2	limitations	NNS	O	limitation	dep	1	SENT_268	[p17l260t1039r689b1106],
3	.	.	O	.	_	0	SENT_268	[p17l260t1039r689b1106],

1	Our	PRP$	O	we	poss	2	SENT_269	[p17l743t1040r888b1106],
2	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_269	[p17l925t1040r1208b1129],
3	can	MD	O	can	aux	5	SENT_269	[p17l1249t1066r1367b1106],
4	only	RB	O	only	advmod	5	SENT_269	[p17l1406t1040r1559b1129],
5	explain	VB	O	explain	_	0	SENT_269	[p17l1595t1040r1845b1129],
6	a	DT	O	a	det	8	SENT_269	[p17l1885t1066r1920b1106],
7	small	JJ	O	small	amod	8	SENT_269	[p17l1959t1040r2142b1106],
8	part	NN	O	part	dobj	5	SENT_269	[p17l9t1163r151b1235],
9	of	IN	O	of	_	0	SENT_269	[p17l175t1146r256b1212],
10	the	DT	O	the	det	12	SENT_269	[p17l269t1146r379b1212],
11	observed	VBN	O	observe	amod	12	SENT_269	[p17l406t1146r714b1212],
12	variability	NN	O	variability	prep_of	8	SENT_269	[p17l735t1146r1090b1235],
13	in	IN	O	in	prep	12	SENT_269	[p17l1112t1149r1179b1211],
14	on	IN	O	on	pcomp	13	SENT_269	[p17l1205t1146r1728b1235],
15	—	NN	O	—	nn	17	SENT_269	[p17l1205t1146r1728b1235],
16	clopidogrel	NN	O	clopidogrel	nn	17	SENT_269	[p17l1205t1146r1728b1235],
17	RPA	NN	O	rpa	pobj	14	SENT_269	[p17l1754t1144r1948b1212],
18	.	.	O	.	_	0	SENT_269	[p17l1754t1144r1948b1212],

1	This	DT	O	this	nsubj	2	SENT_270	[p17l1976t1144r2139b1212],
2	means	VBZ	O	mean	_	0	SENT_270	[p17l11t1278r231b1318],
3	that	IN	O	that	complm	5	SENT_270	[p17l270t1252r411b1318],
4	there	EX	O	there	expl	5	SENT_270	[p17l446t1252r624b1318],
5	are	VBP	O	be	ccomp	2	SENT_270	[p17l663t1278r763b1318],
6	still	RB	O	still	advmod	5	SENT_270	[p17l803t1252r928b1318],
7	some	DT	O	some	det	9	SENT_270	[p17l965t1278r1145b1318],
8	relevant	JJ	O	relevant	amod	9	SENT_270	[p17l1182t1252r1462b1318],
9	factors	NNS	O	factor	nsubj	5	SENT_270	[p17l1496t1252r1728b1318],
10	interfering	VBG	O	interfere	partmod	9	SENT_270	[p17l1767t1252r2142b1341],
11	with	IN	O	with	_	0	SENT_270	[p17l7t1359r168b1425],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_270	[p17l216t1359r611b1448],
13	responses	NNS	O	response	prep_with	10	SENT_270	[p17l656t1385r990b1448],
14	that	WDT	O	that	nsubj	17	SENT_270	[p17l1038t1359r1179b1425],
15	are	VBP	O	be	cop	17	SENT_270	[p17l1226t1385r1327b1425],
16	yet	RB	O	yet	advmod	17	SENT_270	[p17l1372t1376r1478b1448],
17	unknown	JJ	O	unknown	rcmod	13	SENT_270	[p17l1523t1359r1875b1425],
18	.	.	O	.	_	0	SENT_270	[p17l1523t1359r1875b1425],

1	These	DT	O	these	nsubj	3	SENT_271	[p17l1923t1357r2140b1425],
2	might	MD	O	might	aux	3	SENT_271	[p17l11t1500r224b1589],
3	include	VB	O	include	_	0	SENT_271	[p17l254t1500r509b1566],
4	novel	JJ	O	novel	amod	6	SENT_271	[p17l543t1500r731b1566],
5	gene	NN	O	gene	nn	6	SENT_271	[p17l761t1526r924b1589],
6	polymorphisms	NNS	O	polymorphism	dobj	3	SENT_271	[p17l956t1500r1502b1589],
7	that	WDT	O	that	nsubjpass	17	SENT_271	[p17l1535t1500r1694b1581],
8	,	,	O	,	_	0	SENT_271	[p17l1535t1500r1694b1581],
9	so	RB	O	so	advmod	10	SENT_271	[p17l1731t1526r1801b1566],
10	far	RB	O	far	advmod	15	SENT_271	[p17l1834t1500r1946b1581],
11	,	,	O	,	_	0	SENT_271	[p17l1834t1500r1946b1581],
12	have	VBP	O	have	aux	15	SENT_271	[p17l1982t1500r2140b1566],
13	not	RB	O	not	neg	15	SENT_271	[p17l11t1623r129b1672],
14	been	VBN	O	be	auxpass	15	SENT_271	[p17l166t1606r333b1672],
15	identiﬁed	VBN	O	identiﬁed	rcmod	6	SENT_271	[p17l374t1606r711b1672],
16	or	CC	O	or	_	0	SENT_271	[p17l752t1632r824b1672],
17	investigated	VBN	O	investigate	conj_or	15	SENT_271	[p17l864t1606r1286b1695],
18	as	RB	O	as	_	0	SENT_271	[p17l1328t1632r1391b1672],
19	well	RB	O	well	_	0	SENT_271	[p17l1430t1606r1576b1672],
20	as	IN	O	as	_	0	SENT_271	[p17l1617t1632r1680b1672],
21	clinical	JJ	O	clinical	amod	24	SENT_271	[p17l1724t1606r1972b1672],
22	and	CC	O	and	_	0	SENT_271	[p17l2014t1606r2141b1672],
23	demographic	JJ	O	demographic	conj_and	21	SENT_271	[p17l11t1713r473b1802],
24	factors	NNS	O	factor	dobj	3	SENT_271	[p17l523t1713r755b1779],
25	or	CC	O	or	_	0	SENT_271	[p17l809t1739r881b1779],
26	noncompliance	NN	O	noncompliance	conj_and	6	SENT_271	[p17l932t1713r1490b1802],
27	,	,	O	,	_	0	SENT_271	[p17l932t1713r1490b1802],
28	which	WDT	O	which	nsubjpass	31	SENT_271	[p17l1541t1713r1758b1779],
29	were	VBD	O	be	auxpass	31	SENT_271	[p17l1805t1739r1972b1779],
30	not	RB	O	not	neg	31	SENT_271	[p17l2025t1730r2142b1779],
31	considered	VBN	O	consider	rcmod	26	SENT_271	[p17l11t1819r407b1885],
32	.	.	O	.	_	0	SENT_271	[p17l11t1819r407b1885],

1	We	PRP	O	we	nsubj	4	SENT_272	[p17l468t1820r599b1886],
2	can	MD	O	can	aux	4	SENT_272	[p17l661t1836r900b1885],
3	not	RB	O	not	neg	4	SENT_272	[p17l661t1836r900b1885],
4	exclude	VB	O	exclude	_	0	SENT_272	[p17l959t1819r1220b1885],
5	that	IN	O	that	complm	12	SENT_272	[p17l1280t1819r1421b1885],
6	the	DT	O	the	det	7	SENT_272	[p17l1480t1819r1590b1885],
7	prediction	NN	O	prediction	nsubj	12	SENT_272	[p17l1650t1819r2012b1908],
8	of	IN	O	of	_	0	SENT_272	[p17l2073t1819r2153b1885],
9	clopidogrel	NN	O	clopidogrel	nn	10	SENT_272	[p17l11t1925r406b2014],
10	responses	NNS	O	response	prep_of	7	SENT_272	[p17l429t1951r762b2014],
11	might	MD	O	might	aux	12	SENT_272	[p17l790t1925r1002b2014],
12	become	VB	O	become	ccomp	4	SENT_272	[p17l1023t1925r1294b1991],
13	better	RBR	O	better	advmod	12	SENT_272	[p17l1317t1925r1525b1991],
14	as	IN	O	as	mark	17	SENT_272	[p17l1550t1951r1612b1991],
15	further	JJ	O	further	amod	16	SENT_272	[p17l1639t1925r1884b1991],
16	factors	NNS	O	factor	nsubj	17	SENT_272	[p17l1907t1925r2139b1991],
17	emerge	VBP	O	emerge	ccomp	13	SENT_272	[p17l11t2031r284b2094],
18	.	.	O	.	_	0	SENT_272	[p17l11t2031r284b2094],

1	All	DT	O	all	det	2	SENT_273	[p17l97t2110r209b2177],
2	patients	NNS	O	patient	nsubj	31	SENT_273	[p17l263t2115r540b2201],
3	in	IN	O	in	_	0	SENT_273	[p17l598t2115r665b2177],
4	our	PRP$	O	we	poss	5	SENT_273	[p17l723t2138r840b2178],
5	cohort	NN	O	cohort	prep_in	2	SENT_273	[p17l896t2112r1125b2178],
6	receiving	VBG	O	receive	dep	5	SENT_273	[p17l1179t2115r1497b2201],
7	a	DT	O	a	det	11	SENT_273	[p17l1553t2138r1588b2178],
8	proton	NN	O	proton	nn	11	SENT_273	[p17l1642t2129r1880b2201],
9	pump	NN	O	pump	nn	11	SENT_273	[p17l1935t2138r2139b2201],
10	inhibitor	NN	O	inhibitor	nn	11	SENT_273	[p17l10t2218r323b2284],
11	(	NN	O	(	dobj	6	SENT_273	[p17l364t2216r524b2298],
12	8	CD	PERCENT	8	number	13	SENT_273	[p17l364t2216r524b2298],
13	%	NN	PERCENT	%	amod	11	SENT_273	[p17l364t2216r524b2298],
14	)	CD	NUMBER	)	nsubjpass	16	SENT_273	[p17l364t2216r524b2298],
15	were	VBD	O	be	auxpass	16	SENT_273	[p17l564t2244r730b2284],
16	treated	VBN	O	treat	rcmod	11	SENT_273	[p17l771t2218r1015b2284],
17	with	IN	O	with	_	0	SENT_273	[p17l1051t2218r1212b2284],
18	pantoprazole	NN	O	pantoprazole	prep_with	16	SENT_273	[p17l1251t2218r1730b2307],
19	,	,	O	,	_	0	SENT_273	[p17l1251t2218r1730b2307],
20	which	WDT	O	which	nsubjpass	24	SENT_273	[p17l1769t2218r1986b2284],
21	has	VBZ	O	have	aux	24	SENT_273	[p17l2026t2218r2138b2284],
22	not	RB	O	not	neg	24	SENT_273	[p17l11t2341r129b2390],
23	been	VBN	O	be	auxpass	24	SENT_273	[p17l177t2324r344b2390],
24	associated	VBN	O	associate	rcmod	18	SENT_273	[p17l397t2324r750b2390],
25	With	IN	O	with	_	0	SENT_273	[p17l798t2324r959b2390],
26	increased	VBN	O	increase	amod	28	SENT_273	[p17l1011t2324r1338b2390],
27	platelet	NN	O	platelet	nn	28	SENT_273	[p17l1388t2324r1650b2413],
28	reactivity	NN	O	reactivity	prep_with	24	SENT_273	[p17l1700t2327r2025b2413],
29	in	IN	O	in	_	0	SENT_273	[p17l2073t2327r2141b2389],
30	patients	NNS	O	patient	prep_in	28	SENT_273	[p17l9t2434r286b2520],
31	treated	VBN	O	treat	_	0	SENT_273	[p17l311t2431r555b2497],
32	with	IN	O	with	_	0	SENT_273	[p17l574t2431r736b2497],
33	clopidogrel	NN	O	clopidogrel	nn	34	SENT_273	[p17l760t2431r1313b2520],
34	—	NN	O	—	prep_with	31	SENT_273	[p17l760t2431r1313b2520],
35	in	IN	O	in	_	0	SENT_273	[p17l760t2431r1313b2520],
36	contrast	NN	O	contrast	prep_in	34	SENT_273	[p17l1337t2448r1619b2497],
37	to	TO	O	to	_	0	SENT_273	[p17l1640t2448r1708b2497],
38	omeprazole	NN	O	omeprazole	prep_to	36	SENT_273	[p17l1734t2431r2140b2520],
39	or	CC	O	or	_	0	SENT_273	[p17l11t2563r83b2603],
40	esomeprazole	NN	O	esomeprazole	prep_to	36	SENT_273	[p17l132t2537r608b2626],
41	(	CD	NUMBER	(	number	42	SENT_273	[p17l661t2535r820b2617],
42	36	CD	NUMBER	36	num	43	SENT_273	[p17l661t2535r820b2617],
43	)	NN	O	)	dobj	31	SENT_273	[p17l661t2535r820b2617],
44	.	.	O	.	_	0	SENT_273	[p17l661t2535r820b2617],

1	Therefore	RB	O	therefore	advmod	7	SENT_274	[p17l872t2535r1247b2618],
2	,	,	O	,	_	0	SENT_274	[p17l872t2535r1247b2618],
3	our	PRP$	O	we	poss	4	SENT_274	[p17l1301t2563r1417b2603],
4	analysis	NN	O	analysis	nsubj	7	SENT_274	[p17l1467t2537r1732b2626],
5	could	MD	O	could	aux	7	SENT_274	[p17l1784t2537r1975b2603],
6	not	RB	O	not	neg	7	SENT_274	[p17l2025t2554r2143b2603],
7	evaluate	VB	O	evaluate	_	0	SENT_274	[p17l11t2643r293b2709],
8	the	DT	O	the	det	9	SENT_274	[p17l326t2643r436b2709],
9	impact	NN	O	impact	dobj	7	SENT_274	[p17l470t2646r712b2732],
10	of	IN	O	of	_	0	SENT_274	[p17l744t2643r824b2709],
11	this	DT	O	this	det	13	SENT_274	[p17l845t2643r971b2709],
12	drug	NN	O	drug	nn	13	SENT_274	[p17l1007t2643r1169b2732],
13	class	NN	O	class	prep_of	9	SENT_274	[p17l1201t2643r1376b2709],
14	.	.	O	.	_	0	SENT_274	[p17l1201t2643r1376b2709],

1	We	PRP	O	we	nsubj	3	SENT_275	[p17l95t2749r226b2814],
2	also	RB	O	also	advmod	3	SENT_275	[p17l278t2748r408b2813],
3	need	VBP	O	need	_	0	SENT_275	[p17l459t2748r625b2813],
4	to	TO	O	to	aux	5	SENT_275	[p17l673t2765r741b2813],
5	consider	VB	O	consider	xcomp	3	SENT_275	[p17l793t2748r1088b2813],
6	that	DT	O	that	dobj	5	SENT_275	[p17l1135t2748r1276b2813],
7	some	DT	O	some	nsubjpass	13	SENT_275	[p17l1325t2774r1505b2813],
8	of	IN	O	of	_	0	SENT_275	[p17l1556t2748r1636b2813],
9	the	DT	O	the	det	11	SENT_275	[p17l1672t2748r1783b2813],
10	observed	VBN	O	observe	amod	11	SENT_275	[p17l1833t2748r2141b2814],
11	variability	NN	O	variability	prep_of	7	SENT_275	[p17l7t2854r361b2943],
12	was	VBD	O	be	auxpass	13	SENT_275	[p17l388t2880r516b2920],
13	introduced	VBN	O	introduce	rcmod	6	SENT_275	[p17l552t2854r935b2920],
14	by	IN	O	by	_	0	SENT_275	[p17l966t2854r1052b2943],
15	variations	NNS	O	variation	agent	13	SENT_275	[p17l1078t2857r1420b2920],
16	in	IN	O	in	_	0	SENT_275	[p17l1455t2857r1523b2919],
17	sampling	NN	O	sampling	nn	18	SENT_275	[p17l1558t2854r1878b2943],
18	conditions	NNS	O	condition	prep_in	15	SENT_275	[p17l1911t2854r2137b2920, p17l10t2963r202b3041],
19	,	,	O	,	_	0	SENT_275	[p17l1911t2854r2137b2920, p17l10t2963r202b3041],
20	timing	NN	O	timing	agent	13	SENT_275	[p17l257t2963r494b3049],
21	of	IN	O	of	_	0	SENT_275	[p17l546t2960r626b3026],
22	the	DT	O	the	det	25	SENT_275	[p17l666t2960r776b3026],
23	clopidogrel	NN	O	clopidogrel	nn	25	SENT_275	[p17l831t2960r1225b3049],
24	maintenance	NN	O	maintenance	nn	25	SENT_275	[p17l1278t2963r1727b3026],
25	dose	NN	O	dose	prep_of	20	SENT_275	[p17l1782t2960r1957b3041],
26	,	,	O	,	_	0	SENT_275	[p17l1782t2960r1957b3041],
27	and	CC	O	and	_	0	SENT_275	[p17l2014t2960r2141b3026],
28	scatter	NN	O	scatter	agent	13	SENT_275	[p17l12t3083r240b3132],
29	of	IN	O	of	_	0	SENT_275	[p17l266t3066r345b3132],
30	the	DT	O	the	det	32	SENT_275	[p17l360t3066r470b3132],
31	platelet	NN	O	platelet	nn	32	SENT_275	[p17l496t3066r758b3155],
32	assay	NN	O	assay	prep_of	28	SENT_275	[p17l784t3092r976b3155],
33	.	.	O	.	_	0	SENT_275	[p17l784t3092r976b3155],

1	To	TO	O	to	aux	2	SENT_276	[p17l1004t3064r1109b3132],
2	minimize	VB	O	minimize	dep	6	SENT_276	[p17l1138t3069r1471b3132],
3	these	DT	O	these	det	4	SENT_276	[p17l1498t3066r1678b3132],
4	confounders	NNS	O	confounder	dobj	2	SENT_276	[p17l1707t3066r2139b3132],
5	we	PRP	O	we	nsubj	6	SENT_276	[p17l7t3198r105b3238],
6	implemented	VBD	O	implement	_	0	SENT_276	[p17l135t3172r603b3261],
7	a	DT	O	a	det	9	SENT_276	[p17l633t3198r667b3238],
8	strict	JJ	O	strict	amod	9	SENT_276	[p17l697t3175r872b3238],
9	protocol	NN	O	protocol	dobj	6	SENT_276	[p17l898t3172r1194b3261],
10	for	IN	O	for	_	0	SENT_276	[p17l1222t3172r1322b3238],
11	drug	NN	O	drug	nn	12	SENT_276	[p17l1350t3172r1512b3261],
12	intake	NN	O	intake	prep_for	6	SENT_276	[p17l1540t3172r1754b3238],
13	and	CC	O	and	_	0	SENT_276	[p17l1786t3172r1913b3238],
14	blood	NN	O	blood	nn	15	SENT_276	[p17l1939t3172r2141b3238],
15	sampling	NN	O	sampling	conj_and	12	SENT_276	[p17l12t3278r349b3367],
16	.	.	O	.	_	0	SENT_276	[p17l12t3278r349b3367],

1	In	IN	O	in	_	0	SENT_277	[p17l389t3279r467b3343],
2	addition	NN	O	addition	prep_in	6	SENT_277	[p17l505t3278r817b3359],
3	,	,	O	,	_	0	SENT_277	[p17l505t3278r817b3359],
4	we	PRP	O	we	nsubj	6	SENT_277	[p17l853t3304r951b3344],
5	could	MD	O	could	aux	6	SENT_277	[p17l989t3278r1181b3344],
6	verify	VB	O	verify	_	0	SENT_277	[p17l1213t3278r1414b3367],
7	a	DT	O	a	det	9	SENT_277	[p17l1448t3304r1482b3344],
8	low	JJ	O	low	amod	9	SENT_277	[p17l1516t3278r1645b3344],
9	coeﬂicient	NN	O	coeﬂicient	dobj	6	SENT_277	[p17l1679t3278r2037b3344],
10	of	IN	O	of	_	0	SENT_277	[p17l2073t3278r2153b3344],
11	variation	NN	O	variation	nn	12	SENT_277	[p17l7t3387r319b3450],
12	(	NN	O	(	prep_of	9	SENT_277	[p17l362t3382r522b3464],
13	6	CD	PERCENT	6	number	14	SENT_277	[p17l362t3382r522b3464],
14	%	NN	PERCENT	%	amod	12	SENT_277	[p17l362t3382r522b3464],
15	)	CD	NUMBER	)	npadvmod	6	SENT_277	[p17l362t3382r522b3464],
16	for	IN	O	for	_	0	SENT_277	[p17l566t3384r666b3450],
17	our	PRP$	O	we	poss	20	SENT_277	[p17l705t3410r822b3450],
18	optical	JJ	O	optical	amod	20	SENT_277	[p17l861t3384r1098b3473],
19	aggregometry	NN	O	aggregometry	nn	20	SENT_277	[p17l1138t3401r1624b3473],
20	method	NN	O	method	prep_for	6	SENT_277	[p17l1661t3384r1951b3450],
21	.	.	O	.	_	0	SENT_277	[p17l1661t3384r1951b3450],

1	Our	PRP$	O	we	poss	2	SENT_278	[p17l1998t3384r2142b3450],
2	Hochholzer	NNP	O	Hochholzer	_	0	SENT_278	[p17l1337t3486r1652b3538],
3	et	FW	O	et	nn	4	SENT_278	[p17l1678t3488r1736b3538],
4	al.	FW	O	al.	dep	2	SENT_278	[p17l1756t3486r1823b3538],
5	2433	CD	DATE	2433	dep	2	SENT_278	[p17l1993t3486r2143b3538],

1	P450	NN	O	p450	nn	3	SENT_279	[p17l171t3574r321b3627],
2	2019	CD	DATE	2019	num	3	SENT_279	[p17l346t3574r499b3627],
3	Polymorphisms	NNP	O	Polymorphisms	_	0	SENT_279	[p17l526t3575r956b3637],
4	and	CC	O	and	_	0	SENT_279	[p17l981t3575r1082b3627],
5	Residual	NNP	O	Residual	nn	7	SENT_279	[p17l1112t3575r1349b3627],
6	Platelet	NN	O	platelet	nn	7	SENT_279	[p17l1377t3575r1593b3627],
7	Activity	NN	O	activity	conj_and	3	SENT_279	[p17l1616t3575r1826b3637],

1	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_280	[p18l12t87r295b176],
2	only	RB	O	only	advmod	3	SENT_280	[p18l340t87r493b176],
3	apply	VBP	O	apply	_	0	SENT_280	[p18l533t87r723b176],
4	to	TO	O	to	_	0	SENT_280	[p18l761t104r829b153],
5	stable	JJ	O	stable	amod	6	SENT_280	[p18l875t87r1072b153],
6	patients	NNS	O	patient	prep_to	3	SENT_280	[p18l1114t90r1391b176],
7	undergoing	VBG	O	undergo	partmod	6	SENT_280	[p18l1434t87r1842b176],
8	elective	JJ	O	elective	amod	9	SENT_280	[p18l1884t87r2142b153],
9	PCI	NN	O	pcus	dobj	7	SENT_280	[p18l13t194r181b261],
10	.	.	O	.	_	0	SENT_280	[p18l13t194r181b261],

1	We	PRP	O	we	nsubj	3	SENT_281	[p18l222t195r353b261],
2	purposely	RB	O	purposely	advmod	3	SENT_281	[p18l394t194r737b284],
3	excluded	VBD	O	exclude	_	0	SENT_281	[p18l775t194r1083b261],
4	the	DT	O	the	det	5	SENT_281	[p18l1123t194r1234b261],
5	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_281	[p18l1275t194r1595b261],
6	of	IN	O	of	_	0	SENT_281	[p18l1638t194r1718b261],
7	overt	JJ	O	overt	amod	9	SENT_281	[p18l1748t211r1925b261],
8	heart	NN	O	heart	nn	9	SENT_281	[p18l1964t194r2145b261],
9	failure	NN	O	failure	prep_of	5	SENT_281	[p18l12t301r233b367],
10	and	CC	O	and	_	0	SENT_281	[p18l262t301r390b367],
11	MI	NNP	O	MI	prep_of	5	SENT_281	[p18l413t302r552b382],
12	,	,	O	,	_	0	SENT_281	[p18l413t302r552b382],
13	which	WDT	O	which	nsubjpass	16	SENT_281	[p18l577t301r795b367],
14	have	VBP	O	have	aux	16	SENT_281	[p18l821t301r979b367],
15	been	VBN	O	be	auxpass	16	SENT_281	[p18l1004t301r1171b367],
16	shown	VBN	O	show	rcmod	5	SENT_281	[p18l1199t301r1426b367],
17	to	TO	O	to	aux	18	SENT_281	[p18l1452t318r1520b367],
18	modify	VB	O	modify	xcomp	16	SENT_281	[p18l1549t301r1801b390],
19	the	DT	O	the	det	21	SENT_281	[p18l1823t301r1933b367],
20	acute	JJ	O	acute	amod	21	SENT_281	[p18l1962t318r2142b367],
21	responses	NNS	O	response	dobj	18	SENT_281	[p18l12t434r346b498],
22	to	TO	O	to	_	0	SENT_281	[p18l380t426r448b475],
23	clopidogrel	NN	O	clopidogrel	prep_to	18	SENT_281	[p18l484t409r878b498],
24	substantially	RB	O	substantially	advmod	18	SENT_281	[p18l911t409r1365b498],
25	.	.	O	.	_	0	SENT_281	[p18l911t409r1365b498],

1	Clinical	JJ	O	clinical	amod	2	SENT_282	[p18l14t514r310b582],
2	implications	NNS	O	implication	_	0	SENT_282	[p18l331t514r815b605],
3	.	.	O	.	_	0	SENT_282	[p18l331t514r815b605],

1	Given	VBN	O	give	prep	22	SENT_283	[p18l869t515r1083b582],
2	the	DT	O	the	det	3	SENT_283	[p18l1107t515r1217b581],
3	risks	NNS	O	risk	dep	1	SENT_283	[p18l1242t515r1398b581],
4	associated	VBN	O	associate	partmod	3	SENT_283	[p18l1425t515r1778b581],
5	with	IN	O	with	_	0	SENT_283	[p18l1797t515r1958b582],
6	poor	JJ	O	poor	amod	7	SENT_283	[p18l1981t541r2145b605],
7	suppression	NN	O	suppression	prep_with	4	SENT_283	[p18l14t626r424b712],
8	of	IN	O	of	_	0	SENT_283	[p18l468t623r547b689],
9	platelet	NN	O	platelet	nn	10	SENT_283	[p18l576t623r838b712],
10	function	NN	O	function	prep_of	7	SENT_283	[p18l878t623r1195b704],
11	,	,	O	,	_	0	SENT_283	[p18l878t623r1195b704],
12	identiﬁcation	NN	O	identiﬁcation	nsubj	22	SENT_283	[p18l1241t623r1711b689],
13	of	IN	O	of	_	0	SENT_283	[p18l1755t623r1835b689],
14	patients	NNS	O	patient	prep_of	12	SENT_283	[p18l1864t626r2141b712],
15	with	IN	O	with	_	0	SENT_283	[p18l9t756r170b823],
16	high	JJ	O	high	amod	21	SENT_283	[p18l226t756r385b846],
17	on	IN	O	on	_	0	SENT_283	[p18l442t756r964b846],
18	—	CD	NUMBER	—	num	19	SENT_283	[p18l442t756r964b846],
19	clopidogrel	NN	O	clopidogrel	prep_on	16	SENT_283	[p18l442t756r964b846],
20	platelet	NN	O	platelet	nn	21	SENT_283	[p18l1017t756r1278b846],
21	reactivity	NN	O	reactivity	prep_with	14	SENT_283	[p18l1332t759r1656b846],
22	is	VBZ	O	be	_	0	SENT_283	[p18l1708t759r1758b823],
23	of	IN	O	of	_	0	SENT_283	[p18l1817t756r1896b823],
24	major	JJ	O	major	amod	26	SENT_283	[p18l1941t758r2144b846],
25	clinical	JJ	O	clinical	amod	26	SENT_283	[p18l13t863r262b929],
26	interest	NN	O	interest	prep_of	22	SENT_283	[p18l295t866r575b929],
27	.	.	O	.	_	0	SENT_283	[p18l295t866r575b929],

1	In	IN	O	in	_	0	SENT_284	[p18l614t864r691b928],
2	these	DT	O	these	det	3	SENT_284	[p18l725t863r905b929],
3	patients	NNS	O	patient	prep_in	11	SENT_284	[p18l939t866r1237b952],
4	,	,	O	,	_	0	SENT_284	[p18l939t866r1237b952],
5	alternative	JJ	O	alternative	amod	10	SENT_284	[p18l1276t863r1662b944],
6	,	,	O	,	_	0	SENT_284	[p18l1276t863r1662b944],
7	more	RBR	O	more	advmod	8	SENT_284	[p18l1700t889r1879b929],
8	potent	JJ	O	potent	amod	10	SENT_284	[p18l1913t880r2145b953],
9	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_284	[p18l14t971r410b1060],
10	regimens	NNS	O	regimen	nsubj	11	SENT_284	[p18l437t974r755b1060],
11	have	VBP	O	have	_	0	SENT_284	[p18l785t971r944b1037],
12	to	TO	O	to	aux	14	SENT_284	[p18l973t988r1041b1037],
13	be	VB	O	be	auxpass	14	SENT_284	[p18l1069t971r1150b1037],
14	instituted	VBN	O	institute	xcomp	11	SENT_284	[p18l1179t971r1517b1037],
15	or	CC	O	or	dep	19	SENT_284	[p18l1546t996r1618b1037],
16	they	PRP	O	they	nsubj	19	SENT_284	[p18l1645t971r1798b1060],
17	might	MD	O	might	aux	19	SENT_284	[p18l1824t971r2036b1060],
18	be	VB	O	be	cop	19	SENT_284	[p18l2061t971r2141b1037],
19	ineligible	JJ	O	ineligible	parataxis	14	SENT_284	[p18l12t1077r336b1166],
20	for	IN	O	for	_	0	SENT_284	[p18l368t1077r469b1143],
21	high	JJ	O	high	amod	24	SENT_284	[p18l499t1077r828b1166],
22	—	NN	O	—	nn	24	SENT_284	[p18l499t1077r828b1166],
23	risk	NN	O	risk	nn	24	SENT_284	[p18l499t1077r828b1166],
24	interventions	NNS	O	intervention	prep_for	19	SENT_284	[p18l856t1080r1317b1143],
25	such	JJ	O	such	_	0	SENT_284	[p18l1352t1077r1508b1143],
26	as	IN	O	as	_	0	SENT_284	[p18l1541t1103r1604b1143],
27	the	DT	O	the	det	28	SENT_284	[p18l1638t1077r1748b1143],
28	placement	NN	O	placement	prep_such_as	24	SENT_284	[p18l1779t1077r2145b1167],
29	of	IN	O	of	_	0	SENT_284	[p18l13t1185r93b1251],
30	multiple	JJ	O	multiple	amod	31	SENT_284	[p18l117t1185r409b1274],
31	stents	NNS	O	stent	prep_of	28	SENT_284	[p18l447t1202r646b1251],
32	or	CC	O	or	_	0	SENT_284	[p18l683t1210r755b1251],
33	left	VBN	O	leave	conj_or	14	SENT_284	[p18l788t1185r904b1251],
34	main	JJ	O	main	amod	35	SENT_284	[p18l938t1188r1114b1251],
35	interventions	NNS	O	intervention	dobj	33	SENT_284	[p18l1149t1188r1631b1251],
36	.	.	O	.	_	0	SENT_284	[p18l1149t1188r1631b1251],

1	Nevertheless	RB	O	nevertheless	advmod	8	SENT_285	[p18l1670t1185r2139b1266],
2	,	,	O	,	_	0	SENT_285	[p18l1670t1185r2139b1266],
3	platelet	NN	O	platelet	nn	5	SENT_285	[p18l11t1291r273b1381],
4	function	NN	O	function	nn	5	SENT_285	[p18l318t1291r614b1357],
5	assays	NNS	O	assay	nsubj	8	SENT_285	[p18l663t1317r866b1380],
6	have	VBP	O	have	aux	8	SENT_285	[p18l915t1291r1073b1358],
7	not	RB	O	not	neg	8	SENT_285	[p18l1122t1308r1239b1357],
8	entered	VBN	O	enter	_	0	SENT_285	[p18l1286t1291r1548b1357],
9	routine	JJ	O	routine	amod	11	SENT_285	[p18l1594t1294r1847b1357],
10	clinical	JJ	O	clinical	amod	11	SENT_285	[p18l1896t1291r2144b1357],
11	practice	NN	O	practice	dobj	8	SENT_285	[p18l11t1401r285b1487],
12	in	IN	O	in	_	0	SENT_285	[p18l328t1401r395b1463],
13	most	JJS	O	most	amod	14	SENT_285	[p18l438t1415r612b1464],
14	centers	NNS	O	center	prep_in	11	SENT_285	[p18l652t1415r917b1479],
15	,	,	O	,	_	0	SENT_285	[p18l652t1415r917b1479],
16	because	IN	O	because	mark	20	SENT_285	[p18l960t1398r1230b1464],
17	they	PRP	O	they	nsubj	20	SENT_285	[p18l1272t1398r1426b1487],
18	are	VBP	O	be	aux	20	SENT_285	[p18l1465t1424r1565b1464],
19	technically	RB	O	technically	advmod	20	SENT_285	[p18l1608t1398r1989b1487],
20	demanding	VBG	O	demand	dep	11	SENT_285	[p18l2027t1398r2140b1464, p18l13t1505r346b1595],
21	,	,	O	,	_	0	SENT_285	[p18l2027t1398r2140b1464, p18l13t1505r346b1595],
22	poorly	RB	O	poorly	advmod	23	SENT_285	[p18l400t1505r628b1595],
23	standardized	JJ	O	standardized	amod	11	SENT_285	[p18l678t1505r1145b1586],
24	,	,	O	,	_	0	SENT_285	[p18l678t1505r1145b1586],
25	or	CC	O	or	_	0	SENT_285	[p18l1201t1531r1273b1572],
26	expensive	JJ	O	expensive	amod	11	SENT_285	[p18l1325t1508r1679b1595],
27	.	.	O	.	_	0	SENT_285	[p18l1325t1508r1679b1595],

1	Large-scale	JJ	O	large-scale	amod	2	SENT_286	[p18l1737t1506r2142b1595],
2	studies	NNS	O	study	nsubj	15	SENT_286	[p18l14t1639r252b1705],
3	assessing	VBG	O	assess	partmod	2	SENT_286	[p18l287t1642r600b1728],
4	easy	JJ	O	easy	acomp	3	SENT_286	[p18l631t1656r1031b1728],
5	—	CD	NUMBER	—	tmod	4	SENT_286	[p18l631t1656r1031b1728],
6	to	TO	O	to	_	0	SENT_286	[p18l631t1656r1031b1728],
7	—	CD	NUMBER	—	num	10	SENT_286	[p18l631t1656r1031b1728],
8	use	NN	O	use	nn	10	SENT_286	[p18l631t1656r1031b1728],
9	point	NN	O	point	nn	10	SENT_286	[p18l1063t1639r1535b1729],
10	—	NN	O	—	prep_to	4	SENT_286	[p18l1063t1639r1535b1729],
11	of	IN	O	of	_	0	SENT_286	[p18l1063t1639r1535b1729],
12	—	CD	NUMBER	—	num	14	SENT_286	[p18l1063t1639r1535b1729],
13	care	NN	O	care	nn	14	SENT_286	[p18l1063t1639r1535b1729],
14	assays	NNS	O	assay	prep_of	10	SENT_286	[p18l1569t1665r1772b1728],
15	are	VBP	O	be	_	0	SENT_286	[p18l1807t1665r1907b1705],
16	under	IN	O	under	_	0	SENT_286	[p18l1938t1639r2145b1705],
17	way	NN	O	way	prep_under	15	SENT_286	[p18l9t1773r165b1836],
18	.	.	O	.	_	0	SENT_286	[p18l9t1773r165b1836],

1	Until	IN	O	until	mark	5	SENT_287	[p18l206t1747r394b1813],
2	these	DT	O	these	det	3	SENT_287	[p18l432t1747r611b1813],
3	assays	NNS	O	assay	nsubj	5	SENT_287	[p18l652t1773r855b1836],
4	have	VBP	O	have	aux	5	SENT_287	[p18l896t1747r1054b1813],
5	found	VBN	O	find	advcl	24	SENT_287	[p18l1094t1747r1301b1813],
6	their	PRP$	O	they	poss	7	SENT_287	[p18l1339t1747r1506b1813],
7	Way	NN	O	way	dobj	5	SENT_287	[p18l1539t1773r1681b1836],
8	into	IN	O	into	_	0	SENT_287	[p18l1716t1750r1855b1813],
9	clinical	JJ	O	clinical	amod	10	SENT_287	[p18l1896t1747r2144b1813],
10	practice	NN	O	practice	prep_into	5	SENT_287	[p18l11t1857r306b1944],
11	,	,	O	,	_	0	SENT_287	[p18l11t1857r306b1944],
12	clinical	JJ	O	clinical	amod	15	SENT_287	[p18l333t1854r581b1920],
13	or	CC	O	or	_	0	SENT_287	[p18l603t1880r676b1920],
14	laboratory	JJ	O	laboratory	conj_or	12	SENT_287	[p18l696t1854r1057b1943],
15	predictors	NNS	O	predictor	nsubj	24	SENT_287	[p18l1075t1854r1426b1944],
16	of	IN	O	of	_	0	SENT_287	[p18l1452t1854r1531b1920],
17	a	DT	O	a	det	19	SENT_287	[p18l1544t1880r1578b1920],
18	low	JJ	O	low	amod	19	SENT_287	[p18l1599t1854r1728b1921],
19	response	NN	O	response	prep_of	15	SENT_287	[p18l1747t1880r2050b1944],
20	to	TO	O	to	_	0	SENT_287	[p18l2074t1871r2141b1920],
21	clopidogrel	NN	O	clopidogrel	prep_to	19	SENT_287	[p18l13t1961r408b2050],
22	are	VBP	O	be	cop	24	SENT_287	[p18l441t1986r542b2027],
23	highly	RB	O	highly	advmod	24	SENT_287	[p18l575t1961r800b2050],
24	desirable	JJ	O	desirable	_	0	SENT_287	[p18l830t1961r1157b2027],
25	.	.	O	.	_	0	SENT_287	[p18l830t1961r1157b2027],

1	A	DT	O	a	det	4	SENT_288	[p18l99t2067r166b2134],
2	potentially	RB	O	potentially	advmod	3	SENT_288	[p18l205t2068r584b2158],
3	attractive	JJ	O	attractive	amod	4	SENT_288	[p18l624t2071r946b2135],
4	candidate	NN	O	candidate	nsubj	14	SENT_288	[p18l990t2068r1328b2135],
5	in	IN	O	in	_	0	SENT_288	[p18l1370t2071r1438b2134],
6	this	DT	O	this	det	7	SENT_288	[p18l1480t2069r1607b2135],
7	respect	NN	O	respect	prep_in	4	SENT_288	[p18l1650t2085r1897b2158],
8	is	VBZ	O	be	cop	14	SENT_288	[p18l1937t2071r1988b2135],
9	the	DT	O	the	det	14	SENT_288	[p18l2031t2068r2141b2135],
10	CYP2C19	NN	O	cyp2c19	nn	14	SENT_288	[p18l19t2178r433b2242],
11	*	NN	O	*	nn	14	SENT_288	[p18l19t2178r433b2242],
12	2	CD	NUMBER	2	num	14	SENT_288	[p18l19t2178r433b2242],
13	polymorphism	NN	O	polymorphism	nn	14	SENT_288	[p18l470t2175r985b2265],
14	(	NN	O	(	_	0	SENT_288	[p18l1028t2173r1366b2256],
15	8,13,14	CD	NUMBER	8,13,14	num	16	SENT_288	[p18l1028t2173r1366b2256],
16	)	NN	O	)	dep	14	SENT_288	[p18l1028t2173r1366b2256],
17	.	.	O	.	_	0	SENT_288	[p18l1028t2173r1366b2256],

1	Independent	NNP	O	Independent	nsubj	12	SENT_289	[p18l1408t2175r1863b2265],
2	of	IN	O	of	_	0	SENT_289	[p18l1900t2175r1980b2241],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_289	[p18l2008t2175r2140b2241, p18l11t2283r305b2372],
4	intake	NN	O	intake	prep_of	1	SENT_289	[p18l345t2283r581b2364],
5	,	,	O	,	_	0	SENT_289	[p18l345t2283r581b2364],
6	determination	NN	O	determination	appos	4	SENT_289	[p18l627t2283r1127b2349],
7	of	IN	O	of	_	0	SENT_289	[p18l1170t2283r1250b2349],
8	this	DT	O	this	det	10	SENT_289	[p18l1279t2283r1406b2349],
9	genetic	JJ	O	genetic	amod	10	SENT_289	[p18l1449t2286r1702b2372],
10	trait	NN	O	trait	prep_of	6	SENT_289	[p18l1743t2286r1891b2349],
11	might	MD	O	might	aux	12	SENT_289	[p18l1932t2283r2144b2372],
12	give	VB	O	give	_	0	SENT_289	[p18l11t2419r151b2505],
13	an	DT	O	a	det	14	SENT_289	[p18l199t2442r279b2482],
14	estimate	NN	O	estimate	dobj	12	SENT_289	[p18l326t2419r618b2482],
15	of	IN	O	of	_	0	SENT_289	[p18l665t2416r745b2482],
16	the	DT	O	the	det	17	SENT_289	[p18l778t2416r888b2482],
17	probability	NN	O	probability	prep_of	14	SENT_289	[p18l933t2416r1320b2506],
18	of	IN	O	of	_	0	SENT_289	[p18l1362t2416r1442b2482],
19	a	DT	O	a	det	21	SENT_289	[p18l1477t2442r1511b2482],
20	low	JJ	O	low	amod	21	SENT_289	[p18l1553t2416r1683b2482],
21	response	NN	O	response	prep_of	17	SENT_289	[p18l1724t2442r2027b2505],
22	to	TO	O	to	_	0	SENT_289	[p18l2073t2433r2141b2482],
23	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_289	[p18l13t2551r425b2640],
24	.	.	O	.	_	0	SENT_289	[p18l13t2551r425b2640],

1	Our	PRP$	O	we	poss	3	SENT_290	[p18l457t2551r601b2617],
2	current	JJ	DATE	current	amod	3	SENT_290	[p18l626t2568r879b2617],
3	data	NNS	O	datum	nsubj	26	SENT_290	[p18l903t2551r1069b2632],
4	,	,	O	,	_	0	SENT_290	[p18l903t2551r1069b2632],
5	despite	IN	O	despite	_	0	SENT_290	[p18l1098t2551r1344b2640],
6	conﬁrming	VBG	O	conﬁrming	prepc_despite	26	SENT_290	[p18l1371t2551r1762b2640],
7	the	DT	O	the	det	9	SENT_290	[p18l1785t2551r1895b2617],
8	strong	JJ	O	strong	amod	9	SENT_290	[p18l1923t2568r2145b2640],
9	impact	NN	O	impact	dobj	6	SENT_290	[p18l12t2660r255b2747],
10	of	IN	O	of	_	0	SENT_290	[p18l285t2657r365b2723],
11	the	DT	O	the	det	15	SENT_290	[p18l384t2657r494b2723],
12	CYPZCJ	NNP	O	CYPZCJ	nn	15	SENT_290	[p18l533t2660r827b2724],
13	9	CD	NUMBER	9	num	15	SENT_290	[p18l838t2664r877b2724],
14	loss	NN	O	loss	nn	15	SENT_290	[p18l905t2657r1477b2723],
15	—	NN	O	—	prep_of	9	SENT_290	[p18l905t2657r1477b2723],
16	of	IN	O	of	_	0	SENT_290	[p18l905t2657r1477b2723],
17	—	CD	NUMBER	—	num	19	SENT_290	[p18l905t2657r1477b2723],
18	function	NN	O	function	nn	19	SENT_290	[p18l905t2657r1477b2723],
19	polymorphism	NN	O	polymorphism	prep_of	15	SENT_290	[p18l1507t2657r2023b2747],
20	on	IN	O	on	_	0	SENT_290	[p18l2055t2683r2143b2723],
21	antiplatelet	JJ	O	antiplatelet	amod	22	SENT_290	[p18l14t2764r410b2853],
22	effect	NN	O	effect	prep_on	19	SENT_290	[p18l434t2764r619b2830],
23	of	IN	O	of	_	0	SENT_290	[p18l643t2764r723b2830],
24	clopidogrel	NN	O	clopidogrel	prep_of	22	SENT_290	[p18l736t2764r1149b2853],
25	,	,	O	,	_	0	SENT_290	[p18l736t2764r1149b2853],
26	suggest	VBP	O	suggest	_	0	SENT_290	[p18l1178t2781r1436b2853],
27	that	IN	O	that	complm	32	SENT_290	[p18l1459t2764r1600b2830],
28	genotyping	VBG	O	genotype	csubj	32	SENT_290	[p18l1622t2767r2021b2853],
29	for	IN	O	for	_	0	SENT_290	[p18l2044t2764r2144b2830],
30	CYPZCJ9	NN	O	cypzcj9	prep_for	28	SENT_290	[p18l19t2875r363b2939],
31	is	VBZ	O	be	cop	32	SENT_290	[p18l396t2874r447b2938],
32	insufficient	JJ	O	insufficient	ccomp	26	SENT_290	[p18l484t2871r872b2938],
33	for	IN	O	for	_	0	SENT_290	[p18l905t2871r1005b2938],
34	clinical	JJ	O	clinical	amod	35	SENT_290	[p18l1040t2872r1288b2938],
35	decision	NN	O	decision	prep_for	32	SENT_290	[p18l1323t2871r1915b2961],
36	—	CD	NUMBER	—	num	37	SENT_290	[p18l1323t2871r1915b2961],
37	mal	NN	O	mal	npadvmod	38	SENT_290	[p18l1323t2871r1915b2961],
38	<	JJR	O	<	amod	35	SENT_290	[p18l1323t2871r1915b2961],
39	ing	CD	NUMBER	ing	dep	38	SENT_290	[p18l1323t2871r1915b2961],
40	Without	IN	O	without	dep	39	SENT_290	[p18l1945t2871r2139b2938, p18l13t2995r129b3044],
41	platelet	NN	O	platelet	nn	43	SENT_290	[p18l163t2978r424b3068],
42	function	NN	O	function	nn	43	SENT_290	[p18l459t2978r756b3044],
43	testing	NN	O	testing	pobj	40	SENT_290	[p18l793t2981r1048b3067],
44	.	.	O	.	_	0	SENT_290	[p18l793t2981r1048b3067],

1	Addition	NN	O	addition	nsubj	8	SENT_291	[p18l1088t2977r1413b3044],
2	of	IN	O	of	_	0	SENT_291	[p18l1451t2978r1530b3044],
3	clinical	JJ	O	clinical	amod	4	SENT_291	[p18l1557t2978r1805b3044],
4	variables	NNS	O	variable	prep_of	1	SENT_291	[p18l1837t2978r2141b3044],
5	could	MD	O	could	aux	8	SENT_291	[p18l13t3086r205b3152],
6	not	RB	O	not	neg	8	SENT_291	[p18l238t3103r355b3152],
7	fully	RB	O	fully	advmod	8	SENT_291	[p18l386t3086r544b3175],
8	correct	VB	O	correct	_	0	SENT_291	[p18l574t3103r816b3152],
9	this	DT	O	this	det	10	SENT_291	[p18l846t3086r973b3152],
10	shortcoming	NN	O	shortcoming	dobj	8	SENT_291	[p18l1009t3086r1472b3175],
11	.	.	O	.	_	0	SENT_291	[p18l1009t3086r1472b3175],

1	Thus	RB	O	thus	advmod	7	SENT_292	[p18l99t3192r305b3274],
2	,	,	O	,	_	0	SENT_292	[p18l99t3192r305b3274],
3	our	PRP$	O	we	poss	4	SENT_292	[p18l370t3219r487b3259],
4	study	NN	O	study	nsubj	7	SENT_292	[p18l549t3193r738b3282],
5	does	VBZ	O	do	aux	7	SENT_292	[p18l797t3193r951b3259],
6	not	RB	O	not	neg	7	SENT_292	[p18l1016t3210r1133b3259],
7	suggest	VB	O	suggest	_	0	SENT_292	[p18l1194t3210r1452b3282],
8	that	IN	O	that	complm	28	SENT_292	[p18l1512t3193r1671b3274],
9	,	,	O	,	_	0	SENT_292	[p18l1512t3193r1671b3274],
10	in	IN	O	in	dep	28	SENT_292	[p18l1736t3196r1803b3259],
11	patients	NNS	O	patient	pobj	10	SENT_292	[p18l1864t3196r2141b3283],
12	critically	RB	O	critically	advmod	13	SENT_292	[p18l13t3300r314b3389],
13	dependent	JJ	O	dependent	amod	11	SENT_292	[p18l348t3300r721b3389],
14	on	IN	O	on	_	0	SENT_292	[p18l757t3326r844b3366],
15	adequate	JJ	O	adequate	amod	17	SENT_292	[p18l883t3300r1193b3389],
16	platelet	NN	O	platelet	nn	17	SENT_292	[p18l1230t3300r1492b3389],
17	inhibition	NN	O	inhibition	prep_on	11	SENT_292	[p18l1527t3300r1898b3381],
18	,	,	O	,	_	0	SENT_292	[p18l1527t3300r1898b3381],
19	genotyping	NN	O	genotyping	nsubj	28	SENT_292	[p18l1937t3326r2140b3389, p18l12t3410r238b3497],
20	alone	RB	O	alone	dep	19	SENT_292	[p18l285t3407r469b3474],
21	or	CC	O	or	_	0	SENT_292	[p18l518t3433r590b3474],
22	in	IN	O	in	dep	19	SENT_292	[p18l635t3410r703b3473],
23	combination	NN	O	combination	pobj	22	SENT_292	[p18l751t3408r1197b3474],
24	with	IN	O	with	_	0	SENT_292	[p18l1241t3407r1402b3474],
25	clinical	JJ	O	clinical	amod	26	SENT_292	[p18l1450t3407r1698b3474],
26	factors	NNS	O	factor	prep_with	23	SENT_292	[p18l1744t3407r1975b3474],
27	can	MD	O	can	aux	28	SENT_292	[p18l2025t3434r2143b3474],
28	replace	VB	O	replace	ccomp	7	SENT_292	[p18l12t3541r257b3631],
29	phenotyping	NN	O	phenotyping	dobj	28	SENT_292	[p18l290t3541r739b3631],
30	of	IN	O	of	_	0	SENT_292	[p18l771t3541r851b3607],
31	platelet	NN	O	platelet	nn	32	SENT_292	[p18l871t3541r1132b3631],
32	function	NN	O	function	prep_of	29	SENT_292	[p18l1163t3541r1478b3607],
33	.	.	O	.	_	0	SENT_292	[p18l1163t3541r1478b3607],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_293	[p19l7t87r633b168],
2	The	DT	O	the	det	3	SENT_293	[p19l10t185r157b253],
3	authors	NNS	O	author	nsubj	4	SENT_293	[p19l203t187r462b253],
4	thank	VBP	O	thank	rcmod	1	SENT_293	[p19l507t187r714b253],
5	Charles	NNP	PERSON	Charles	nn	7	SENT_293	[p19l756t187r1024b253],
6	F.	NNP	PERSON	F.	nn	7	SENT_293	[p19l1070t188r1137b253],
7	Contant	NNP	PERSON	Contant	dobj	4	SENT_293	[p19l1188t187r1484b253],
8	and	CC	O	and	_	0	SENT_293	[p19l1528t187r1655b253],
9	Satishkumar	NNP	PERSON	Satishkumar	dobj	4	SENT_293	[p19l1702t187r2144b253],

1	Mohanavelu	NNP	O	Mohanavelu	_	0	SENT_294	[p19l11t294r456b360],
2	for	IN	O	for	_	0	SENT_294	[p19l489t294r589b360],
3	their	PRP$	O	they	poss	6	SENT_294	[p19l620t294r787b360],
4	excellent	JJ	O	excellent	amod	6	SENT_294	[p19l819t294r1127b360],
5	statistical	JJ	O	statistical	amod	6	SENT_294	[p19l1160t294r1487b360],
6	support	NN	O	support	prep_for	1	SENT_294	[p19l1520t311r1804b383],
7	.	.	O	.	_	0	SENT_294	[p19l1520t311r1804b383],

1	Reprint	JJ	MISC	reprint	amod	2	SENT_295	[p19l14t529r274b609],
2	requests	NNS	O	request	_	0	SENT_295	[p19l305t543r579b609],
3	and	CC	O	and	_	0	SENT_295	[p19l614t527r736b588],
4	correspondence	NN	O	correspondence	conj_and	2	SENT_295	[p19l768t527r1312b609],
5	:	:	O	:	_	0	SENT_295	[p19l768t527r1312b609],
6	Dr.	NNP	O	Dr.	nn	8	SENT_295	[p19l1349t529r1455b588],
7	Willibald	NNP	PERSON	Willibald	nn	8	SENT_295	[p19l1489t528r1794b588],
8	Hochhol	NNP	PERSON	Hochhol	dep	2	SENT_295	[p19l1827t528r2140b588],
9	—	CD	NUMBER	—	num	10	SENT_295	[p19l1827t528r2140b588],
10	zer	NN	O	zer	dep	2	SENT_295	[p19l11t648r123b698],
11	,	,	O	,	_	0	SENT_295	[p19l11t648r123b698],
12	TIMI	NNP	ORGANIZATION	TIMI	nn	14	SENT_295	[p19l159t624r351b684],
13	Study	NNP	ORGANIZATION	Study	nn	14	SENT_295	[p19l392t625r576b705],
14	Group	NNP	ORGANIZATION	Group	appos	2	SENT_295	[p19l610t625r837b706],
15	,	,	O	,	_	0	SENT_295	[p19l610t625r837b706],
16	Cardiovascular	NNP	MISC	Cardiovascular	nn	17	SENT_295	[p19l877t625r1351b685],
17	Division	NNP	MISC	Division	appos	2	SENT_295	[p19l1385t626r1674b698],
18	,	,	O	,	_	0	SENT_295	[p19l1385t626r1674b698],
19	Brigham	NNP	ORGANIZATION	Brigham	appos	2	SENT_295	[p19l1713t625r1991b705],
20	and	CC	O	and	_	0	SENT_295	[p19l2029t626r2144b685],
21	Women	NNP	O	Women	poss	23	SENT_295	[p19l9t723r316b783],
22	’s	POS	O	’s	_	0	SENT_295	[p19l9t723r316b783],
23	Hospital	NNP	O	Hospital	conj_and	19	SENT_295	[p19l370t723r663b803],
24	,	,	O	,	_	0	SENT_295	[p19l370t723r663b803],
25	75	CD	NUMBER	75	appos	2	SENT_295	[p19l718t723r791b782],
26	Francis	NNP	LOCATION	Francis	nn	31	SENT_295	[p19l845t723r1075b782],
27	Street	NNP	LOCATION	Street	nn	31	SENT_295	[p19l1131t723r1333b795],
28	,	,	O	,	_	0	SENT_295	[p19l1131t723r1333b795],
29	Boston	NNP	LOCATION	Boston	appos	31	SENT_295	[p19l1387t724r1630b795],
30	,	,	O	,	_	0	SENT_295	[p19l1387t724r1630b795],
31	Massachusetts	NNP	LOCATION	Massachusetts	dep	25	SENT_295	[p19l1683t723r2142b782],
32	02115	CD	DATE	02115	num	31	SENT_295	[p19l13t820r226b880],
33	.	.	O	.	_	0	SENT_295	[p19l13t820r226b880],

1	E	NN	O	e	nn	3	SENT_296	[p19l261t820r501b879],
2	—	CD	NUMBER	—	num	3	SENT_296	[p19l261t820r501b879],
3	mail	NN	O	mail	_	0	SENT_296	[p19l261t820r501b879],
4	:	:	O	:	_	0	SENT_296	[p19l261t820r501b879],
5	whochholzer@partners.org	NN	O	whochholzer@partners.org	dep	3	SENT_296	[p19l531t820r1411b900],
6	.	.	O	.	_	0	SENT_296	[p19l531t820r1411b900],

1	REFERENCES	NNS	O	reference	_	0	SENT_297	[p19l13t1116r402b1160],

1	1	LS	NUMBER	1	_	0	SENT_298	[p19l51t1271r95b1321],
2	.	.	O	.	_	0	SENT_298	[p19l51t1271r95b1321],

1	Leon	NNP	O	Leon	nn	2	SENT_299	[p19l138t1269r285b1321],
2	MB	NNP	O	MB	_	0	SENT_299	[p19l307t1269r438b1333],
3	,	,	O	,	_	0	SENT_299	[p19l307t1269r438b1333],
4	Baim	NNP	PERSON	Baim	nn	5	SENT_299	[p19l464t1269r614b1321],
5	DS	NN	O	d	appos	2	SENT_299	[p19l638t1268r748b1333],
6	,	,	O	,	_	0	SENT_299	[p19l638t1268r748b1333],
7	Popma	NNP	PERSON	Popma	nn	8	SENT_299	[p19l774t1269r975b1340],
8	JJ	NN	PERSON	jj	appos	2	SENT_299	[p19l990t1269r1057b1336],
9	,	,	O	,	_	0	SENT_299	[p19l990t1269r1057b1336],
10	et	FW	O	et	nn	11	SENT_299	[p19l1084t1282r1134b1321],
11	al.	FW	O	al.	appos	2	SENT_299	[p19l1158t1268r1217b1321],
12	.	.	O	.	_	0	SENT_299	[p19l1158t1268r1217b1321],

1	A	DT	O	a	det	3	SENT_300	[p19l1242t1267r1296b1320],
2	clinical	JJ	O	clinical	amod	3	SENT_300	[p19l1318t1268r1516b1321],
3	trial	NN	O	trial	_	0	SENT_300	[p19l1539t1268r1652b1321],
4	comparing	VBG	O	compare	partmod	3	SENT_300	[p19l1675t1270r1977b1340],
5	three	CD	NUMBER	three	num	9	SENT_300	[p19l1999t1268r2142b1321],
6	antithrombotic	JJ	O	antithrombotic	amod	9	SENT_300	[p19l138t1349r726b1420],
7	—	NN	O	—	nn	9	SENT_300	[p19l138t1349r726b1420],
8	drug	NN	O	drug	nn	9	SENT_300	[p19l138t1349r726b1420],
9	regimens	NNS	O	regimen	dobj	4	SENT_300	[p19l751t1352r1006b1420],
10	after	IN	O	after	_	0	SENT_300	[p19l1036t1349r1163b1402],
11	coronary	JJ	O	coronary	amod	14	SENT_300	[p19l1190t1363r1628b1420],
12	—	NN	O	—	nn	14	SENT_300	[p19l1190t1363r1628b1420],
13	artery	NN	O	artery	nn	14	SENT_300	[p19l1190t1363r1628b1420],
14	stenting	NN	O	stenting	prep_after	9	SENT_300	[p19l1654t1352r1894b1420],
15	.	.	O	.	_	0	SENT_300	[p19l1654t1352r1894b1420],

1	N	NN	O	n	nn	3	SENT_301	[p19l1925t1350r1977b1401],
2	Engl	NNP	O	Engl	nn	3	SENT_301	[p19l2008t1349r2144b1420],
3	J	NNP	O	J	nsubj	4	SENT_301	[p19l130t1446r158b1513],
4	Med	VBD	O	med	_	0	SENT_301	[p19l183t1446r319b1498],
5	1998	CD	DATE	1998	dobj	4	SENT_301	[p19l348t1446r891b1510],
6	;	:	O	;	_	0	SENT_301	[p19l348t1446r891b1510],
7	339:1665	CD	NUMBER	339:1665	number	8	SENT_301	[p19l348t1446r891b1510],
8	—	CD	NUMBER	—	dep	5	SENT_301	[p19l348t1446r891b1510],
9	71	CD	NUMBER	71	dep	8	SENT_301	[p19l348t1446r891b1510],
10	.	.	O	.	_	0	SENT_301	[p19l348t1446r891b1510],

1	2	LS	NUMBER	2	_	0	SENT_302	[p19l46t1527r95b1578],
2	.	.	O	.	_	0	SENT_302	[p19l46t1527r95b1578],

1	Schomig	NNP	O	Schomig	nn	2	SENT_303	[p19l140t1524r389b1596],
2	A	NNP	O	A	_	0	SENT_303	[p19l406t1523r473b1589],
3	,	,	O	,	_	0	SENT_303	[p19l406t1523r473b1589],
4	Neumann	NNP	PERSON	Neumann	nn	5	SENT_303	[p19l495t1525r779b1577],
5	FJ	NNP	O	FJ	appos	2	SENT_303	[p19l800t1525r879b1592],
6	,	,	O	,	_	0	SENT_303	[p19l800t1525r879b1592],
7	Kastrati	NNP	PERSON	Kastrati	nn	8	SENT_303	[p19l904t1525r1124b1577],
8	A	NNP	O	A	appos	2	SENT_303	[p19l1143t1523r1210b1589],
9	,	,	O	,	_	0	SENT_303	[p19l1143t1523r1210b1589],
10	et	FW	O	et	nn	11	SENT_303	[p19l1234t1538r1285b1577],
11	al.	FW	O	al.	appos	2	SENT_303	[p19l1305t1524r1364b1577],
12	.	.	O	.	_	0	SENT_303	[p19l1305t1524r1364b1577],

1	A	DT	O	a	_	0	SENT_304	[p19l1386t1523r1439b1577],
2	randomized	VBN	O	randomize	dep	1	SENT_304	[p19l1458t1524r1796b1577],
3	comparison	NN	O	comparison	dobj	2	SENT_304	[p19l1816t1527r2143b1596],
4	of	IN	O	of	_	0	SENT_304	[p19l138t1606r201b1658],
5	antiplatelet	JJ	O	antiplatelet	prep_of	3	SENT_304	[p19l240t1606r557b1676],
6	and	CC	O	and	_	0	SENT_304	[p19l604t1606r706b1658],
7	anticoagulant	JJ	O	anticoagulant	amod	8	SENT_304	[p19l754t1606r1136b1676],
8	therapy	NN	O	therapy	conj_and	2	SENT_304	[p19l1182t1606r1396b1676],
9	after	IN	O	after	dep	8	SENT_304	[p19l1441t1606r1569b1658],
10	the	DT	O	the	pobj	9	SENT_304	[p19l1615t1606r1703b1658],
11	placement	NN	O	placement	tmod	10	SENT_304	[p19l1750t1606r2042b1676],
12	of	IN	O	of	_	0	SENT_304	[p19l2089t1606r2152b1658],
13	coronary-artery	JJ	O	coronary-artery	prep_of	10	SENT_304	[p19l138t1697r577b1754],
14	stents	NNS	O	stent	dep	10	SENT_304	[p19l601t1697r776b1735],
15	.	.	O	.	_	0	SENT_304	[p19l601t1697r776b1735],

1	N	NN	O	n	nn	2	SENT_305	[p19l806t1684r858b1735],
2	EnglJ	NN	O	englj	nsubj	3	SENT_305	[p19l887t1683r1070b1754],
3	Med	VBD	O	med	_	0	SENT_305	[p19l1095t1683r1232b1735],
4	1996	CD	DATE	1996	dobj	3	SENT_305	[p19l1261t1686r1776b1747],
5	;	:	O	;	_	0	SENT_305	[p19l1261t1686r1776b1747],
6	334:1084	CD	NUMBER	334:1084	number	7	SENT_305	[p19l1261t1686r1776b1747],
7	—	CD	NUMBER	—	dep	4	SENT_305	[p19l1261t1686r1776b1747],
8	9	CD	NUMBER	9	dep	7	SENT_305	[p19l1261t1686r1776b1747],
9	.	.	O	.	_	0	SENT_305	[p19l1261t1686r1776b1747],

1	3	LS	NUMBER	3	_	0	SENT_306	[p19l49t1764r95b1815],
2	.	.	O	.	_	0	SENT_306	[p19l49t1764r95b1815],

1	Hochholzer	NNP	O	Hochholzer	nn	2	SENT_307	[p19l138t1762r476b1815],
2	W	NNP	O	W	_	0	SENT_307	[p19l513t1762r603b1827],
3	,	,	O	,	_	0	SENT_307	[p19l513t1762r603b1827],
4	Trenk	NNP	PERSON	Trenk	nn	5	SENT_307	[p19l644t1760r824b1815],
5	D	NNP	O	D	appos	2	SENT_307	[p19l861t1762r932b1827],
6	,	,	O	,	_	0	SENT_307	[p19l861t1762r932b1827],
7	Frundi	NNP	O	Frundi	nn	8	SENT_307	[p19l976t1762r1169b1815],
8	D	NNP	O	D	appos	2	SENT_307	[p19l1210t1762r1281b1827],
9	,	,	O	,	_	0	SENT_307	[p19l1210t1762r1281b1827],
10	et	FW	O	et	nn	11	SENT_307	[p19l1324t1776r1375b1815],
11	al.	FW	O	al.	appos	2	SENT_307	[p19l1416t1762r1475b1815],
12	.	.	O	.	_	0	SENT_307	[p19l1416t1762r1475b1815],

1	Time	NNP	O	Time	nn	2	SENT_308	[p19l1517t1760r1672b1815],
2	dependence	NN	O	dependence	_	0	SENT_308	[p19l1714t1762r2047b1833],
3	of	IN	O	of	_	0	SENT_308	[p19l2089t1762r2152b1815],
4	platelet	NN	O	platelet	nn	5	SENT_308	[p19l136t1840r345b1911],
5	inhibition	NN	O	inhibition	prep_of	2	SENT_308	[p19l379t1840r660b1892],
6	after	IN	O	after	_	0	SENT_308	[p19l696t1840r823b1892],
7	a	DT	O	a	det	10	SENT_308	[p19l858t1861r886b1892],
8	600-mg	JJ	O	600-mg	amod	10	SENT_308	[p19l921t1843r1146b1911],
9	loading	NN	O	loading	nn	10	SENT_308	[p19l1179t1840r1391b1911],
10	dose	NN	O	dose	prep_after	2	SENT_308	[p19l1425t1840r1549b1892],
11	of	IN	O	of	_	0	SENT_308	[p19l1586t1840r1650b1892],
12	clopidogrel	NN	O	clopidogrel	prep_of	10	SENT_308	[p19l1676t1840r1991b1911],
13	in	IN	O	in	_	0	SENT_308	[p19l2026t1842r2080b1892],
14	a	DT	O	a	det	18	SENT_308	[p19l2116t1861r2144b1892],
15	large	JJ	O	large	amod	18	SENT_308	[p19l136t1919r288b1989],
16	,	,	O	,	_	0	SENT_308	[p19l136t1919r288b1989],
17	unselected	JJ	O	unselected	amod	18	SENT_308	[p19l336t1919r632b1971],
18	cohort	NN	O	cohort	prep_in	2	SENT_308	[p19l679t1919r863b1971],
19	of	IN	O	of	_	0	SENT_308	[p19l909t1918r973b1971],
20	candidates	NNS	O	candidate	prep_of	18	SENT_308	[p19l1011t1918r1305b1971],
21	for	IN	O	for	_	0	SENT_308	[p19l1353t1918r1434b1971],
22	percutaneous	JJ	O	percutaneous	amod	24	SENT_308	[p19l1479t1932r1850b1989],
23	coronary	JJ	O	coronary	amod	24	SENT_308	[p19l1899t1939r2146b1989],
24	intervention	NN	O	intervention	prep_for	20	SENT_308	[p19l137t1999r497b2050],
25	.	.	O	.	_	0	SENT_308	[p19l137t1999r497b2050],

1	Circulation	NN	O	circulation	_	0	SENT_309	[p19l528t1997r849b2050],
2	2005	CD	DATE	2005	num	1	SENT_309	[p19l874t1997r1402b2061],
3	;	:	O	;	_	0	SENT_309	[p19l874t1997r1402b2061],
4	111:2560	CD	NUMBER	111:2560	number	5	SENT_309	[p19l874t1997r1402b2061],
5	—	CD	NUMBER	—	dep	1	SENT_309	[p19l874t1997r1402b2061],
6	4	CD	NUMBER	4	dep	5	SENT_309	[p19l874t1997r1402b2061],
7	.	.	O	.	_	0	SENT_309	[p19l874t1997r1402b2061],

1	4	LS	NUMBER	4	_	0	SENT_310	[p19l47t2079r95b2130],
2	.	.	O	.	_	0	SENT_310	[p19l47t2079r95b2130],

1	Angiolillo	JJ	O	angiolillo	amod	2	SENT_311	[p19l135t2075r422b2148],
2	DJ	NNP	O	DJ	_	0	SENT_311	[p19l468t2077r562b2144],
3	,	,	O	,	_	0	SENT_311	[p19l468t2077r562b2144],
4	Bernardo	NNP	PERSON	Bernardo	nn	5	SENT_311	[p19l610t2077r872b2130],
5	E	NNP	PERSON	E	appos	2	SENT_311	[p19l919t2077r980b2142],
6	,	,	O	,	_	0	SENT_311	[p19l919t2077r980b2142],
7	Sabate	NNP	O	Sabate	nn	8	SENT_311	[p19l1030t2076r1212b2130],
8	M	NNP	O	M	appos	2	SENT_311	[p19l1257t2077r1340b2141],
9	,	,	O	,	_	0	SENT_311	[p19l1257t2077r1340b2141],
10	et	FW	O	et	nn	11	SENT_311	[p19l1388t2090r1439b2130],
11	al.	FW	O	al.	appos	2	SENT_311	[p19l1484t2077r1543b2130],
12	.	.	O	.	_	0	SENT_311	[p19l1484t2077r1543b2130],

1	Impact	NN	O	impact	_	0	SENT_312	[p19l1591t2077r1793b2148],
2	of	IN	O	of	_	0	SENT_312	[p19l1837t2076r1901b2130],
3	platelet	NN	O	platelet	nn	4	SENT_312	[p19l1935t2077r2144b2148],
4	reactivity	NN	O	reactivity	prep_of	1	SENT_312	[p19l137t2160r396b2228],
5	on	IN	O	on	_	0	SENT_312	[p19l420t2178r490b2210],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_312	[p19l517t2158r914b2210],
7	outcomes	NNS	O	outcome	prep_on	1	SENT_312	[p19l939t2172r1206b2210],
8	in	IN	O	in	_	0	SENT_312	[p19l1233t2160r1287b2210],
9	patients	NNS	O	patient	prep_in	1	SENT_312	[p19l1312t2160r1534b2229],
10	with	IN	O	with	_	0	SENT_312	[p19l1558t2158r1687b2210],
11	type	NN	O	type	nn	14	SENT_312	[p19l1713t2172r1830b2229],
12	2	CD	NUMBER	2	num	14	SENT_312	[p19l1855t2161r1888b2211],
13	diabetes	NN	O	diabetes	nn	14	SENT_312	[p19l1916t2158r2142b2210],
14	mellitus	NN	O	mellitus	prep_with	9	SENT_312	[p19l138t2238r360b2291],
15	and	CC	O	and	_	0	SENT_312	[p19l401t2238r503b2291],
16	coronary	JJ	O	coronary	amod	18	SENT_312	[p19l542t2258r789b2309],
17	artery	NN	O	artery	nn	18	SENT_312	[p19l826t2251r988b2309],
18	disease	NN	O	disease	prep_with	9	SENT_312	[p19l1025t2238r1234b2291],
19	.	.	O	.	_	0	SENT_312	[p19l1025t2238r1234b2291],

1	J	NNP	O	J	nn	4	SENT_313	[p19l1269t2238r1297b2305],
2	Am	NNP	O	Am	nn	4	SENT_313	[p19l1334t2236r1443b2290],
3	Coll	NNP	O	Coll	nn	4	SENT_313	[p19l1484t2237r1605b2291],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_313	[p19l1644t2237r1859b2291],
5	2007	CD	DATE	2007	num	4	SENT_313	[p19l1895t2238r2139b2303],
6	;	:	O	;	_	0	SENT_313	[p19l1895t2238r2139b2303],
7	50	CD	NUMBER	50	num	9	SENT_313	[p19l1895t2238r2139b2303],
8	:	:	O	:	_	0	SENT_313	[p19l1895t2238r2139b2303],
9	1541-7	CD	NUMBER	1541-7	dep	4	SENT_313	[p19l140t2318r362b2370],
10	.	.	O	.	_	0	SENT_313	[p19l140t2318r362b2370],

1	2434	CD	DATE	2434	num	2	SENT_314	[p19l8t2406r159b2458],
2	Hochholzer	NNP	O	Hochholzer	_	0	SENT_314	[p19l330t2407r646b2458],
3	et	FW	O	et	nn	4	SENT_314	[p19l666t2408r723b2458],
4	al.	FW	O	al.	dep	2	SENT_314	[p19l738t2406r805b2458],
5	.	.	O	.	_	0	SENT_314	[p19l738t2406r805b2458],

1	P450	NN	O	p450	_	0	SENT_315	[p19l330t2494r480b2547],
2	20	CD	NUMBER	20	num	1	SENT_315	[p19l500t2494r575b2547],
3	19	CD	NUMBER	19	num	4	SENT_315	[p19l583t2494r652b2547],
4	Polymorphisms	NNS	O	polymorphism	dep	1	SENT_315	[p19l673t2495r1104b2557],
5	and	CC	O	and	_	0	SENT_315	[p19l1123t2495r1224b2547],
6	Residual	JJ	O	residual	amod	8	SENT_315	[p19l1248t2495r1486b2547],
7	Platelet	NN	O	platelet	nn	8	SENT_315	[p19l1509t2495r1725b2547],
8	Activity	NN	O	activity	conj_and	4	SENT_315	[p19l1742t2495r1952b2557],

1	5	CD	NUMBER	5	_	0	SENT_316	[p19l43t2717r91b2770],
2	.	.	O	.	_	0	SENT_316	[p19l43t2717r91b2770],

1	Buonamici	NNP	PERSON	Buonamici	nn	2	SENT_317	[p19l133t2717r442b2770],
2	P	NN	PERSON	p	_	0	SENT_317	[p19l479t2717r535b2782],
3	,	,	O	,	_	0	SENT_317	[p19l479t2717r535b2782],
4	Marcucci	NNP	PERSON	Marcucci	nn	5	SENT_317	[p19l574t2717r840b2770],
5	R	NNP	PERSON	R	appos	2	SENT_317	[p19l879t2717r940b2782],
6	,	,	O	,	_	0	SENT_317	[p19l879t2717r940b2782],
7	Migliorini	NNP	PERSON	Migliorini	nn	8	SENT_317	[p19l978t2717r1273b2788],
8	A	NNP	O	A	appos	2	SENT_317	[p19l1309t2715r1377b2782],
9	,	,	O	,	_	0	SENT_317	[p19l1309t2715r1377b2782],
10	et	FW	O	et	nn	11	SENT_317	[p19l1417t2730r1468b2770],
11	al.	FW	O	al.	appos	2	SENT_317	[p19l1505t2717r1565b2770],
12	.	.	O	.	_	0	SENT_317	[p19l1505t2717r1565b2770],

1	Impact	NN	O	impact	_	0	SENT_318	[p19l1605t2717r1807b2788],
2	of	IN	O	of	_	0	SENT_318	[p19l1843t2716r1907b2770],
3	platelet	NN	O	platelet	nn	4	SENT_318	[p19l1934t2716r2143b2788],
4	reactivity	NN	O	reactivity	prep_of	1	SENT_318	[p19l133t2800r397b2869],
5	after	IN	O	after	_	0	SENT_318	[p19l446t2797r575b2851],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_318	[p19l625t2798r946b2869],
7	administration	NN	O	administration	prep_after	1	SENT_318	[p19l997t2798r1417b2851],
8	on	IN	O	on	_	0	SENT_318	[p19l1469t2818r1539b2851],
9	drug-eluting	JJ	O	drug-eluting	amod	11	SENT_318	[p19l1591t2797r1953b2869],
10	stent	NN	O	stent	nn	11	SENT_318	[p19l2003t2811r2142b2851],
11	thrombosis	NN	O	thrombosis	prep_on	1	SENT_318	[p19l133t2878r464b2930],
12	.	.	O	.	_	0	SENT_318	[p19l133t2878r464b2930],

1	J	NNP	O	J	nn	4	SENT_319	[p19l487t2878r515b2945],
2	Am	NNP	O	Am	nn	4	SENT_319	[p19l539t2876r648b2929],
3	Coll	NNP	O	Coll	nn	4	SENT_319	[p19l677t2877r799b2930],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_319	[p19l826t2877r1040b2930],
5	2007	CD	DATE	2007	num	4	SENT_319	[p19l1064t2879r1541b2942],
6	;	:	O	;	_	0	SENT_319	[p19l1064t2879r1541b2942],
7	49:2312	CD	NUMBER	49:2312	number	8	SENT_319	[p19l1064t2879r1541b2942],
8	-7	CD	NUMBER	-7	dep	4	SENT_319	[p19l1064t2879r1541b2942],
9	.	.	O	.	_	0	SENT_319	[p19l1064t2879r1541b2942],

1	6	CD	NUMBER	6	_	0	SENT_320	[p19l45t2959r91b3010],
2	.	.	O	.	_	0	SENT_320	[p19l45t2959r91b3010],

1	Hochholzer	NNP	O	Hochholzer	nn	2	SENT_321	[p19l133t2957r473b3010],
2	W	NNP	O	W	_	0	SENT_321	[p19l494t2957r585b3022],
3	,	,	O	,	_	0	SENT_321	[p19l494t2957r585b3022],
4	Trenk	NNP	ORGANIZATION	Trenk	nn	5	SENT_321	[p19l610t2955r791b3010],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_321	[p19l813t2957r884b3021],
6	,	,	O	,	_	0	SENT_321	[p19l813t2957r884b3021],
7	Bestehorn	NNP	O	Bestehorn	nn	8	SENT_321	[p19l913t2957r1201b3010],
8	HP	NNP	O	HP	appos	2	SENT_321	[p19l1227t2957r1344b3021],
9	,	,	O	,	_	0	SENT_321	[p19l1227t2957r1344b3021],
10	et	FW	O	et	nn	11	SENT_321	[p19l1372t2970r1423b3010],
11	al.	FW	O	al.	appos	2	SENT_321	[p19l1449t2957r1508b3010],
12	.	.	O	.	_	0	SENT_321	[p19l1449t2957r1508b3010],

1	Impact	NN	O	impact	_	0	SENT_322	[p19l1537t2957r1739b3028],
2	of	IN	O	of	_	0	SENT_322	[p19l1763t2957r1827b3010],
3	the	DT	O	the	det	4	SENT_322	[p19l1843t2957r1931b3010],
4	degree	NN	O	degree	prep_of	1	SENT_322	[p19l1958t2957r2141b3028],
5	of	IN	O	of	_	0	SENT_322	[p19l133t3036r197b3090],
6	peri	FW	O	peri	nn	7	SENT_322	[p19l209t3037r744b3108],
7	—	FW	O	—	amod	10	SENT_322	[p19l209t3037r744b3108],
8	interventional	JJ	O	interventional	amod	10	SENT_322	[p19l209t3037r744b3108],
9	platelet	NN	O	platelet	nn	10	SENT_322	[p19l764t3037r973b3108],
10	inhibition	NN	O	inhibition	prep_of	1	SENT_322	[p19l994t3037r1275b3090],
11	after	IN	O	after	_	0	SENT_322	[p19l1298t3036r1426b3090],
12	loading	VBG	O	load	prepc_after	1	SENT_322	[p19l1445t3036r1657b3108],
13	with	IN	O	with	_	0	SENT_322	[p19l1675t3037r1804b3090],
14	clopidogrel	NN	O	clopidogrel	prep_with	12	SENT_322	[p19l1827t3036r2143b3108],
15	on	IN	O	on	_	0	SENT_322	[p19l133t3137r204b3170],
16	early	JJ	O	early	amod	18	SENT_322	[p19l232t3117r366b3188],
17	clinical	JJ	O	clinical	amod	18	SENT_322	[p19l392t3116r591b3170],
18	outcome	NN	O	outcome	prep_on	1	SENT_322	[p19l619t3130r862b3170],
19	of	IN	O	of	_	0	SENT_322	[p19l891t3116r955b3170],
20	elective	JJ	O	elective	amod	23	SENT_322	[p19l974t3117r1181b3170],
21	coronary	JJ	O	coronary	amod	23	SENT_322	[p19l1211t3137r1459b3188],
22	stent	NN	O	stent	nn	23	SENT_322	[p19l1485t3130r1621b3170],
23	placement	NN	O	placement	prep_of	1	SENT_322	[p19l1647t3117r1953b3188],
24	.	.	O	.	_	0	SENT_322	[p19l1647t3117r1953b3188],

1	J	NNP	O	J	nn	4	SENT_323	[p19l1978t3117r2006b3184],
2	Am	NNP	O	Am	nn	4	SENT_323	[p19l2032t3115r2141b3169],
3	Coll	NNP	O	Coll	nn	4	SENT_323	[p19l134t3197r256b3250],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_323	[p19l283t3197r498b3250],
5	2006	CD	DATE	2006	num	4	SENT_323	[p19l522t3197r1034b3262],
6	;	:	O	;	_	0	SENT_323	[p19l522t3197r1034b3262],
7	48:1742	CD	NUMBER	48:1742	number	8	SENT_323	[p19l522t3197r1034b3262],
8	—	CD	NUMBER	—	dep	4	SENT_323	[p19l522t3197r1034b3262],
9	50	CD	NUMBER	50	dep	8	SENT_323	[p19l522t3197r1034b3262],
10	.	.	O	.	_	0	SENT_323	[p19l522t3197r1034b3262],

1	7	CD	NUMBER	7	_	0	SENT_324	[p19l45t3278r91b3330],
2	.	.	O	.	_	0	SENT_324	[p19l45t3278r91b3330],

1	Sibbing	VBG	O	sibb	_	0	SENT_325	[p19l136t3276r353b3348],
2	D	NN	O	d	dobj	1	SENT_325	[p19l401t3277r472b3342],
3	,	,	O	,	_	0	SENT_325	[p19l401t3277r472b3342],
4	Braun	NNP	PERSON	Braun	nn	5	SENT_325	[p19l524t3277r696b3330],
5	S	NNP	O	S	appos	2	SENT_325	[p19l749t3276r798b3341],
6	,	,	O	,	_	0	SENT_325	[p19l749t3276r798b3341],
7	Morath	NNP	PERSON	Morath	nn	8	SENT_325	[p19l849t3277r1068b3330],
8	T	NN	O	t	appos	2	SENT_325	[p19l1115t3275r1180b3342],
9	,	,	O	,	_	0	SENT_325	[p19l1115t3275r1180b3342],
10	et	FW	O	et	nn	11	SENT_325	[p19l1233t3290r1284b3330],
11	al.	FW	O	al.	appos	2	SENT_325	[p19l1334t3277r1393b3330],
12	.	.	O	.	_	0	SENT_325	[p19l1334t3277r1393b3330],

1	Platelet	NN	O	platelet	nn	2	SENT_326	[p19l1446t3277r1661b3330],
2	reactivity	NN	O	reactivity	nsubj	6	SENT_326	[p19l1708t3279r1968b3348],
3	after	IN	O	after	_	0	SENT_326	[p19l2016t3276r2143b3330],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_326	[p19l134t3358r450b3429],
5	treatment	NN	O	treatment	prep_after	2	SENT_326	[p19l482t3371r760b3411],
6	assessed	VBN	O	assess	_	0	SENT_326	[p19l793t3357r1020b3411],
7	with	IN	O	with	_	0	SENT_326	[p19l1050t3358r1179b3411],
8	point	NN	O	point	nn	9	SENT_326	[p19l1212t3357r1591b3429],
9	—	NN	O	—	prep_with	6	SENT_326	[p19l1212t3357r1591b3429],
10	of	IN	O	of	_	0	SENT_326	[p19l1212t3357r1591b3429],
11	—	CD	NUMBER	—	num	13	SENT_326	[p19l1212t3357r1591b3429],
12	care	NN	O	care	nn	13	SENT_326	[p19l1212t3357r1591b3429],
13	analysis	NN	O	analysis	prep_of	9	SENT_326	[p19l1626t3358r1839b3429],
14	and	CC	O	and	_	0	SENT_326	[p19l1875t3358r1977b3411],
15	early	JJ	O	early	amod	18	SENT_326	[p19l2011t3358r2145b3429],
16	drug-eluting	JJ	O	drug-eluting	amod	18	SENT_326	[p19l134t3438r491b3509],
17	stent	NN	O	stent	nn	18	SENT_326	[p19l517t3451r654b3491],
18	thrombosis	NN	O	thrombosis	prep_of	9	SENT_326	[p19l679t3437r1010b3491],
19	.	.	O	.	_	0	SENT_326	[p19l679t3437r1010b3491],

1	J	NNP	O	J	nn	4	SENT_327	[p19l1032t3438r1061b3505],
2	Am	NNP	O	Am	nn	4	SENT_327	[p19l1085t3436r1194b3490],
3	Coll	NNP	O	Coll	nn	4	SENT_327	[p19l1223t3437r1345b3491],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_327	[p19l1371t3437r1586b3491],
5	2009	CD	DATE	2009	num	4	SENT_327	[p19l1610t3438r1963b3502],
6	;	:	O	;	_	0	SENT_327	[p19l1610t3438r1963b3502],
7	539:849	CD	NUMBER	539:849	number	8	SENT_327	[p19l1610t3438r1963b3502],
8	-56	CD	NUMBER	-56	dep	4	SENT_327	[p19l1975t3437r2095b3491],
9	.	.	O	.	_	0	SENT_327	[p19l1975t3437r2095b3491],

1	8	CD	NUMBER	8	_	0	SENT_328	[p19l46t3520r91b3571],
2	.	.	O	.	_	0	SENT_328	[p19l46t3520r91b3571],

1	Trenk	NN	PERSON	trenk	nn	2	SENT_329	[p19l131t3516r311b3571],
2	D	NN	O	d	_	0	SENT_329	[p19l330t3518r400b3582],
3	,	,	O	,	_	0	SENT_329	[p19l330t3518r400b3582],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_329	[p19l425t3518r765b3571],
5	W	NNP	PERSON	W	appos	2	SENT_329	[p19l782t3518r872b3582],
6	,	,	O	,	_	0	SENT_329	[p19l782t3518r872b3582],
7	Fromm	NNP	PERSON	Fromm	nn	8	SENT_329	[p19l897t3518r1110b3571],
8	MF	NN	O	mf	appos	2	SENT_329	[p19l1131t3518r1258b3583],
9	,	,	O	,	_	0	SENT_329	[p19l1131t3518r1258b3583],
10	et	FW	O	et	nn	11	SENT_329	[p19l1283t3531r1334b3571],
11	al.	FW	O	al.	appos	2	SENT_329	[p19l1355t3518r1414b3571],
12	.	.	O	.	_	0	SENT_329	[p19l1355t3518r1414b3571],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_330	[p19l1441t3517r1794b3589],
2	P450	NN	O	p450	nn	4	SENT_330	[p19l1816t3518r1963b3571],
3	2C19	NN	O	2c19	nn	4	SENT_330	[p19l1984t3517r2140b3571],
4	681G	NN	O	681g	nn	14	SENT_330	[p19l134t3596r409b3651],
5	>	JJR	O	>	amod	7	SENT_330	[p19l134t3596r409b3651],
6	A	DT	O	a	det	7	SENT_330	[p19l134t3596r409b3651],
7	polymorphism	NN	O	polymorphism	dep	4	SENT_330	[p19l441t3597r854b3669],
8	and	CC	O	and	_	0	SENT_330	[p19l891t3598r993b3651],
9	high	JJ	O	high	conj_and	4	SENT_330	[p19l1027t3598r1155b3669],
10	on	IN	O	on	_	0	SENT_330	[p19l1191t3597r1609b3669],
11	—	CD	NUMBER	—	num	12	SENT_330	[p19l1191t3597r1609b3669],
12	clopidogrel	NN	O	clopidogrel	prep_on	9	SENT_330	[p19l1191t3597r1609b3669],
13	platelet	NN	O	platelet	nn	14	SENT_330	[p19l1642t3597r1851b3669],
14	reactivity	NN	O	reactivity	nsubj	15	SENT_330	[p19l1885t3600r2145b3669],
15	associated	VBN	O	associate	_	0	SENT_330	[p19l134t3678r416b3731],
16	with	IN	O	with	_	0	SENT_330	[p19l438t3678r568b3731],
17	adverse	JJ	O	adverse	amod	20	SENT_330	[p19l595t3677r799b3731],
18	1-year	JJ	DURATION	1-year	amod	20	SENT_330	[p19l829t3680r1005b3749],
19	clinical	JJ	O	clinical	amod	20	SENT_330	[p19l1030t3678r1228b3731],
20	outcome	NN	O	outcome	prep_with	15	SENT_330	[p19l1254t3691r1497b3731],
21	of	IN	O	of	_	0	SENT_330	[p19l1524t3677r1588b3731],
22	elective	JJ	O	elective	amod	25	SENT_330	[p19l1605t3678r1812b3731],
23	percutaneous	JJ	O	percutaneous	amod	25	SENT_330	[p19l1837t3691r2140b3749, p19l133t3778r226b3811],
24	coronary	JJ	O	coronary	amod	25	SENT_330	[p19l247t3778r494b3829],
25	intervention	NN	O	intervention	prep_of	20	SENT_330	[p19l510t3760r856b3811],
26	with	IN	O	with	_	0	SENT_330	[p19l872t3758r1001b3811],
27	drug-eluting	NN	O	drug-eluting	nn	32	SENT_330	[p19l1021t3758r1378b3829],
28	or	CC	O	or	_	0	SENT_330	[p19l1396t3778r1454b3811],
29	bare	JJ	O	bare	nn	32	SENT_330	[p19l1470t3758r1778b3811],
30	—	NN	O	—	nn	32	SENT_330	[p19l1470t3758r1778b3811],
31	metal	NN	O	metal	nn	32	SENT_330	[p19l1470t3758r1778b3811],
32	stents	NNS	O	stent	prep_with	15	SENT_330	[p19l1797t3771r1973b3811],
33	.	.	O	.	_	0	SENT_330	[p19l1797t3771r1973b3811],

1	J	NNP	O	J	nn	2	SENT_331	[p19l1988t3758r2016b3825],
2	Am	NNP	O	Am	_	0	SENT_331	[p19l2033t3756r2142b3810],

1	Coll	NNP	O	Coll	nn	2	SENT_332	[p20l134t13r256b66],
2	Cardiol	NNP	O	Cardiol	_	0	SENT_332	[p20l283t13r498b66],
3	2008	CD	DATE	2008	num	2	SENT_332	[p20l522t13r1034b78],
4	;	:	O	;	_	0	SENT_332	[p20l522t13r1034b78],
5	51:1925	CD	NUMBER	51:1925	number	6	SENT_332	[p20l522t13r1034b78],
6	—	CD	NUMBER	—	dep	2	SENT_332	[p20l522t13r1034b78],
7	34	CD	NUMBER	34	dep	6	SENT_332	[p20l522t13r1034b78],
8	.	.	O	.	_	0	SENT_332	[p20l522t13r1034b78],

1	.	.	O	.	_	0	SENT_333	[p20l82t137r91b146],

1	von	NNP	PERSON	von	nn	3	SENT_334	[p20l130t113r235b146],
2	Beckerath	NNP	PERSON	Beckerath	nn	3	SENT_334	[p20l254t93r539b146],
3	N	NNP	PERSON	N	_	0	SENT_334	[p20l558t93r628b157],
4	,	,	O	,	_	0	SENT_334	[p20l558t93r628b157],
5	Taubert	NNP	PERSON	Taubert	nn	6	SENT_334	[p20l648t91r878b146],
6	D	NNP	O	D	conj_and	3	SENT_334	[p20l896t93r967b157],
7	,	,	O	,	_	0	SENT_334	[p20l896t93r967b157],
8	Pogatsa-Murray	NNP	O	Pogatsa-Murray	nn	9	SENT_334	[p20l989t93r1456b164],
9	G	NNP	O	G	conj_and	3	SENT_334	[p20l1474t93r1543b157],
10	,	,	O	,	_	0	SENT_334	[p20l1474t93r1543b157],
11	Schomig	NNP	O	Schomig	nn	12	SENT_334	[p20l1568t92r1817b164],
12	E	NNP	O	E	conj_and	3	SENT_334	[p20l1837t93r1897b158],
13	,	,	O	,	_	0	SENT_334	[p20l1837t93r1897b158],
14	Kastrati	NNP	PERSON	Kastrati	nn	15	SENT_334	[p20l1921t93r2142b146],
15	A	NNP	O	A	conj_and	3	SENT_334	[p20l131t171r199b237],
16	,	,	O	,	_	0	SENT_334	[p20l131t171r199b237],
17	Schomig	NNP	O	Schomig	nn	19	SENT_334	[p20l228t172r477b244],
18	A.	NNP	O	A.	nn	19	SENT_334	[p20l497t171r564b226],
19	Absorption	NNP	O	Absorption	conj_and	3	SENT_334	[p20l590t171r931b244],
20	,	,	O	,	_	0	SENT_334	[p20l590t171r931b244],
21	metabolization	NN	O	metabolization	conj_and	3	SENT_334	[p20l958t172r1396b237],
22	,	,	O	,	_	0	SENT_334	[p20l958t172r1396b237],
23	and	CC	O	and	_	0	SENT_334	[p20l1423t173r1525b226],
24	antiplatelet	JJ	O	antiplatelet	amod	25	SENT_334	[p20l1550t172r1867b244],
25	effects	NNS	O	effect	conj_and	3	SENT_334	[p20l1891t172r2062b226],
26	of	IN	O	of	_	0	SENT_334	[p20l2088t172r2152b226],
27	300	CD	NUMBER	300	prep_of	25	SENT_334	[p20l133t255r282b318],
28	-	:	O	-	_	0	SENT_334	[p20l133t255r282b318],
29	,	,	O	,	_	0	SENT_334	[p20l133t255r282b318],
30	600	CD	NUMBER	600	appos	25	SENT_334	[p20l316t255r463b317],
31	-	:	O	-	_	0	SENT_334	[p20l316t255r463b317],
32	,	,	O	,	_	0	SENT_334	[p20l316t255r463b317],
33	and	CC	O	and	_	0	SENT_334	[p20l497t253r599b306],
34	900	CD	NUMBER	900	num	38	SENT_334	[p20l631t255r856b324],
35	—	CD	NUMBER	—	num	38	SENT_334	[p20l631t255r856b324],
36	mg	NN	O	mg	nn	38	SENT_334	[p20l631t255r856b324],
37	loading	NN	O	loading	nn	38	SENT_334	[p20l884t253r1097b324],
38	doses	NNS	O	dose	conj_and	3	SENT_334	[p20l1126t253r1275b306],
39	of	IN	O	of	_	0	SENT_334	[p20l1308t252r1372b306],
40	clopidogrel	NN	O	clopidogrel	prep_of	38	SENT_334	[p20l1393t253r1723b324],
41	:	:	O	:	_	0	SENT_334	[p20l1393t253r1723b324],
42	results	NNS	O	result	dep	3	SENT_334	[p20l1757t252r1935b306],
43	of	IN	O	of	_	0	SENT_334	[p20l1968t252r2032b306],
44	the	DT	O	the	det	48	SENT_334	[p20l2053t253r2142b306],
45	ISAR-CHOICE	NN	O	isar-choice	nn	48	SENT_334	[p20l132t331r627b386],
46	(	NN	O	(	nn	48	SENT_334	[p20l660t331r1071b404],
47	Intracoronary	JJ	O	intracoronary	amod	48	SENT_334	[p20l660t331r1071b404],
48	Stenting	NN	O	stenting	prep_of	42	SENT_334	[p20l1101t332r1341b404],
49	and	CC	O	and	_	0	SENT_334	[p20l1371t333r1473b386],
50	Antithrombotic	JJ	O	antithrombotic	amod	51	SENT_334	[p20l1500t331r1953b386],
51	Regimen	NN	O	regimen	conj_and	48	SENT_334	[p20l1984t333r2139b404, p20l133t433r270b466],
52	:	:	O	:	_	0	SENT_334	[p20l1984t333r2139b404, p20l133t433r270b466],
53	Choose	VB	O	choose	dep	3	SENT_334	[p20l297t412r510b466],
54	Betvveen	NN	O	betvveen	nsubj	58	SENT_334	[p20l533t413r778b466],
55	3	CD	NUMBER	3	num	58	SENT_334	[p20l801t415r829b466],
56	High	JJ	O	high	amod	58	SENT_334	[p20l855t413r1005b484],
57	Oral	JJ	O	oral	amod	58	SENT_334	[p20l1028t412r1156b466],
58	Doses	NNS	O	dose	xcomp	53	SENT_334	[p20l1178t413r1348b466],
59	for	IN	O	for	_	0	SENT_334	[p20l1371t412r1451b466],
60	Immediate	NNP	O	Immediate	nn	62	SENT_334	[p20l1471t413r1780b466],
61	Clopidogrel	NNP	O	Clopidogrel	nn	62	SENT_334	[p20l1804t412r2143b484],
62	Effect	NN	O	effect	prep_for	58	SENT_334	[p20l134t491r320b556],
63	)	CD	NUMBER	)	num	64	SENT_334	[p20l134t491r320b556],
64	Trial	NN	O	trial	nsubj	53	SENT_334	[p20l347t491r503b545],
65	.	.	O	.	_	0	SENT_334	[p20l347t491r503b545],

1	Circulation	NN	O	circulation	_	0	SENT_335	[p20l535t492r856b545],
2	2005	CD	DATE	2005	num	1	SENT_335	[p20l881t492r1437b557],
3	;	:	O	;	_	0	SENT_335	[p20l881t492r1437b557],
4	112:2946	CD	NUMBER	112:2946	number	5	SENT_335	[p20l881t492r1437b557],
5	-50	CD	NUMBER	-50	dep	1	SENT_335	[p20l881t492r1437b557],
6	.	.	O	.	_	0	SENT_335	[p20l881t492r1437b557],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_336	[p20l133t572r331b625],
2	JT	NNP	O	JT	_	0	SENT_336	[p20l349t570r442b639],
3	,	,	O	,	_	0	SENT_336	[p20l349t570r442b639],
4	Payne	NNP	PERSON	Payne	nn	5	SENT_336	[p20l471t572r641b643],
5	CD	NNP	O	CD	appos	2	SENT_336	[p20l669t571r791b636],
6	,	,	O	,	_	0	SENT_336	[p20l669t571r791b636],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_336	[p20l817t572r1042b625],
8	SD	NN	O	sd	appos	2	SENT_336	[p20l1070t571r1177b637],
9	,	,	O	,	_	0	SENT_336	[p20l1070t571r1177b637],
10	et	FW	O	et	nn	11	SENT_336	[p20l1206t585r1257b625],
11	al.	FW	O	al.	appos	2	SENT_336	[p20l1283t571r1343b625],
12	.	.	O	.	_	0	SENT_336	[p20l1283t571r1343b625],

1	A	DT	O	a	det	2	SENT_337	[p20l1371t570r1424b624],
2	comparison	NN	O	comparison	nsubjpass	18	SENT_337	[p20l1450t574r1777b643],
3	of	IN	O	of	_	0	SENT_337	[p20l1804t572r1868b625],
4	prasugrel	NN	O	prasugrel	prep_of	2	SENT_337	[p20l1884t572r2143b643],
5	and	CC	O	and	_	0	SENT_337	[p20l134t652r236b705],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_337	[p20l278t651r595b723],
7	loading	NN	O	loading	nn	8	SENT_337	[p20l635t652r848b723],
8	doses	NNS	O	dose	conj_and	2	SENT_337	[p20l889t652r1038b705],
9	on	IN	O	on	_	0	SENT_337	[p20l1083t672r1152b705],
10	platelet	NN	O	platelet	nn	11	SENT_337	[p20l1194t651r1403b723],
11	function	NN	O	function	prep_on	8	SENT_337	[p20l1444t651r1696b705],
12	:	:	O	:	_	0	SENT_337	[p20l1444t651r1696b705],
13	magnitude	NN	O	magnitude	dep	8	SENT_337	[p20l1743t652r2044b723],
14	of	IN	O	of	_	0	SENT_337	[p20l2088t651r2152b705],
15	platelet	NN	O	platelet	nn	16	SENT_337	[p20l132t731r341b803],
16	inhibition	NN	O	inhibition	prep_of	13	SENT_337	[p20l385t732r667b785],
17	is	VBZ	O	be	auxpass	18	SENT_337	[p20l713t734r753b785],
18	related	VBN	O	relate	_	0	SENT_337	[p20l800t732r991b785],
19	to	TO	O	to	_	0	SENT_337	[p20l1036t745r1090b785],
20	active	JJ	O	active	amod	22	SENT_337	[p20l1139t734r1297b785],
21	metabolite	NN	O	metabolite	nn	22	SENT_337	[p20l1344t732r1642b785],
22	formation	NN	O	formation	prep_to	18	SENT_337	[p20l1688t732r1985b785],
23	.	.	O	.	_	0	SENT_337	[p20l1688t732r1985b785],

1	Am	VBP	O	be	cop	3	SENT_338	[p20l2032t730r2141b784],
2	Heart	NNP	O	Heart	nn	3	SENT_338	[p20l133t812r300b864],
3	J	NNP	O	J	_	0	SENT_338	[p20l318t812r346b879],
4	2007	CD	DATE	2007	num	6	SENT_338	[p20l371t812r808b876],
5	;	:	O	;	_	0	SENT_338	[p20l371t812r808b876],
6	153:66	CD	NUMBER	153:66	dep	3	SENT_338	[p20l371t812r808b876],
7	.	.	O	.	_	0	SENT_338	[p20l371t812r808b876],

1	e9	NN	O	e9	_	0	SENT_339	[p20l371t812r808b876],
2	-16	CD	NUMBER	-16	dep	1	SENT_339	[p20l820t814r940b864],
3	.	.	O	.	_	0	SENT_339	[p20l820t814r940b864],

1	Savi	NNP	PERSON	Savi	nn	2	SENT_340	[p20l136t890r250b944],
2	P	NN	PERSON	p	_	0	SENT_340	[p20l276t891r331b956],
3	,	,	O	,	_	0	SENT_340	[p20l276t891r331b956],
4	Combalbert	NNP	O	Combalbert	nn	5	SENT_340	[p20l361t890r702b944],
5	J	NNP	O	J	appos	2	SENT_340	[p20l719t891r763b958],
6	,	,	O	,	_	0	SENT_340	[p20l719t891r763b958],
7	Gaich	NNP	O	Gaich	nn	8	SENT_340	[p20l793t890r964b944],
8	C	NNP	O	C	appos	2	SENT_340	[p20l992t890r1056b955],
9	,	,	O	,	_	0	SENT_340	[p20l992t890r1056b955],
10	et	FW	O	et	nn	11	SENT_340	[p20l1085t904r1136b944],
11	al.	FW	O	al.	appos	2	SENT_340	[p20l1162t891r1221b944],
12	.	.	O	.	_	0	SENT_340	[p20l1162t891r1221b944],

1	The	DT	O	the	det	3	SENT_341	[p20l1248t889r1366b944],
2	antiaggregating	JJ	O	antiaggregating	amod	3	SENT_341	[p20l1394t893r1834b962],
3	activity	NN	O	activity	nsubj	7	SENT_341	[p20l1860t893r2064b962],
4	of	IN	O	of	_	0	SENT_341	[p20l2088t891r2151b944],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_341	[p20l134t972r450b1043],
6	is	VBZ	O	be	cop	7	SENT_341	[p20l472t974r512b1025],
7	due	JJ	O	due	_	0	SENT_341	[p20l537t972r636b1025],
8	to	TO	O	to	_	0	SENT_341	[p20l659t985r714b1025],
9	a	DT	O	a	det	11	SENT_341	[p20l739t992r767b1025],
10	metabolic	JJ	O	metabolic	amod	11	SENT_341	[p20l789t971r1065b1025],
11	activation	NN	O	activation	prep_to	7	SENT_341	[p20l1089t974r1363b1025],
12	by	IN	O	by	_	0	SENT_341	[p20l1384t972r1453b1043],
13	the	DT	O	the	det	18	SENT_341	[p20l1472t972r1561b1025],
14	hepatic	JJ	O	hepatic	amod	18	SENT_341	[p20l1584t972r1789b1043],
15	cytochrome	NN	O	cytochrome	nn	18	SENT_341	[p20l1812t972r2141b1043],
16	P450	NN	O	p450	nn	18	SENT_341	[p20l133t1050r412b1104],
17	—	CD	NUMBER	—	num	18	SENT_341	[p20l133t1050r412b1104],
18	1A	NN	O	1a	prep_by	11	SENT_341	[p20l133t1050r412b1104],
19	.	.	O	.	_	0	SENT_341	[p20l133t1050r412b1104],

1	Thromb	NNP	O	Thromb	nn	2	SENT_342	[p20l440t1050r679b1104],
2	Haemost	NNP	O	Haemost	_	0	SENT_342	[p20l708t1052r968b1104],
3	1994	CD	DATE	1994	num	2	SENT_342	[p20l997t1053r1433b1116],
4	;	:	O	;	_	0	SENT_342	[p20l997t1053r1433b1116],
5	72:313	CD	NUMBER	72:313	num	6	SENT_342	[p20l997t1053r1433b1116],
6	—	NN	O	—	dep	2	SENT_342	[p20l997t1053r1433b1116],
7	7	CD	NUMBER	7	dep	6	SENT_342	[p20l997t1053r1433b1116],
8	.	.	O	.	_	0	SENT_342	[p20l997t1053r1433b1116],

1	Savi	NNP	PERSON	Savi	nn	2	SENT_343	[p20l136t1130r250b1184],
2	P	NN	O	p	_	0	SENT_343	[p20l274t1131r330b1196],
3	,	,	O	,	_	0	SENT_343	[p20l274t1131r330b1196],
4	Pereillo	NNP	O	Pereillo	nn	5	SENT_343	[p20l357t1131r572b1184],
5	JM	NN	O	jm	appos	2	SENT_343	[p20l590t1131r704b1198],
6	,	,	O	,	_	0	SENT_343	[p20l590t1131r704b1198],
7	Uzabiaga	NNP	O	Uzabiaga	nn	8	SENT_343	[p20l730t1130r994b1202],
8	MF	NN	O	mf	appos	2	SENT_343	[p20l1016t1131r1143b1195],
9	,	,	O	,	_	0	SENT_343	[p20l1016t1131r1143b1195],
10	et	FW	O	et	nn	11	SENT_343	[p20l1170t1144r1222b1184],
11	al.	FW	O	al.	appos	2	SENT_343	[p20l1246t1131r1305b1184],
12	.	.	O	.	_	0	SENT_343	[p20l1246t1131r1305b1184],

1	Identiﬁcation	NN	O	identiﬁcation	nn	4	SENT_344	[p20l1333t1130r1717b1184],
2	and	CC	O	and	_	0	SENT_344	[p20l1743t1130r1845b1184],
3	biological	JJ	O	biological	nn	4	SENT_344	[p20l1868t1131r2143b1202],
4	activity	NN	O	activity	_	0	SENT_344	[p20l134t1213r338b1282],
5	of	IN	O	of	_	0	SENT_344	[p20l375t1210r440b1264],
6	the	DT	O	the	det	8	SENT_344	[p20l469t1211r557b1264],
7	active	JJ	O	active	amod	8	SENT_344	[p20l599t1213r757b1264],
8	metabolite	NN	O	metabolite	prep_of	4	SENT_344	[p20l797t1211r1096b1264],
9	of	IN	O	of	_	0	SENT_344	[p20l1137t1211r1200b1264],
10	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_344	[p20l1231t1211r1561b1282],
11	.	.	O	.	_	0	SENT_344	[p20l1231t1211r1561b1282],

1	Thromb	NNP	O	Thromb	nn	2	SENT_345	[p20l1602t1209r1841b1264],
2	Haemost	NNP	O	Haemost	_	0	SENT_345	[p20l1883t1211r2143b1264],
3	2000	CD	DATE	2000	num	2	SENT_345	[p20l131t1293r581b1355],
4	;	:	O	;	_	0	SENT_345	[p20l131t1293r581b1355],
5	84:891	CD	NUMBER	84:891	number	6	SENT_345	[p20l131t1293r581b1355],
6	—	CD	NUMBER	—	dep	2	SENT_345	[p20l131t1293r581b1355],
7	6	CD	NUMBER	6	dep	6	SENT_345	[p20l131t1293r581b1355],
8	.	.	O	.	_	0	SENT_345	[p20l131t1293r581b1355],

1	Hulot	NNP	PERSON	Hulot	nn	2	SENT_346	[p20l133t1370r305b1423],
2	JS	NNP	O	JS	_	0	SENT_346	[p20l324t1369r407b1437],
3	,	,	O	,	_	0	SENT_346	[p20l324t1369r407b1437],
4	Bura	NNP	PERSON	Bura	nn	5	SENT_346	[p20l437t1370r573b1423],
5	A	NNP	O	A	appos	2	SENT_346	[p20l598t1368r666b1434],
6	,	,	O	,	_	0	SENT_346	[p20l598t1368r666b1434],
7	Villard	NNP	O	Villard	nn	8	SENT_346	[p20l696t1369r892b1423],
8	E	NNP	O	E	appos	2	SENT_346	[p20l920t1370r981b1435],
9	,	,	O	,	_	0	SENT_346	[p20l920t1370r981b1435],
10	et	FW	O	et	nn	11	SENT_346	[p20l1012t1383r1063b1423],
11	al.	FW	O	al.	appos	2	SENT_346	[p20l1091t1370r1150b1423],
12	.	.	O	.	_	0	SENT_346	[p20l1091t1370r1150b1423],

1	Cytochrome	NN	O	cytochrome	nn	5	SENT_347	[p20l1183t1369r1536b1441],
2	P450	NN	O	p450	nn	5	SENT_347	[p20l1565t1370r1711b1423],
3	2C19	NN	O	2c19	nn	5	SENT_347	[p20l1738t1369r1895b1423],
4	loss	NN	O	loss	nn	5	SENT_347	[p20l1924t1370r2139b1423],
5	—	NN	O	—	nsubj	13	SENT_347	[p20l1924t1370r2139b1423],
6	of	IN	O	of	_	0	SENT_347	[p20l1924t1370r2139b1423],
7	—	CD	NUMBER	—	num	9	SENT_347	[p20l1924t1370r2139b1423],
8	function	NN	O	function	nn	9	SENT_347	[p20l133t1450r370b1504],
9	polymorphism	NN	O	polymorphism	prep_of	5	SENT_347	[p20l394t1450r807b1522],
10	is	VBZ	O	be	cop	13	SENT_347	[p20l831t1453r871b1504],
11	a	DT	O	a	det	13	SENT_347	[p20l899t1471r926b1504],
12	major	JJ	O	major	amod	13	SENT_347	[p20l950t1452r1113b1522],
13	determinant	NN	O	determinant	_	0	SENT_347	[p20l1136t1450r1484b1504],
14	of	IN	O	of	_	0	SENT_347	[p20l1508t1450r1572b1504],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_347	[p20l1587t1451r1903b1522],
16	responsiveness	NN	O	responsiveness	prep_of	13	SENT_347	[p20l1926t1471r2139b1522, p20l134t1533r353b1584],
17	in	IN	O	in	_	0	SENT_347	[p20l381t1533r435b1583],
18	healthy	JJ	O	healthy	amod	19	SENT_347	[p20l462t1530r672b1602],
19	subjects	NNS	O	subject	prep_in	16	SENT_347	[p20l696t1531r929b1602],
20	.	.	O	.	_	0	SENT_347	[p20l696t1531r929b1602],

1	Blood	NN	O	blood	_	0	SENT_348	[p20l960t1531r1130b1584],
2	2006	CD	DATE	2006	num	1	SENT_348	[p20l1155t1532r1676b1595],
3	;	:	O	;	_	0	SENT_348	[p20l1155t1532r1676b1595],
4	108:2244	CD	NUMBER	108:2244	num	5	SENT_348	[p20l1155t1532r1676b1595],
5	—	NN	O	—	dep	1	SENT_348	[p20l1155t1532r1676b1595],
6	7	CD	NUMBER	7	dep	5	SENT_348	[p20l1155t1532r1676b1595],
7	.	.	O	.	_	0	SENT_348	[p20l1155t1532r1676b1595],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_349	[p20l133t1610r331b1664],
2	JT	NNP	O	JT	_	0	SENT_349	[p20l354t1609r448b1678],
3	,	,	O	,	_	0	SENT_349	[p20l354t1609r448b1678],
4	Close	NNP	O	Close	nn	5	SENT_349	[p20l485t1610r642b1664],
5	SL	NNP	O	SL	appos	2	SENT_349	[p20l678t1610r774b1675],
6	,	,	O	,	_	0	SENT_349	[p20l678t1610r774b1675],
7	Iturria	NNP	PERSON	Iturria	nn	8	SENT_349	[p20l808t1611r990b1664],
8	SJ	NNP	O	SJ	appos	2	SENT_349	[p20l1025t1610r1097b1678],
9	,	,	O	,	_	0	SENT_349	[p20l1025t1610r1097b1678],
10	et	FW	O	et	nn	11	SENT_349	[p20l1133t1624r1183b1664],
11	al.	FW	O	al.	appos	2	SENT_349	[p20l1216t1611r1275b1664],
12	.	.	O	.	_	0	SENT_349	[p20l1216t1611r1275b1664],

1	Common	JJ	O	common	amod	2	SENT_350	[p20l1312t1610r1585b1664],
2	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_350	[p20l1616t1611r2054b1682],
3	of	IN	O	of	_	0	SENT_350	[p20l2088t1610r2152b1664],
4	CYP2C19	NN	O	cyp2c19	prep_of	2	SENT_350	[p20l134t1690r432b1744],
5	and	CC	O	and	_	0	SENT_350	[p20l466t1691r568b1744],
6	CYP2C9	NN	O	cyp2c9	conj_and	4	SENT_350	[p20l601t1690r863b1744],
7	affect	VBP	O	affect	_	0	SENT_350	[p20l897t1690r1045b1744],
8	the	DT	O	the	det	12	SENT_350	[p20l1075t1691r1163b1744],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_350	[p20l1194t1691r1668b1762],
10	and	CC	O	and	_	0	SENT_350	[p20l1701t1691r1803b1744],
11	pharmacodynamic	JJ	O	pharmacodynamic	amod	12	SENT_350	[p20l1832t1691r2139b1762, p20l134t1772r373b1843],
12	response	NN	O	response	dobj	7	SENT_350	[p20l391t1792r634b1843],
13	to	TO	O	to	_	0	SENT_350	[p20l654t1785r708b1825],
14	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_350	[p20l730t1771r1046b1843],
15	but	CC	O	but	_	0	SENT_350	[p20l1063t1772r1158b1825],
16	not	RB	O	not	_	0	SENT_350	[p20l1177t1785r1271b1825],
17	prasugrel	NN	O	prasugrel	dobj	7	SENT_350	[p20l1288t1771r1561b1843],
18	.	.	O	.	_	0	SENT_350	[p20l1288t1771r1561b1843],

1	J	NNP	O	J	nn	3	SENT_351	[p20l1576t1772r1605b1839],
2	Thromb	NNP	O	Thromb	nn	3	SENT_351	[p20l1622t1770r1862b1825],
3	Haemost	NNP	O	Haemost	_	0	SENT_351	[p20l1883t1772r2144b1825],
4	2007	CD	DATE	2007	num	3	SENT_351	[p20l131t1852r617b1917],
5	;	:	O	;	_	0	SENT_351	[p20l131t1852r617b1917],
6	5:2429	CD	NUMBER	5:2429	number	7	SENT_351	[p20l131t1852r617b1917],
7	—	CD	NUMBER	—	dep	3	SENT_351	[p20l131t1852r617b1917],
8	36	CD	NUMBER	36	dep	7	SENT_351	[p20l131t1852r617b1917],
9	.	.	O	.	_	0	SENT_351	[p20l131t1852r617b1917],

1	Mega	JJ	O	mega	amod	2	SENT_352	[p20l132t1932r296b2003],
2	JL	NN	O	jl	_	0	SENT_352	[p20l314t1932r405b1999],
3	,	,	O	,	_	0	SENT_352	[p20l314t1932r405b1999],
4	Close	NNP	O	Close	nn	5	SENT_352	[p20l435t1931r593b1985],
5	SL	NNP	O	SL	appos	2	SENT_352	[p20l623t1931r719b1997],
6	,	,	O	,	_	0	SENT_352	[p20l623t1931r719b1997],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_352	[p20l745t1932r971b1985],
8	SD	NN	O	sd	appos	2	SENT_352	[p20l998t1931r1105b1996],
9	,	,	O	,	_	0	SENT_352	[p20l998t1931r1105b1996],
10	et	FW	O	et	nn	11	SENT_352	[p20l1135t1945r1185b1985],
11	al.	FW	O	al.	appos	2	SENT_352	[p20l1212t1932r1271b1985],
12	.	.	O	.	_	0	SENT_352	[p20l1212t1932r1271b1985],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_353	[p20l1302t1931r1655b2003],
2	p	NN	O	p	_	0	SENT_353	[p20l1681t1932r1850b2003],
3	—	CD	NUMBER	—	number	4	SENT_353	[p20l1681t1932r1850b2003],
4	450	CD	NUMBER	450	num	5	SENT_353	[p20l1681t1932r1850b2003],
5	polymorphisms	NNS	O	polymorphism	dep	2	SENT_353	[p20l1876t1932r2139b2003, p20l132t2011r331b2083],
6	and	CC	O	and	_	0	SENT_353	[p20l355t2012r457b2065],
7	response	NN	O	response	conj_and	5	SENT_353	[p20l478t2032r721b2083],
8	to	TO	O	to	_	0	SENT_353	[p20l743t2025r798b2065],
9	clopidogrel	NN	O	clopidogrel	prep_to	7	SENT_353	[p20l822t2012r1151b2083],
10	.	.	O	.	_	0	SENT_353	[p20l822t2012r1151b2083],

1	N	NN	O	n	nn	2	SENT_354	[p20l1176t2012r1229b2064],
2	EnglJ	NN	O	englj	nsubj	3	SENT_354	[p20l1254t2011r1432b2083],
3	Med	VBD	O	med	_	0	SENT_354	[p20l1453t2012r1589b2065],
4	2009	CD	DATE	2009	dobj	3	SENT_354	[p20l1609t2012r2138b2076],
5	;	:	O	;	_	0	SENT_354	[p20l1609t2012r2138b2076],
6	360:354	CD	NUMBER	360:354	number	7	SENT_354	[p20l1609t2012r2138b2076],
7	—	CD	NUMBER	—	dep	4	SENT_354	[p20l1609t2012r2138b2076],
8	62	CD	NUMBER	62	dep	7	SENT_354	[p20l1609t2012r2138b2076],
9	.	.	O	.	_	0	SENT_354	[p20l1609t2012r2138b2076],

1	Shuldiner	NNP	PERSON	Shuldiner	nn	2	SENT_355	[p20l136t2091r412b2144],
2	AR	NNS	O	ar	_	0	SENT_355	[p20l456t2090r574b2156],
3	,	,	O	,	_	0	SENT_355	[p20l456t2090r574b2156],
4	O’Connell	NN	O	o’connell	nn	5	SENT_355	[p20l625t2091r925b2144],
5	JR	NN	O	jr	appos	2	SENT_355	[p20l964t2092r1058b2159],
6	,	,	O	,	_	0	SENT_355	[p20l964t2092r1058b2159],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_355	[p20l1108t2092r1295b2144],
8	KP	NNP	O	KP	appos	2	SENT_355	[p20l1345t2092r1449b2156],
9	,	,	O	,	_	0	SENT_355	[p20l1345t2092r1449b2156],
10	et	FW	O	et	nn	11	SENT_355	[p20l1500t2105r1551b2144],
11	al.	FW	O	al.	appos	2	SENT_355	[p20l1599t2092r1658b2144],
12	.	.	O	.	_	0	SENT_355	[p20l1599t2092r1658b2144],

1	Association	NNP	O	Association	_	0	SENT_356	[p20l1707t2090r2040b2144],
2	of	IN	O	of	_	0	SENT_356	[p20l2088t2092r2151b2144],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_356	[p20l134t2171r463b2242],
4	P450	NN	O	p450	nn	6	SENT_356	[p20l506t2171r652b2224],
5	2C19	NN	O	2c19	nn	6	SENT_356	[p20l694t2170r850b2224],
6	genotype	NN	O	genotype	prep_of	1	SENT_356	[p20l893t2184r1150b2242],
7	with	IN	O	with	_	0	SENT_356	[p20l1189t2170r1319b2224],
8	the	DT	O	the	det	10	SENT_356	[p20l1360t2171r1448b2224],
9	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_356	[p20l1492t2170r1809b2242],
10	effect	NN	O	effect	prep_with	1	SENT_356	[p20l1851t2170r1999b2224],
11	and	CC	O	and	_	0	SENT_356	[p20l2041t2170r2142b2224],
12	clinical	JJ	O	clinical	amod	13	SENT_356	[p20l134t2251r332b2304],
13	eﬂicacy	NN	O	eﬂicacy	conj_and	10	SENT_356	[p20l359t2251r563b2322],
14	of	IN	O	of	_	0	SENT_356	[p20l587t2251r651b2304],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_356	[p20l669t2250r985b2322],
16	therapy	NN	O	therapy	prep_of	1	SENT_356	[p20l1010t2251r1236b2322],
17	.	.	O	.	_	0	SENT_356	[p20l1010t2251r1236b2322],

1	JAMA	NNP	O	JAMA	_	0	SENT_357	[p20l1259t2249r1463b2318],
2	2009	CD	DATE	2009	num	1	SENT_357	[p20l1487t2253r1876b2316],
3	;	:	O	;	_	0	SENT_357	[p20l1487t2253r1876b2316],
4	302:849	CD	NUMBER	302:849	number	5	SENT_357	[p20l1487t2253r1876b2316],
5	-57	CD	NUMBER	-57	dep	1	SENT_357	[p20l1888t2251r2008b2304],
6	.	.	O	.	_	0	SENT_357	[p20l1888t2251r2008b2304],

1	Sibbing	VBG	O	sibb	_	0	SENT_358	[p20l136t2330r353b2402],
2	D	NN	O	d	dobj	1	SENT_358	[p20l396t2331r467b2395],
3	,	,	O	,	_	0	SENT_358	[p20l396t2331r467b2395],
4	Stegherr	NN	PERSON	stegherr	nn	5	SENT_358	[p20l516t2330r756b2402],
5	J	NN	PERSON	j	appos	2	SENT_358	[p20l792t2331r836b2398],
6	,	,	O	,	_	0	SENT_358	[p20l792t2331r836b2398],
7	Latz	NNP	PERSON	Latz	nn	8	SENT_358	[p20l884t2331r1013b2384],
8	W	NNP	O	W	appos	2	SENT_358	[p20l1053t2331r1143b2396],
9	,	,	O	,	_	0	SENT_358	[p20l1053t2331r1143b2396],
10	et	FW	O	et	nn	11	SENT_358	[p20l1191t2344r1242b2384],
11	al.	FW	O	al.	appos	2	SENT_358	[p20l1286t2331r1346b2384],
12	.	.	O	.	_	0	SENT_358	[p20l1286t2331r1346b2384],

1	Cytochrome	NN	O	cytochrome	nn	7	SENT_359	[p20l1395t2330r1748b2402],
2	P450	NN	O	p450	nn	7	SENT_359	[p20l1793t2331r1939b2384],
3	2C19	NN	O	2c19	nn	7	SENT_359	[p20l1983t2330r2140b2385],
4	loss	NN	O	loss	nn	7	SENT_359	[p20l132t2410r590b2464],
5	—	CD	NUMBER	—	num	7	SENT_359	[p20l132t2410r590b2464],
6	of-function	NN	O	of-function	nn	7	SENT_359	[p20l132t2410r590b2464],
7	polymorphism	NN	O	polymorphism	_	0	SENT_359	[p20l611t2410r1024b2482],
8	and	CC	O	and	_	0	SENT_359	[p20l1048t2411r1150b2464],
9	stent	NN	O	stent	nn	10	SENT_359	[p20l1173t2424r1310b2464],
10	thrombosis	NN	O	thrombosis	conj_and	7	SENT_359	[p20l1331t2411r1646b2464],
11	following	VBG	O	follow	partmod	7	SENT_359	[p20l1670t2410r1938b2482],
12	percutaneous	JJ	O	percutaneous	amod	14	SENT_359	[p20l1958t2431r2139b2482, p20l133t2504r347b2544],
13	coronary	JJ	O	coronary	amod	14	SENT_359	[p20l375t2511r623b2562],
14	intervention	NN	O	intervention	dobj	11	SENT_359	[p20l647t2493r1007b2544],
15	.	.	O	.	_	0	SENT_359	[p20l647t2493r1007b2544],

1	Eur	NNP	MISC	Eur	nn	2	SENT_360	[p20l1038t2491r1145b2544],
2	HeartJ	NNP	O	HeartJ	_	0	SENT_360	[p20l1170t2491r1383b2558],
3	2009	CD	DATE	2009	num	2	SENT_360	[p20l1408t2493r1893b2555],
4	;	:	O	;	_	0	SENT_360	[p20l1408t2493r1893b2555],
5	30:916	CD	NUMBER	30:916	number	6	SENT_360	[p20l1408t2493r1893b2555],
6	—	CD	NUMBER	—	dep	2	SENT_360	[p20l1408t2493r1893b2555],
7	22	CD	NUMBER	22	dep	6	SENT_360	[p20l1408t2493r1893b2555],
8	.	.	O	.	_	0	SENT_360	[p20l1408t2493r1893b2555],

1	Trenk	NN	PERSON	trenk	nn	2	SENT_361	[p20l131t2569r311b2624],
2	D	NN	O	d	_	0	SENT_361	[p20l329t2571r400b2635],
3	,	,	O	,	_	0	SENT_361	[p20l329t2571r400b2635],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_361	[p20l424t2571r764b2624],
5	W	NNP	PERSON	W	appos	2	SENT_361	[p20l781t2571r871b2635],
6	,	,	O	,	_	0	SENT_361	[p20l781t2571r871b2635],
7	Muller	NNP	PERSON	Muller	nn	8	SENT_361	[p20l894t2570r1090b2624],
8	B	NNP	O	B	appos	2	SENT_361	[p20l1111t2571r1170b2635],
9	,	,	O	,	_	0	SENT_361	[p20l1111t2571r1170b2635],
10	et	FW	O	et	nn	11	SENT_361	[p20l1195t2584r1246b2624],
11	al.	FW	O	al.	appos	2	SENT_361	[p20l1267t2571r1326b2624],
12	.	.	O	.	_	0	SENT_361	[p20l1267t2571r1326b2624],

1	Antiplatelet	JJ	O	antiplatelet	amod	2	SENT_362	[p20l1349t2569r1692b2642],
2	response	NN	O	response	_	0	SENT_362	[p20l1712t2591r1954b2642],
3	to	TO	O	to	_	0	SENT_362	[p20l1976t2584r2030b2624],
4	the	DT	O	the	det	9	SENT_362	[p20l2053t2571r2141b2624],
5	150	CD	NUMBER	150	number	6	SENT_362	[p20l136t2650r359b2722],
6	—	CD	NUMBER	—	num	9	SENT_362	[p20l136t2650r359b2722],
7	mg	NN	O	mg	nn	9	SENT_362	[p20l136t2650r359b2722],
8	maintenance	NN	O	maintenance	nn	9	SENT_362	[p20l385t2653r745b2704],
9	dose	NN	O	dose	prep_to	2	SENT_362	[p20l773t2651r897b2704],
10	of	IN	O	of	_	0	SENT_362	[p20l925t2650r989b2704],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_362	[p20l1007t2651r1323b2722],
12	in	IN	O	in	_	0	SENT_362	[p20l1349t2653r1403b2703],
13	patients	NNS	O	patient	prep_in	11	SENT_362	[p20l1429t2653r1651b2722],
14	with	IN	O	with	_	0	SENT_362	[p20l1676t2651r1806b2704],
15	insufficient	JJ	O	insufficient	amod	17	SENT_362	[p20l1832t2650r2143b2704],
16	platelet	NN	O	platelet	nn	17	SENT_362	[p20l132t2730r341b2802],
17	inhibition	NN	O	inhibition	prep_with	13	SENT_362	[p20l365t2731r646b2784],
18	after	IN	O	after	_	0	SENT_362	[p20l672t2730r800b2784],
19	clopidogrel	NN	O	clopidogrel	prep_after	17	SENT_362	[p20l824t2731r1139b2802],
20	loading	VBG	O	load	partmod	2	SENT_362	[p20l1162t2730r1375b2802],
21	for	IN	O	for	_	0	SENT_362	[p20l1398t2730r1478b2784],
22	elective	JJ	O	elective	amod	25	SENT_362	[p20l1503t2731r1710b2784],
23	coronary	JJ	O	coronary	amod	25	SENT_362	[p20l1736t2751r1983b2802],
24	stent	NN	O	stent	nn	25	SENT_362	[p20l2007t2744r2143b2784],
25	placement	NN	O	placement	prep_for	20	SENT_362	[p20l132t2810r438b2882],
26	.	.	O	.	_	0	SENT_362	[p20l132t2810r438b2882],

1	EuroIntervention	NNP	O	EuroIntervention	_	0	SENT_363	[p20l469t2811r966b2864],
2	2008	CD	DATE	2008	num	1	SENT_363	[p20l991t2813r1441b2876],
3	;	:	O	;	_	0	SENT_363	[p20l991t2813r1441b2876],
4	4:214	CD	NUMBER	4:214	number	5	SENT_363	[p20l991t2813r1441b2876],
5	-21	CD	NUMBER	-21	dep	1	SENT_363	[p20l991t2813r1441b2876],
6	.	.	O	.	_	0	SENT_363	[p20l991t2813r1441b2876],

1	Gladding	VBG	PERSON	gladd	_	0	SENT_364	[p20l134t2890r404b2962],
2	P	NN	PERSON	p	dep	1	SENT_364	[p20l435t2891r491b2956],
3	,	,	O	,	_	0	SENT_364	[p20l435t2891r491b2956],
4	Webster	NNP	PERSON	Webster	nn	5	SENT_364	[p20l522t2891r768b2944],
5	M	NNP	O	M	appos	2	SENT_364	[p20l797t2891r881b2955],
6	,	,	O	,	_	0	SENT_364	[p20l797t2891r881b2955],
7	Zeng	NNP	O	Zeng	appos	2	SENT_364	[p20l917t2891r1067b2962],
8	I	PRP	O	I	dep	7	SENT_364	[p20l1097t2891r1137b2955],
9	,	,	O	,	_	0	SENT_364	[p20l1097t2891r1137b2955],
10	et	FW	O	et	nn	11	SENT_364	[p20l1172t2904r1223b2944],
11	al.	FW	O	al.	appos	2	SENT_364	[p20l1256t2891r1315b2944],
12	.	.	O	.	_	0	SENT_364	[p20l1256t2891r1315b2944],

1	The	DT	O	the	det	2	SENT_365	[p20l1348t2889r1466b2944],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_365	[p20l1498t2891r2006b2962],
3	and	CC	O	and	_	0	SENT_365	[p20l2041t2891r2143b2944],
4	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	2	SENT_365	[p20l132t2971r678b3043],
5	of	IN	O	of	_	0	SENT_365	[p20l727t2971r791b3025],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_365	[p20l828t2971r1144b3043],
7	response	NN	O	response	prep_of	2	SENT_365	[p20l1189t2992r1447b3043],
8	:	:	O	:	_	0	SENT_365	[p20l1189t2992r1447b3043],
9	an	DT	O	a	det	10	SENT_365	[p20l1498t2992r1563b3025],
10	analysis	NN	O	analysis	dep	2	SENT_365	[p20l1610t2972r1823b3043],
11	from	IN	O	from	_	0	SENT_365	[p20l1870t2971r2006b3025],
12	the	DT	O	the	det	16	SENT_365	[p20l2053t2972r2141b3025],
13	PRINC	NNP	O	PRINC	nn	16	SENT_365	[p20l133t3051r358b3105],
14	(	CD	NUMBER	(	num	16	SENT_365	[p20l388t3050r581b3116],
15	Plavix	NNP	O	Plavix	nn	16	SENT_365	[p20l388t3050r581b3116],
16	Response	NN	O	response	prep_from	10	SENT_365	[p20l608t3052r874b3123],
17	in	IN	O	in	_	0	SENT_365	[p20l901t3054r955b3104],
18	Coronary	JJ	O	coronary	amod	21	SENT_365	[p20l983t3051r1254b3123],
19	Intervention	NN	O	intervention	nn	21	SENT_365	[p20l1277t3050r1651b3116],
20	)	NN	O	)	nn	21	SENT_365	[p20l1277t3050r1651b3116],
21	trial	NN	O	trial	prep_in	10	SENT_365	[p20l1681t3052r1807b3105],
22	.	.	O	.	_	0	SENT_365	[p20l1681t3052r1807b3105],

1	J	NNP	O	J	nn	5	SENT_366	[p20l1830t3052r1859b3119],
2	Am	NNP	O	Am	nn	5	SENT_366	[p20l1883t3050r1992b3104],
3	Coll	NNP	O	Coll	nn	5	SENT_366	[p20l2021t3051r2143b3105],
4	Cardiol	NNP	O	Cardiol	nn	5	SENT_366	[p20l134t3131r349b3184],
5	Intv	NNP	O	Intv	_	0	SENT_366	[p20l373t3132r492b3184],
6	2008	CD	DATE	2008	num	5	SENT_366	[p20l514t3133r928b3196],
7	;	:	O	;	_	0	SENT_366	[p20l514t3133r928b3196],
8	1:620	CD	NUMBER	1:620	num	9	SENT_366	[p20l514t3133r928b3196],
9	—	NN	O	—	dep	5	SENT_366	[p20l514t3133r928b3196],
10	7	CD	NUMBER	7	dep	9	SENT_366	[p20l514t3133r928b3196],
11	.	.	O	.	_	0	SENT_366	[p20l514t3133r928b3196],

1	Pena	NNP	PERSON	Pena	nn	2	SENT_367	[p20l133t3211r273b3264],
2	A	NNP	O	A	_	0	SENT_367	[p20l310t3209r378b3276],
3	,	,	O	,	_	0	SENT_367	[p20l310t3209r378b3276],
4	Collet	NNP	ORGANIZATION	Collet	nn	5	SENT_367	[p20l422t3210r597b3264],
5	JP	NNP	ORGANIZATION	JP	appos	2	SENT_367	[p20l629t3211r716b3278],
6	,	,	O	,	_	0	SENT_367	[p20l629t3211r716b3278],
7	Hulot	NNP	PERSON	Hulot	nn	8	SENT_367	[p20l759t3211r930b3264],
8	JS	NNP	O	JS	appos	2	SENT_367	[p20l962t3210r1044b3278],
9	,	,	O	,	_	0	SENT_367	[p20l962t3210r1044b3278],
10	et	FW	O	et	nn	11	SENT_367	[p20l1088t3224r1139b3264],
11	al.	FW	O	al.	appos	2	SENT_367	[p20l1179t3211r1238b3264],
12	.	.	O	.	_	0	SENT_367	[p20l1179t3211r1238b3264],

1	Can	MD	O	can	aux	3	SENT_368	[p20l1283t3210r1400b3264],
2	we	PRP	O	we	nsubj	3	SENT_368	[p20l1437t3231r1516b3264],
3	override	VB	O	override	_	0	SENT_368	[p20l1558t3211r1786b3264],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_368	[p20l1827t3210r2143b3282],
5	resistance	NN	O	resistance	dobj	3	SENT_368	[p20l133t3293r430b3343],
6	?	.	O	?	_	0	SENT_368	[p20l133t3293r430b3343],

1	Circulation	NN	O	circulation	_	0	SENT_369	[p20l460t3290r781b3343],
2	2009	CD	DATE	2009	num	1	SENT_369	[p20l806t3291r1326b3355],
3	;	:	O	;	_	0	SENT_369	[p20l806t3291r1326b3355],
4	119:2854	CD	NUMBER	119:2854	number	5	SENT_369	[p20l806t3291r1326b3355],
5	-7	CD	NUMBER	-7	dep	1	SENT_369	[p20l806t3291r1326b3355],
6	.	.	O	.	_	0	SENT_369	[p20l806t3291r1326b3355],

1	Geisler	NNP	PERSON	Geisler	nn	2	SENT_370	[p20l134t3369r337b3423],
2	T	NN	O	t	_	0	SENT_370	[p20l359t3368r424b3435],
3	,	,	O	,	_	0	SENT_370	[p20l359t3368r424b3435],
4	Grass	NN	O	grass	nn	5	SENT_370	[p20l453t3369r611b3423],
5	D	NN	O	d	appos	2	SENT_370	[p20l638t3370r709b3435],
6	,	,	O	,	_	0	SENT_370	[p20l638t3370r709b3435],
7	Bigalke	NN	O	bigalke	nn	8	SENT_370	[p20l737t3370r948b3441],
8	B	NN	O	b	appos	2	SENT_370	[p20l974t3370r1034b3435],
9	,	,	O	,	_	0	SENT_370	[p20l974t3370r1034b3435],
10	et	FW	O	et	nn	11	SENT_370	[p20l1062t3383r1113b3423],
11	al.	FW	O	al.	appos	2	SENT_370	[p20l1138t3370r1197b3423],
12	.	.	O	.	_	0	SENT_370	[p20l1138t3370r1197b3423],

1	The	DT	O	the	det	4	SENT_371	[p20l1224t3368r1341b3423],
2	Residual	JJ	O	residual	amod	4	SENT_371	[p20l1369t3370r1612b3423],
3	Platelet	NN	O	platelet	nn	4	SENT_371	[p20l1636t3370r1851b3423],
4	Aggregation	NN	O	aggregation	_	0	SENT_371	[p20l1873t3368r2140b3441, p20l133t3452r245b3503],
5	after	IN	O	after	_	0	SENT_371	[p20l280t3449r407b3503],
6	Deployment	NNP	O	Deployment	prep_after	4	SENT_371	[p20l439t3450r796b3521],
7	of	IN	O	of	_	0	SENT_371	[p20l828t3449r893b3503],
8	Intracoronary	NNP	O	Intracoronary	nn	13	SENT_371	[p20l916t3450r1306b3521],
9	Stent	NNP	O	Stent	nn	13	SENT_371	[p20l1340t3449r1488b3503],
10	(	NNP	O	(	nn	13	SENT_371	[p20l1523t3448r1891b3514],
11	PREDICT	NNP	O	PREDICT	nn	13	SENT_371	[p20l1523t3448r1891b3514],
12	)	NN	O	)	nn	13	SENT_371	[p20l1523t3448r1891b3514],
13	score	NN	NUMBER	score	prep_of	4	SENT_371	[p20l1929t3470r2084b3503],
14	.	.	O	.	_	0	SENT_371	[p20l1929t3470r2084b3503],

1	J	NNP	O	J	nn	3	SENT_372	[p20l2114t3450r2142b3517],
2	Thromb	NNP	O	Thromb	nn	3	SENT_372	[p20l131t3528r370b3582],
3	Haemost	NNP	O	Haemost	_	0	SENT_372	[p20l399t3530r659b3582],
4	2008	CD	DATE	2008	num	3	SENT_372	[p20l683t3529r1105b3593],
5	;	:	O	;	_	0	SENT_372	[p20l683t3529r1105b3593],
6	6:54	CD	TIME	6:54	number	7	SENT_372	[p20l683t3529r1105b3593],
7	—	CD	NUMBER	—	dep	3	SENT_372	[p20l683t3529r1105b3593],
8	61	CD	NUMBER	61	dep	7	SENT_372	[p20l683t3529r1105b3593],
9	.	.	O	.	_	0	SENT_372	[p20l683t3529r1105b3593],

1	JACC	NNP	O	JACC	nn	2	SENT_373	[p20l1482t3620r1597b3671],
2	Vol	NNP	O	Vol	_	0	SENT_373	[p20l1618t3621r1700b3671],
3	.	.	O	.	_	0	SENT_373	[p20l1618t3621r1700b3671],

1	55	CD	NUMBER	55	_	0	SENT_374	[p20l1725t3621r1798b3680],
2	,	,	O	,	_	0	SENT_374	[p20l1725t3621r1798b3680],
3	No.	NN	O	no.	amod	1	SENT_374	[p20l1824t3621r1896b3671],
4	22	CD	NUMBER	22	number	3	SENT_374	[p20l1921t3620r1994b3680],
5	,	,	O	,	_	0	SENT_374	[p20l1921t3620r1994b3680],
6	2010	CD	DATE	2010	appos	1	SENT_374	[p20l2019t3620r2142b3671],
7	June	NNP	DATE	June	tmod	6	SENT_374	[p20l1590t3709r1696b3760],
8	1	CD	DATE	1	num	7	SENT_374	[p20l1719t3709r1759b3768],
9	,	,	O	,	_	0	SENT_374	[p20l1719t3709r1759b3768],
10	2010:2427	CD	NUMBER	2010:2427	num	7	SENT_374	[p20l1784t3709r2143b3760],
11	—	CD	NUMBER	—	num	12	SENT_374	[p20l1784t3709r2143b3760],
12	34	CD	NUMBER	34	dep	1	SENT_374	[p20l1784t3709r2143b3760],

1	Sibbing	VBG	O	sibb	_	0	SENT_375	[p21l137t135r354b207],
2	D	NN	O	d	dobj	1	SENT_375	[p21l379t136r449b201],
3	,	,	O	,	_	0	SENT_375	[p21l379t136r449b201],
4	von	NNP	PERSON	von	nn	6	SENT_375	[p21l475t156r579b189],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_375	[p21l606t136r891b189],
6	O	NNP	PERSON	O	appos	2	SENT_375	[p21l918t135r988b201],
7	,	,	O	,	_	0	SENT_375	[p21l918t135r988b201],
8	Schomig	NNP	O	Schomig	nn	9	SENT_375	[p21l1019t135r1268b207],
9	A	NNP	O	A	appos	2	SENT_375	[p21l1291t134r1359b200],
10	,	,	O	,	_	0	SENT_375	[p21l1291t134r1359b200],
11	Kastrati	NNP	PERSON	Kastrati	nn	12	SENT_375	[p21l1389t136r1610b189],
12	A	NNP	O	A	appos	2	SENT_375	[p21l1634t134r1702b200],
13	,	,	O	,	_	0	SENT_375	[p21l1634t134r1702b200],
14	von	NNP	O	von	nn	18	SENT_375	[p21l1728t156r1832b189],
15	Beckerath	NNP	O	Beckerath	nn	18	SENT_375	[p21l1858t136r2143b189],
16	N.	NNP	O	N.	nn	18	SENT_375	[p21l134t218r202b271],
17	Platelet	NN	O	platelet	nn	18	SENT_375	[p21l225t218r439b271],
18	function	NN	O	function	appos	2	SENT_375	[p21l457t218r694b271],
19	in	IN	O	in	_	0	SENT_375	[p21l713t220r767b270],
20	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	21	SENT_375	[p21l787t218r1329b289],
21	patients	NNS	O	patient	prep_in	18	SENT_375	[p21l1346t220r1568b289],
22	with	IN	O	with	_	0	SENT_375	[p21l1585t218r1714b271],
23	acute	JJ	O	acute	amod	25	SENT_375	[p21l1734t232r1878b271],
24	coronary	JJ	O	coronary	amod	25	SENT_375	[p21l1899t238r2146b289],
25	syndrome	NN	O	syndrome	prep_with	1	SENT_375	[p21l135t299r425b370],
26	.	.	O	.	_	0	SENT_375	[p21l135t299r425b370],

1	Blood	NNP	O	Blood	nn	3	SENT_376	[p21l455t299r626b352],
2	Coagul	NNP	O	Coagul	nn	3	SENT_376	[p21l653t299r858b370],
3	Fibrinolysis	NNP	O	Fibrinolysis	_	0	SENT_376	[p21l884t299r1212b370],
4	2007	CD	DATE	2007	num	3	SENT_376	[p21l1239t299r1680b364],
5	;	:	O	;	_	0	SENT_376	[p21l1239t299r1680b364],
6	18:335	CD	NUMBER	18:335	number	7	SENT_376	[p21l1239t299r1680b364],
7	-9	CD	NUMBER	-9	dep	3	SENT_376	[p21l1239t299r1680b364],
8	.	.	O	.	_	0	SENT_376	[p21l1239t299r1680b364],

1	Alpert	NNP	PERSON	Alpert	nn	2	SENT_377	[p21l132t380r318b453],
2	JS	NNP	O	JS	_	0	SENT_377	[p21l331t381r414b449],
3	,	,	O	,	_	0	SENT_377	[p21l331t381r414b449],
4	Thygesen	NNP	PERSON	Thygesen	nn	5	SENT_377	[p21l435t380r713b453],
5	K	NNP	PERSON	K	appos	2	SENT_377	[p21l737t382r799b446],
6	,	,	O	,	_	0	SENT_377	[p21l737t382r799b446],
7	Antman	NNP	PERSON	Antman	nn	8	SENT_377	[p21l821t380r1059b434],
8	E	NNP	O	E	appos	2	SENT_377	[p21l1082t382r1143b446],
9	,	,	O	,	_	0	SENT_377	[p21l1082t382r1143b446],
10	Bassand	NNP	O	Bassand	nn	11	SENT_377	[p21l1167t381r1398b434],
11	JP	NNP	O	JP	appos	2	SENT_377	[p21l1412t382r1498b449],
12	.	.	O	.	_	0	SENT_377	[p21l1412t382r1498b449],

1	Myocardial	JJ	O	myocardial	amod	2	SENT_378	[p21l1522t381r1847b453],
2	infarction	NN	O	infarction	nsubj	3	SENT_378	[p21l1868t381r2143b434],
3	redeﬁned	VBD	O	redeﬁned	_	0	SENT_378	[p21l134t464r500b517],
4	—	CD	NUMBER	—	dobj	3	SENT_378	[p21l134t464r500b517],
5	a	DT	O	a	det	7	SENT_378	[p21l134t464r500b517],
6	consensus	NN	O	consensus	nn	7	SENT_378	[p21l529t484r807b517],
7	document	NN	O	document	tmod	3	SENT_378	[p21l839t463r1123b517],
8	of	IN	O	of	_	0	SENT_378	[p21l1152t464r1216b517],
9	The	DT	ORGANIZATION	the	det	12	SENT_378	[p21l1234t462r1352b517],
10	Joint	JJ	ORGANIZATION	joint	amod	12	SENT_378	[p21l1375t464r1519b531],
11	European	JJ	ORGANIZATION	european	amod	12	SENT_378	[p21l1549t464r1825b535],
12	Society	NNP	ORGANIZATION	Society	prep_of	7	SENT_378	[p21l1857t463r2062b535],
13	of	IN	ORGANIZATION	of	_	0	SENT_378	[p21l2089t464r2153b517],
14	Cardiology/American	NNP	ORGANIZATION	Cardiology/American	nn	15	SENT_378	[p21l135t545r756b617],
15	College	NNP	ORGANIZATION	College	prep_of	12	SENT_378	[p21l790t546r1005b617],
16	of	IN	ORGANIZATION	of	_	0	SENT_378	[p21l1039t546r1102b599],
17	Cardiology	NNP	ORGANIZATION	Cardiology	nn	18	SENT_378	[p21l1126t546r1444b617],
18	Committee	NNP	ORGANIZATION	Committee	prep_of	15	SENT_378	[p21l1474t546r1798b599],
19	for	IN	O	for	_	0	SENT_378	[p21l1830t546r1911b599],
20	the	DT	O	the	det	21	SENT_378	[p21l1941t546r2029b599],
21	redefinition	NN	O	redefinition	prep_for	18	SENT_378	[p21l2062t566r2140b599, p21l135t627r410b680],
22	of	IN	O	of	_	0	SENT_378	[p21l456t627r520b680],
23	myocardial	JJ	O	myocardial	amod	24	SENT_378	[p21l556t627r866b699],
24	infarction	NN	O	infarction	prep_of	21	SENT_378	[p21l910t627r1200b680],
25	.	.	O	.	_	0	SENT_378	[p21l910t627r1200b680],

1	J	NNP	O	J	nn	4	SENT_379	[p21l1242t628r1270b695],
2	Am	NNP	O	Am	nn	4	SENT_379	[p21l1313t626r1422b680],
3	Coll	NNP	O	Coll	nn	4	SENT_379	[p21l1469t627r1591b680],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_379	[p21l1637t627r1852b680],
5	2000	CD	DATE	2000	num	4	SENT_379	[p21l1894t630r2139b692],
6	;	:	O	;	_	0	SENT_379	[p21l1894t630r2139b692],
7	36	CD	NUMBER	36	num	9	SENT_379	[p21l1894t630r2139b692],
8	:	:	O	:	_	0	SENT_379	[p21l1894t630r2139b692],
9	959-69	CD	NUMBER	959-69	dep	4	SENT_379	[p21l135t720r376b773],
10	.	.	O	.	_	0	SENT_379	[p21l135t720r376b773],

1	Hochholzer	NNP	O	Hochholzer	nn	2	SENT_380	[p21l135t787r474b840],
2	W	NNP	O	W	_	0	SENT_380	[p21l508t788r599b852],
3	,	,	O	,	_	0	SENT_380	[p21l508t788r599b852],
4	Trenk	NNP	ORGANIZATION	Trenk	nn	5	SENT_380	[p21l637t786r818b840],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_380	[p21l853t788r924b852],
6	,	,	O	,	_	0	SENT_380	[p21l853t788r924b852],
7	Frundi	NNP	O	Frundi	nn	8	SENT_380	[p21l965t788r1159b840],
8	D	NNP	O	D	appos	2	SENT_380	[p21l1197t788r1268b852],
9	,	,	O	,	_	0	SENT_380	[p21l1197t788r1268b852],
10	Neumann	NNP	PERSON	Neumann	appos	2	SENT_380	[p21l1308t788r1592b840],
11	@	IN	O	@	dep	12	SENT_380	[p21l1631t788r1709b855],
12	l	NN	O	l	amod	10	SENT_380	[p21l1631t788r1709b855],
13	+	CC	O	+	_	0	SENT_380	[p21l1631t788r1709b855],
14	Whole	JJ	O	whole	amod	16	SENT_380	[p21l1748t788r1944b840],
15	blood	NN	O	blood	nn	16	SENT_380	[p21l1982t787r2144b840],
16	aggregometry	NN	O	aggregometry	conj_+	10	SENT_380	[p21l135t882r524b939],
17	for	IN	O	for	_	0	SENT_380	[p21l550t868r631b921],
18	evaluation	NN	O	evaluation	prep_for	16	SENT_380	[p21l659t868r947b921],
19	of	IN	O	of	_	0	SENT_380	[p21l977t868r1040b921],
20	the	DT	O	the	det	22	SENT_380	[p21l1059t868r1148b921],
21	antiplatelet	JJ	O	antiplatelet	amod	22	SENT_380	[p21l1179t868r1495b940],
22	effects	NNS	O	effect	prep_of	18	SENT_380	[p21l1524t868r1695b921],
23	of	IN	O	of	_	0	SENT_380	[p21l1726t868r1790b921],
24	clopidogrel	NN	O	clopidogrel	prep_of	22	SENT_380	[p21l1810t868r2139b940],
25	.	.	O	.	_	0	SENT_380	[p21l1810t868r2139b940],

1	Thromb	NNP	O	Thromb	nn	2	SENT_381	[p21l132t966r371b1020],
2	Res	NNP	O	Res	_	0	SENT_381	[p21l401t968r500b1020],
3	2007	CD	DATE	2007	num	2	SENT_381	[p21l527t967r1039b1031],
4	;	:	O	;	_	0	SENT_381	[p21l527t967r1039b1031],
5	119:285	CD	NUMBER	119:285	number	6	SENT_381	[p21l527t967r1039b1031],
6	-91	CD	NUMBER	-91	dep	2	SENT_381	[p21l527t967r1039b1031],
7	.	.	O	.	_	0	SENT_381	[p21l527t967r1039b1031],

1	Trenk	NN	PERSON	trenk	nn	2	SENT_382	[p21l132t1047r313b1101],
2	D	NN	O	d	_	0	SENT_382	[p21l339t1049r410b1113],
3	,	,	O	,	_	0	SENT_382	[p21l339t1049r410b1113],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_382	[p21l443t1048r783b1101],
5	W	NNP	PERSON	W	appos	2	SENT_382	[p21l808t1049r898b1112],
6	,	,	O	,	_	0	SENT_382	[p21l808t1049r898b1112],
7	Fromm	NNP	ORGANIZATION	Fromm	nn	8	SENT_382	[p21l931t1049r1145b1101],
8	MF	NN	ORGANIZATION	mf	appos	5	SENT_382	[p21l1174t1049r1301b1113],
9	,	,	O	,	_	0	SENT_382	[p21l1174t1049r1301b1113],
10	Zolk	NN	PERSON	zolk	nn	11	SENT_382	[p21l1334t1048r1473b1101],
11	O	NN	PERSON	o	appos	5	SENT_382	[p21l1501t1048r1571b1113],
12	,	,	O	,	_	0	SENT_382	[p21l1501t1048r1571b1113],
13	Pahl	NN	PERSON	pahl	nn	14	SENT_382	[p21l1604t1048r1732b1101],
14	A	NN	O	a	appos	5	SENT_382	[p21l1759t1047r1826b1112],
15	,	,	O	,	_	0	SENT_382	[p21l1759t1047r1826b1112],
16	Neumann	NNP	PERSON	Neumann	nn	17	SENT_382	[p21l1859t1049r2143b1101],
17	F	NN	O	f	appos	5	SENT_382	[p21l134t1130r241b1198],
18	.	.	O	.	_	0	SENT_382	[p21l134t1130r241b1198],

1	—	NN	O	—	_	0	SENT_383	[p21l134t1130r241b1198],
2	.	.	O	.	_	0	SENT_383	[p21l134t1130r241b1198],

1	J.	NNP	O	J.	nn	2	SENT_384	[p21l134t1130r241b1198],
2	Impact	NNP	O	Impact	_	0	SENT_384	[p21l266t1130r468b1202],
3	of	IN	O	of	_	0	SENT_384	[p21l489t1130r553b1183],
4	polymorphic	JJ	O	polymorphic	amod	5	SENT_384	[p21l564t1130r925b1202],
5	expression	NN	O	expression	prep_of	2	SENT_384	[p21l947t1132r1240b1202],
6	of	IN	O	of	_	0	SENT_384	[p21l1262t1130r1326b1183],
7	cytochrome	NN	O	cytochrome	nn	9	SENT_384	[p21l1340t1130r1669b1201],
8	P450	NN	O	p450	nn	9	SENT_384	[p21l1692t1130r1838b1183],
9	2C19	NN	O	2c19	prep_of	2	SENT_384	[p21l1860t1130r2016b1184],
10	and	CC	O	and	_	0	SENT_384	[p21l2042t1130r2144b1183],
11	CYP	NN	O	cyp	nn	12	SENT_384	[p21l136t1211r275b1264],
12	2C9	NN	O	2c9	conj_and	9	SENT_384	[p21l305t1211r426b1265],
13	on	IN	O	on	_	0	SENT_384	[p21l461t1232r531b1264],
14	antiplatelet	JJ	O	antiplatelet	amod	15	SENT_384	[p21l563t1211r880b1283],
15	effect	NN	O	effect	prep_on	9	SENT_384	[p21l912t1211r1060b1264],
16	of	IN	O	of	_	0	SENT_384	[p21l1091t1211r1155b1264],
17	a	DT	O	a	det	20	SENT_384	[p21l1178t1232r1206b1264],
18	600-mg	JJ	O	600-mg	amod	20	SENT_384	[p21l1237t1214r1462b1282],
19	loading	NN	O	loading	nn	20	SENT_384	[p21l1492t1211r1704b1282],
20	dose	NN	O	dose	prep_of	2	SENT_384	[p21l1735t1211r1859b1264],
21	of	IN	O	of	_	0	SENT_384	[p21l1892t1211r1956b1264],
22	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_384	[p21l1979t1211r2140b1283, p21l135t1293r312b1365],
23	in	IN	O	in	_	0	SENT_384	[p21l348t1295r401b1346],
24	a	DT	O	a	det	26	SENT_384	[p21l439t1314r466b1346],
25	large	JJ	O	large	amod	26	SENT_384	[p21l501t1293r636b1365],
26	cohort	NN	O	cohort	prep_in	2	SENT_384	[p21l674t1293r857b1346],
27	of	IN	O	of	_	0	SENT_384	[p21l893t1293r957b1346],
28	patients	NNS	O	patient	prep_of	2	SENT_384	[p21l982t1296r1204b1365],
29	undergoing	VBG	O	undergo	partmod	28	SENT_384	[p21l1241t1293r1568b1365],
30	PCI	NN	O	pcus	dobj	29	SENT_384	[p21l1603t1293r1737b1346],
31	.	.	O	.	_	0	SENT_384	[p21l1603t1293r1737b1346],

1	Eur	NNP	MISC	Eur	nn	2	SENT_385	[p21l1778t1294r1885b1346],
2	HeartJ	NNP	O	HeartJ	_	0	SENT_385	[p21l1921t1294r2143b1361],
3	2008	CD	DATE	2008	num	2	SENT_385	[p21l133t1379r361b1441],
4	;	:	O	;	_	0	SENT_385	[p21l133t1379r361b1441],
5	29	CD	NUMBER	29	num	6	SENT_385	[p21l133t1379r361b1441],
6	Suppl	NN	O	suppl	dep	2	SENT_385	[p21l392t1376r693b1448],
7	:759	CD	NUMBER	:759	dep	6	SENT_385	[p21l392t1376r693b1448],
8	.	.	O	.	_	0	SENT_385	[p21l392t1376r693b1448],

1	Gladding	VBG	PERSON	gladd	_	0	SENT_386	[p21l136t1459r405b1530],
2	P	NN	PERSON	p	dep	1	SENT_386	[p21l436t1459r492b1524],
3	,	,	O	,	_	0	SENT_386	[p21l436t1459r492b1524],
4	Webster	NNP	PERSON	Webster	nn	5	SENT_386	[p21l523t1459r769b1512],
5	M	NNP	O	M	appos	2	SENT_386	[p21l798t1459r882b1524],
6	,	,	O	,	_	0	SENT_386	[p21l798t1459r882b1524],
7	Zeng	NNP	O	Zeng	appos	2	SENT_386	[p21l918t1459r1068b1530],
8	I	PRP	O	I	dep	7	SENT_386	[p21l1098t1459r1138b1524],
9	,	,	O	,	_	0	SENT_386	[p21l1098t1459r1138b1524],
10	et	FW	O	et	nn	11	SENT_386	[p21l1173t1472r1224b1512],
11	al.	FW	O	al.	appos	2	SENT_386	[p21l1257t1459r1316b1512],
12	.	.	O	.	_	0	SENT_386	[p21l1257t1459r1316b1512],

1	The	DT	O	the	det	2	SENT_387	[p21l1349t1457r1467b1512],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_387	[p21l1498t1459r2007b1531],
3	and	CC	O	and	_	0	SENT_387	[p21l2042t1459r2144b1512],
4	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	2	SENT_387	[p21l133t1542r680b1614],
5	of	IN	O	of	_	0	SENT_387	[p21l728t1542r792b1595],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_387	[p21l829t1542r1145b1614],
7	response	NN	O	response	prep_of	2	SENT_387	[p21l1190t1562r1448b1614],
8	:	:	O	:	_	0	SENT_387	[p21l1190t1562r1448b1614],
9	an	DT	O	a	det	10	SENT_387	[p21l1499t1563r1564b1595],
10	analysis	NN	O	analysis	dep	2	SENT_387	[p21l1611t1542r1824b1613],
11	from	IN	O	from	_	0	SENT_387	[p21l1871t1542r2007b1595],
12	the	DT	O	the	det	16	SENT_387	[p21l2054t1542r2142b1595],
13	PRINC	NNP	O	PRINC	nn	16	SENT_387	[p21l134t1624r359b1678],
14	(	CD	NUMBER	(	num	16	SENT_387	[p21l389t1623r582b1689],
15	Plavix	NNP	O	Plavix	nn	16	SENT_387	[p21l389t1623r582b1689],
16	Response	NN	O	response	prep_from	10	SENT_387	[p21l609t1625r875b1696],
17	in	IN	O	in	_	0	SENT_387	[p21l902t1627r956b1677],
18	Coronary	JJ	O	coronary	amod	21	SENT_387	[p21l984t1624r1255b1696],
19	Intervention	NN	O	intervention	nn	21	SENT_387	[p21l1278t1623r1652b1689],
20	)	NN	O	)	nn	21	SENT_387	[p21l1278t1623r1652b1689],
21	trial	NN	O	trial	prep_in	10	SENT_387	[p21l1682t1624r1808b1677],
22	.	.	O	.	_	0	SENT_387	[p21l1682t1624r1808b1677],

1	J	NNP	O	J	nn	5	SENT_388	[p21l1831t1625r1860b1692],
2	Am	NNP	O	Am	nn	5	SENT_388	[p21l1885t1623r1993b1677],
3	Coll	NNP	O	Coll	nn	5	SENT_388	[p21l2022t1624r2144b1678],
4	Cardiol	NNP	O	Cardiol	nn	5	SENT_388	[p21l136t1706r350b1759],
5	Intv	NNP	O	Intv	_	0	SENT_388	[p21l375t1707r493b1759],
6	2008	CD	DATE	2008	num	5	SENT_388	[p21l515t1708r929b1771],
7	;	:	O	;	_	0	SENT_388	[p21l515t1708r929b1771],
8	1:620	CD	NUMBER	1:620	num	9	SENT_388	[p21l515t1708r929b1771],
9	—	NN	O	—	dep	5	SENT_388	[p21l515t1708r929b1771],
10	7	CD	NUMBER	7	dep	9	SENT_388	[p21l515t1708r929b1771],
11	.	.	O	.	_	0	SENT_388	[p21l515t1708r929b1771],

1	Taubert	NNP	PERSON	Taubert	nn	2	SENT_389	[p21l132t1786r370b1841],
2	D	NNP	PERSON	D	_	0	SENT_389	[p21l417t1788r489b1853],
3	,	,	O	,	_	0	SENT_389	[p21l417t1788r489b1853],
4	von	NNP	PERSON	von	nn	6	SENT_389	[p21l537t1809r644b1841],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_389	[p21l692t1788r988b1841],
6	N	NNP	PERSON	N	appos	2	SENT_389	[p21l1035t1788r1106b1853],
7	,	,	O	,	_	0	SENT_389	[p21l1035t1788r1106b1853],
8	Grimberg	NNP	PERSON	Grimberg	nn	9	SENT_389	[p21l1158t1788r1449b1859],
9	G	NNP	PERSON	G	appos	2	SENT_389	[p21l1497t1788r1568b1853],
10	,	,	O	,	_	0	SENT_389	[p21l1497t1788r1568b1853],
11	et	FW	O	et	nn	12	SENT_389	[p21l1619t1802r1671b1841],
12	al.	FW	O	al.	appos	2	SENT_389	[p21l1719t1788r1781b1841],
13	.	.	O	.	_	0	SENT_389	[p21l1719t1788r1781b1841],

1	Impact	NN	O	impact	_	0	SENT_390	[p21l1831t1788r2040b1859],
2	of	IN	O	of	_	0	SENT_390	[p21l2088t1788r2153b1841],
3	P	NN	O	p	nn	5	SENT_390	[p21l134t1869r576b1941],
4	—	CD	NUMBER	—	num	5	SENT_390	[p21l134t1869r576b1941],
5	glycoprotein	NN	O	glycoprotein	prep_of	1	SENT_390	[p21l134t1869r576b1941],
6	on	IN	O	on	_	0	SENT_390	[p21l618t1890r689b1922],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_390	[p21l730t1869r1060b1941],
8	absorption	NN	O	absorption	prep_on	1	SENT_390	[p21l1101t1869r1429b1941],
9	.	.	O	.	_	0	SENT_390	[p21l1101t1869r1429b1941],

1	Clin	NNP	O	Clin	nn	3	SENT_391	[p21l1474t1869r1602b1922],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_391	[p21l1643t1869r1959b1922],
3	Ther	NNP	O	Ther	_	0	SENT_391	[p21l1996t1868r2145b1922],
4	2006	CD	DATE	2006	num	3	SENT_391	[p21l133t1951r675b2016],
5	;	:	O	;	_	0	SENT_391	[p21l133t1951r675b2016],
6	80:486	CD	NUMBER	80:486	number	7	SENT_391	[p21l133t1951r675b2016],
7	-501	CD	NUMBER	-501	dep	3	SENT_391	[p21l133t1951r675b2016],
8	.	.	O	.	_	0	SENT_391	[p21l133t1951r675b2016],

1	Trenk	NN	PERSON	trenk	nn	2	SENT_392	[p21l132t2031r313b2086],
2	D	NN	O	d	_	0	SENT_392	[p21l335t2033r406b2098],
3	,	,	O	,	_	0	SENT_392	[p21l335t2033r406b2098],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_392	[p21l435t2033r774b2086],
5	W	NNP	PERSON	W	appos	2	SENT_392	[p21l796t2033r886b2097],
6	,	,	O	,	_	0	SENT_392	[p21l796t2033r886b2097],
7	Fromm	NNP	ORGANIZATION	Fromm	nn	8	SENT_392	[p21l915t2033r1129b2086],
8	MF	NN	ORGANIZATION	mf	appos	5	SENT_392	[p21l1154t2033r1281b2097],
9	,	,	O	,	_	0	SENT_392	[p21l1154t2033r1281b2097],
10	Kleyer	NNP	O	Kleyer	nn	11	SENT_392	[p21l1311t2032r1493b2104],
11	A	NNP	O	A	appos	5	SENT_392	[p21l1515t2031r1583b2098],
12	,	,	O	,	_	0	SENT_392	[p21l1515t2031r1583b2098],
13	Pahl	NNP	PERSON	Pahl	nn	14	SENT_392	[p21l1612t2033r1740b2086],
14	A	NNP	O	A	appos	5	SENT_392	[p21l1763t2031r1831b2098],
15	,	,	O	,	_	0	SENT_392	[p21l1763t2031r1831b2098],
16	Neumann	NNP	PERSON	Neumann	nn	17	SENT_392	[p21l1859t2033r2143b2086],
17	F	NN	O	f	appos	5	SENT_392	[p21l134t2115r241b2182],
18	.	.	O	.	_	0	SENT_392	[p21l134t2115r241b2182],

1	—	NN	O	—	_	0	SENT_393	[p21l134t2115r241b2182],
2	.	.	O	.	_	0	SENT_393	[p21l134t2115r241b2182],

1	J.	NNP	MISC	J.	nn	2	SENT_394	[p21l134t2115r241b2182],
2	Polymorphism	NN	MISC	polymorphism	nsubj	14	SENT_394	[p21l280t2114r698b2186],
3	of	IN	MISC	of	_	0	SENT_394	[p21l735t2114r799b2167],
4	MDR-1	NN	MISC	mdr-1	prep_of	2	SENT_394	[p21l823t2115r1059b2166],
5	and	CC	O	and	_	0	SENT_394	[p21l1101t2114r1202b2167],
6	the	DT	O	the	det	9	SENT_394	[p21l1237t2114r1325b2167],
7	organic	JJ	O	organic	amod	9	SENT_394	[p21l1362t2116r1570b2185],
8	anion-transporting	JJ	O	anion-transporting	amod	9	SENT_394	[p21l1606t2116r2145b2186],
9	polypeptide	NN	O	polypeptide	conj_and	2	SENT_394	[p21l133t2196r464b2268],
10	(	CD	NUMBER	(	num	11	SENT_394	[p21l498t2195r742b2261],
11	OATP	NN	O	oatp	dep	9	SENT_394	[p21l498t2195r742b2261],
12	)	CD	NUMBER	)	num	13	SENT_394	[p21l498t2195r742b2261],
13	1B1	NN	O	1b1	dep	9	SENT_394	[p21l779t2197r886b2249],
14	have	VBP	O	have	_	0	SENT_394	[p21l921t2196r1048b2249],
15	no	DT	O	no	det	16	SENT_394	[p21l1080t2217r1148b2249],
16	impact	NN	O	impact	dobj	14	SENT_394	[p21l1180t2199r1374b2268],
17	on	IN	O	on	_	0	SENT_394	[p21l1404t2217r1474b2249],
18	antiplatelet	JJ	O	antiplatelet	amod	19	SENT_394	[p21l1506t2196r1822b2268],
19	effect	NN	O	effect	prep_on	16	SENT_394	[p21l1853t2196r2001b2249],
20	of	IN	O	of	_	0	SENT_394	[p21l2030t2196r2094b2249],
21	a	DT	O	a	det	24	SENT_394	[p21l2116t2217r2144b2249],
22	600-mg	JJ	O	600-mg	amod	24	SENT_394	[p21l135t2281r360b2350],
23	loading	NN	O	loading	nn	24	SENT_394	[p21l384t2278r596b2350],
24	dose	NN	O	dose	prep_of	19	SENT_394	[p21l621t2278r745b2331],
25	of	IN	O	of	_	0	SENT_394	[p21l772t2278r836b2331],
26	clopidogrel	NN	O	clopidogrel	prep_of	24	SENT_394	[p21l853t2278r1169b2350],
27	in	IN	O	in	_	0	SENT_394	[p21l1194t2281r1248b2331],
28	patients	NNS	O	patient	prep_in	14	SENT_394	[p21l1273t2281r1495b2350],
29	undergoing	VBG	O	undergo	partmod	28	SENT_394	[p21l1521t2278r1848b2350],
30	PCI	NN	O	pcus	dobj	29	SENT_394	[p21l1872t2278r2007b2332],
31	.	.	O	.	_	0	SENT_394	[p21l1872t2278r2007b2332],

1	Eur	NNP	O	Eur	nn	2	SENT_395	[p21l2037t2279r2144b2331],
2	Heart	NNP	O	Heart	_	0	SENT_395	[p21l135t2361r347b2429],
3	]	CD	NUMBER	]	num	4	SENT_395	[p21l135t2361r347b2429],
4	2008	CD	DATE	2008	dep	2	SENT_395	[p21l372t2363r601b2426],
5	;	:	O	;	_	0	SENT_395	[p21l372t2363r601b2426],
6	29	CD	NUMBER	29	num	7	SENT_395	[p21l372t2363r601b2426],
7	Suppl	NN	O	suppl	dep	2	SENT_395	[p21l632t2361r932b2432],
8	:832	CD	NUMBER	:832	dep	7	SENT_395	[p21l632t2361r932b2432],
9	.	.	O	.	_	0	SENT_395	[p21l632t2361r932b2432],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_396	[p21l137t2442r320b2495],
2	T	NN	PERSON	t	_	0	SENT_396	[p21l337t2441r402b2507],
3	,	,	O	,	_	0	SENT_396	[p21l337t2441r402b2507],
4	Verstuyft	NNP	O	Verstuyft	nn	5	SENT_396	[p21l425t2442r688b2513],
5	C	NNP	O	C	appos	2	SENT_396	[p21l708t2442r772b2507],
6	,	,	O	,	_	0	SENT_396	[p21l708t2442r772b2507],
7	Mary-Krause	NNP	O	Mary-Krause	nn	8	SENT_396	[p21l793t2443r1172b2513],
8	M	NNP	O	M	appos	2	SENT_396	[p21l1191t2443r1275b2507],
9	,	,	O	,	_	0	SENT_396	[p21l1191t2443r1275b2507],
10	et	FW	O	et	nn	11	SENT_396	[p21l1298t2456r1349b2495],
11	al.	FW	O	al.	appos	2	SENT_396	[p21l1369t2442r1428b2495],
12	.	.	O	.	_	0	SENT_396	[p21l1369t2442r1428b2495],

1	Genetic	JJ	O	genetic	amod	2	SENT_397	[p21l1453t2442r1677b2495],
2	determinants	NNS	O	determinant	_	0	SENT_397	[p21l1697t2442r2067b2495],
3	of	IN	O	of	_	0	SENT_397	[p21l2089t2442r2152b2495],
4	response	NN	O	response	prep_of	2	SENT_397	[p21l134t2545r376b2596],
5	to	TO	O	to	_	0	SENT_397	[p21l416t2538r471b2577],
6	clopidogrel	NN	O	clopidogrel	nn	9	SENT_397	[p21l512t2524r828b2596],
7	and	CC	O	and	_	0	SENT_397	[p21l868t2524r970b2577],
8	cardiovascular	JJ	O	cardiovascular	nn	9	SENT_397	[p21l1009t2524r1408b2577],
9	events	NNS	O	event	prep_to	2	SENT_397	[p21l1447t2538r1635b2577],
10	.	.	O	.	_	0	SENT_397	[p21l1447t2538r1635b2577],

1	N	NN	O	n	nn	2	SENT_398	[p21l1678t2525r1730b2577],
2	EnglJ	NN	O	englj	nsubj	3	SENT_398	[p21l1773t2524r1969b2596],
3	Med	VBD	O	med	_	0	SENT_398	[p21l2007t2524r2143b2577],
4	2009	CD	DATE	2009	dobj	3	SENT_398	[p21l133t2607r645b2671],
5	;	:	O	;	_	0	SENT_398	[p21l133t2607r645b2671],
6	360:363	CD	NUMBER	360:363	num	7	SENT_398	[p21l133t2607r645b2671],
7	-75	CD	NUMBER	-75	dep	4	SENT_398	[p21l133t2607r645b2671],
8	.	.	O	.	_	0	SENT_398	[p21l133t2607r645b2671],

1	Angiolillo	JJ	O	angiolillo	amod	2	SENT_399	[p21l132t2686r419b2759],
2	DJ	NNP	O	DJ	_	0	SENT_399	[p21l463t2688r557b2756],
3	,	,	O	,	_	0	SENT_399	[p21l463t2688r557b2756],
4	Bernardo	NNP	PERSON	Bernardo	nn	5	SENT_399	[p21l602t2688r865b2741],
5	E	NNP	PERSON	E	appos	2	SENT_399	[p21l909t2688r970b2753],
6	,	,	O	,	_	0	SENT_399	[p21l909t2688r970b2753],
7	Ramirez	NNP	PERSON	Ramirez	nn	8	SENT_399	[p21l1017t2688r1257b2741],
8	C	NNP	O	C	appos	2	SENT_399	[p21l1298t2688r1363b2753],
9	,	,	O	,	_	0	SENT_399	[p21l1298t2688r1363b2753],
10	et	FW	O	et	nn	11	SENT_399	[p21l1408t2701r1459b2741],
11	al.	FW	O	al.	appos	2	SENT_399	[p21l1501t2688r1561b2741],
12	.	.	O	.	_	0	SENT_399	[p21l1501t2688r1561b2741],

1	Insulin	NN	MISC	insulin	nn	2	SENT_400	[p21l1606t2688r1805b2741],
2	therapy	NN	O	therapy	nsubjpass	4	SENT_400	[p21l1847t2688r2061b2759],
3	is	VBZ	O	be	auxpass	4	SENT_400	[p21l2101t2690r2141b2741],
4	associated	VBN	O	associate	_	0	SENT_400	[p21l135t2769r417b2822],
5	with	IN	O	with	_	0	SENT_400	[p21l445t2769r574b2822],
6	platelet	NN	O	platelet	nn	7	SENT_400	[p21l604t2769r813b2841],
7	dysfunction	NN	O	dysfunction	prep_with	4	SENT_400	[p21l844t2769r1174b2840],
8	in	IN	O	in	_	0	SENT_400	[p21l1205t2771r1260b2821],
9	patients	NNS	O	patient	prep_in	7	SENT_400	[p21l1290t2771r1512b2841],
10	with	IN	O	with	_	0	SENT_400	[p21l1541t2769r1670b2822],
11	type	NN	O	type	nn	14	SENT_400	[p21l1701t2783r1819b2841],
12	2	CD	NUMBER	2	num	14	SENT_400	[p21l1849t2772r1882b2823],
13	diabetes	NN	O	diabetes	nn	14	SENT_400	[p21l1916t2769r2142b2822],
14	mellitus	NN	O	mellitus	prep_with	9	SENT_400	[p21l135t2851r357b2904],
15	on	IN	O	on	_	0	SENT_400	[p21l405t2872r475b2904],
16	dual	JJ	O	dual	amod	19	SENT_400	[p21l522t2851r641b2904],
17	oral	JJ	O	oral	amod	19	SENT_400	[p21l686t2851r792b2904],
18	antiplatelet	JJ	O	antiplatelet	amod	19	SENT_400	[p21l838t2851r1155b2923],
19	treatment	NN	O	treatment	prep_on	4	SENT_400	[p21l1200t2865r1490b2904],
20	.	.	O	.	_	0	SENT_400	[p21l1200t2865r1490b2904],

1	J	NNP	O	J	nn	4	SENT_401	[p21l1532t2852r1561b2919],
2	Am	NNP	O	Am	nn	4	SENT_401	[p21l1605t2850r1714b2904],
3	Coll	NNP	O	Coll	nn	4	SENT_401	[p21l1761t2851r1883b2904],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_401	[p21l1930t2851r2144b2904],
5	2006	CD	DATE	2006	num	4	SENT_401	[p21l133t2936r653b2997],
6	;	:	O	;	_	0	SENT_401	[p21l133t2936r653b2997],
7	48:298	CD	NUMBER	48:298	number	8	SENT_401	[p21l133t2936r653b2997],
8	-304	CD	NUMBER	-304	dep	4	SENT_401	[p21l133t2936r653b2997],
9	.	.	O	.	_	0	SENT_401	[p21l133t2936r653b2997],

1	Sibbing	VBG	O	sibb	_	0	SENT_402	[p21l137t3014r354b3086],
2	D	NN	O	d	dobj	1	SENT_402	[p21l379t3015r449b3079],
3	,	,	O	,	_	0	SENT_402	[p21l379t3015r449b3079],
4	von	NNP	PERSON	von	nn	6	SENT_402	[p21l475t3035r579b3068],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_402	[p21l606t3015r891b3068],
6	O	NNP	PERSON	O	appos	2	SENT_402	[p21l918t3014r988b3079],
7	,	,	O	,	_	0	SENT_402	[p21l918t3014r988b3079],
8	Schomig	NNP	O	Schomig	nn	9	SENT_402	[p21l1019t3015r1268b3086],
9	A	NNP	O	A	appos	2	SENT_402	[p21l1291t3013r1359b3079],
10	,	,	O	,	_	0	SENT_402	[p21l1291t3013r1359b3079],
11	Kastrati	NNP	PERSON	Kastrati	nn	12	SENT_402	[p21l1389t3015r1610b3068],
12	A	NNP	O	A	appos	2	SENT_402	[p21l1634t3013r1702b3079],
13	,	,	O	,	_	0	SENT_402	[p21l1634t3013r1702b3079],
14	von	NNP	PERSON	von	nn	17	SENT_402	[p21l1728t3035r1832b3068],
15	Beckerath	NNP	PERSON	Beckerath	nn	17	SENT_402	[p21l1858t3015r2143b3068],
16	N.	NNP	PERSON	N.	nn	17	SENT_402	[p21l134t3097r202b3150],
17	Impact	NNP	PERSON	Impact	appos	2	SENT_402	[p21l232t3097r434b3168],
18	of	IN	O	of	_	0	SENT_402	[p21l460t3097r524b3150],
19	body	NN	O	body	nn	21	SENT_402	[p21l540t3097r681b3168],
20	mass	NN	O	mass	nn	21	SENT_402	[p21l706t3117r839b3150],
21	index	NN	O	index	prep_of	17	SENT_402	[p21l868t3097r1022b3150],
22	on	IN	O	on	_	0	SENT_402	[p21l1048t3117r1118b3150],
23	platelet	NN	O	platelet	nn	24	SENT_402	[p21l1144t3097r1353b3169],
24	aggregation	NN	O	aggregation	prep_on	21	SENT_402	[p21l1380t3099r1710b3168],
25	after	IN	O	after	_	0	SENT_402	[p21l1738t3097r1866b3150],
26	administration	NN	O	administration	prep_after	1	SENT_402	[p21l1892t3097r2141b3150, p21l134t3180r324b3231],
27	of	IN	O	of	_	0	SENT_402	[p21l368t3178r432b3231],
28	a	DT	O	a	det	31	SENT_402	[p21l467t3199r494b3231],
29	high	JJ	O	high	amod	31	SENT_402	[p21l537t3178r664b3249],
30	loading	NN	O	loading	nn	31	SENT_402	[p21l707t3178r919b3249],
31	dose	NN	O	dose	prep_of	26	SENT_402	[p21l962t3178r1086b3231],
32	of	IN	O	of	_	0	SENT_402	[p21l1131t3178r1195b3231],
33	600	CD	NUMBER	600	num	34	SENT_402	[p21l1230t3181r1332b3231],
34	mg	NN	O	mg	prep_of	31	SENT_402	[p21l1377t3199r1467b3249],
35	of	IN	O	of	_	0	SENT_402	[p21l1510t3178r1574b3231],
36	clopidogrel	NN	O	clopidogrel	prep_of	34	SENT_402	[p21l1608t3178r1924b3250],
37	before	IN	O	before	_	0	SENT_402	[p21l1965t3178r2142b3231],
38	percutaneous	JJ	O	percutaneous	amod	40	SENT_402	[p21l133t3274r505b3332],
39	coronary	JJ	O	coronary	amod	40	SENT_402	[p21l533t3281r781b3332],
40	intervention	NN	O	intervention	prep_before	1	SENT_402	[p21l804t3263r1164b3313],
41	.	.	O	.	_	0	SENT_402	[p21l804t3263r1164b3313],

1	AmJ	NN	O	amj	nn	2	SENT_403	[p21l1192t3259r1350b3328],
2	Cardiol	NN	O	cardiol	_	0	SENT_403	[p21l1377t3260r1591b3313],
3	2007	CD	DATE	2007	dep	2	SENT_403	[p21l1616t3260r2092b3325],
4	;	:	O	;	_	0	SENT_403	[p21l1616t3260r2092b3325],
5	100:203	CD	NUMBER	100:203	num	6	SENT_403	[p21l1616t3260r2092b3325],
6	-5	CD	NUMBER	-5	dep	2	SENT_403	[p21l1616t3260r2092b3325],
7	.	.	O	.	_	0	SENT_403	[p21l1616t3260r2092b3325],

1	Schwartz	NNP	PERSON	Schwartz	nn	2	SENT_404	[p21l137t3342r397b3396],
2	JB	NNP	O	JB	_	0	SENT_404	[p21l418t3343r508b3410],
3	.	.	O	.	_	0	SENT_404	[p21l418t3343r508b3410],

1	The	DT	O	the	det	3	SENT_405	[p21l540t3341r658b3395],
2	current	JJ	DATE	current	amod	3	SENT_405	[p21l690t3356r893b3395],
3	state	NN	O	state	_	0	SENT_405	[p21l923t3356r1050b3395],
4	of	IN	O	of	_	0	SENT_405	[p21l1082t3342r1146b3395],
5	knowledge	NN	O	knowledge	prep_of	3	SENT_405	[p21l1167t3342r1472b3414],
6	on	IN	O	on	_	0	SENT_405	[p21l1503t3363r1573b3395],
7	age	NN	O	age	prep_on	3	SENT_405	[p21l1605t3363r1712b3414],
8	,	,	O	,	_	0	SENT_405	[p21l1605t3363r1712b3414],
9	sex	NN	O	sex	prep_on	3	SENT_405	[p21l1746t3363r1845b3407],
10	,	,	O	,	_	0	SENT_405	[p21l1746t3363r1845b3407],
11	and	CC	O	and	_	0	SENT_405	[p21l1879t3342r1981b3395],
12	their	PRP$	O	they	poss	13	SENT_405	[p21l2011t3342r2145b3395],
13	interactions	NNS	O	interaction	prep_on	3	SENT_405	[p21l134t3427r464b3478],
14	on	IN	O	on	_	0	SENT_405	[p21l491t3445r561b3478],
15	clinical	JJ	O	clinical	amod	16	SENT_405	[p21l587t3425r786b3478],
16	pharmacology	NN	O	pharmacology	prep_on	3	SENT_405	[p21l808t3424r1223b3496],
17	.	.	O	.	_	0	SENT_405	[p21l808t3424r1223b3496],

1	Clin	NNP	O	Clin	nn	3	SENT_406	[p21l1253t3424r1377b3478],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_406	[p21l1402t3425r1707b3478],
3	Ther	NNP	O	Ther	_	0	SENT_406	[p21l1729t3423r1872b3478],
4	2007	CD	DATE	2007	num	3	SENT_406	[p21l1894t3426r2139b3490],
5	;	:	O	;	_	0	SENT_406	[p21l1894t3426r2139b3490],
6	82	CD	NUMBER	82	num	8	SENT_406	[p21l1894t3426r2139b3490],
7	:	:	O	:	_	0	SENT_406	[p21l1894t3426r2139b3490],
8	87-96	CD	DATE	87-96	dep	3	SENT_406	[p21l136t3508r324b3559],
9	.	.	O	.	_	0	SENT_406	[p21l136t3508r324b3559],

1	33	CD	NUMBER	33	_	0	SENT_407	[p22l10t24r92b74],
2	.	.	O	.	_	0	SENT_407	[p22l10t24r92b74],

1	Aleil	NN	O	aleil	nn	2	SENT_408	[p22l132t20r271b74],
2	B	NN	O	b	nsubj	20	SENT_408	[p22l292t22r351b86],
3	,	,	O	,	_	0	SENT_408	[p22l292t22r351b86],
4	Leon	NNP	PERSON	Leon	nn	5	SENT_408	[p22l376t22r523b74],
5	C	NNP	PERSON	C	appos	2	SENT_408	[p22l546t21r611b86],
6	,	,	O	,	_	0	SENT_408	[p22l546t21r611b86],
7	Cazenave	NNP	PERSON	Cazenave	nn	8	SENT_408	[p22l636t21r905b74],
8	JP	NNP	O	JP	appos	2	SENT_408	[p22l920t22r1007b89],
9	,	,	O	,	_	0	SENT_408	[p22l920t22r1007b89],
10	Gachet	NNP	PERSON	Gachet	nn	15	SENT_408	[p22l1032t21r1239b74],
11	C.	NNP	O	C.	nn	15	SENT_408	[p22l1260t21r1324b74],
12	CYP2C19	NNP	O	CYP2C19	nn	15	SENT_408	[p22l1350t21r1708b75],
13	*	NN	O	*	nn	15	SENT_408	[p22l1350t21r1708b75],
14	2	CD	NUMBER	2	num	15	SENT_408	[p22l1350t21r1708b75],
15	polymorphism	NN	O	polymorphism	appos	2	SENT_408	[p22l1729t21r2142b93],
16	is	VBZ	O	be	cop	20	SENT_408	[p22l134t105r174b156],
17	not	RB	O	not	neg	20	SENT_408	[p22l197t117r291b156],
18	the	DT	O	the	det	20	SENT_408	[p22l310t103r399b156],
19	sole	JJ	O	sole	amod	20	SENT_408	[p22l421t103r526b156],
20	determinant	NN	O	determinant	_	0	SENT_408	[p22l548t103r896b156],
21	of	IN	O	of	_	0	SENT_408	[p22l916t103r980b156],
22	the	DT	O	the	det	23	SENT_408	[p22l991t103r1080b156],
23	response	NN	O	response	prep_of	20	SENT_408	[p22l1101t123r1343b175],
24	to	TO	O	to	_	0	SENT_408	[p22l1365t117r1419b156],
25	clopidogrel	NN	O	clopidogrel	prep_to	23	SENT_408	[p22l1442t103r1771b175],
26	:	:	O	:	_	0	SENT_408	[p22l1442t103r1771b175],
27	implications	NNS	O	implication	dep	20	SENT_408	[p22l1795t103r2142b175],
28	for	IN	O	for	_	0	SENT_408	[p22l134t185r214b238],
29	its	PRP$	O	its	poss	30	SENT_408	[p22l240t188r302b238],
30	monitoring	NN	O	monitoring	prep_for	27	SENT_408	[p22l331t188r666b257],
31	.	.	O	.	_	0	SENT_408	[p22l331t188r666b257],

1	J	NNP	O	J	nn	3	SENT_409	[p22l688t186r717b253],
2	Thromb	NNP	O	Thromb	nn	3	SENT_409	[p22l741t184r980b238],
3	Haemost	NNP	O	Haemost	_	0	SENT_409	[p22l1009t186r1269b238],
4	2009	CD	DATE	2009	num	3	SENT_409	[p22l1293t187r1734b250],
5	;	:	O	;	_	0	SENT_409	[p22l1293t187r1734b250],
6	7:1747	CD	NUMBER	7:1747	number	7	SENT_409	[p22l1293t187r1734b250],
7	—	CD	NUMBER	—	dep	3	SENT_409	[p22l1293t187r1734b250],
8	9	CD	NUMBER	9	dep	7	SENT_409	[p22l1293t187r1734b250],
9	.	.	O	.	_	0	SENT_409	[p22l1293t187r1734b250],

1	34	CD	NUMBER	34	_	0	SENT_410	[p22l10t270r92b321],
2	.	.	O	.	_	0	SENT_410	[p22l10t270r92b321],

1	Geisler	NNP	PERSON	Geisler	nn	2	SENT_411	[p22l135t267r338b321],
2	T	NN	O	t	_	0	SENT_411	[p22l363t266r428b333],
3	,	,	O	,	_	0	SENT_411	[p22l363t266r428b333],
4	Schaeffeler	NN	O	schaeffeler	nn	5	SENT_411	[p22l461t267r765b321],
5	E	NN	O	e	appos	2	SENT_411	[p22l793t268r854b332],
6	,	,	O	,	_	0	SENT_411	[p22l793t268r854b332],
7	Dippon	NNP	PERSON	Dippon	nn	8	SENT_411	[p22l885t268r1105b339],
8	J	NNP	PERSON	J	appos	2	SENT_411	[p22l1126t268r1170b335],
9	,	,	O	,	_	0	SENT_411	[p22l1126t268r1170b335],
10	et	FW	O	et	nn	11	SENT_411	[p22l1201t281r1252b321],
11	al.	FW	O	al.	appos	2	SENT_411	[p22l1280t268r1339b321],
12	.	.	O	.	_	0	SENT_411	[p22l1280t268r1339b321],

1	CYPZC19	NN	O	cypzc19	nsubj	5	SENT_412	[p22l1372t267r1670b322],
2	and	CC	O	and	_	0	SENT_412	[p22l1701t268r1803b321],
3	nongenetic	JJ	O	nongenetic	amod	4	SENT_412	[p22l1831t270r2143b339],
4	factors	NNS	O	factor	conj_and	1	SENT_412	[p22l134t351r319b404],
5	predict	VBP	O	predict	_	0	SENT_412	[p22l351t351r550b423],
6	poor	JJ	O	poor	amod	7	SENT_412	[p22l579t371r710b422],
7	responsiveness	NN	O	responsiveness	dobj	5	SENT_412	[p22l740t353r1151b422],
8	to	TO	O	to	_	0	SENT_412	[p22l1183t365r1238b404],
9	clopidogrel	NN	O	clopidogrel	nn	11	SENT_412	[p22l1271t351r1587b423],
10	loading	NN	O	loading	nn	11	SENT_412	[p22l1617t351r1829b422],
11	dose	NN	O	dose	prep_to	5	SENT_412	[p22l1859t351r1983b404],
12	after	IN	O	after	_	0	SENT_412	[p22l2017t351r2144b404],
13	coronary	JJ	O	coronary	amod	15	SENT_412	[p22l135t452r382b503],
14	stent	NN	O	stent	nn	15	SENT_412	[p22l407t446r543b485],
15	implantation	NN	O	implantation	prep_after	11	SENT_412	[p22l569t432r948b504],
16	.	.	O	.	_	0	SENT_412	[p22l569t432r948b504],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_413	[p22l978t432r1532b503],
2	2008	CD	DATE	2008	num	1	SENT_413	[p22l1558t432r1999b497],
3	;	:	O	;	_	0	SENT_413	[p22l1558t432r1999b497],
4	9:1251	CD	NUMBER	9:1251	number	5	SENT_413	[p22l1558t432r1999b497],
5	—	CD	NUMBER	—	dep	1	SENT_413	[p22l1558t432r1999b497],
6	9	CD	NUMBER	9	dep	5	SENT_413	[p22l1558t432r1999b497],
7	.	.	O	.	_	0	SENT_413	[p22l1558t432r1999b497],

1	35	CD	NUMBER	35	_	0	SENT_414	[p22l10t514r92b567],
2	.	.	O	.	_	0	SENT_414	[p22l10t514r92b567],

1	Siller	NNP	PERSON	Siller	_	0	SENT_415	[p22l137t514r518b567],
2	.	.	O	.	_	0	SENT_415	[p22l137t514r518b567],

1	—	NN	O	—	_	0	SENT_416	[p22l137t514r518b567],
2	.	.	O	.	_	0	SENT_416	[p22l137t514r518b567],

1	Matula	NNP	PERSON	Matula	nn	2	SENT_417	[p22l137t514r518b567],
2	JM	NN	O	jm	_	0	SENT_417	[p22l556t515r670b582],
3	,	,	O	,	_	0	SENT_417	[p22l556t515r670b582],
4	Lang	NNP	PERSON	Lang	nn	8	SENT_417	[p22l720t515r868b586],
5	I	PRP	O	I	dep	8	SENT_417	[p22l913t515r953b579],
6	,	,	O	,	_	0	SENT_417	[p22l913t515r953b579],
7	Christ	NNP	O	Christ	dep	8	SENT_417	[p22l1003t514r1183b567],
8	G	NNP	O	G	appos	2	SENT_417	[p22l1230t514r1300b579],
9	,	,	O	,	_	0	SENT_417	[p22l1230t514r1300b579],
10	]	CD	NUMBER	]	num	12	SENT_417	[p22l1342t514r1496b582],
11	ilma	NN	O	ilma	nn	12	SENT_417	[p22l1342t514r1496b582],
12	B.	NNP	O	B.	appos	2	SENT_417	[p22l1542t515r1601b567],
13	Calcium	NN	O	calcium	nn	16	SENT_417	[p22l1653t514r2144b567],
14	—	NN	O	—	nn	16	SENT_417	[p22l1653t514r2144b567],
15	channel	NN	O	channel	nn	16	SENT_417	[p22l1653t514r2144b567],
16	blockers	NNS	O	blocker	nsubj	17	SENT_417	[p22l133t596r364b649],
17	reduce	VB	O	reduce	rcmod	12	SENT_417	[p22l384t596r568b649],
18	the	DT	O	the	det	20	SENT_417	[p22l587t596r675b649],
19	antiplatelet	JJ	O	antiplatelet	amod	20	SENT_417	[p22l696t596r1012b668],
20	eﬂect	NN	O	eﬂect	dobj	17	SENT_417	[p22l1030t596r1179b649],
21	of	IN	O	of	_	0	SENT_417	[p22l1197t596r1260b649],
22	clopidogrel	NN	O	clopidogrel	prep_of	20	SENT_417	[p22l1270t596r1600b668],
23	.	.	O	.	_	0	SENT_417	[p22l1270t596r1600b668],

1	J	NNP	O	J	nn	4	SENT_418	[p22l1614t597r1643b664],
2	Am	NNP	O	Am	nn	4	SENT_418	[p22l1659t595r1768b649],
3	Coll	NNP	O	Coll	nn	4	SENT_418	[p22l1789t596r1911b650],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_418	[p22l1930t596r2144b650],
5	2008	CD	DATE	2008	num	4	SENT_418	[p22l133t678r653b743],
6	;	:	O	;	_	0	SENT_418	[p22l133t678r653b743],
7	52:1557	CD	NUMBER	52:1557	number	8	SENT_418	[p22l133t678r653b743],
8	—	CD	NUMBER	—	dep	4	SENT_418	[p22l133t678r653b743],
9	63	CD	NUMBER	63	dep	8	SENT_418	[p22l133t678r653b743],
10	.	.	O	.	_	0	SENT_418	[p22l133t678r653b743],

1	36	CD	NUMBER	36	_	0	SENT_419	[p22l10t762r92b813],
2	.	.	O	.	_	0	SENT_419	[p22l10t762r92b813],

1	Sibbing	VBG	O	sibb	_	0	SENT_420	[p22l137t760r354b831],
2	D	NN	O	d	dobj	1	SENT_420	[p22l392t760r462b825],
3	,	,	O	,	_	0	SENT_420	[p22l392t760r462b825],
4	Morath	NNP	PERSON	Morath	nn	5	SENT_420	[p22l503t760r723b813],
5	T	NN	O	t	appos	2	SENT_420	[p22l759t758r824b825],
6	,	,	O	,	_	0	SENT_420	[p22l759t758r824b825],
7	Stegherr	NN	PERSON	stegherr	nn	8	SENT_420	[p22l869t760r1108b831],
8	J	NN	PERSON	j	appos	2	SENT_420	[p22l1139t760r1183b828],
9	,	,	O	,	_	0	SENT_420	[p22l1139t760r1183b828],
10	et	FW	O	et	nn	11	SENT_420	[p22l1225t774r1276b813],
11	al.	FW	O	al.	appos	2	SENT_420	[p22l1315t760r1374b813],
12	.	.	O	.	_	0	SENT_420	[p22l1315t760r1374b813],

1	Impact	NN	O	impact	_	0	SENT_421	[p22l1417t760r1618b832],
2	of	IN	O	of	_	0	SENT_421	[p22l1657t760r1721b813],
3	proton	NN	O	proton	nn	5	SENT_421	[p22l1749t773r1940b831],
4	pump	NN	O	pump	nn	5	SENT_421	[p22l1978t781r2141b831],
5	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_421	[p22l134t841r407b894],
6	on	IN	O	on	_	0	SENT_421	[p22l434t862r504b894],
7	the	DT	O	the	det	9	SENT_421	[p22l528t841r616b894],
8	antiplatelet	JJ	O	antiplatelet	amod	9	SENT_421	[p22l643t841r960b913],
9	effects	NNS	O	effect	prep_on	1	SENT_421	[p22l984t841r1155b894],
10	of	IN	O	of	_	0	SENT_421	[p22l1182t841r1246b894],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_421	[p22l1262t841r1591b913],
12	.	.	O	.	_	0	SENT_421	[p22l1262t841r1591b913],

1	Thromb	NNP	O	Thromb	nn	2	SENT_422	[p22l1618t840r1857b894],
2	Haemost	NNP	O	Haemost	_	0	SENT_422	[p22l1884t842r2144b894],
3	2009	CD	DATE	2009	num	2	SENT_422	[p22l133t924r618b987],
4	;	:	O	;	_	0	SENT_422	[p22l133t924r618b987],
5	101:714	CD	NUMBER	101:714	number	6	SENT_422	[p22l133t924r618b987],
6	—	CD	NUMBER	—	dep	2	SENT_422	[p22l133t924r618b987],
7	9	CD	NUMBER	9	dep	6	SENT_422	[p22l133t924r618b987],
8	.	.	O	.	_	0	SENT_422	[p22l133t924r618b987],

1	Key	NN	O	key	nn	2	SENT_423	[p22l11t1113r126b1184],
2	Words	NNS	O	word	_	0	SENT_423	[p22l147t1111r367b1166],
3	:	:	O	:	_	0	SENT_423	[p22l147t1111r367b1166],
4	antiplatelet	JJ	O	antiplatelet	amod	5	SENT_423	[p22l398t1112r715b1184],
5	therapy	NN	O	therapy	dep	2	SENT_423	[p22l740t1112r954b1184],
6	I	PRP	O	I	nsubj	7	SENT_423	[p22l986t1125r1014b1153],
7	CYPZC19	VBP	O	cypzc19	rcmod	5	SENT_423	[p22l1051t1112r1349b1166],
8	I	PRP	O	I	nsubj	10	SENT_423	[p22l1385t1125r1413b1153],
9	platelet	NN	O	platelet	nn	10	SENT_423	[p22l1448t1112r1657b1184],
10	function	NN	O	function	xcomp	7	SENT_423	[p22l1682t1112r1919b1165],
11	I	CD	NUMBER	i	num	12	SENT_423	[p22l1954t1125r1982b1153],
12	polymorphism	NN	O	polymorphism	dep	10	SENT_423	[p22l8t1196r421b1267],
13	I	PRP	O	I	dep	10	SENT_423	[p22l457t1208r485b1236],
14	predictor	NN	O	predictor	dep	13	SENT_423	[p22l519t1196r790b1267],
15	.	.	O	.	_	0	SENT_423	[p22l519t1196r790b1267],

